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Abstract
Evidence in the literature suggests that Crohn’s disease involves an abnormal, innate 
immune response to the “commensal microbiota”. It is hypothesised that when 
symbiosis between the residential microbiota and the epithelial cells of the 
gastrointestinal tract is broken, secretion of potent inflammatory mediators initiates a 
chronic adaptive immune response, which leads to the pathology seen in Crohn’s 
disease. The aims of the studentship were to a) characterise and compare the innate 
mucosal signals generated in vitro in response to the presence of “commensal”, 
“probiotic” and “pathogenic bacteria” and b) to establish the typical ex vivo mucosal 
response in order to ascertain if the immunological responses to bacterial stimuli in 
Crohn’s disease is abnormal.
On investigation of a range of bacterial species it was found that bacterial “properties” 
that influence host responses are not necessarily linked to pathogenicity and bacteria did 
not segregate into good (commensal / probiotic) and bad (pathogenic) bacteria. Bacterial 
phenotype was assessed by electron microscopy and both pathogenic and non­
pathogen ic bacteria expressed external structures associated with virulence. Virulence 
gene deletion mutants of pathogenic bacterial strains were used to determine what 
bacterial epitopes drove the in vitro responses. Epithelial responses to the whole 
organism were found to be complex, with a range of responses to soluble and/or 
external microbial structures. In addition, bacterial supernatants had minimal effect, 
implying that bacterial contact was an essential part of the process. Evidence was found 
to suggest that the host recognises the bacterium by combinations of microbial products 
and may also require co-stimulatory signals to confirm “danger” before responding. 
The influence of the maturity of the epithelium was studied using Caco-2 cells and 
immature primary crypt cells (HIEC). Evidence was found to support a hypothesis that 
the abnormal response in Crohn’s disease could originate from the inappropriate 
stimulus of immature epithelial cells. In vitro organ culture was used to assess the 
mucosal response to bacterial stimulus ex vivo. Regional and bacterial specific 
differences were observed in biopsies from Crohn’s disease, and evidence was found to 
support the hypothesis of abnormal innate immune responses to bacterial stimuli.
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CHAPTER 1: Introduction
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1.0 Gastro-intestinal tract structure and immune function
The epithelial surface of the gastrointestinal (GI) tract is the largest area of the body that 
serves as an interface between the external and internal environment. This single cell 
layer has the highly complex task of facilitating digestive and absorptive processes; 
while being constantly assaulted by a spectrum of antigens including digested nutrients 
and the inhabiting microbiota (Bajaj-Elliott & Sanderson 2004). The complex 
microbiota comprises approximately 500-1000 distinct microbial species (Kelly et al. 
2007, Xu et al. 2007). Bacteria account for the majority of these microorganisms; 
estimated at 1014 cells representing a 10 fold greater number of cells than in a human 
host (Lupp &. Finlay 2005).
The microbe ecosystem, although stable is influenced by genotype, immune status, age, 
diet and environmental factors. Thus, it consequently varies amongst people (Lupp & 
Finlay 2005). In addition, in each individual there are variations along the Gl tract due 
to nutrient availability, pH and oxygen concentration (Sekirov & Finlay 2006). To deal 
with this continuous and diverse antigenic exposure, a unique mucosal immune system 
exists, which is distinct from the systemic immune system (Gewirtz & Madara 2001, 
Bajaj-Elliott & Sanderson 2004, Wershil & Furuta 2008).
The paradox for mucosal immunity is tolerance to ingested antigens and the commensal 
microbiota, whilst providing a rapid response to pathogenic insults (Dann & Eckmann 
2007). Gut homeostasis is maintained by physical and chemical defence of the epithelial 
barrier (Lievin-Le & Servin 2006), in conjunction with organised Gut-associated 
lymphoid tissue (GALT) (Kuby 1997). Continual antigen sampling, discrimination of 
danger from innocuous stimuli, and tight regulation of effecter responses are therefore 
required (Shanahan 2000).
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1.1 Structure of Gastrointestinal tract
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Figure 1: S tructure of the human gastrointestinal tract (Edwards LA)
1.1.1 Oral cavity
Food enters the digestive system through the mouth (Fig 1). Digestion begins with the 
salivary glands, releasing saliva, which contains antibodies (secretory Immunoglobulin 
A, slgA) a range of endogenous antimicrobial peptides (AMPs) and mucins (Devine 
2003, Martini 2004). Despite a potent antimicrobial environment, the mouth is still able 
to harbour a complex microbiota, consisting of facultative and strict anaerobes, 
including streptococci, Bacteroides, Lactobacilli and yeasts (Isolauri et al. 2004a).
1.1.2 Oesophagus/Stomach
Once swallowed, food travels down the pharynx into the oesophagus, which connects to 
the stomach (Fig 1). Resident microbiota and pathogens must pass through the 
oesophagus and stomach environment to reside in the lower bowel (Isolauri et al. 
2004b). Once food reaches the stomach it is converted into a viscous highly acidic 
mixture, this acidic environment helps in host defence. The columnar epithelium of the
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stomach produces mucus that provides a protective layer, thus maintaining the integrity 
of the stomach against the luminal acid (Martini 2004). It also prevents microbial 
colonisation. Further, AMPs such as the (3-defensins and LL-37 contribute to local 
innate defence (George et al. 2003, Hase et al. 2003). Despite the stomach’s hostile 
environment, H. pylori and other species including Candida albicans, Lactobacilli and 
Streptococcus do colonise susceptible individuals (Isolauri et al. 2004b).
1.13 Small intestine
Microvilli
> Villus
lgA+ plasma cell
M cell
Figure 2: Cross sectional structure of the small intestine (Edwards LA)
Digestion continues in the small intestine (SI) aided by enzymes and bile. The SI is the 
major site o f food absorption. The large 400m2 surface of the SI is mainly due to the 
minute foldings/projections called ‘villi’ (Fig 2). In addition, each villus is covered by a 
single epithelial layer that has microvilli, which allow optimum absorption (Phillips et 
al. 1979). The small intestine can be divided into three anatomical regions: (1) the 
duodenum, (2) the jejunum, and (3) the ileum (Fig 1) (Martini 2004).
Page 29
1.13.1 Duodenum
The duodenum connects the stomach to the jejunum. The duodenum is responsible for 
chemical digestion, which is aided by liver and pancreatic secretions. The duodenum 
contains approximately 103-104 CFU/g (Colony Forming Unit per gram) of microbes, 
which mainly comprises of Bacteroides, Candida albicans, Lactobacillus and 
Streptococcus species (Isolauri et al. 2004a).
1.133 Jejunum
The jejunum is about 2.5 meters long where the bulk of digestion and nutrient 
absorption takes place (Martini 2004). The villi in the jejunum are much longer than in 
the duodenum or the ileum. The jejunum contains approximately 105- 107 CFU/g of 
microbes, which like the duodenum mainly comprises the species: Bacteroides, 
Candida albicans, Lactobacillus and Streptococcus (Isolauri et al. 2004a).
1.133 Ileum
The ileum is the longest segment of the SI. The ileum ends at the ileocecal valve, a 
sphincter that controls the flow of materials from the ileum into the cecum (Martini 
2004). Its main function is to absorb vitamin B12, bile salts, and unabsorbed products. 
The diffuse neuroendocrine system (DNES) cells that line the ileum contain the 
proteases responsible for the final stages of digestion. The ileum has abundant Peyer’s 
patches (PP). These lymphoid nodules contain large amounts of lymphocytes and other 
immune system cells. PPs are most abundant in the terminal portion of the ileum 
(Martini 2004). The ileum contains approximately 107-108 CFU/g of microbes, which 
mainly comprises o f Bacteroides, Clostridium, Enterobacteriaceae, Enterococcus, 
Lactobacillus and Veillonella species (Isolauri et al. 2004b).
1.1.4 The large Intestine
The main functions of the large intestine (LI) include (1) water reabsorption and 
compaction of the intestinal contents into faeces, (2) production of vitamins and (3) the 
storage of faecal material prior to defecation. The cecum or caecum (from the Latin 
caecus meaning blind) is a pouch connected to the ascending colon of the LI and the 
ileum (Fig 1). It is separated from the ileum by the ileocecal valve (ICV) and is 
considered the beginning of the LI. The cecum is followed by the ascending colon, 
which passes upward to the right lobe of the liver, where it bends abruptly forward and
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to the left, forming the right colic flexure. The transverse colon reaches the left side of 
the body near the spleen making a turn at the left colic flexure; where it becomes the 
descending colon leading to the sigmoid colon, which empties into the rectum (Martini
2004).
The major characteristics of the colon are the lack of villi, but the abundance of goblet 
cells, and the presence of distinctive intestinal crypts (Fig 3). The crypts are deeper than 
those of the small intestine. Large lymphoid nodules are scattered throughout the lamina 
propria (LP) and submucosa (Martini 2004).
The colon contains approximately 10IO-10n CFU/g of microbes, with over 700 species 
of bacteria. The main detectable species are: Bacteroides, Bacillus, Bifidobacterium, 
Clostridium, Enterococcus, Eubacterium, Fusobacterium, Pepto streptococcus,
Ruminococcus and Streptococcus (Isolauri et al. 2004b).
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Figure 3: Cross sectional structure of the large intestine
(From http://www.cancerline.com/gUserFiles/structure_of_the_colon.gif)
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1.2 Intestinal epithelium & Barrier Structure
The epithelium is a single cell layer, which forms a barrier between the external 
environment and the underlying host’s internal milieu (Laukoetter et al. 2008).
1.2.1 Stem cell
In the SI, towards the base of the crypts of Lieberkuhn, stem cell division produces new 
epithelial cells, which in approximately 5 days reach the villus-tip where they are shed. 
There are four main epithelial cell lineages: columnar (absorptive), mucin-secreting 
(goblet), endocrine, and Paneth cells (Fig 4). The columnar cells are referred to as 
enterocytes in the small bowel and colonocytes in the colon (Yen & Wright 2006).
Figure 4: Differentiation of epithelial cell lineages (Radtke & Clevers 2005)
In the colon, Paneth cells are absent, and the stem cells reside directly at the crypt 
bottom (Booth & Potten 2000). Colonic epithelium lacks villi and proliferative cells 
occupy the bottom two-thirds of crypts, with differentiated cells constituting the top of 
the surface, see Fig 5, (Radtke & Clevers 2005).
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Figure 5: Comparison of small and large intestine morphology (Radtke & Clevers
2005).
1.2.2 Intestinal epithelial cells (IECs)
The IEC is polarised, with a distinct apical and mid-basal region with a basal nucleus. 
The apical region is characterised by the microvillus brush border, bearing the 
glycocalyx (Massey-Harroche 2000). Cells are joined along the lateral membrane by an 
apical tight junction, desmosomes and by membranous inter-digitations (Tsukita et al. 
2001). IECs are responsible for secretory and absorptive properties (Yen & Wright
2006). IECs not only provide an efficient barrier, they also actively participate as innate 
immune sensors of microbial pathogens and commensal organisms. Signals generated 
by the IEC via Pattern Recognition Receptors (PRRs) in response to diverse microbial 
agents, have a key role in the initiation of the host innate and underlying adaptive 
immune system (Clavel & Haller 2007).
1.2.3 Goblet cell
Goblet cells increase in numbers from the duodenum to the colon (Radtke & Clevers
2005). They perform a role in host defence by secreting mucin, which protects and 
lubricates the mucosa (Yen & Wright 2006). The role of mucin in host defence is 
discussed further in section 1.3.1.2.
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1.2.4 Endocrine cell
Neuroendocrine or enteroendocrine cells are found throughout the epithelium. They 
contain basally-sited dense core neurosecretory granules, which contain a range of 
neurotransmitters and peptide hormones (Yen & Wright 2006).
1.2.5 Paneth cell
The appearance of Paneth cells (PC) coincides with initial colonization of the gut 
(Stappenbeck et al. 2002). Although PCs are usually confined to the SI at the crypt base, 
they are sometimes seen in the proximal colon. In some inflammatory conditions they 
are prominent in the colon due to PC metaplasia (Wright 2000). PCs contain large 
secretory granules and express Tumor Necrosis Factor (TNF) and antimicrobial agents 
such as cryptdins, defensins and lysozyme (Ayabe et al. 2000, Porter et al. 2002). PCs 
also have phagocytic properties: all these characteristics indicate a role in the 
maintenance of a sterile environment in the crypt (Yen & Wright 2006).
12.6 Myofibroblasts
Myofibroblasts are located immediately subjacent to the basement membrane of the 
base of IECs. Myofibroblasts are specialised mesenchymal cells with features of both 
fibroblasts and smooth muscle cells (Yen & Wright 2006). Their location suggests that 
these cells, through epithelial-mesenchymal crosstalk, may regulate of a number of IEC 
functions; such as proliferation, differentiation, and/or extracellular matrix metabolism, 
affecting the growth of the basement membrane (Andoh et al. 2005).
1.2.7 M cells
M cells, otherwise known as 'Manifold* or ‘Membranous’ cells, are distinctive IECs. 
They occur only in the follicle-associated epithelia that overlie organised mucosa- 
associated lymphoid tissues. They are structurally and functionally specialised for trans- 
epithelial transport, delivering foreign antigens and microorganisms to the GALT. M 
cells have unique features that allow them to capture and transfer bacteria to underlying 
phagocytes. The lack of a glycocalyx, a rearranged apical membrane, reduced lysosomal 
apparatus, with a deeply invaginated baso-lateral surface allow M cells to traffic 
microorgan is ims through their cytoplasm (Fig 6) (Mach et al. 2005). M cell transport is 
considered a double-edged sword; as certain pathogens exploit the features of M cells 
for enhanced uptake (Kraehenbuhl & Neutra 2000).
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Figure 6: S tructure of an M cell
(From http://www.beta-glucan.info/images/mcells-reduced.jpg)
1.3 Physical and chemical defence of the epithelial barrier
The epithelium represents a physical barrier but also protects the mucosal barrier 
through mounting an innate immune response by inducing AMPs such as p-defensins 
and cathelicidins (Kagnoff 2006). Although the gastrointestinal tract is colonised by a 
multitude of bacteria, intestinal infection or translocation of bacterial agents across the 
epithelial barrier is the exception and not the rule. It is mostly limited to highly 
pathogenic bacteria or predisposing disease states (Wehkamp et al. 2007).
13.1 Physical B arrier
13.1.1 Microvilli and tight junctions
The microvilli brush border and tight junctions form the barrier architecture (Staehelin 
et al. 1969, Turner 2006). Microvilli are associated with a dense meshwork of actin 
Filaments that link to the adherens and tight junctions (AJs & TJs) between IECs 
thereby regulating epithelial permeability (Turner et al. 1997).
Intercellular junctional complexes are composed of TJs, AJs, desmosomes and gap 
junctions (Fig 7, (Lievin-Le & Servin 2006). TJs are the most apical components of the 
junctional complex and are characterised by the presence of transmembrane proteins, 
such as claudin (Furuse et al. 1998), occludin (Furuse et al. 1996), Zona-Occludens-1
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(ZO-1) and Junction Adhesion Molecule A (JAM-A) (Morris et al. 2006). TJs create a 
semipermeable diffusion barrier between individual cells (Anderson et al. 1993, 
Schneeberger & Lynch 2004).
Downstream, the AJs are composed of a cadherin-catenin complex (Nagafuchi 2001, 
Tepass 2002). Importantly, TJs and AJs play a pivotal role in maintaining cell 
polarization (Lievin-Le & Servin 2006) whereas gap junctions allow intercellular 
communication to occur (Fig 7, (Lievin-Le & Servin 2006). Many pathogenic enteric 
bacteria target and exploit the TJs, thus modulating intestinal permeability, which will 
be discussed in section 1.6.7 (Hofman 2003, Fasano & Nataro 2004).
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Figure 7: A Schematic drawing of IECs. (a) The junctional complex, which is located 
at the most apical region of lateral membranes, is circled, (b) Electron micrograph of the 
junctional complex in murine IECs. The tight junction is circled. (Mv, microvilli, TJ, 
tight junction, AJ, adherens junction, DS, desmosome.) Scale bar, 200 nm (Tsukita et al. 
2001).
13.1.2 The glycocalyx and mucus production
The physical barrier is further reinforced by the glycocalyx, which is composed of 
mucins that bind the apical membrane of IECs. In addition, a thick layer of mucus, 
comprising diverse mucins provides additional protection. MUC-type mucins constitute: 
(1) secretory, gel-forming mucins (MUC2, MUC5AC, MUC5B, and MUC6) (2) membrane-
Page 36
bound (MUCl, MUC3A, MUC3B, MUCH, MUC12, MUC17 MUC4) and (3) soluble forms 
(MUC7, MUC8, MUC15) (Hayashi et al. 2001, Einerhand et al. 2002). The colonic mucus 
layer constitutes of trefoil peptides and mucins, including MUCl, MUC2, MUC3, and 
MUC4, in which MUC2 is the predominant secretory mucin (Hayashi et al. 2001). The 
membrane-bound mucins are involved in IEC signalling, adhesion, growth, and immune 
modulation (Einerhand et al. 2002).
Mucins interact with bacterial polysaccharides and protein appendages (such as 
flagella), thereby trapping bacteria in the mucus flow (Wadolkowski et al. 1988) 
reducing direct contact and attachment of microbes to the epithelial surface (Swidsinski 
et al. 2005, Lotz et al. 2007).
1 J 2  Chemical barrier
In addition to physical defence, chemical and innate immune defence also fortifies the 
epithelial barrier. Chemical defence is provided by gastric acid, pancreatic proteolytic 
enzymes and bile (Dommett et al. 2005). The innate immune response comprises all 
mechanisms that resist infection but do not require specific recognition of pathogens 
(Wehkamp et al. 2007).
13.2.1 IgA
Secretory IgA neutralises toxins and prevents luminal antigens from penetrating the 
intestinal surface (Mestecky et al. 1999), and may regulate microbiota composition as 
well as limit inflammation induced by Microbe Associated Molecular Patterns 
(MAMP), such as Lipopolysaccharide (LPS) (Fernandez et al. 2003, Fagarasan & 
Honjo 2004). IgA production will be discussed further in section 1.5.2.
1 3 3 3  Anti-microbial peptides (AMPs)
A healthy gastrointestinal (GI) surface is nearly devoid of bacteria (McCracken & 
Lorenz 2001), and secretory AMPs aid in maintaining this status quo (Wehkamp et al.
2007). AMPs are an evolutionarily ancient arsenal that provides the first line of defence 
(Zasloff 2002a, Zasloff 2002b). Since the discovery of the first AMP (Steiner et al. 
1981) more than 800 peptides have been identified (Izadpanah & Gallo 2005). AMPs 
are classified based on their primary and tertiary structures (Beisswenger & Bals 2005, 
Brogden 2005, Gordon et al. 2005, Harder & Schroder 2005b, Toke 2005). AMPs
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exhibit a broad range of activity against a range of microbes including Gram-negative 
and Gram-positive bacteria, fungi, protozoa and viruses. Most AMPs are small, cationic 
(lysine and arginine rich) molecules with spatially spaced hydrophobic regions 
(Hancock & Diamond 2000). In humans, two main classes of AMPs: defensins and 
cathelicidin are found on the epithelial surfaces and in circulating phagocytes (Zasloff 
2002b).
13.2.2.1 Defensins
Defensins are small, (2-6 KiloDaltons [kDa]), cationic, with 3 characteristic disulfide 
bonds with an overall p-sheet structure. Based on disulfide linkage, defensins are 
divided into three groups: a, p and 6, of which only a and P-defensins are found in 
humans. Although comparative genome analyses have revealed numerous (>50) a  and 
P-defensin genes in humans and mice, their exact number and functions remain unclear 
(Dann & Eckmann 2007).
133.2.2 Human a-defensins
Of the six human a-defensin genes identified, four (HD 1-4) are expressed by 
neutrophils, while human a-defensin 5 and 6 are expressed predominantly in PCs 
located in the small intestinal crypts (Dann & Eckmann 2007). HD5 and HD6 require 
post-translational proteolysis for maturation and activation (Ghosh et al. 2002, Ouellette
2006). Studies investigating the role of a-defensins during infection have been few, as 
currently no cell culture model system is available to investigate PC biology. Decreased 
a-defensin expression with an increased risk of infectious diarrhea has been reported 
(Kelly et al. 2006). Furthermore, a selective deficiency in a-defensin is implicated in 
ileal but not colonic Crohn’s disease (CD) (Wehkamp et al. 2005).
13.2.23 Human p-defensins (hBD)
The hBD genes comprise at least 10, possibly as many as 40 members that are 
expressed in a wide variety of epithelial tissues (Pazgier et al. 2006). IECs in the SI and 
colon constitutively produce hBDl (Zhao et al. 1996, O’Neil et al. 1999). hBDl is 
generally not responsive to pro-inflammatory stimuli or bacterial infection (O'Neil et al. 
1999). However, simple nutrients can up-regulate hBDl in IECs (Sherman et al. 2006). 
In addition, down-modulation of hBDl is observed during H. pylori, Shigella and
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Cryptosporidium parvum infection (Islam et al. 2001, Bajaj-Elliott et al. 2002, Zaalouk 
et al. 2004).
hBD2 is not generally expressed in un-inflamed intestinal mucosa, but is strongly 
induced in response to infection or inflammation (O'Neil et al. 1999, Wehkamp et al. 
2003, Fahlgren et al. 2004, Sherman et al 2006). Interleukins IL-a and IL-1 (3, TNF-a, 
IFN-y (Interferon), PMA (phorbol 12-myristate 13-acetate), isoleucine, D3 (1,25- 
dihydroxyvitamin), LPS and some Gram-negative bacteria can modulate hBD2 
(Fehlbaum et al. 2000, Harder et al. 2000, O'Neil et al. 2000, Dale & Krisanaprakomkit 
2001, Duits et al. 2002, Dunsche et al. 2002, Fang et al. 2003, Tsutsumi-Ishii & 
Nagaoka 2003, Wang et al. 2004, Selsted & Ouellette 2005). Individuals with a low 
hBD2 gene copy number (<3) are at a significantly higher risk for developing colonic 
CD (Fellermann et al. 2006). It must be noted that the DNA copy number of the (3- 
defensin gene cluster on chromosome 8 is highly polymorphic within the healthy 
population, ranging from 2 to 10 hBD2 gene copies per genome. Although correlative in 
nature, these findings underscore that relative defensin deficiency may be a contributing 
factor to the development of CD.
hBD3 is constitutively expressed in the colon and SI, mainly in the lower crypt region 
(Fahlgren et al. 2004) but is inducible in inflammatory conditions such as Ulcerative 
colitis (UC) but not Crohn's Disease (CD) (Wehkamp et al. 2003, Fahlgren et al. 2004) 
or during infection (George et al. 2003, Zilbauer et al. 2005). hBD3 can also be induced 
by IFN-y but not IL-1P or TNF-a (Fahlgren et al. 2004).
hBD4 is also inducible and expressed by SI and colonic IECs, particularly in the crypt 
regions (Fahlgren et al. 2004). Factors up regulating hBD4 expressions are similar to 
those noted for hBD2 and hBD3 (Sorensen et al. 2003, Harder et al. 2004). Expression 
of both hBD3 and 4 is markedly decreased or absent in IECs in CD (Fahlgren et al.
2004).
The potential in-vivo microbicidal activity of the P-defensins has been mainly inferred 
by in-vitro experiments, p-defensins have the capacity to kill or inhibit in-vitro a wide 
variety of bacteria and fungi, particularly at low concentrations of salt and plasma 
proteins (Ganz et al. 1992, Selsted et al. 1993, Bensch et al. 1995, Ganz & Lehrer 1998,
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Zucht et al. 1998, Lehrer & Ganz 2002, Zasloff 2002a). The spectrum of this 
antibacterial activity varies for each of the four proteins. hBDl and -2 are particularly 
effective against Gram-negative bacteria and some fungi (Harder et al. 1997, Goldman 
et al. 1997, Bals et al. 1998, Schulz et al. 2005). hBD3 is a powerful antimicrobial agent 
against yeast, Gram-negative and -positive bacteria, including the vancomycin-resistant 
Enterococcus faecium  (Garcia et al. 2001a, Harder et al. 2001). Amongst oral 
pathogens, hBD2 and hBD3 show greater potency against aerobic (100% effective) than 
anaerobic bacteria (21.4% and 50% effective for hBD2 and hBD3, respectively) (Joly et 
al. 2004). Both defensins also demonstrate strain-specific activity against Candida 
species (Feng et al. 2005). Synergistic antibacterial activity with a combination of 
various AMPs against Staphylococcus aureus and Campylobacter jejuni has been 
described (Chen et al. 2005, Zilbauer et al. 2005).
In addition to their well-recognised AM properties, p-defensins are potent 
immunomodulators (Fig 8). hBD 1-3 are chemotactic for immature dendritic cells 
(iDCs) and memory T cells, an effect mediated by the Gi-protein-coupled receptor 
(GiPCR) CCR6 (which is shared by the chemokine macrophage inflammatory protein 
3a, MIP-3a) present on the surface of dendritic cells (DCs) and T cells (Yang et al. 
1999, Zlotnik & Yoshie 2000, Biragyn et al. 2001, Biragyn et al. 2002, Conejo-Garcia 
et al. 2004, Niyonsaba et al. 2004). In addition to CCR6-mediated chemotaxis by hBDl- 
3, gradient-dependent recruitment of CCR6-deficient monocytes and macrophages 
observed for hBD3 and hBD4 suggests utilization of an additional GiPCR receptor(s) 
(Oppenheim et al. 2005). Human Neutrophil Defensins 1-3 (HNP) recruit monocytes 
(Territo et al. 1989), as do hBD2 to 4 (Garcia et al. 2001a, Garcia et al. 2001b, 
Niyonsaba et al. 2002, Niyonsaba et al. 2004).
The ability of p-defensins to chemoattract and/or activate a wide variety of cells suggest 
that p-defensins play roles in both the innate and antigen-specific immunity of the host 
(Ganz et al. 1992, Hoffmann et al. 1999, Medzhitov & Janeway, Jr. 1999, Yang et al. 
1999, Boman 2000, Fiuza & Suffredini 2001, Lehrer & Ganz 2002, Zasloff 2002b, 
Donald et al. 2003, Ganz 2003, Steinstraesser et al. 2004, Yang et al. 2004, Harder & 
Schroder 2005a, Niyonsaba et al. 2005, Oppenheim et al. 2005, Wehkamp et al. 2005, 
Pazgier et al. 2006). Furthermore, the chemotactic activity of p-defensins towards
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immature DCs also facilitates antigen uptake, processing and presentation, leading to 
induction of antigen-specific immune responses (Brogden et al. 2003, Yang et al. 2004).
Defensins have been implicated in epithelial and fibroblast cell division (Murphy et al. 
1993), wound closure (Aarbiou et al. 2004) mast cell activation (Niyonsaba et al. 2001). 
Their different mechanisms of action, when compared to traditional antibacterial and 
antiviral drugs make P-defensins attractive therapeutic targets (Chang & Klotman 2004, 
Leikina et al. 2005, Adermann et al. 2004, Steinstraesser et al. 2004, Wehkamp et al.
2005).
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Figure 8: Multiple functions of defensins (Selsted & Ouellette 2005).
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13.2.2.4 Cathelicidins
Cathelicidins are a-helical cationic AMPs with a highly conserved N-terminal structural 
domain, cathelin, linked to a variable C-terminal peptide with antimicrobial activity. 
The human cathelicidin antimicrobial peptide (CAMP) gene, encodes an inactive 
precursor, the active LL-37/human cationic protein 18 kDa (hCAP18), is constitutively 
expressed by neutrophils, mast cells, and ECs of stomach, ileum and colon especially 
the lining of the colonic crypts (Hase et al. 2003, Schauber et al. 2003, Iimura et al. 
2005, Wehkamp et al. 2007). Mature human cathelicidin LL-37 is induced in UC but 
not CD (Schauber et al. 2006, Wehkamp et al. 2007). Microbial products except 
butyrate generally do not activate epithelial LL-37 expression (Hase et al. 2002, 
Schauber et al. 2003a, Schauber et al. 2003b, Schauber et al. 2006, Wehkamp et al.
2007). Interestingly, oral butyrate treatment of Shigella-infected dysenteric rabbits 
showed improvement of clinical symptoms, which paralleled LL-37 expression (Raqib 
et al. 2006). LL-37 inhibits the growth of microorganisms, including bacteria, fungi, 
certain parasites and viruses (Boman 2003). Besides bacterial killing, LL-37 may have 
multiple roles in inflammation including re-epithelialization, LPS neutralisation, 
chemotaxis, cytokine release, angiogenesis, and cell proliferation (Larrick et al. 1995, 
Huang et al. 1997, De et al. 2000, Heilbom et al. 2003, Koczulla et al. 2003, Tjabringa 
et al. 2003, Kurosaka et al. 2005). A critical role for cathelicidin in epithelial defence is 
demonstrated in Morbus Kostmann (a severe congenital neutropenia) patients (Putsep et 
al. 2002).
1 3 3  Mucosal alert
Another important function of the epithelium is to sense diverse microbes and microbial 
products, via Pattern Recognition Receptors (PRRs) to alert die underlying immune 
system. How the mucosal immune system differentiates between commensal and 
pathogens in the context of PRR activation remains unclear. What is clear is that after 
stimulation with pro-inflammatory mediators or infection, IECs up-regulate a program 
of genes that signal the onset of an acute inflammatory response. Characterised by an 
influx of neutrophils and monocytes (Eckmann et al. 1993a, Eckmann et al. 1993b, Jung 
et al. 1995, Reinecker et al. 1995, Laurent et al. 1997, Savkovicet al. 1997, Yang et al. 
1997, Steiner et al. 2000, Izadpanah et al. 2001).
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Production of chemokines, by the IECs in response to infection, alerts the host to direct 
the immune response to the site of infection (Shanahan 2002). CXCL8 (IL-8) is a 
chemokine produced by IECs that chemo-attracts and is a potent stimulator of 
neutrophils. In response to microbial infection, there is increased IL-8 production and 
release from the basolateral membrane of IECs (Eckmann et al. 1993a, Eckmann et al. 
1993b, Kagnoff & Eckmann 1997).
IL-8 also plays a crucial role in resealing the epithelial barrier, as IL-8 significantly 
stimulates IEC proliferation and migration, thus terminating penetration of 
inflammatory agents into the host that may maintain intestinal inflammation (Sturm et 
al. 2005). IL-8 functions in epithelial cells of various origins (Ishiko et al. 1995, Kitadai 
et al. 1998, Inoue et al. 2000, Smith et al. 1994).
In healthy tissues, IL-8 protein is barely detectable, but is rapidly induced by a range of 
stimuli including cytokines such as IL-1, bacterial, or viral products, and cellular stress 
(Kasahara et al. 1991, DeForge et al. 1993, Shapiro & Dinarello 1995, Aihara et al. 
1997, Hobbie et al. 1997, Lee et al. 1997, Sonoda et al. 1997, Brasier et al. 1998, 
Mastronarde et al. 1998).
Increased IL-8 expression has been observed in inflamed intestinal mucosa of patients 
with inflammatory bowel diseases (IBD) (Schaufelberger et al. 1994, Daig et al. 1996, 
Daig et al. 2000, Williams et al. 2000).
Another chemokine important to the alert response is Macrophage Inflammatory Protein 
or chemokine ligand 20 (MIP-3a/CCL20) (Rossi et al. 1997), also known as liver and 
activation-regulated chemokine (LARC) (Hieshima et al. 1997) or Exodus (Hromas et 
al. 1997). CCL20 is a NF-kB target gene, widely expressed in human IECs and is up- 
regulated by stimulation with cytokines IL-1 a  and TNF-a, during acute inflammation, 
or in response to bacterial infection (Izadpanah et al.2001).
CCL20 chemo-attracts to the subepithelial region of mucosal surfaces, Natural Killer 
(NK) cells and, both CD45R01 memory T cells and CD341 bone marrow cell-derived 
immature DCs (iDCs), which express the CCR6 receptor (Baba et al. 1997, Greaves et 
al. 1997, Power et al. 1997, Liao et al. 1997, Al-Aoukaty et al. 1998, Campbell et al.
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1998, Dieu et al. 1998, Sallusto et al. 1998, dieu-Nosjean et al. 1999, Liao et al. 1999, 
Iwasaki & Kelsall 2000, Macpherson & Uhr 2004b).
As i£)Cs capture antigen at mucosal surfaces, they undergo a functional and phenotypic 
change that includes a decrease in CCR6 expression and a concomitant increase in 
expression of CCR7, the receptor for secondary lymphoid tissue chemokine (SLC) and 
MIP-3p. This change enables DCs to traffic out of the tissues, where they encounter 
antigen and migrate to the blood and secondary lymphoid organs (Dieu et al. 1998, 
Sallusto et al. 1998, Willimann et al. 1998).
The pattern of expression of CCL20 throughout the epithelium of human intestine and 
its expression in other sites such as human lung and liver, suggests that the functional 
activity of this chemokine goes beyond a proposed role in the genesis and function of 
mucosal lymphoid follicles. Constitutive low levels of epithelial expression of CCL20 
serve to maintain iDCs and memory T cells in close proximity to the epithelial surface, 
the first site of host contact with antigen in the intestinal lumen (Hieshima et al. 1997, 
Hromas et al. 1997, Dieu et al. 1998, dieu-Nosjean et al. 1999, Tanaka et al. 1999, 
Iwasaki Sc Kelsall 2000,).
Interestingly, CCR6 acts as receptor for a second IEC produced ligand hBD2 (Yang et 
al. 1999). This has led to the suggestion that similar structured motifs are present in both 
ligands (Skelton et al. 1995, Yang et al. 1999, Perez-Canadillas et al. 2001, Hoover et 
al. 2002). However, CCL20 secretion by human IECs was 100-fold greater than that of 
hBD2 in response to identical pro-inflammatoiy stimuli (O'Neil et al. 1999, Izadpanah 
et al. 2001). Coupled with a lower affinity of hBD2 binding to CCR6 compared with 
CCL20, suggest hBD2 produced by intestinal epithelium may not compete effectively 
with CCL20 for binding to CCR6 on iDCs or mucosal T cells or to CCR6 expressed by 
intestinal epithelium (Yang et al. 1999).
1.4 Innate recognition of microbial components
1.4.1 Bacterial structure and components
In contrast to mammalian cells, bacteria form complex structures outside the 
cytoplasmic membrane. A cell wall maintains bacterial integrity providing protection
Page 44
against environmental stress. Bacteria are divided into Gram-positive and Gram- 
negative species according to differences in the constituents and the structure of the cell 
wall (Fig 9). The gram-positive bacterial cell wall is composed of a thick layer of 
peptidoglycan (PGN) with chains of lipoteichoic acid (LTA) and teichoic acid linked to 
the cytoplasmic membrane. In contrast, Gram-negative bacteria have a thinner PGN 
layer and are arranged with an outer membrane containing lipopolysaccharide (LPS). 
Furthermore, lipoproteins are found in both gram-positive and -negative bacterial cell 
walls (Cabeen & Jacobs-Wagner 2005). Many of these bacterial surface components are 
recognised by the immune system.
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Figure 9: Composition of the gram-positive and -negative bacterial cell wall (From 
http://focosi.immunesig.org/gram+-bacteria.jpg)
1.4.2 Pattern recognition receptors (PRRs)
Bacterial recognition is dependent on PRRs, including the structurally homologous toll­
like receptors (TLRs), the intracellular NOD-like receptor (NLR) family, the retinoic 
acid-inducible gene I (RIG-I)-like receptors (RLRs) and some C-type lectin receptors
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(CLRs) (Geijtenbeek et al. 2004, Robinson et al. 2006, Strober et al. 2006, Strober et al. 
2007, Xavier & Podolsky 2007, Yoneyama & Fujita 2007, Willment & Brown 2008).
They cooperate to recognise conserved molecular structures that normally are essential 
for the survival of microbes. This is an elegant design that prevents microbes from 
escaping innate recognition. They recognise microbial cell walls, bacterial motor 
flagellin, microbial (and modified host) nucleic acids, or stress (danger)-induced 
molecules on the cell surface, in the endosomes, or in the cytosol (Ishii et al. 2008).
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1.4.2.1 PRRs localisation
The IEC is highly polarised and PRRs are targeted to the apical, intracellular or 
basolateral pole, Fig 10 (Xavier & Podolsky 2000). Toll-like receptors (TLR) 1, 2, 4 
and 6 are optimally positioned to monitor the luminal milieu as they are expressed on 
the apical surface (Cario et al. 2002, Abreu et al 2005, Triantafilou et al. 2006). TLR3, 
TLR7, TLR8, and TLR9 localise within endosomal compartments and the NLRs and 
RLRs are cytoplasmic (Lotz et al. 2007, Ishii et al. 2008). TLR5 is thought to be 
expressed at the basolateral pole in vitro and in vivo (Cario & Podolsky 2000, Gewirtz 
et al. 2001a, Reed et al. 2002). However, TLR polarization may be dynamically 
influenced by their specific ligands in vivo (Duchmann et al. 1995, Cario et al. 2002, 
Takeuchi et al. 2000). A recent report found that prolonged flagellin exposure results in 
the internalization of a fraction of the basolateral TLR5 without affecting the polarity or 
total expression of TLR5 (Sun et al. 2007).
1.4.2.2 PRRs signalling pathways
Ligation of these bacterial receptors stimulates central signalling cascades (Fig 10). For 
example, all TLRs recruit different combinations of Toll/lL-1 receptor (TIR) domain- 
containing adaptor molecules, such as Myeloid differentiation factor 88 (MyD88), TIR 
domain containing adapter protein (TIRAP/MAL), TIR domain-containing adaptor 
inducing IFN-beta (TRIF/TICAM1) and TRIF-related adaptor molecule (TRAM) 
(Akira & Takeda 2004). MyD88 is used by all TLRs except TLR3, TIRAP is used by 
TLR2 and TLR4, TRIF is used by TLR3 and TLR4, and TRAM is used only by TLR4 
(Kawai & Akira 2006). Ligand recognition by the NODs induces recruitment of the 
CARD (Caspase-Recruiting Domain)-containing serine/threonine kinase RICK (also 
called RIP2), to the receptors via CARD-CARD interactions (Inohara et al. 2005, 
Strober et al 2006).
These signalling pathways activate the transcription factors nuclear factor-icB (NF-kB), 
activator protein-1 (AP-1), AKT/phosphatidylinositol-3’-kinase, and mitogen-activated 
protein kinase (MAPK) pathways; leading to the production of inflammatory cytokines 
and chemokines. They also activate interferon regulatory factor 3 (IRF3) and/or IRF7 in 
TLRs 3,4, 7, 8, and 9, leading to the production of type I IFNs (Ishii et al. 2008).
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Subsequently, the cytokines and chemokines initiate and amplify inflammatory 
responses by recruiting and activating various innate immune cells such as neutrophils, 
DCs and NK cells (Iwasaki & Medzhitov 2004). In turn, TLR-activated DCs provide 
naive T cells with two signals required for their activation: microbial antigen loaded on 
major histocompatibility complex (MHC) and costimulatory molecules such as CD80 
and CD86. Thus, priming the adaptive immune response, see section 1.5 (Iwasaki & 
Medzhitov 2004).
Table 1. Mammalian PRRs and their major ligands
Family Member (major ligand)
TLRs TLR1 Triacyl-lipopeptides
TLR2 LTA, zymosan, lipopeptides,
TLR3 dsRNA, poIylrC
TLR4 LPS
TLR5 flagellin
TLR6 diacyl lipopeptides
TLR7 ssRNA, R848
TLR8 ssRNA, R848
TLR9 CpGDNA
TLR11 profilin-like molecule
C-type
lectin
receptors
Mannose receptor ligands bearing mannose, fucose, or N-acetyl 
glucosamine
DC-SIGN ICAM-2/3, HIV gpl20, Mycobacterium 
tuberculosis ManLAM
Dectin-l zymosan, p-glucans from fungi
NOD-like
receptors
NODI iE-DAP
NOD2 MDP
14
NALPs
NALP1 cell rupture
NALPlb anthrax lethal toxin
NALP3 bacterial mRNA, R848, extracellular ATP, uric 
acid crystals
1PAF Salmonella flagellin
NA1P5 Legionella flagellin
CARD
helkases
RIG-1 uncapped 5'-triphosphate RNA
MDA5 Poly I:C, dsRNA from EMCV
Table 1.1 Host innate immune receptors (Adapted from Lee & Kim 2007).
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1.4.23 PRR Ligands
To initiate immune responses PRRs recognise highly conserved microbial structures, 
so-called microbe-associated molecular patterns (MAMPs, table 1). Bacterial cell wall 
can be recognised on the IEC surface, by the CLR dectin-1 through its adaptor CARD9. 
TLR4 homodimers with an LPS-binding accessory molecule (MD-2) recognise LPS 
(Kohara et al. 2006) and activate cells through MyD88 and TIRAP via the cell surface 
or TRAM and TRIF via the endosomal pathway (Ishii et al. 2008). TLR2 can dimerize 
with either TLR1 or TLR6 through the TIR-containing adaptor MyD88 and TIRAP. The 
subfamilies of TLR1, 2, and 6 recognise lipid and carbohydrate compounds from Gram- 
positive bacterial cell walls; such as PGN, LTA, and lipoproteins (Takeuchi et al. 1999). 
TLR2 heterodimers with TLR1 or TLR6 appear to be involved in the differential 
recognition of lipoproteins with different lipid moieties (Takeuchi & Akira 2001, 
Takeuchi et al. 2002).
Specific elements of PGN are sensed by the intracellular NLR system. Dipeptide g-D- 
glutamyl-meso-diaminopimelic acid (iE-DAP) is sensed by NODI, while muramyl 
dipeptide (MDP) is recognised by NOD2. iE-DAP is found in PGN gene of Gram- 
negative bacteria (Chamaillard et al. 2003), while MDP is present in both Gram-positive 
and Gram-negative PGN (Inohara et al. 2003). Ligation induces RIP2-dependent 
signalling pathway, all of which can cooperate to activate cells through activator 
protein-1 (AP-1), NF-kB, and MAPK activation (Ishii et al. 2008).
Bacterial flagellin is recognised by TLR5, NAIP5 and IPAF (NLRs). TLR5 is on the 
cell surface and binds to a 13 amino acid motif present in the flagellin profilament, 
which is not accessible in polymerised flagella (Smith et al. 2003). Ligation activates 
NF-kB pathways through MyD88. PRR’s NAIP5 (NLR family, apoptosis inhibitory 
protein 5) and ICE protease-activating factor (IPAF) sense flagellin in the cytosol, they 
do not act through MyD88 but result in caspase-1 activation and IL-lp, IL-18 and IL-33 
secretion (Franchi et al. 2006, Miao et al. 2006, Molofsky et al. 2006, Ren et al. 2006, 
Steiner 2007, Ishii et al. 2008).
Other NLRs, such as NALP3, can recognise a variety of microbial signatures or even 
host molecules derived from damaged or dying cells, including bacterial toxins, nucleic 
acids, and uric acids. This activation leads to caspase-1 activation along with ASC (an
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adaptor for NALP1 and NALP3), inducing the release of IL-lp and IL-18 (Ishii et al
2008).
TLR3, 7-9 recognise nucleic acids in the endosome, and RLRs such as RIG-I, MDA5, 
and LGP2 as well as uncharacterised DNA sensor(s) detect nucleic acids in the 
cytoplasm, most probably in the cytosol. TLR3, 7-9 mediated signalling pathways are 
through TRIF and MyD88, respectively leading to induction of cytokine and type IIFN 
production (Ishii et al. 2008).
1.4.2.4 PRRs In the GI tract
As well as cell compartmentalization, PRRs exhibit varied expression through the GI 
tract. Studies suggest that TLR2, 4, CD 14 and MD-2 expression is down-regulated; 
providing a mechanism of tolerance to the commensal microbiota (Cario & Podolsky 
2000, Abreu et al. 2001, Naik et al. 2001, Abreu et al. 2002, Melmed et al. 2003, Abreu 
et al 2005). However, reports on TLR4/MD-2/CD14 expression remain contradictory as 
some studies note expression in primary EECs of the intestinal crypts in the SI with 
stronger expression in colon segments (Martin-Villa et al. 1997, Suzuki et al. 2003, Otte 
et al. 2004). TLR3 and TLR5 are expressed on IECs throughout the lower GI tract 
(Cario & Podolsky 2000). However, TLR5 is selectively expressed by the surface 
epithelium but not the crypt epithelium (Cario & Podolsky 2000).
PRR expression may alter on ligand-interaction. Down-regulation of TLR4/MD-2 and 
CD 14 may occur resulting in tolerance to LPS in the villus epithelium (Antal-Szalmas 
2000, Sato et al. 2000). TLR5 is down-regulated by pre-incubation with purified 
Salmonella flagellin, resulting in hypo-responsiveness to further colonisation (Reed et 
al. 2002). The physiological and/or pathological consequences of IEC TLR localization 
during health and disease remains to be elucidated (Latz et al. 2002, Latz et al. 2004).
1 .425  Regulation of PRR induced responses
Regulation of PRR interactions and thus the downstream outcome can occur by the 
selective usage of adaptor molecules (Albiger et al. 2007). Negative regulation by post- 
transcriptional and post-translational modification can also play a role (Liew et al. 2005, 
Miggin & O'Neill 2006, Doyle & O'Neill 2006). Several critical molecules have also 
been implicated in the negative regulation of TLR signalling. Although at present only
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IRAK-M, PPARy, A20, NOD2 and Tollip have been found to act in the GI tract 
(Shibolet & Podolsky 2007).
In addition, TLR signalling can be down-regulated by anti-inflammatory cytokines. For 
instance, TGF-p induces MyD88 degradation (Naiki et al. 2005). Collectively, emerging 
data suggests that the IEC is able to sense microbial immuno-stimulatory molecules. 
However, they rely on life-long negative regulatory mechanisms to prevent 
inappropriate immune activation and tissue inflammation (Lotz et al. 2007).
1.43 NF-kB a central mediator of IEC innate immune response
Many of the genes activated in IECs in response to bacterial infection, are indeed target 
genes of the transcription factor NF-kB (Savkovic et al. 1997, Jobin et al. 1998, Elewaut 
et al. 1999, Jobin et al. 1999). In this regard, NF-kB can be viewed as a central regulator 
of IEC responses, and in turn of mucosal innate and adaptive inflammatory responses 
(Elewaut et al. 1999, Jobin & Sartor 2000, Li & Stark 2002).
The family of NF-kB proteins consists of five different members, which are namely p65 
(RelA), c-Rel, RelB, p50 and p52. These proteins are all characterised by a structurally 
conserved N-terminal 300 amino acid region containing specific domains, which allow 
dimerization, nuclear localization and DNA-binding (Siebenlist et al. 1994, Li & Verma 
2002, Dejardin 2006). Amongst the NF-kB family, only p65, c-Rel and RelB are 
directly able to activate the transcription of target genes. The transcriptional capacity of 
p50 and p52, which are initially synthesised as large precursors called p i05 and p i00, 
are dependent on dimerization with p65, c-Rel or RelB (Siebenlist et al. 1994, Dejardin
2006).
In un-stimulated cells, the majority of NF-kB dimers are inactivated and retained in the 
cytoplasm by association with small inhibitory molecules IkBo, IkBP or IkBe 
(Siebenlist et al. 2005). These inhibitors mask a motif within NF-kB, which is 
responsible for the nuclear localization. In addition, hcBa is also able to enter the 
nucleus by itself and subsequently mediates the blockade of DNA-binding of NF-kB 
and promotes the nuclear export of NF-kB (Siebenlist et al. 2005).
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To activate NF-kB. there exist two different intracellular pathways -  the classical and 
the alternative pathway -  where both result in the release of NF-kB from its inhibitors 
and nuclear localization (Fig 11), (Bonizzi & Karin 2004, Greten & Karin 2004, Karin 
& Greten 2005).
Input
Alternative Classical
( 3 £ >26s proteosome 26s proteosome
Figure 11: NF-kB signalling pathways
Classic activation of NF-kB can be initiated by a broad panel of different stimuli as 
detailed in section 1.4.2.3. These stimuli induce intracellular signalling cascades, 
resulting in a subsequent activation of the IkB kinase (IKK) complex. The IKK complex 
is composed of two catalytic subunits IKKa and IKKp as well as a regulatory protein y, 
named NF-kB essential modulator (NEMO). Both catalytic subunits are able to 
phosphorylate specific serine residues within IkB molecules (Zandi et al. 1997, Li et al. 
2001, Li & Verma 2002). Phosphorylation of NF-KB-bound IkB, mainly mediated by 
IKKp in case of classic NF-kB activation, subsequently initiates the proteosomal 
degradation of IkB and finally allows the nuclear localization of NF-kB (Bonizzi & 
Karin 2004, Greten & Karin 2004).
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Some inducers are able to trigger the alternative NF-kB pathway, which involves post- 
translational processing of the p i00 precursor to mature p52 (Bonizzi & Karin 2004, 
Dejardin 2006). In contrast, to the classical pathway, IKKp and NEMO are not 
absolutely required (Bonizzi & Karin 2004, Dejardin 2006).
Irrespective of the signalling cascade, which leads to NF-kB activation, activated and 
translocated NF-kB dimers in the nucleus are able to interact with regulatory NF-kB 
elements in promoters and enhancers, thereby inducing the expression of NF-kB target 
genes (Baeuerle & Henkel 1994). For example, IL-8, hBD2 and CCL20 promoters 
contain NF-kB binding sites (Mukaida et al. 1990, Mukaida et al. 1994, Harant et al. 
1996, Liu et al. 1998, Fujiie et al. 2001). Generally, genes which are regulated by the 
transcriptional activity of NF-kB can be categorised into four functional groups: 
inflammatory and immunoregulatory, cell cycle regulating, anti-apoptotic and genes 
that encode negative regulators of NF-kB (auto inhibitory feedback loop) (Greten et al.
2007).
1.5 Acquired immunity in the gut
The gut associated lymphoid tissues (GALT) contain the largest pool of 
immunocompetent cells in the human body, which is strongly influenced by the 
presence of the intestinal microbiota. GALT comprises the Peyer’s Patches in the small 
intestine and lymphoid follicles in the large bowel (Brandtzaeg 2002).
The hallmarks of the adaptive immune system in the gut are the sampling of luminal 
antigens by M cells and DCs, the antigen driven priming and maturation of naive T 
cells, which in turn activate B cells in Payers Patches. These lymphocytes egress to 
mesenteric lymph nodes (MLN) through the lymphatics that drain the gut mucosa and 
then migration of the lymphocytes back to the lamina propria (Wershil & Furuta 2008).
1.5.1 Antigen driven priming and maturation of naive T ceils
Peripheral naive CD4+T cells can differentiate into either three subsets of effecter T 
cells (Thl, Th2 and Thl7 cells) or certain populations of regulatory T cells (Tregs) (Fig 
12). TLR-activated DCs induce differentiation of naive CD4+ T cells into regulatory T 
cells by producing high levels of anti-inflammatory cytokine IL-10 and little IL-12.
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Tregs suppress T cell function and maintain oral tolerance. TH1 cells differentiate with 
high levels of IL-12, IL-1, IL-6, TNF-a and IFN-y. TH1 cells activate cellular immunity 
against intracellular pathogens. TLR2-activated DCs promote the differentiation of TH2 
cells with IL-4, 1L-5, and IL-10. TH2 cells activate humoral immunity against 
extracellular pathogens. IL-23 promotes the development of an IL-17 producing CD4+ 
helper T cell subset through mechanisms that are distinct from the Thl and Th2. Thl7 
cells are an important mediator of the T-cell responses in gut inflammation. (Shanahan 
2002, Aggarwal et al. 2003, Dillon et al. 2004, Iwasaki & Medzhitov 2004, Harrington 
et al. 2005a, Park et al. 2005a, Pulendran & Ahmed 2006).
IL-17 is a pro-inflammatory cytokine that regulates innate immunity by stimulating 
fibroblasts, endothelial cells, macrophages, and epithelial cells to produce multiple pro- 
inflammatory mediators such as IL-1, IL-6, IL-8, TNF, CCL20, NOS2, and G-CSF 
through activation of the NF-kB transcription factor (Yao et al. 1995, Fossiez et al. 
19%, Kolls 8c Linden 2004, Kao et al. 2005). Furthermore, In vivo studies indicated that 
IL-17 is an especially potent activator of neutrophils (Gaffen 2008). In addition, IL-17 
promotes expression of various anti-microbial genes such as p-defensins and mucins 
(Chen et al. 2003, Kao et al. 2004, Liang et al. 2006, Zheng et al. 2007). Interestingly, 
bacterial colonization stimulates IL-23 expression by ileal dendritic cells (Becker et al. 
2003) and the levels of both IL-23 and IL-17 are increased in Crohn’s disease tissue 
(Fujino et al. 2003b, Schmidt et al. 2005).
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Figure 12: Differentiation of T-cell subsets (Shih & Targan 2008).
1.5.2 Antigen driven priming and maturation of B cells
While capturing antigen, DCs are exposed to microbial TLR ligands and IEC-derived 
cytokines, including thymic stromal lymphopoietin (TSLP). These signals promote the 
generation of tiDCs, which are DCs that express tumour-necrosis factor and inducible 
nitric oxide synthase (Fig 13). DCs present antigen to follicular IgM+IgD+ naive B 
cells, in Peyer’s patches, inducing the expression of TGFpl receptor (TGFpR) through 
nitric oxide (NO). During cognate interactions with CD4+ T cells, B cells undergo IgA 
class-switch recombination (CSR) in response to CD40 ligand (CD40L) and TGFpi 
from activated T cells. IgA expression requires IL-5, IL-6 and IL-10 from activated T 
cells (Cerutti & Rescigno 2008). After being imprinted by retinoic acid (RA) from DCs, 
IgA+ effecter B cells migrate to the lamina propria, where they differentiate into IgA- 
secreting plasma cells. This differentiation is enhanced by a proliferation inducing 
ligand (APRIL) secreted by epithelial cells, DCs and tiDCs (Cerutti & Rescigno 2008).
IgA produced in the gut is dimeric joined by the J-chain. Dimeric IgA forms a covalent 
complex with the polymeric immunoglobulin receptor (plgR) expressed on the 
basolateral aspect of the IEC before being actively transported to the apical surface. The 
bound IgA is released by proteolytic cleavage into the intestinal lumen (Macpherson &
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Slack 2007, Wershil & Furuta 2008)). Bacteria in the intestinal lumen become coated 
with IgA (Brandtzaeg & Korsrud 1984).
Under steady-state conditions, iDCs are continually entering the gut and are sampling 
antigens (Dieu et al. 1998, Cook et al. 2000). It has been proposed that DCs present in 
the lamina propria may retain live commensals, which induce the secretion of protective 
IgA; thus, limiting contact between commensal bacteria and the epithelium 
(Macpherson & Uhr 2004b).
An emerging model of mucosal immunity suggests B cell differentiation to IgA- 
producing plasma cells can occur locally in the lamina propria of the small intestine by 
T cell-independent mechanisms (Fagarasan & Honjo 2004), especially in response to 
commensal bacteria (Macpherson et al. 2000). Factors implicated are APRIL, B-cell- 
activating factor (BAFF), and TGF-p (Litinskiy et al. 2002, Castigli et al. 2004, 
Macpherson & Uhr 2004b, Castigli et al. 2005, McCarthy et al. 2006, He et al. 2007, 
Cerutti & Rescigno 2008). In particular, interactions between APRIL and its receptors 
potentially overcome the requirements for CD40—CD40L signalling (Macpherson & 
Slack 2007). Locally controlled IgA production creates a feedback loop that bypasses 
the systemic immune system (Peterson et al. 2007).
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Figure 13: Cellular interactions causing IgA class switching in the gut (Cerutti & 
Rescigno 2008).
1.6 Interactions of the microbiota with the mucosal barrier
A major theme of life is the complex and beneficial interactions that occur between 
eukaryotes and prokaryotes; humans are no exception. The intestine represents an 
especially attractive niche, rich in carbon and mineral sources, maintained at a stable 
temperature (Smith et al. 2007). Thus, as adults, we harbour diverse communities of 
microorganisms, whose total number exceeds the sum of all of our somatic and germ 
cells (Savage 1977).
Despite the innumerable diverse microbes encountered in the lifetime of a mammal, the 
vast majority o f gut microbiota consists of just 3 members of the 55 known divisions of 
bacteria (Backhed et al. 2005). This observation suggests that there has been specific 
selection for commensals and has led to hypotheses of symbiosis and co-evolution of 
mammals and microbes (Ley et al. 2006).
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As yet, the ways in which these communities contribute to normal postnatal 
development and adult physiology are largely unexplored. An estimated 2 to 4 million 
genes are embedded in the aggregate genome (microbiome) of an intestinal community 
of 500 to 1000 bacterial species (Hooper & Gordon 2001). The microbiome contains 
more than 100 times the number of genes found in the human genome, and this genetic 
material, even though not controlled directly by the human host itself, contributes 
strongly to the global fitness and well-being of healthy individuals (Backhed et al. 
2005).
1.6.1 Co-evolution of the epithelial barrier and microbes
Co-evolution of microbes and the intestine dates back at least 1.7 billion years at the 
point of the evolution of multicellular organisms. It is thought that gut formation was 
one of the first outcomes of multicellularity (Alberts et al. 1994). It is suggested that a 
simple spherical colony of flagellates, invaginated to form a two layered ball of cells. A 
secondary opening in the opposite side of the sphere to the point of invagination 
resulted in a two layered tube of cells; the inside of the tube becoming a simple gut. 
Selective pressure then lead to the emergence of epithelia forming an outer protective 
coat (the ectoderm) and an inner layer (the endoderm) involved in food absorption. By 
forming a tightly coherent epithelial sheet, all the molecules produced by digestion were 
prevented from being lost to the exterior. Thus, the endodermal cells created an 
environment in the gut that suited digestive tasks. Meanwhile, the ectodermal cells, 
facing the exterior, became specialised for encounters with the outside world. Today, 
epithelial sheets of cells, line all external and internal surfaces in the body, creating 
sheltered compartments and controlled internal environments in which specialised 
functions are performed by differentiated cells (Alberts et al. 1994).
At the time where multicellular organisms developed, it is thought that there was strong 
competition for resources and there would have been a selective advantage in 
collaboration and division of labour. Bringing cells together in this way gave organisms 
the opportunity to make specialised cell types. It then became possible to exploit 
resources unavailable to other organisms; hence symbiosis and/or mutualism developed. 
Different forms of symbiosis have resulted in some of the most profound evolutionary 
events. For example, the origin of the mitochondrion from a symbiosis of a 
proteobacterium with early eukaryotes, and the origin of the chloroplast, from a
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symbiosis of a cyanobacterium with an originally heterotrophic eukaryote; thus 
resulting in the evolution of all photosynthetic lines of eukaryotes, and the 
establishment of multicellular photosynthetic organisms (plants) in terrestrial 
environments from a symbiosis of a fungus and a green alga (Alberts et al. 1994).
Similarly, the development of the endoderm produced a localised area with a 
concentration of nutrients to hijack, and thus came parasitism and the requirement for 
defence. This defence was provided by the development of the immune system. Thus, 
the origins of immunity may go back to the earliest competition for resources; even 
bacteria release antibiotic peptides that kill other species of bacteria (Dushay & Eldon 
1998).
Homo sapiens, it seems, first walked the Earth about 130,000 years ago. Our distant 
ancestors presumably carried within their bowels a large and complex community of 
microbes, just as we do today (Tannock 1997). Whether this microbial community has 
the same composition in humans of the 21st century as it did with our ancient 
progenitors, somewhere in Africa, will perhaps never be determined (Tannock 2007). 
Microbial anthropology focuses on genome-based analysis of the microbiota in suitably 
preserved and procured samples of faeces and/or intestines derived from ancient 
humans (Cano et al. 2000). In conjunction with analysis of current and relatively 
isolated human populations, living in ecologically distinctive niches of our planet, 
should provide a new understanding of how our migrations, dietary transitions, and 
social innovations/interactions conspired to craft modem symbionts (and Homo 
sapiens); as well as how they influenced the birth and spread of pathogens (Xu et al. 
2003). Indeed, Rollo and colleagues and other molecular archaeologists are 
investigating the commensal microbiota of neolithic mummies in comparison to the 
microbiota of modem day man (Flicker et al. 1997, Ubaldi et al. 1998, Cano et al. 2000, 
Rollo et al. 2006).
There have been several periods of environmental change with immense importance, 
which have no doubt shaped the co-evolution of the intestine with microbes. The first 
would have been the neolithic period, characterised by great innovations and changes 
that deeply influenced human life. Before the advent of agriculture about 10,000 years 
ago, in the paleolithic period, all people were hunter-gatherers: they gathered various
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fruits and vegetables to eat; they hunted animals for their meat and rarely if ever drank 
milk beyond infancy or ate grains. At the end of this period there was a transition from a 
nomadic way of life to agriculture, people shifted to relatively stable and larger societies 
tending and cultivating the land. Culture and knowledge flourished. People also began 
consuming large amounts of grain, milk, and domesticated meat, and they became more 
sedentary as well (Coumede et al. 1996). The neolithic period is generally regarded as 
demarcating a crucial point in the history of the co-existence of humans and microbes. 
Almost certainly, the human intestinal microbiota would have changed dramatically, 
with cross-exchange of bacteria from newly domesticated animal species. Furthermore, 
at that time, the transition to living in large sedentary human aggregates is presumed to 
have favoured the spread of diseases including those characterised by an oral-fecal route 
of transmission; resulting in the reduction in survival curves of the early neolithic 
human population (Ubaldi et al. 1998, Coumede et al. 1996).
The relationship between microbe and the human gut has changed dramatically since 
the Industrial Revolution at the turn of the 19th century. Beginning around 1900, whole 
grains were routinely refined, removing much of their nutrition and refined sugar 
became “commonplace”. These dramatic changes coincided with a sharp decline in 
physical activity and the introduction of thousands of artificial chemicals and the 
widespread industrial use of toxic chemicals. Reflecting on the changes in 1939, 
nutritionist Jean Bogert noted: “The machine age has had the effect o f forcing upon the 
peoples o f the industrial nations the most gigantic human feeding experiment ever 
attempted" (Timmerman 2006).
Another major period of change in environmental challenge has occurred in the last 
century in developed countries, reduced colonization by helminths; hospital births, lack 
of early pathogen challenge and immunization, antibiotics, improved hygiene and better 
socio-economic conditions have resulted in additional alterations to the composition of 
the bowel community because exposure to certain bacteria may be less common 
(Gerrard et al. 1976, Hopkin 1997).
The environmental change has led to the “hygiene hypothesis”. It has been postulated 
that limited exposure to bacterial and viral pathogens during early childhood results in 
an insufficient stimulation of TH1 cells (associated with bacterial and viral infections).
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In turn, this cannot counterbalance the expansion of TH2 cells (associated with helminth 
infections and allergic diseases) and results in a predisposition to allergy. 
Epidemiological data provides strong evidence to show a steady rise in the incidence of 
allergic and autoimmune diseases in developed countries over the past three decades, 
making host-microbe interactions an important area that requires greater attention (Bach 
2002).
We may well be on the dawn of another era with the introduction of the use of pro- and 
prebiotics and genetically modified crops mainstream.
1.6.2 Defining microbial interactions with the mucosal barrier
Interactions between bacteria and their host can be viewed in terms of a continuum 
between symbiosis, commensalism, and pathogenicity (Hooper & Gordon 2001). 
Symbiotic alliances can be broadly classified according to (0 their means of 
transmission from generation to generation (if) the physical relationship between 
symbiont and host (intracellular vs. extracellular); and (iif) whether the association is 
binary (one host and one microbial species), as is typical in invertebrates, or consortia!, 
as in the human gut (McFall-Ngai 2002).
The word commensal is from the Latin prefix com- (with, together, jointly) and the 
Latin adjective mensalis (of the table) thus it literally means ‘to eat from the same table* 
and is usually defined as a relationship in which one organism derives food or other 
benefits from another organism without hurting or helping it (Kohler et al. 2003). 
Commensals are acquired early in life while the immune system is immature and their 
acquisition is sometimes associated with symptomatic infection (Casadevall & Pirofski
2000).
The term probiotic is derived from the Greek meaning “for life”. The term was first 
used in 1965 to describe “substances secreted by one micro-organism, which stimulates 
the growth of another” (Lilley & Stillwell 1965). Since 1974, the term probiotic meant 
“Substances that have a beneficial effect on animals by contributing to the balance of 
the intestinal flora” (Parker 1974). From then many definitions have been proposed with 
the most recently suggested by Isolauri E et al. “Specific live or inactivated microbial 
cultures that have documented targets in reducing the risk of human disease or in their
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nutritional management” (Isolauri et al. 2002). There is a long history of health claims 
concerning living micro-organisms in food, particularly lactic acid bacteria. For 
example, in a Persian version of the Old Testament (Genesis 18:8) it states that 
“Abraham owed his longevity to the consumption of sour milk” (Schrezenmeir & de 
Vrese 2001, Timmerman 2006a). The positive health effects of consuming fermented 
foods were also noted more than 100 years ago when Elie Metchnikoff correlated their 
ingestion with increased life span in Bulgarian peasants (Timmerman 2006b).
The term pathogen is derived from the Greek pathos meaning suffering/emotion and 
gene meaning to give birth to; thus meaning "that which produces suffering." In other 
words, a pathogen is a biological agent that causes disease or illness to its host. 
However, there is still no consensus about what a pathogen is, and may well reflect the 
residual distinction about whether one studies pathogenicity from a host or microbial 
perspective (Falkow 2004). Koch's postulates, proposed by Robert Koch in 1890, were 
criteria designed to establish a causal relationship between a causative microbe and a 
disease. Microbes were considered pathogens if they met the stipulations of Koch's 
postulate. However, it is apparent that (i) although there are many microbes, most 
human infections are caused by only a few; (ii) some microbes are classified as 
pathogens although they do not cause disease in every host; and (iii) some microbes are 
classified as non-pathogens, although they do cause disease in certain hosts. In addition, 
normal individuals harbour within their mouth, gut, and skin, large numbers of microbes 
that do not cause disease. By the early twentieth century, it was apparent that 
pathogenicity was neither an invariant nor a stable characteristic of most microbes and 
that the acquisition of pathogenic microbes was not necessarily synonymous with 
disease (Casadevall & Pirofski 2000).
Bacterial pathogens possess highly specialised adaptive processes that enable them to 
use host cells to aid their own adherence, replication and/or dissemination (Bhavsar et 
al. 2007). In addition to the capacity for antigenic variation that allows escape from the 
host immune defences (Deitsch et al. 1997). Falkow also notes that “a key distinction is 
that a pathogen has an inherent capacity to breach host cell barriers, whereas 
commensal and opportunistic pathogens do not” (Falkow S et al 1997). Thus, 
pathogenic bacteria have unique virulence factors that allow them to establish 
themselves in the host (Finlay & Falkow 1997). Many genes required for virulence in
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bacteria are in discrete DNA segments, e.g., pathogenicity islands (Hacker et al. 1997), 
which implies that their acquisition is sufficient for a bacterium to become virulent.
Thus, when a pathogen comes in to contact with the host, a struggle between the 
pathogen and the local innate host defence systems ensues. The resolution of this 
encounter is a critical determinant of whether the interaction leads to infection or overt 
disease (Lu & Walker 2001). There are major conceptual differences between infection 
and disease, particularly in the case of commensals (Romani et al. 2003). Even 
pathogenic microorganisms such as Clostridium tetani and Corynebacterium 
diphtheriae, for which virulence is attributed to a toxin, do not cause disease in 
immunized hosts. Other examples of conditions where "infection* is not synonymous 
with "disease* include HIV infection, before the onset of symptomatic disease and 
primary tuberculosis, conditions where the organism exists in the host without causing 
symptoms or clinical illness (Casadevall & Pirofski 2003). An even more dramatic 
example of the fact that infection is not synonymous with disease is that of toxin- 
mediated diseases, in which pre-formed toxins cause host damage and disease within 
themselves. For example, staphylococcal toxins induce gastrointestinal disease even if 
the host does not harbour or indeed was never exposed to the microbe (Pirofski & 
Casadevall 2002).
Casadevall et al. propose the damage framework where a pathogen is a microbe that is 
capable of causing damage in a host and commensals are microbes that do not induce 
damage in a host. However, microbes regarded as commensals can be pathogens in 
hosts with impaired immunity. The framework accounts for the fact that microbial 
pathogenesis results from an interaction between a host and a microbe, in which each 
entity can play a critical part in disease causation. Furthermore, virulence is a microbial 
characteristic that can only be expressed in a susceptible host (Casadevall & Pirofski 
1999, Casadevall & Pirofski 2000, Casadevall & Pirofski 2001).
1.63 The establishment of the intestinal microbiota
The gut of an unborn human infant resembles that of the germfree animal because it 
does not harbour a microbial community (Tannock 2007). This germfree state is short­
lived because within minutes of birth the baby is exposed to environmental microbes 
(Tannock 2007). The establishment of the gut microbiota generally proceeds in an
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ordered fashion, via the episodic persistence of some bacterial populations, but the 
elimination of others (Cooperstock et al. 1983). The final result is a complex 
community predominated by gram-negative anaerobes (Rotimi & Duerden 1981, 
Savage et al. 1968, Lee et al. 1971). It takes several years to produce a climax 
community resembling that of adults and once assembled, the community remains 
remarkably dynamic (Norin et al. 1985). Throughout its establishment the microbiota 
continuously provides stimulation of the immune system via the GI tract (Wold & 
Adlerberth 2000). Thus, the commensal microbiota may be of specific importance for 
the proper maturation of the neonatal immune system (Wold & Adlerberth 2000).
The “Hygiene Hypothesis” proposes that atopic diseases could be prevented by 
infections in early childhood because the neonatal immune system would be driven 
towards a TH1 response, but a specific “infectious protective factor” has never been 
identified (Murray CS 2006, Strachan 1989). Attention has turned to the bacterial 
community of the bowel and the possibility that colonisation of the gut by specific 
bacterial species might be more important than the impact of sporadic infections. The 
environmental conditions into which a child is bom and nurtured may affect which 
microbes they are exposed to, and subsequently influence the composition of their 
bowel community (Tannock 2007, Brandtzaeg 2002, Sepp et al. 1997).
1.6.4 Tolerance to the commensal microbiota
Despite the presence of large numbers of commensal bacteria in the GI tract, which are 
continuously stimulating the immune system, commensals are well tolerated by the 
mucosal immune system of the healthy intestine (Duchmann et al. 1995, Xavier & 
Podolsky 2000, Cario et al. 2000). Several mechanisms have been proposed to explain 
how the host sensing machinery could discriminate between harmless commensals and 
dangerous pathogenic microbes, even though they share, in most cases, identical 
molecular signatures (Magalhaes et al. 2007, Pedron & Sansonetti 2008).
Pathogens differ from commensals mainly in their ability to colonise mucosal surfaces 
and/or invade the host tissue. Therefore, on the host side, discrimination between 
commensals and pathogens can be achieved by compartmentalization or reduction of 
PRRs expression as previously detailed in section 1.4.2.1 and 4.
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The host may express factors and enzymes that assist in tolerating the commensal by 
blunting microbial components that would typically induce inflammation (Pedron & 
Sansonetti 2008). For example, recent evidence indicates that the brush border alkaline 
phosphatase expressed by IECs can detoxify luminal LPS by dephosphorylating the 
lipid A (Bates et al. 2007).
Furthermore, the mucosal immune system is strongly oriented towards tolerance. The 
epithelial lining gets tolerized to LPS very early in life (Lotz et al. 2006). IECs produce 
TSLP, which orientates T cell responses toward non-inflammatory responses, i.e. non 
TH1 (Rimoldi et al. 2005). Tregs produce IL-10 and TGF-P essential effecters of 
tolerance (Izcue et al. 2006). In addition, live commensal bacteria are confined to the 
mucosal immune compartment because they are readily killed by macrophages and can 
only survive in DCs; therefore, the systemic immune system is essentially ignorant of 
these organisms (Macpherson & Uhr 2004b).
Bacteria may remain “ stealth” due to diversity in MAMPS and thus may escape the 
inflammatory response. For example, pentacylated lipid A of commensal Bacteroidetes 
is unable to signal via TLR4 (Pedron & Sansonetti 2008). Commensal bacteria may also 
actively suppress epithelial pro-inflammatory signalling via inactivation of NF-kB 
(Neish et al. 2000, Kelly et al. 2004, Tien et al. 2006) see section 1.6.5.
There is also a physical dimension to the tolerogenic process (Pedron & Sansonetti 
2008); preventing exposure of PPRs to gut luminal content (Ortega-Cava et al. 2003, 
Shibolet & Podolsky 2007). As detailed in section 1.3.1.2, the mucosal surface of the 
bowel is covered with a blanket of mucus that flows away from the epithelium and is 
continuously replaced by fresh mucus from the goblet cells (Lievin-Le & Servin 2006). 
The mucus serves as a matrix for the AMPs secreted by IECs, and together they are 
likely to maintain commensals restrained and separated from the epithelial surface. 
Moreover, the adaptive immune system is enrolled in this tolerogenic process through 
the local production of commensal-specific IgA (see section 1.5) that seem, 
experimentally, to be able to reduce intestinal pro-inflammatory signalling (Peterson, 
McNulty, Guruge, & Gordon 2007, Peterson et al. 2008). Thus, bacterial cells in the 
bowel are coated with slgA, possibly counteracting effective use of bacterial adhesins 
(van der Waaij et al. 1996).
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Everything is designed to stop bacteria associating with the mucosal surface. Contained 
within the virtual tube in the bowel lumen, the bacterial community can be retained 
safely (Tannock 2007). Nevertheless, it does not seem to be a totally efficacious system 
since pathogens can reach the mucosal surface and attach by means of adhesins to 
specific receptors prior to proliferation or invasion (Tannock 2007).
1.6.5 Interaction of the commensal microbiota with the epithelial barrier
Traditional scientific investigation of microbes largely has focused on pathogens and 
action of the host immune system upon them. It was thought that the commensal 
microbiota reside benignly within the virtual tube in the bowel lumen with no 
deleterious effect and with no cross-talk with the IECs. To maintain a healthy gut 
interaction between bacteria and the IEC must occur (Kalliomaki & Walker 2005).
Work using experimental animals raised in sterile conditions has revealed that this 
interaction is in fact bidirectional.(Ley, Peterson, & Gordon 2006). In recent years there 
has been a rapid growth in evidence revealing beneficial roles for microbes in their 
mammalian hosts. From participating in host nutrition, physiology and control of the 
immune system (Hooper & Gordon 2001, Isolauri et al. 2002) to the regulation of 
allergy proposed in the hygiene hypothesis (Strachan 1989). Some investigators have 
referred to the microbiota as an “extra organ” of the host (O'Hara & Shanahan 2006). 
There is no question that the host is highly adapted to the presence of commensal 
intestinal bacteria. The evidence for this comes from comparing germ-free mice, which 
have no commensal microbiota, with specific-pathogen-ffee (SPF) animals of the same 
strain, which contain commensals (Macpherson & Uhr 2004b).
1.6.5.1 Effect of commensals on barrier integrity
The concept of “colonisation resistance” also called the barrier effect is a long-standing 
one. The prevailing theory is that the commensal microbiota prevents pathogenic 
colonisation by competing for attachment sites and nutrition, in addition to producing 
and secreting bacteriocins (microbially derived antibiotics) (van der waaij 1989, Hooper 
& Gordon 2001, Stappenbeck et al. 2002, Hooper et al. 2003, O'Hara & Shanahan 2006, 
Stecher & Hardt 2008). Indeed, pre-treatment of animals with oral antibiotics, such as 
streptomycin, which significantly reduces (but does not eliminate) the intestinal
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microbiota, rendering the animals much more susceptible to intestinal infection by a 
variety of bacterial pathogens (Salzman, Underwood, & Bevins 2007).
Commensal bacteria also seem to be important for maintaining epithelial integrity and 
for tissue repair. As functional TLR recognition of gut microbiota by the host immune 
system is required to prevent gut pathology (Rakoff-Nahoum et al. 2004, Magalhaes, et 
al. 2007). This TLR-mediated protection works through at least two possible 
mechanisms that are not mutually exclusive. The first is the steady-state induction of 
protective factors, via the constitutive detection of microbial products from commensals 
by TLRs (Magalhaes et al. 2007). The second possibility is that upon epithelial damage 
(induced by chemicals or pathogens), commensal-derived TLR ligands may induce the 
production of protective factors (Rakoff-Nahoum et al. 2004).
Germ-free mice and mice pre-treated with broad-spectrum antibiotics to reduce the 
intestinal microbiota are significantly more susceptible to dextran sodium sulfate (DSS) 
induced colonic inflammation (Kitajima et al. 2001, Rakoff-Nahoum et al. 2004). 
Surprisingly, mice that cannot adequately detect the intestinal microbiota because of a 
genetically engineered deficiency in MyD88 have similar heightened sensitivity to DSS 
colitis (Rakoff-Nahoum et al. 2004). These were unexpected findings because 
previously, the intestinal microbiota was thought to fuel the inflammation of DSS 
colitis. Thus, these investigations highlight the key role of the intestinal microbiota in 
resistance to epithelial injury.
Commensal bacteria aid in metabolism, they synthesise vitamin K and some B vitamins 
(Wostmann 1981). The human genome lacks most of the enzymes required for 
fermentation of glycans to short-chain fatty acids (SCFAs) and, importantly, the distal 
gut commensal microbiome provides its host with this capacity (Cummings & 
Macfarlane 1991, Gibson 1999, Hooper et al. 2002, Smith et al. 2007).
SCFAs, are important for colon barrier function (Magalhaes et al. 2007). In particular, 
butyrate affects several cellular functions: proliferation, membrane synthesis, sodium 
absorption (Zampa et al. 2004). It has been shown that butyrate strongly inhibits the 
production of the pro-inflammatory cytokines IL-12 and TNF, and increases release of 
the anti-inflammatory cytokine IL-10, upon bacterial stimulation (Nancey et al. 2002,
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Saemann et al. 2000, Weber & Kerr 2006). It has been hypothesised that butyrate 
mediates some of its effects through the modulation of the NF-kB pathway (Saemann et 
al. 2000).
Butyrate and LPS, which exist in high concentrations in the colonic lumen, both 
contribute to the expression of heat shock proteins HSP25 and HSP72 (Arvans et al. 
2005). In turn, these factors are important for preserving cell viability and function, 
such as epithelial barrier integrity (Magalhaes et al. 2007). Furthermore, HSPs may 
protect cells by down regulating the production of pro-inflammatory cytokines, which 
in turn, increases the inhibitory effect of butyrate (Kojima et al. 2004, Arvans et al.
2005).
As well as the alterations in the vasculature and the lymphocyte content of the lamina 
propria, the epithelial differentiation programme is also affected by the resident 
microbiota (Berg 1996, Falk et al. 1998, Hooper & Gordon 2001, Hooper et al. 2003, 
Backhed et al. 2004). For example, IEC renewal is reduced in the SI and the villi are 
longer in germ-free animals (Umesaki et al. 1995). Mono-association of germ-free mice 
increases crypt cell proliferation and the ratio of enterocytes to goblet cells on the villus 
(Umesaki et al. 1995).
The responsibility for degradation of mucus glycoproteins produced by the epithelium is 
assigned to components of the intestinal microbiota (Lindstedt et al. 1965), such as 
Peptostreptococcus micros and members of the genera Ruminococcus and 
Bifidobacterium, which produce a variety of glycoside hydrolases (Hoskins et al. 1985, 
Carlstedt-Duke et al. 1986). Germ-ffee animals exhibit a dramatic enlargement of their 
cecum; this is due in large part to accumulation of un-degraded mucus (Gustafsson et al. 
1970) and can be rapidly reversed by mono-association with Peptostreptococcus micros 
(Carlstedt-Duke et al. 1986).
1.6.5.2 Effect of commensals on the immune system
The gut microbiota is a key regulator of the immune system. Some degree of innate 
immune recognition of commensal bacteria is essential for normal development and 
function of the mucosal and peripheral immune system (Macpherson & Uhr 2004b).
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Postnatal colonisation educates the immune system to develop oral tolerance to 
microbial epitopes, resulting in reduced allergic and inflammatory responses (Moreau & 
Corthier 1988, Sudo et al. 1997, Cebra 1999, Hooper & Gordon 2001, Braun-Fahrlander 
2001, Braun-Fahrlander 2002, Macpherson & Uhr 2004b, MacDonald & Gordon 2005, 
Mueller & Macpherson 2006).
The mucosal immune system is undeveloped in germ-free animals: they have 
hypoplastic Peyer’s Patches that contain few germinal centres and reduced IgA 
producing plasma cells (Crabbe et al. 1968, Benveniste et al. 1971, Saito et al. 1998, 
Yamanaka et al. 2003, Macpherson & Uhr 2004b, Smith et al. 2007). The T cell 
content, particularly the CD4+ cells and the apT cell receptor CD8aP~bearing subset are 
also reduced (Guy-Grand et al. 1978, Umesaki et al. 1993, Helgeland et al. 1996, 
Helgeland et al. 1997, Macpherson & Uhr 2004a). In addition, evidence suggests that 
commensals also promote the differentiation, and maintenance of mucosa-associated 
invariant T cells (Treiner et al. 2003).
The immunological abnormalities in germ-free animals are not just confined to the 
mucosal immune system (Smith et al. 2007). Germ-free animals have little to no GALT 
and there is marked skewing of the T-helper cell balance (Bauer et al. 1963, Smith, et al. 
2007). The mice also have hypogammaglobulinaemic serum, mainly because of reduced 
levels of IgG (Benveniste et al. 1971). Colonisation of germ-free mice with Bacteroides 
fragilis or administration of purified bacterial polysaccharide (PSA) corrects the splenic 
architecture, resulting in improved follicle size and organization (Mazmanian et al. 
2005, Wang et al. 2006).
These observations indicate that molecular cross-talk between host and microbe must 
exist to facilitate the normal development and function of immune cells (Artis 2008). 
The IEC gene-expression profile is altered between colonised and germ-free animals, 
colonisation by the model symbiotic microorganism Bacteroides thetaiotaomicron (B. 
theta) induces expression of antibacterial molecules such as the bactericidal angiogenin- 
4 and Reg3y (Bry et al. 1996, Hooper et al. 1999, Hooper et al 2000, Hooper & Gordon 
2001, Stappenbeck, Hooper, & Gordon 2002, Hooper et al. 2003, Backhed et al. 2004, 
Macpherson & Uhr 2004b, Cash et al. 2006, Salzman et al. 2007). In addition, Kelly et 
al. discovered that B. theta induces PPARy expression, which was found to induce
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PPARy-dependent shuttling of the RelA subunit of the NF-kB transcription factor, from 
the nucleus to the cytosolic compartment (Kelly et al. 2004).
Interestingly, it has been proposed that commensal bacteria induce the expression of 
PPARy through the activation of the TLR4-dependent NF-kB signalling pathway, 
suggesting the existence of a negative feedback loop that would help control the 
intensity of NF-kB signals by the microbiota (Dubuquoy et al. 2003). The fact that 
PPARy may play a central role as regulator of intestinal inflammation is also suggested 
by a study in mice, in which an experimental colitis was induced by DSS treatment; 
subsequent administration of an exogenous source of PPARy by local gene therapy 
resulted in an apparent decreased inflammation (Katayama et al. 2003).
Another immunosuppressive effect of commensal bacteria involves the inhibition of the 
N F-kB pathway through the stabilization of IkBgl Incubation of IECs with non- 
pathogenic Salmonella has been shown to induce the accumulation of IkBoi through the 
down-regulation of the protein’s ubiquitination (Neish et al. 2000).
The gut commensal microbiota also bio-transform conjugated bile acids (Hylemon & 
Harder 1998), degrade dietary oxalates (Duncan et al. 2002) and metabolise xenobiotics 
and endogenous toxins (Hooper & Gordon 2001). They influence gut motility (Husebye 
et al. 1994) and affect components of the enteric nervous system (Liu et al. 1997). In 
addition, germ-free conditions are associated with altered composition of serum and 
changes in cardiovascular and neurophysiology (Smith et al. 2007).
Together, these observations support the notion of co-evolution of host and microbe and 
the resultant symbiosis between the two (Gilbert 2001, McFall-Ngai 2002). This 
incredible range of immune and non-immune host changes demonstrate that mammalian 
bodies could be powerfully shaped by the presence of commensal microorganisms. 
Normal host function of many systems is dependent on colonisation, but intestinal 
inflammatory immunopathology can also result from defective mutualism (Smith et al.
2007). These observations emphasise the need to understand more about the roles 
played by the microbiota in humans, as well as the potential for their control and 
modulation. (Kelly et al. 2005, Rakoff-Nahoum & Medzhitov 2006, Ley et al. 2006, 
Winkler et al. 2007, Salzman et al. 2007). Conceptually, these studies support the idea
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that commensals are capable of shaping the host’s immune system, each in organism- 
specific ways and new studies will be needed to evaluate the multitude of species 
(Cassel et al. 2008).
1.6.53 Gram negative Bacteroides thetaiotaomicron as an example of the 
interaction of commensals with the epithelial barrier
B. theta is a predominant member of the normal human (and murine) distal small 
intestinal and colonic microbiota (Moore & Holdeman 1974), which becomes 
prominent during a critical postnatal transition: the switch from mother’s milk to a diet 
rich in plant polysaccharides (Mackie et al. 1999). Members of the genus Bacteroides 
account for 25% of the total bacterial population in the adult human intestine (Moore et 
al. 1978).
Bacteroides species are known to break down a wide variety of otherwise indigestible 
dietary plant polysaccharides (e.g., amylose, amylopectin, and pullulan) (Hooper et al.
2002). B. theta has also evolved the capacity to harvest nutrients from the mucus layer 
that overlies the intestinal epithelium by using a variety of host-derived glycans, 
including chondroitin sulfate, mucin, hyaluronate, and heparin (Hooper et al. 2002). 
Another intriguing manifestation of this symbiont’s highly evolved capacity is to sense 
and respond to environmental cues by one- and two-component signal transduction 
systems (Xu et al. 2003).
B. theta colonisation produces no detectable inflammatory response, as judged by 
histologic surveys (Bry et al. 1996). An influx of IgA-producing B cells does occur in 
the ileal mucosa, 10 days after introduction of B. theta (Bry et al. 1996), but similar 
commensal induced IgA responses have been shown to be T cell-independent and to 
enforce barrier integrity (Macpherson et al. 2000). The influx of IgA-producing B cells 
is accompanied by increased expression of the polymeric immunoglobulin receptor 
(plgR) that transports IgA across the epithelium. There is augmented expression of the 
CRP-ductin gene, encoding both a mucus layer component (muclin) and a putative 
receptor for trefoil peptides (Thim & Mortz 2000). Decay accelerating factor (DAF), an 
apical epithelial inhibitor of complement-mediated cytolysis, increases six fold (Hooper 
& Gordon 2001). In addition, B. theta elicits a 280-fold increase in small proline-rich
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protein-2 (sprr2a) mRNA in villus epithelia (Hooper & Gordon 2001). Members of the 
sprr family contribute to the barrier functions of squamous epithelia, both as a 
component of the comified cell envelope and as cross-bridging proteins linked to 
desmosomal desmoplakin (Steinert et al. 1999). The epithelial sprr2a response suggests 
that this protein participates in fortifying the intestinal epithelial barrier in response to 
bacterial colonization (Hooper & Gordon 2001). Coincident enhancement of expression 
of these three genes should help prevent bacteria from crossing the epithelial barrier and 
to avoid mucosal damage from activation of complement components in intestinal 
secretions (Hooper & Gordon 2001).
B. theta lacks proteins with detectable homology to all known adhesins or flagella 
components (Xu et al. 2003). However, B. theta modulates host expression of a large 
repertoire of outer membrane polysaccharide-binding proteins, suggesting one way that 
B. theta may be able to maintain residency in its niche in the absence of these 
components (Xu et al. 2003).
B. theta has seven capsular polysaccharide synthesis (CPS) loci. Each locus contains 
one or two genes, encoding conserved regulatory proteins, (UpcY and UpcZ homologs) 
positioned upstream of open reading frames (ORFs) specifying carbohydrate 
biosynthetic enzymes, including a variety of putative glycosyltransferases (Krinos et al. 
2001). This mechanism may allow the organism to evade detection by the host immune 
system (Xu et al. 2003). As mentioned above, B. theta can also modulate host 
inflammation by induction of PPARy expression, found to induce shuttling of NF-icB 
from the nucleus to the cytosolic compartment (Kelly et al. 2004).
1.6.6 Effects of probiotics on the gastrointestinal tract
Over the millennia, our species has evolved to cope with, and perhaps benefit from, 
consuming microbes present in decomposing food. Microbes have even been co-opted 
by humans to transform foods via fermentation (Molin 2001). During the last century, 
technological improvements, such as refrigeration and pasteurization, have resulted in 
dramatic decreases, in many countries, of the consumption of food-borne microbes 
(Sonnenburg et al. 2006). This sanitization has coincided with the increased prevalence 
of a number of disorders, both within and outside the GI tract. This includes 
inflammatory bowel disease and atopic states (e.g., asthma and food allergies)
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(Sonnenburg et al. 2006). The “hygiene hypothesis” links these diseases to a decreased 
exposure to microbes (Bach 2002). Thus, the effects of consuming live microbial 
supplements, with presumptive health benefits on human physiology, have become the 
subject of various clinical studies (Marteau et al. 2001, Saavedra 2001).
The known mechanism(s) of action of probiotics has extended beyond just providing 
competitive exclusion of pathogenic bacteria. It has confirmed that probiotic bacteria 
modulate mucosal and systemic immune activity and epithelial function (Fedorak
2008).
1.6.6.1 Probiotics inhibit growth of pathogenic bacteria
The in vitro pathogen (Escherichia coli, Salmonella, Campylobacter, Shigella, Vibrio 
and Clostridium) growth inhibiting properties of probiotics are well documented 
(O'Sullivan & Kullen 2008). Lactic acid bacteria ferment non-absorbed sugars, which 
result mainly into lactic acid, which is absorbed and converted into glucose. The 
presence of Lactobacilli in the proximal intestine, transforming non-absorbed sugars 
into a safe form of energy, may function to prevent bacterial overgrowth with potential 
pathogens (Timmerman 2006a). Furthermore, lactic acid also decreases the luminal pH 
causing a bacteriostatic effect (Timmerman 2006a, Boirivant & Strober 2007). 
Probiotics have been shown to produce a range of antimicrobial substances such as 
diacetyl, bacteriocins, hydrogen peroxide and carbon dioxide (Ouwehand et al. 1999, 
Klaenhammer 2000, Morelli 2000, Saarela et al. 2000). Apart from inhibiting 
pathogenic constituents, probiotics may also exert their health-promoting effects 
through maintenance or stimulation of their commensal counterparts (Timmerman 
2006a).
1.6.6.2 Probiotics ‘silence’ the production of virulence factors
Probiotic bacteria are capable of preventing infection with Staphylococcus aureus, 
without overt growth inhibition or elimination of the pathogen (Gan et al. 2002, Strauss 
2000). In the context of interspecies quorum sensing, a potential mechanism of action 
may be that probiotics are able to ‘silence’ the production of virulence factors (Reid et 
al. 2001). Whether this, so-called quorum quenching, might be a potential probiotic 
mechanism to prevent bacterial disease remains to be answered (Timmerman 2006a). A
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recent report confirmed the potential of Lactobacillus plantarum to inhibit production of 
auto inducers in Pseudomonas aeruginosa (Valdez et al. 2005).
1.6.63 Probiotics block microbial attachment or invasion
Lactobacilli have been shown to adhere to the intestinal mucosa (Tuomola et al. 1999). 
Adhesion to the mucosal epithelium can competitively inhibit the attachment of more 
pathogenic organisms a phenomenon known as competitive exclusion (Mack et al. 
1999, Todoriki et al. 2001). This can occur by physically blocking receptor specific 
adhesion analogs or by steric hindrance. Furthermore, selected Lactobacillus strains, 
which are capable of adhering to IECs, induced the expression of mucin genes in vitro. 
Resulting mucin secretion protected against adhesion of enteropathogenic E. coli 
(EPEC) (Mack et al. 1999, Mack et al. 2003). In addition, soluble factors) secreted by 
probiotics have been found to increase galactose surface expression, which 
consequently might hide other cell surface compounds. This alteration in glycocalyx 
prevented rotavirus attachment and entry into IECs (Freitas et al. 2003).
1.6.6.4 Probiotics improve epithelial and mucosal barrier function
Probiotic intake has been shown to strengthen mucosal barrier function by promoting 
the production of mucosal antibodies and reducing the trans-mucosal transfer of 
antigens (Gill 2003). Various in vitro and in vivo models have shown the potential of 
probiotics to protect the intestinal epithelium against EPEC-induced disruption of 
cytoskeleton and TJ homeostasis (Madsen et al. 2001, Resta-Lenert & Barrett 2003, 
Otte & Podolsky 2004, Zyrek et al. 2007). Moreover, Yan et al. showed protein isolates 
from Lactobacillus rhamnosus inhibit TNF-a-mediated apoptosis and promoted growth 
of both human and mouse IECs and colon explants (Yan et al. 2007).
Probiotics may also indirectly limit mucosal injury through their anti-inflammatory 
effect (Ulisse et al. 2001). For example, production of IL-6 mediates IEC regeneration 
and inhibits apoptosis (Rakoff-Nahoum et al. 2004). Pre-incubation of IECs with the 
Streptococcus thermophilus and Lactobacillus acidophilus prevented epithelial 
permeability changes caused by incubation with TNF-a and IFN-y (Resta-Lenert & 
Barrett 2006). In addition, Lactobacillus plantarum can reverse TNF-a-induced changes 
in intestinal permeability and IL-8 secretion (Ko et al. 2007).
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1.6.6.5 Probiotics alter host immune responses
A large variation in the ability of different Lactobacilli strains to induce pro- and anti­
inflammatory cytokines has been observed (Maassen et al. 2000, Perdigon et al. 2002, 
Halpem et al. 1991, Aattouri & Lemonnier 1997, Solis-Pereyra & Lemonnier 1993, 
Solis-Pereyra et al. 1997, Miettinen et al. 1996, Cross 2002, Miettinen et al. 1998). 
Variations may be related to the unique capacities of probiotics to express particular 
surface or secreted molecules (Boirivant & Strober 2007).
It has been recently reported that the probiotic bacteria Lactobacillus casei also inhibits 
the NF-kB pathway by targeting the degradation of IicBa by transcriptional repression 
of several key proteins involved in the ubiquitination and proteasome-dependent 
degradation of proteins, such as the E3 ligase complex protein Rbxl (Tien et al. 2006).
Probiotics have been shown to enhance humoral immune responses to natural infections 
and systemic or oral immunizations in human subjects (Kaila et al. 1992, Link-Amster 
et al. 1994, Isolauri et al. 1995, Kaila et al. 1995, Majamaa et al. 1995 Marteau et al. 
1997, Fukushima et al. 1998, de Vrese et al. 2001b). An enhancement of serum IgA 
antibody, and IgA, IgG and IgM antibody secreting cells have been reported (Majamaa 
et al. 1995, Kaila et al. 1995, Link-Amster et al. 1994, Kaila et al. 1992). It is important 
to note that probiotic administration is also known to stimulate antibody responses to 
completely unrelated antigens as well as to themselves (Link-Amster et al. 1994, Yasui 
etal. 1989).
Enhanced phagocytic activity of neutrophils and monocytes has been reported in human 
volunteers; following the regular consumption of yoghurt or milk containing probiotics 
(Schiffrin et al. 1995, Pelto et al. 1998, Donnet-Hughes et al. 1999). In addition, 
neutrophils demonstrated an increased oxidative burst or microbicidal capacity (Mikes 
et al. 1995, Arunachalam et al. 2000). Probiotic intake has been reported to be effective 
in restoring the age-related decline in phagocyte function (Arunachalam et al. 2000, Gill 
et al. 2001, Gill & Rutherfurd 2001, Sheih et al. 2001a, Gill 2003).
An enhancement of Natural Killer cell (NK) activity and an increase in the proportion of 
NK cells in the peripheral blood of human volunteers following the regular 
consumption of yoghurt or milk containing probiotics has also been reported (Gill et al.
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2001, Chiang et al. 2000, Sheih et al. 2001b, Takeda et al. 2006). As with phagocytic 
function, the augmentation of NK cell function in the elderly following the 
administration of LAB was significantly correlated with age.
Probiotic species that are good inducers of 1L-12 and TNF-a can skew T-cell 
polarization toward TH1 (Christensen et al. 2002, Mohamadzadeh et al. 2005, 
O'Mahony et al. 2006). However, selected probiotic species are potent inducers of IL-10 
and TGF-p (von der Weid et al. 2001, Niers et al. 2005, Niers et al. 2007), which 
selectively induced regulatory T-cell populations (Kapsenberg 2003, Rachmilewitz et 
al. 2004, Di et al. 2005b, Smits et al. 2005, Baba et al. 2008). Smits et al observed that 
not all Lactobacillus species had the ability to induce suppressor T cells. This implies 
that proteins or other molecules on the surface of bacteria may determine if and how 
they serve as probiotics (Smits et al. 2005).
Given the potential complexity of probiotic function, it is unlikely that any one 
probiotic organism has the capacity to accomplish more than a few of the above 
functions. Indeed, significant differences exist between different probiotic bacterial 
species and strains. Some of these properties are observable only with viable probiotic 
organisms, while others are also observable with dead probiotic organisms or 
components derived from dead organisms. In addition, while most probiotics exert their 
effects, when introduced into the GI tract, there are some that exert their effects through 
systemically administered components. Thus, organisms need to be selected in a more 
rational manner to treat disease (Boirivant & Strober 2007, Ng et al. 2008).
1.6.6.6 Gram positive Lactobacilli as examples of the interaction of probiotics with 
the epithelial barrier
Lactobacillus rhamnosus GG (LGG) is one of the best studied probiotic bacteria in 
clinical trials. It is effective in preventing and treating diarrhoea, primary rotavirus 
infection; atopic dermatitis and milk-hypersensitivity (Pelto et al. 1998, Szajewska et al. 
2001, Kiijavainen et al. 2003). It is of particular interest as it has been found to have a 
benefit in Crohn’s Disease (Malin et al. 1996, Gupta et al. 2000).
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Lactobacillus plantarum 299v (L299v) is a member of the facultatively 
heterofermentative group of Lactobacilli that are frequently isolated from plant material 
and various fermented foods (Vescovo et al. 1993). L299v was originally isolated from 
human intestinal tracts (Johansson et al. 1993) and is one of the major Lactobacillus 
species encountered in the human gut (Finegold et al. 1983, Mikelsaar & Mandar 1993, 
Molin et al. 1993). L299v is reported to bring relief of Irritable Bowel Syndrome 
(Niedzielin et al. 2001).
L299v and LGG are able to bind to ECs in vitro (Johansson et al. 1993), and induce 
increased MUC2 and MUC3 expression, which quantitatively inhibited the adherence of 
EPEC to ECs (Mack et al. 2003).
L299v can colonise the intestinal mucosa of healthy volunteers as the bacterium 
remained for 11 days after administration (Johansson et al. 1993). A mannose specific 
adherence mechanism has been demonstrated in L299v. In addition, mucus-binding 
protein homologues have also been implicated (Altermann et al. 2005). An adhesion­
like protein, classified as elongation factor Tu (EF-Tu), protein has been isolated from 
L299v (Granato et al. 2004).
L299v is capable of inhibiting the trans-epithelial neutrophil migration induced by 
EPEC, but only when added to the monolayers before EPEC. Rather than an indirect 
effect, through a secreted substance produced by the probiotic agent, its effect is direct 
and requires the presence of the bacterium (Michail & Abernathy 2003).
LGG has been found to possess immune-modulatory effects by inducing activation of 
NF-kB (Miettinen et al. 2000), production of cytokines (Miettinen et al. 1998) and nitric 
oxide (NO) (Korhonen et al. 2001, Korhonen et al. 2002). In vivo administration of 
LGG promotes systemic antibody responses in children suffering from rotavirus 
infection (Kaila et al. 1992). Cell wall components, soluble factors, and genomic DNA 
from LGG have all been found to be immunostimulatory (Iliev et al. 2005, Tao et al.
2006). The pro-inflammatory capacity of L299v was found to be due to LTA and to be 
TLR2-dependent (Grangette et al. 2005).
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LGG may also directly alter the intestinal epithelium phenotype by regulating gene- 
expression. LGG significantly altered gene expression in small bowel (Di et al. 2005a). 
334 genes were up-regulated and 92 genes were down-regulated, most involved in 
immune responses and inflammation, apoptosis and other specific cellular pathways 
maintaining epithelial homeostasis (Di Caro et al. 2005a).
1.6.7 Interaction of pathogens with the epithelial barrier
Intestinal inflammation occurs when an enteric pathogen bypasses barriers imposed by 
the commensal microbiota, and the epithelial lining. Altogether, these signals incite a 
rapid inflammatory host response characterised by secretion of pro-inflammatory 
cytokines and chemokines attracting neutrophils, monocytes, and DCs to the site of 
infection, aimed at bacterial eradication (Pedron & Sansonetti 2008). In reality, a much 
more subtle game is engaged in which the pathogen subverts inflammation to escape its 
lethal effect. Concomitantly pathogens can take advantage of inflammation, to breach 
the barrier effect imposed by the microbiota and the epithelium itself (Pedron & 
Sansonetti 2008). For example, Listeria monocytogenes invades recruited monocytes 
and uses them as vehicles to spread to distant tissues (Gray & Killinger 1966). In 
addition, gastric epithelial inflammation seems to be vital for Helicobacter pylori to 
establish long-term colonization (Mimuro et al. 2007).
I.6.7.1 The interaction of Gram negative Enteropathogenic E  coli with the 
epithelial barrier
Escherichia coli are a genetically diverse group exhibiting varied phenotypes within 
vertebrate hosts. The natural habitat of E. coli is the GI tract, and in humans it is the 
predominant facultative anaerobe of the colonic microbiota. The majority of the E. coli 
strains reside in a commensal fashion within their host without causing damage but may 
cause harm in the immunocompromised host or when the intestinal barrier is disrupted. 
Pathogenic E. coli can be distinguished from the commensal microbiota by their ability 
to colonise the host and cause clinically significant pathology (Casadevall & Pirofski
2001).
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Diarrhoeagenic E. coli strains have evolved with distinctive virulence mechanisms, 
common amongst diarrhoeagenic E. coli is the ability to colonise the intestinal mucosae, 
evade host defences, multiply and cause host damage. Three general diarrhoeagenic 
mechanisms have been identified: Enterotoxigenic E. coli (ETEC) and
Enteroaggregative E. coli (EAEC) produce enterotoxin, Enteroinvasive E. coli (EIEC) 
invade host cells and Enteropathogenic E. coli (EPEC) and Enterohaemoragic E. coli 
(EHEC) adhere intimately, translocate bacterial effecter proteins into the host cell and 
produce an attaching effacing lesion (Nataro & Kaper 1998)
1.6.7.1.1 EPEC Colonisation by ‘localised adherence’
Once the bacterium has transversed the mucus layer and reached the epithelial surface, 
adherence and colonisation follows. Adherence to host cells prevents bacterial removal 
by the faecal stream, enabling commensal organisms to select an ecological niche and 
allowing pathogens to target their site of infection (Hedlund et al. 2001a). Bacteria carry 
fimbriae, also known as pili, hair-like appendages (2-8nm in diameter), built by protein 
subunits called fimbrins or pilins that usually extend l-2pm (Fernandez & Berenguer 
2000). Fimbriae possess lectin-like domains that recognise oligosaccharide epitopes on 
host cell surface glycolipids or glycoproteins (Hedlund et al. 2001b). The resulting 
specific adherence promotes colonisation, but adherence has also been identified as a 
virulence factor, facilitating tissue attack, invasion and inflammation.
Indeed, the first stage of EPEC and EAEC pathogenesis involves the initial adherence 
of bacteria to epithelial cells in a characteristic pattern called “localised adherence” 
where bacteria form localised micro-colonies on the surface of cells (Scaletsky et al. 
1984). Several bacterial surface-organelles and secreted products have been implicated 
in this adherence.
The bundle forming pilus (BFP) a 7nm type IV fimbriae (Giron et al. 1991, Giron et al. 
1993) is encoded on a large plasmid (~80kb and 50-70 MDa) called the EPEC 
adherence factor plasmid (EAF) (Nataro et al. 1987c). Several studies have also 
implicated BFP in initial binding of EPEC to host IECs (Giron et al. 1991, Donnenberg 
et al. 1992, Tobe & Sasakawa 2001, Tobe & Sasakawa 2002, Cleary et al. 2004). Cleary 
et al. found early rapid bacterial adhesion correlated with BFP fibrils connecting 
bacteria to brush border surface (Cleary et al. 2004). An adhesive role for BFP implies a
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specific host cell BFP receptor. Numerous candidates have been proposed, including a 
variety of oligosaccharides due to their inhibition of localised adherence. These include 
acetyl-galactosamine, fucosylated tetra- and penta-saccharides and lactosyl glycans 
(Vanmaele et al. 1999, Cravioto et al. 1991). The phospholipid 
phosphatidylethanolamine (PE) receptor has also been implicated (Nougayrede et al.
2003). However, in all cases saturability and strength of the interaction has been weak 
suggesting a specific receptor for BFP remains unidentified. Antibodies to BFP only 
partially block adherence (Giron, Ho, & Schoolnik 1991); suggesting that other factors 
may also be involved in EPEC adherence (Elliott & Kaper 1997). Flagella have been 
implicated during adhesion (Giron et al. 2002). However, mutation offliC  the gene for 
the flagellin structural protein of EPEC also resulted in a reduction in the expression of 
BFP (Giron et al. 2002). Therefore, the role of flagella in adhesion remains to be 
clarified.
Type 1 fimbriae have also been implicated in EPEC adhesion (Yamamoto et al. 1990, 
Bloch et al. 1992, Connell et al. 1996, Mulvey et al. 1998, Sokurenko et al. 1998). The 
type 1 fimbria is the most common adhesin observed in commensal and pathogenic E. 
coli isolates (Ofek & Doyle 1994). A type 1 fimbria is a 7nm-wide, approximately lpm- 
long, rod shaped structure consisting of four different components that are added to the 
base of the growing organelle (Lowe, Holt, & Eisenstein 1987). It has been shown that 
the receptor-recognizing element of type 1 fimbriae is the 30kDa FimH protein 
(Krogfelt et al. 1990). FimH mediates adhesion to a variety of mannosylated 
glycoprotiens (Schembri & Klemm 2001). This attachment can be inhibited by the 
addition of mannose or a-methyl-D-mannoside (Pratt & Kolter 1998). Immunization 
with type 1 fimbria prevents subsequent urogenital mucosal infection by E. coli 
(Langermann et al. 1997, Langermann et al. 2000).
EPEC secreted protein A (EspA) filaments part of the EPEC Type Three Secretion 
System (TTSS) may also function as an adhesins (Knutton et al. 1998, Daniell et al. 
2001, Shaw et al. 2001, Cleary et al. 2004). Lymphostatin has also been identified to 
function as an adhesion factor for EPEC (Stevens et al. 2002). Mutations of lifA, the 
gene for lymphostatin, or pre-treatment with polyclonal antibodies lead to a marked 
decrease in adherence to IECs. In addition, inactivation of lifA in STEC serotypes 05
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and Ol 11 result in reduced association with cultured Hela cells (Stevens et al. 2002). In 
the same study, inoculation of calves with mutant STEC led to significantly reduced 
numbers of shed bacteria in the faeces. In addition, there is evidence to support for a 
regulatory function of lifA in bacteria adherence (Tatsuno et al. 2001).
1.6.7.1.2 Signal transduction and formation of intimate adherence
The second stage in EPEC infection is characterised by signal transduction, EPEC 
secretes a number of proteins (EPEC secreted proteins, Esp) via a TTSS (Jarvis et al. 
1995, Kenny & Finlay 1995, Kenny et al. 1996). The TTSS apparatus is utilised by 
many enteric pathogens; it acts as a molecular syringe to inject effecter proteins directly 
into host cells (Hueck 1998, Donnenberg 2000). The TTSS apparatus is encoded by the 
LEE pathogenicity island. The LEE encoded genes are separated into three functional 
domains a region encoding the biogenesis of the TTSS such as structural components 
EscN and EscF (Elliott et al. 1998), EscN is an ATPase that powers the type three 
secretion system and EscF the putative needle component (Rosenshine et al. 2000, 
Wilson et al. 2001). A second region encodes the EPEC secreted proteins including 
EspA, EspB, EspD and EspF and a third region encoding for intimate adherence (Tir 
and intimin).
Briefly, EspA binds to EscF, the structural needle protein, and forms a 0.7pm long 
hollow extension of the TTSS needle complex made up of polymorphic EspA filaments 
(Daniell et al. 2001, Sekiya et al. 2001, Shaw et al. 2001), through which the EspB and 
EspD passes before inserting into the host plasma membrane to form a translocation- 
pore in the host cell membrane (Fig 14); thus allowing translocation of LEE encoded 
effecter proteins into the host cell cytosol to interfere with signalling processes (Frankel 
et al. 1998, Knutton et al. 1998). EscN a functionally unique ATPase provides an inner- 
membrane recognition gate for the TTSS chaperone-virulence effecter complexes as 
well as a potential source of energy for their subsequent secretion (Woestyn et al. 1994, 
Hueck 1998, Akeda & Galan 2004).
One of the prominent pathogenic features of EPEC during the colonisation of IECs is 
the ability to injure the epithelial barrier and eventually kill host cells (Nagai et al.
2005). Until recently the meaning of this biological paradoxical activity in bacterial 
colonisation remained largely speculative. However, as mentioned above Pedron et al.
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suggest that pathogens use the inflammation they elicit to subvert the integrated barrier 
established by the resident microbiota and the epithelium. They eventually suppress this 
inflammation in order to secure their colonisation and full invasion potential (Pedron & 
Sansonetti 2008).
EscN
Figure 14: Schematic representation of the Type Three Secretion System (Pallen et 
al. 2005).
EspF is not required for A/E lesion formation (McNamara & Donnenberg 1998) but has 
complex and multiple functions overlapping with various other EPEC encoded 
molecules; which are collectively involved in disrupting epithelial barrier; affecting host 
cell death, colonisation and immune evasion. EspF increases permeability via tight 
junction associated protein occludin (McNamara et al. 2001, Viswanathan et al. 2004a, 
Viswanathan et al. 2004b). EspF can also interact with intermediate filament protein 
cytokeratin 18 collapsing the intermediate filament network (Batchelor et al. 2004, 
Viswanathan et al. 2004b) and has been implicated to play a role in brush border 
remodelling (Shaw et al. 2005). Interestingly, EspF in conjunction with Map and
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Intimin as well as Tir can rapidly inactivate the major water pump of the small intestine 
sodium-D-glucose co-transporters (SGLT-1) (Dean et al. 2006). EspF seems to play an 
important role by targeting mitochondria to induce programmed cell death (Kenny & 
Jepson 2000, Crane et al. 2001, Nougayrede & Donnenberg 2004, Nagai et al. 2005). 
Recently, it has also been found that EspF induces or facilitates host cell death by 
targeting and interfering with the putative protective function of AbcfZ, a protein of 
unknown function, but a member of the ABC-transporter family (Nougayrede et al.
2007).
Nagai et al. suggest that EspF activity was also required for promotion of bacterial 
colonisation (Nagai et al. 2005). They speculated that EspF activity may be needed for 
the pathogen to stimulate intestinal cell metabolism, thereby increasing the opportunity 
for bacteria to attach to freshly renewed cell surface; possibly conferring some 
advantage over epithelia in a normal metabolic state.
EspF has also been implicated in immune evasion of EPEC; it has been reported to be 
required for EPEC-induced inhibition of macrophage phagocytosis (Quitard et al.
2006). Furthermore, EPEC has recently been shown to actively regulate their 
translocation across M cells via a PI3K-dependent cellular mechanism and EspF is 
required (Martinez-Argudo et al. 2007).
EPEC also encodes non-TTSS-dependent virulence-associated proteins, such as the 
serine protease EspC (Stein et al. 1996), secreted into supernatant by the type V 
secretion system an auto-transporter mechanism (Stein et al. 1996, Mellies et al. 2001, 
Henderson & Nataro 2001, Henderson et al. 2004). Biological properties of EspC 
include affects on the short circuit current (Henderson et al. 1999) and an enterotoxic 
effect resulting in actin cytoskeleton disruption (Mellies et al. 2001); EspC causes 
cytotoxic epithelial damage on HEp-2 cells characterised by cell contraction and 
detachment (Navarro-Garcia et al. 2004), hydrolysis of pepsin, human coagulation 
factor V and spectrin (Dutta et al. 2002). EspC displays protease activity towards human 
haemoglobin allowing utilization of haem as an iron source for bacterial growth (Drago- 
Serrano et al. 2006).
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Another non-TTSS-dependent virulence-associated protein is lymphocyte-inhibiting 
factor LifA. The lifA gene encodes for a toxin, lymphostatin, which inhibits peripheral 
blood, human and murine G1 lymphocyte proliferation, and the mitogen-stimulated 
cytokine synthesis (Klapproth et al. 1995, Klapproth et al. 2000). lifA is a chromosomal 
gene that spans 9669bp and lymphostatin has a molecular mass of 366kDa making it 
one of the largest bacterial toxins known (Klapproth et al. 2000). Recently, Afset et al. 
found that in atypical EPEC, lifA was the gene with the strongest association with 
diarrhoea (Afset et al. 2006).
1.6.7.13 The attaching and effacing lesion of EPEC
EPEC produces an attaching and effacing (A/E) lesion (Moon et al. 1983), which results 
in enteropathy. Characteristic brush border membrane lesions consist of intimate 
attachment of bacterial micro-colonies. Furthermore, localised destruction of brush 
border microvilli, and pedestal formation of the apical enterocyte plasma membrane 
beneath the attached bacteria (Ulshen & Rollo 1980, Rothbaum et al. 1982). Ultra 
structural studies show beneath this bacterium-host cell interface, are dense actin 
microfilaments and the bacteria are seen adhering to cellular projections, which were 
termed pedestals (Moon et al 1983, Batt et al. 1987, Knutton et al. 1987) (Fig 15). The 
presence of A/E lesion on the intestinal mucosae produces a reduction in the absorptive 
surface area leading to malabsorption (Rothbaum et al. 1982).
Intimin is necessary for the intimate adhesion of EPEC to host cells. The 94kDa outer 
membrane protein from the prototype EPEC strain E2348/69 is encoded by the eae (E. 
coli attaching and effacing) gene located in the LEE upstream from the esp genes 
(Donnenberg & Kaper 1991, Jerse & Kaper 1991, Kenny & Finlay 1997).
The EPEC TTSS allows EPEC to inject the receptor, for intimin, into the host cell to 
enable intimate attachment to the cellular membrane, via the translocated intimin 
receptor (Tir). Tir is the first example of a bacterial pathogen injecting a receptor for its 
own ligand into the host cell (Knutton, Rosenshine, Pallen, Nisan, Neves, Bain, Wolff, 
Dougan, & Frankel 1998). Tir binds to cytoskeletal proteins, which may anchor the 
bacteria to the host cell and allow cell signalling events to occur. Tir is essential for 
A/E lesion formation and actin nucleation (Rosenshine et al. 1992, Rosenshine et al. 
1996).
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(a)
Figure 15: The attaching and effacing lesion of EPEC
a Molecules involved in AE lesion formation (Bhavsar et al. 2007) b AE histopathology 
(Kaper et al. 2004).
1.6.7.2 Enteroaggregative E. coli (EAEC)
EAEC was first described in 1985 (Mathewson et al. 1985), recognised by its distinctive 
adherence to HEp-2 cells in an aggregative, stacked brick-like pattern (Nataro et al. 
1987b). This adherence pattern, distinguishable from the adherence patterns manifested 
by EPEC and DAEC, was first significantly associated with diarrhea among children in 
Santiago, Chile in 1987 (Nataro et al. 1987c). 042 was isolated from an infant with 
diarrhoea in Lima, Peru, in 1983. It adheres to HEp-2 cells in a distinctive aggregative
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pattern, and the HEp-2 assay (Nataro et al. 1987b) and a DNA probe (Baudry et al. 
1990) are used as diagnostic tools for EAEC. Human volunteers inoculated with 042 
developed watery, non-bloody diarrhoea without fever (Nataro et al. 1995).
EAEC targets both the small and large bowel mucosal surface followed by the 
elaboration of enterotoxins, it is genetically negative for intimin and Stx (Nataro et al.
1998). EAEC adherence requires expression of aggregative adherence fimbriae (AAFs), 
which are encoded on 55-65MDa plasmids, collectively called pAA (Vial et al. 1988, 
Elias et al. 1999). At least three distinctive AAF alleles have been described (Nataro et 
al. 1992, Czeczulin et al. 1997, Bernier et al. 2002). The EAEC prototype strain 042, 
express the AAF/II allele, encoded on plasmid pAA2. The AAF/II fimbria is 5nm in 
diameter and mediates adhesion to HEp-2 cells and colonic explants during IVOC 
(Czeczulin et al. 1997). Cota et al. proposed that the AAF adhesins are composed of 
homopolymeric fimbrial shaft, comprising the AafA protein in AAF/II and a minor 
fimbria-associated adhesin, AafB in AAF/II (Cota et al. 2004). The AafB protein is 
similar to AfaD of uropathogenic E. coli which mediates binding to pi intergrin 
(Plancon et al. 2003). However, an aaJB null mutant of 042 adhered as well as the 
parent strain to human colonic tissue sections in vitro (Elias et al. 1999); so the 
contribution of AafB is unclear.
1.6.73 Gram positive Staphylococcus aureus
Staphylococcus aureus is an opportunistic pathogen, often colonizing hosts 
asymptomatically (Fournier & Philpott 2005). S. aureus is a common coloniser of 
human skin and mucosal surfaces and is a normal inhabitant of the GI tract (Christie et 
al. 1988, Kluytmans et al. 1997). Breached mucocutaneous membranes or impaired host 
immunity facilitate tissue invasion and blood dissemination of S. aureus. The primary 
site of infection is often a breach in the body surface such as skin or soft tissue rather 
than enteric (Reuben et al. 1989, Fournier & Philpott 2005). Although in the GI tract, in 
certain situations, the organism may overgrow and become associated with disease. 
However, since the advent of the antibiotic era, reports of staphylococcal enterocolitis 
have been uncommon in adults and children (Christie et al. 1988). Once barrier breach 
and dissemination occurs, S. aureus causes life-threatening systemic diseases, such as 
osteomyelitis, endocarditis, pneumonia and septic and toxic shock (Marrack & Kappler 
1990, Fournier & Philpott 2005), resulting from the ability of this pathogen to attach to
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cells or tissues; escape the host immune system and elaborate proteases, exotoxins, and 
enzymes, factors that specifically cause cell and tissue damage (Projan & Novick 1997).
1.8 Role of bacteria in Inflammatory Bowel Disease pathogenesis
Chronic inflammatory bowel diseases (IBD) represent a group of disorders that cause 
chronic relapsing intestinal inflammation or ulceration in the intestine. IBD is classified 
into two main idiotypes: Ulcerative Colitis (UC) and Crohn’s Disease (CD), with those 
that cannot be defined into either category called indeterminate colitis (Podolsky 2002).
1.8.1 Prevalence of IBD
The prevalence of IBD is highest in North America, northern Europe and the United 
Kingdom, with the average number of cases ranging from 100 to 200 per 100,000 
persons (Cho 2008). Most reports show IBD is more common in European Americans 
compared with African Americans, with the lowest rates of IBD reported in Hispanics 
and Asians (Sandler 1994, Yang & Rotter 1994, Calkins & Mendeloff 1995). However, 
the prevalence of IBD increases in populations and regions with industrialization 
(Ogunbi et al. 1998). Within populations of European ancestry, the rates of IBD are 
higher in persons of Jewish descent than other ethnic groups (Sandler 1994, Yang & 
Rotter 1994). The lower incidence of IBD in Asia and Africa compared with North 
America and Europe probably reflects both genetic and environmental factors (Cho 
2008). Although the precise environmental factors that account for changing IBD 
prevalence have not been defined, the role of changing dietary and the intestinal 
microbial milieu probably has a key pathogenic role that is common to CD and UC 
(Cho 2008).
1.8.2 Pathology of IBD
CD can be distinguished from UC in that the inflammation associated with CD is 
transmural and often discontinuous lesions can occur anywhere in the GI tract. By 
contrast, the inflammatory changes of UC typically involve only the superficial mucosal 
and sub-mucosal layers of the intestinal wall. CD most commonly involves the ileum 
and colon but can affect any region of the gut; UC always involves the rectum, and 
inflammation may extend as far as the cecum in a continuous pattern (Podolsky 2002).
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In CD involvement of the ileocaecal region is observed in 29% of affected children 
while the colon is involved in 20% of affected children; both the colon and ileum are 
involved in 42% of children. These percentages are roughly comparable to the values 
observed in patients with adult-onset disease (Hugot & Bellaiche 2007). This is not the 
case for jejunal and proximal ileum involvement, which is more frequent (9%) in 
children (Cuffari et al. 2005).
Key histopathological features of UC include a neutrophil influx into the lamina propria 
and the crypts, leading to micro-abscess formation (Fig 16). Depletion of goblet cell 
mucin is also common. In CD fistulae and strictures occur and macrophage aggregates 
frequently form non-caseating granulomas. Involvement of the terminal ileum is most 
common and the earliest mucosal lesions in CD often appear over Peyer’s Patches (Fig 
15) (Podolsky 2002, Xavier & Podolsky 2007).
C ro h n ’s disease Ulcerative colitis
Granuloma Crypt abscess
Figure 16: Histological hallmarks of IBD (Xavier & Podolsky 2007). CD-(biopsy 
from terminal ileum with active disease) a discrete granuloma composed of compact 
macrophages, giant cells and epithelioid cells. Surrounding the nodule there is marked 
infiltration of lymphoid cells, plasma cells and other inflammatory cells, but there is no 
necrosis. UC-(biopsy from colon with active disease) a crypt abscess composed of 
transmigrated neutrophils and the surrounding epithelium exhibits features of acute 
mucosal injury.
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Endoscopically, characteristic CD lesions are discontinuous. Aphthous ulcers are small 
lesions limited to the mucosa while longitudinal deep ulcerations and pseudopolyps are 
more severe lesions. In UC, the mucosa appears friable with spontaneous or induced 
bleeding, Fig 17 (Hugot & Bellaiche 2007).
Figure 17: Endoscopic findings in children affected by CD or UC (Hugot & 
Bellaiche 2007) (a) aphthous ulcers in CD, (b), (c) ulcerations in CD, (d) pseudopolyps 
in CD, (e), (f) inflammation and ulceration in UC
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1.83 Clinical features of CD
In CD clinical features are rather variable depending on the site of bowel involvement. 
However, the most common symptoms are fever, pain in the abdomen, persistent 
diarrhoea, a feeling of fullness, loss of appetite and weight loss. If the colon is inflamed 
the symptoms can exactly mimic those of UC. With the rather more typical pattern of 
ileal inflammation, obstructive symptoms of abdominal pain and distension after meals 
can be more prominent than the symptoms of diarrhoea. In the early stages it is often 
mistaken for appendicitis. Sometimes there will be rectal bleeding and fever; and in 
extreme cases can lead to blockages of the intestine, caused by scar tissue. If perforation 
through the intestine wall occurs, this can lead to peritonitis and death (Podolsky 2002, 
Xavier & Podolsky 2007).
The peak age of onset is in the second to fourth decades of life (Cho 2008). Depending 
on the definition of the paediatric age group, in 7% to 15% of patients the reported onset 
is in childhood (Hugot & Bellaiche 2007). The incidence of IBDs in children has 
recently increased (Hugot & Bellaiche 2007), with CD reported to be more frequent 
than UC with a male predominance (Griffith & Hugot 2004). The condition lasts for a 
lifetime; there are many periods of quiescence, but flare-ups are always liable to occur. 
For many patients CD imposes a substantial personal burden, with unpredictable 
fluctuating symptoms, time off school or work, the need for expensive drugs, or surgery 
and multidisciplinary care (Parkes & Jewell 2001, Bonen & Cho 2003, Cho 2008).
1.8.4 Immune status of Crohn’s Disease
The aetiology of CD remains unknown and will be explored in section 1.8.6, but 
dysfunctional innate immune responses against microbial factors seem important 
(Henckaerts et al. 2007). Mutations in PRRs of the innate immune system have been 
associated with CD susceptibility, which are detailed in section 1.8.5, these mutations 
may be responsible for the aberrant recognition of microbes observed in CD.
Alternatively, altered expression of PRRs may be responsible. For example, TLR4 
expression is significantly increased in IECs and lamina propria mononuclear cells 
throughout the lower GI tract in IBD (Cario & Podolsky 2000, Hausmann et al. 2002, 
Kalis et al. 2003, Hart et al. 2005). CD 14 is also highly up-regulated in recruited 
monocytes of the intestinal mucosa in active IBD (Rogler et al. 1998) and has been
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suggested to play a role promoting hyper-responsiveness of intestinal epithelium to LPS 
(Cario et al. 2000). Furthermore, TH1 cytokines such as IFN-y and TNF-a strongly up- 
regulate TLR4 possibly acting in an autocrine loop, which may lead to perpetuation of 
intestinal inflammation by altering TLR4 responsiveness to commensals (Abreu et al. 
2002, Suzuki et al. 2003).
The recognition of microbes by PPRs on innate immune cells initiates sequential 
activation of the adaptive immunity. By inducing pro-inflammatory cytokine production 
and enhanced antigen presentation to naive T cells (Hemmi & Akira 2005). Thus, the 
loss of tolerance to intestinal bacteria that underlies CD, results in an elevated adaptive 
immune response to these bacteria (Henckaerts et al. 2007).
In established lesions, there is an infiltration of inflammatory cells focally in the bowel, 
leading to the production of pro-inflammatory cytokines and propagation of the immune 
response. Expression and activation of NF-kB p65 is strongly induced in the inflamed 
gut of IBD patients, especially in macrophages and crypt IECs (Neurath et al. 1996, 
Rogler et al. 1998). Interestingly, the amount of activated NF-icB correlates significantly 
with the severity of intestinal inflammation (Rogler et al. 1998). The increased NF-kB 
expression is accompanied by an increased capacity of these cells to over-express a TH1 
cytokine profile such as TNF-a, IL-1, IL-6 & IL-8 involved in the acute phase response 
and IFN-y with TNF-a involved in chronic inflammation (Neurath et al. 1996, Podolsky
2002). NF-kB is also able to regulate the expression of IL-12 and IL-23 (Becker et al.
2003); thus leading to TH1 and TH17 differentiation. TH17 immune responses also play 
a role in the pathogenesis of CD (Xavier St Podolsky 2007, Strober et al. 2007).
To some extent, these pro-inflammatory cytokines are directly involved in the mucosal 
tissue damage typically occurring in CD. For example, TNF-a, IL-1 and IL-17 mediate 
up-regulation of matrix metalloproteinase production, notably stromolysin-1, which 
results in severe damage of the extracellular matrix and mucosal degradation (Pallone & 
Monteleone 2001, Holtmann & Neurath 2004, Kolls & Linden 2004).
Additionally, cytokines such as IL-6 up-regulate adhesion molecules, such as ICAM1, 
and facilitate recruitment of auxiliary effecter cells, including neutrophils and
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phagocytes, which contribute to amplification of the inflammatory response and further 
tissue damage (Shanahan 2002, Wang et al. 2003, Sartor 2006).
IL-8 is the main chemokine involved in neutrophil recruitment and activation 
(Baggiolini et al. 1994). A major role for IL-8 in mucosal ulcerations in IBD has been 
suspected (MacDermott et al. 1998). Cole et al. reported that inflamed colonic mucosa 
is associated with more neutrophil migration than un-inflamed mucosa (Cole et al. 
1996). Activated neutrophils are capable of producing and releasing tissue-degrading 
enzymes, reactive oxygen species (Raab et al. 1993, Mazzucchelli et al. 1994). 
Furthermore, neutrophil granulocytes contain myloperoxidase, an antibacterial, tissue* 
degrading enzyme which collectively may contribute to IBD tissue damage (Raab et al. 
1993).
Chronically activated macrophages stimulate fibroblast proliferation and collagen 
production, scar tissue develops (fibrosis) resulting in the significant tissue damage and 
granuloma formation seen in CD (Kovacs & DiPietro 1994, von et al. 2000).
Activation of NF-kB stimulates expression of co-stimulatory molecules (CD40, CD80, 
CD86, and the inducible T-cell co-stimulator [ICOS]) (Sartor 2006). In conjunction 
with NF-xB-induced cytokines further stimulation, activation and differentiation of 
lamina propria immune cells, results in the perpetuation of mucosal inflammation; 
especially, the differentiation of TH1 cells which are of pivotal importance for the 
pathogenesis of IBD (Pallone & Monteleone 2001, Neurath et al. 2002). This is strongly 
driven by the major TH1 -inducing cytokine IL-12, but is also supported by IL-23 and 
TNF-a (Plevy et al. 1997, Oppmann et al. 2000, Pallone & Monteleone 2001, Neurath 
et al. 2002). As an additional feature, NF-kB induced TNF-a is in turn able to potentiate 
the activation of NF-kB, thereby providing a kind of positive feedback (Holtmann & 
Neurath 2004).
TH17 cells have emerged as important mediators of the T-cell response in gut 
inflammation. IL-17 is a pro-inflammatory cytokine that enhances T-cell priming and 
stimulates fibroblasts, endothelial cells, macrophages, and epithelial cells to produce 
multiple pro-inflammatory mediators such as IL-1, IL-6, TNF, NOS2, metalloproteases, 
and chemokines (Kolls & Linden 2004). The levels of both IL-23 and IL-17 are
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increased in CD tissue (Fujino et al. 2003a, Schmidt et al. 2005) and expansion of a 
pathogenic IL-6/IL-17 producing memory-activated T-cell population that can trigger 
the inflammatory cascade leading to intestinal inflammation have been observed (Shih 
& Targan 2008). Bacteria-reactive TH17 cells are potent effecter cells in chronic colitis 
(Elson et al. 2006), in addition to producing IL-17, TH17 cells produce IL-22, the 
receptors of which are not expressed by haematopoietic cells but by IECs. Interestingly, 
serum IL-22 levels are increased in individuals with CD and this correlates positively 
with CD activity (Wolk et al. 2007).
In CD, mucosal T cells are resistant to apoptosis, this leads to accumulation of T cells 
and perpetuation of the inflammatory response. Such resistance has been attributed to 
signalling of T cells by increased mucosal concentrations of IL-6. sIL-6R that is 
released by activated macrophages in CD is thought to form a complex with IL-6 and 
stimulate a cascade of anti-apoptotic gene expression within intestinal T cells (Shanahan 
2002).
Many systemic acute phase effects are due to the combined action of IL-1, TNF-a and 
IL-6. Each of these cytokines acts on the hypothalamus to induce a fever response. 
Within 12-24h of the onset of an acute-phase inflammatory response, increased levels of 
IL-1, TNF-a and IL-6 induce synthesis of hormones such as hydrocortisone and induce 
production of acute-phase proteins including C-reactive protein, by hepatocytes. TNF-a 
also acts on vascular endothelial cells and macrophages to induce secretion of colony- 
stimulating factors. These stimulate haematopoiesis, resulting in transient increases in 
the necessary white blood cells to fight an infection (Mazlam & Hodgson 1992, 
Mackowiak 1998, Belfer et al. 2004).
Reports are conflicting with regard to IL-8 expression in IBD (Mahida et al. 1992, 
Nielsen et al. 1997, Daig et al. 2000, Imada et al. 2001, Katsuta et al. 2000, Korzenik & 
Dieckgraefe 2005, Marks et al. 2006, Reddy et al. 2007). Discrepancies exist between 
IL-8 levels and histological inflammation or disease activity (Mazzucchelli et al. 1994, 
Gibson & Rosella 1995, McLaughlan et al. 1997, Nielsen et al. 1997, Daig et al. 2000, 
Stallmach et al. 2004, Reddy et al. 2007). Most studies have focused on adult patients 
with long standing disease and established chronic inflammatory lesions (Reddy et al.
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2007). High levels of IL-8 are observed in chronic lesions compared with early disease 
(Brandt et al. 2000). Further, IL-8 expression increases with age (Nanthakumar et al. 
2000). To date, very few studies have investigated IL-8 expression in a paediatric IBD 
population.
Whilst NF-kB in macrophages is regarded as a potent pro-inflammatory player, its role 
in IECs has recently been suggested to be dual in nature (Nenci et al. 2007, Zaph et al. 
2007). Although increased NF-kB expression is accompanied by an increased TH1 
cytokine profile; NEMO-deficient IECs show an increased rate of apoptosis and a 
decreased production of AMPs, subsequently resulting in an impaired integrity of the 
epithelial barrier and enhanced mucosal immune responses. Furthermore, mice with an 
IEC-specific deletion of IKK-p showed a reduced expression of TSLP, an impaired 
development of TH2 response, and therefore an exacerbated production of pro- 
inflammatory TH1 cytokines (Zaph et al. 2007, Nenci et al. 2007). Both models of IEC- 
specific NF-kB inhibition highlight an anti-inflammatory role for NF-kB (Nenci et al. 
2007, Zaph et al. 2007). Thus, NF-kB influences numerous immunological processes 
within the intestinal mucosa in cell-specific ways. The involvement of this transcription 
factor is central to the development, maintenance and chronification of IBD.
1.8.5 Genetics of CD
5-20% of patients with CD have a family history of the disease without increased 
frequency in spouses. In addition, there are significantly higher rates of disease 
concordance in monozygotic twins (44%) compared with dizygotic twins (3.8%), 
suggesting that CD is heritable (Binder 1998). Furthermore, ethnic differences in 
disease frequency, e.g. prevalence in Ashkenazi Jews all strongly suggest that CD is a 
genetic disorder (Binder 1998). Genome wide scanning (GWS) has led to the 
identification of IBD susceptibility loci at chromosomes 1, 3-7, 12, 14, 16, and 19 
(Hugot et al. 1996, Ohmen et al. 1996, Thompson et al. 1996, Cavanaugh et al. 1998, 
Cho et al. 1998, Curran et al. 1998, Annese et al. 1999, Orholm et al. 2000, Rioux et al. 
2000, Rioux et al. 2001, Halfvarson et al. 2003).
The discovery of NOD2/CARD15 within the IBD1 locus as the first susceptibility gene 
in CD has shifted the focus of research into the pathogenesis of CD, firmly to the innate 
immune response and the integrity of the epithelial barrier (Hampe et al. 2001, Hugot et
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al. 2001, Ogura et al. 2001). The 3 major CD-associated polymorphisms (Arg702Trp, 
Gly908Arg, and Leul007fsinsC) are located in or near the Leucine Rich Repeat (LRR) 
domain, interfering with the ability of NOD2/CARD15 to recognise MDP (Ahmad et al.
2002, Lesage et al. 2002, Bairead et al. 2003, Brant et al. 2003, Abraham & Cho 2006, 
Gaya et al. 2006, van Heel et al. 2006). There are several contradictory findings on 
mutations conferring gain or loss of protein function and they do not all sufficiently 
explain the increased cytokine production that is characteristic of CD (Girardin et al.
2003, Inohara et al. 2003, Watanabe et al. 2004b, Wehkamp et al. 2004b, Zelinkova, et 
al. 2005, Kobayashi et al. 2005, Maeda et al. 2005, Hugot 2006). Perhaps the mutations 
have different effects in different context, i.e. in the APC versus epithelial cells or in the 
mucosa versus the periphery. More studies are needed to elucidate the immuno- 
pathogenesis of CARD 15 mutations in IBD (Shih & Targan 2008).
Subsequently other mutations have been associated with innate PRRs such as: 
NOD1/CARD4 (Satsangi et al. 1996, McGovern et al. 2005), 
TUCAN/CARDINAL/CARD8 (McGovern et al. 2006), TLR4 (Franchimont et al. 
2004), CD 14, TLR2, TLR3, (van Heel et al. 2004), TLR9 (Torok et al. 2004) and 
TLR1, TLR2, TLR6 (Pierik et al. 2006). In addition to a CD 14 promoter polymorphism, 
159C/T (Klein et al. 2002, Gazouli et al. 2005). The TOLLIP gene lies in the IBD locus 
on chromosome 11 (Williams et al. 2002, Paavoia-Sakki et al. 2003, van Heel et al.
2004); although no genetic variants of TOLLIP have been reported in IBD so far.
There are also contradictory findings with some of these receptors, with loss of protein 
function, which does not sufficiently explain the increased cytokine production that is 
characteristic o f CD. For example, The two frequent single nucleotide polymorphisms 
(SNPs) of TLR-4, Asp299Gly and Thr399Ile, have been associated with the 
development of CD in Caucasian populations by several groups; except Amott et al. 
who found no association to CD in a Scottish population (Franchimont et al. 2004, 
Torok et al. 2004, Amott et al. 2005, Gazouli et al. 2005, Lakatos et al. 2005, 
Oostenbrug et al. 2005, De Jager et al. 2007, Heimesaat et al. 2007, Yamamoto-Furusho 
2007). However, the potential deleterious or beneficial role for TLR4 signal 
transduction in intestinal inflammation is not clear. As the TLR4 Asp299Gly 
polymorphism is located in the extra cellular LRR domain of TLR4, which impairs LPS 
signalling and results in decreased NF-kB activation.
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Interestingly, approximately 15% of normal humans possess a mutated form of TLR5 
unable to transmit pro-inflammatory signals (Hawn et al. 2003). Indeed, recently it has 
been found that in individuals of Ashkenazi Jewish ethnicity, carriage of a dominant 
negative TLR5 stop polymorphism was negatively associated with CD suggesting that 
reduced TLR5 signalling may offer some protection against the development of CD 
(Gewirtz et al. 2006). Furthermore, flagellin has been suggested as the dominant antigen 
in CD (Lodes et al. 2004, Sitaraman et al. 2005, Targan et al. 2005, Elson et al. 2006, 
Sanders et al. 2006).
Taken together, there is increased evidence that variations within the genes of the family 
of innate immune receptors may account in part for the inherited differences in CD 
susceptibility (Hamann et al. 2004).
As well as innate receptors SNPs in molecules of the innate barrier have been associated 
with CD, such as membrane bound mucins MUC3A, MUC3B, MUCH and MUC12 
(Pigny et al. 1996, Satsangi et al. 1996, Kyo et al. 1999, Kyo et al. 2001, Einerhand, et 
al. 2002, Porchet & Aubert 2004, van Heel et al. 2004, Koscinski et al. 2006, Van et al.
2007). In addition, distinct defensin gene clusters have been identified on IBD loci (van 
Heel et al. 2004, Pazgier et al. 2006, Van Limbergen et al. 2007). Furthermore, two 
genes that are associated with CD which affect mucosal permeability are the IBD 5 gene 
organic cation transporter (OCTN) and Drosophila discs large homologue 5 (DLG5). 
Miss-sense mutations in the OCTN gene form a haplotype that is associated with 
susceptibility to CD and the mutant protein has impaired ability to pump xenobotics and 
amino acids across cell membrane (Peltekova et al. 2004). DLG5 is a member of the 
membrane-associated guanylate kinase (MAGUK) family of scaffold proteins, involved 
in intracellular signal transduction and the maintenance of epithelial integrity. DLG5 is 
important in maintaining the epithelial structure and polarity, the genetic variants in 
DLG5 could therefore interfere with the epithelial barrier (Stoll et al. 2004, Vermeire
2004). Two distinct haplotypes in the DLG5 gene represented by non-synonymous 
SNPs are associated with IBD (Stoll et al. 2004). Recently, variant alleles of the myosin 
IX B gene have been associated with IBD (van Bodegraven et al. 2006). Myosin IX B is 
expressed in leukocytes and IECs and is thought to influence intestinal permeability.
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Recently SNPs in auto-phagocytic genes ATG16L1 and 1RGM have been associated 
with increased risk for CD (Hampe et al. 2007, Parkes et al. 2007, Rioux et al. 2007). 
The autophagy pathway plays a part in protecting mammalian cells against various 
bacterial pathogens and the cytotoxic effect on bacterial toxins (Ogawa et al. 2005, 
Gutierrez et al. 2007, Mizushima 2007). Preliminary data have implicated ATG16L1 in 
host responses to intracellular bacteria (Rioux et al. 2007). IRGM is required for 
mycobacterial immunity and may have an analogous role in the granulomatous response 
often seen in CD (Singh et al. 2006, Taylor 2007). NADPH oxidases are also essential 
components of cellular response in microbial invasion (Matute et al. 2005, Stuart & 
Ezekowitz 2005, Ellson et al. 2006. An SNP in NCF4 is associated with enhanced 
susceptibility to IBD (Rioux et al. 2007). This prompts a hypothesis that altered 
phagosome function affecting handling of commensal microbiota may contribute to 
disease. Functionally altered phagosomes may kill microbes less effectively, resulting in 
prolonged immune activation or incomplete pathogen clearance (Xavier & Podolsky
2007).
One of the strongest gene associations observed in GWA studies of CD is in the gene 
encoding IL-23R (Cho 2008). It is thought that an important, possibly exclusive, 
component of this association is mediated through the role of IL-23 in the induction of 
IL-17 expression by TH17 cells. Increased levels of IL-17 expression in the intestinal 
lamina propria of patients with CD have been reported (Fujino et al. 2003a, Cho 2008).
Collectively the discoveries of mutations in innate immune and epithelial barrier 
integrity have led to the focus of research into the pathogenesis of CD, into the innate 
immune response.
1.8.6 Theories of Aetiology
Despite numerous studies performed over several decades, the cause of CD remains 
poorly understood. The two leading theories were that of an infectious agent or an 
autoimmune disorder (Chamberlin et al. 2000). Recent evidence from a variety of 
disciplines, including genetics, molecular microbiology, basic immunology, 
experimental mouse models, immunodiagnostics, translational research, and clinical 
trials, combine to firmly implicate abnormal host-microbial interactions in the 
pathogenesis of IBD (Sartor & Muehlbauer 2007).
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1.8.6.1 Evidence of commensal microbes in the pathogenesis of CD
An important role for microbial agents in the pathogenesis of CD is suggested by 
clinical, experimental, and therapeutic studies. In addition to the polymorphisms in the 
bacterial PRRs linking bacterial recognition to CD as mentioned above, CD 
preferentially occurs in the colon and distal ileum, which contain the highest intestinal 
bacterial concentrations. Further supported by reduced pathology on diversion of the 
faecal stream and reactivation of histological and biochemical inflammation within 1 
week following reinfusion of ileostomy contents (Harper et al. 1983, Rutgeerts et al. 
1991, D'Haens et al. 1998).
The ability of metronidazole (Rutgeerts et al. 1995) and omidazole (Rutgeerts et al.
2005) to decrease postoperative recurrence of ileal CD suggests a role for anaerobic 
bacteria. Numerous studies show the efficacy of altering the microbiota by antibiotics, 
probiotics, and prebiotics in experimental colitis suggesting a deleterious composition is 
present in CD (Sartor 2004, Sheil et al. 2007). Indeed, the composition and function of 
the microbiota in CD are abnormal (Bibiloni et al. 2006, Frank et al. 2007).
Germ-free mice have no intestinal inflammation or immune activation but rapidly 
develop pathogenic TH1 or TH17 immune responses and disease after colonisation with 
specific pathogen-free commensal bacteria (Rath et al. 1996, Sellon et al. 1998, Schultz 
et al. 1999, Kim et al. 2005, Bamias et al. 2007). As with human IBD, experimental 
intestinal inflammation is associated with increased mucosal adherence (Hale et al.
2005) and translocation of viable bacteria and bacterial products across the injured 
mucosa to regional lymph nodes and portal and systemic blood (Gardiner et al. 1993, 
Yamada et al. 1993, Nenci et al. 2007).
CD patients exhibit T-cell and serologic responses to a number of enteric bacterial and 
fungal species (Mow et al. 2004, Duchmann et al. 1995). Antibodies to specific 
microbial antigens are clustered into 4 major groups in CD patients: (1) oligomannan 
[anti-Saccharomyces cerevisiae (ASCA)] (Landers et al. 2002); (2) Escherichia coli 
outer membrane protein C (anti-OmpC) and a CD-related protein from Pseudomonas 
fluorescence (12) (Prantera et al. 1996, Cohavy et al. 2000); (3) nuclear antigens 
[perinuclear anti-neutrophil cytoplasmic antibody (pANCA)] (Saxon et al. 1990); or (4) 
flagellin, CBirl (Targan et al. 2005).
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Positive serologic responses to CBirl, ASCA, OmpC, or 12, have been reported in 50- 
80% of CD patients and these serologies correlate with the aggressiveness and need for 
surgery in both prospective and retrospective studies (Duchmann et al. 1995, Lodes et 
al. 2004, Mow WS 2004, Dubinsky et al. 2006).
While it is now generally accepted that commensal enteric bacteria exacerbate the 
adaptive immune system in CD (Eckburg & Reiman 2007, Strober et al. 2007, Sartor 
2006, Xavier & Podolsky 2007); it is not clear if commensal bacteria are responsible for 
the miss-trigger of the innate immune response and in turn the aberrant adaptive 
response seen in CD; especially as no single species has been consistently linked to all 
cases of CD (Duchmann et al. 1999, Sydora et al. 2005). Moreover, T cells cloned from 
IBD patients (i.e., T cells that should be mono-specific) respond to multiple and 
divergent commensal species (Duchmann et al. 1999).
1.8.63 Microbial Pathogen
The presence of granulomas associated with CD resembles the pathology of a number 
of other conditions, notably certain infections, which has influenced and supported the 
search for a specific pathogen as the causative agent (Salzman et al. 2007, Marks & 
Segal 2008).
It has not been possible to consistently culture any specific bacterium that fulfils Koch’s 
postulates. However, more elaborate techniques have been used, which have found 
pathogens in increasing frequency in IBD. These include Pectinatus, Sutterella, 
Fusobacterium, Verrucomicrobium, various Clostridia, Mycobacterium
paratuberculosis, M. paramyxovirus, Listeria monocytogenes, Helicobacter hepaticus 
Yersinia and Campylobacter (Chiodini et al. 1986, Liu et al. 1995, Karlinger et al. 2000, 
Colletti 2004, Seksik et al. 2006).
Mycobacterium avium subspecies paratuberculosis (MAP) causes spontaneous 
granulomatous enterocolitis in ruminants with clinical and pathological manifestations 
similar to that of CD (Chiodini 1989, Sartor 2005). It was first cultured from resected 
CD tissues in 1984 (Chiodini et al. 1984). This obligate intracellular pathogen evades 
killing within phagolysosomes (Rumsey et al. 2006) and has been postulated to 
selectively infect hosts with defective innate immune killing, such as those with NOD2
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polymorphisms (Sartor 200, Behr & Schurr 2006). The vast majority of studies report 
increased recovery or detection of MAP in CD tissues (Autschbach et al. 2005, Sartor 
2005, Behr & Schurr 2006). However, a recent blinded study showed no difference in 
the rate of culture recovery by 2 independent laboratories (Sartor & Muehlbauer 2007) 
and no detection of MAP 16s rRNA (Frank et al. 2007). In addition, no association 
between MAP serologies and NOD2 polymorphisms has been found to date (Sechi et al. 
2005, Bernstein et al. 2007). Finally, despite uncontrolled reports of long-standing cures 
of CD by triple anti-mycobacterial antibiotics (Gui et al. 1997), a well-designed, 2-year 
prospective trial of clarithromycin, rifabutin, and ethambutol failed to show sustained 
response (Selby et al. 2007). Collectively, these studies suggest that MAP is not the 
causative agent of most CD patients (Sartor 2008).
Enterotoxins from pathogens and commensal bacterial species can cause clinical and 
experimental intestinal inflammation (Sartor 2008). Clostridium difficile toxin can 
reactivate quiescent IBD (Issa et al. 2007) and induce acute experimental epithelial 
injury (Kim et al. 2007). Likewise, enterotoxigenic Bacteroides fragilis can induce 
experimental colitis and 1L-17 production (Rabizadeh et al. 2007). Functional 
alterations other than toxin elaboration, such as superoxide generation (Huycke et al.
2002), can also affect the ability of bacteria to induce experimental inflammation.
Commensal bacteria that undergo functional alterations might contribute to the 
pathogenesis of IBD. Commensal E. coli play an important role in maintaining normal 
intestinal homeostasis. Modifications of luminal bacteria concentrations, including E. 
coli, have been observed in CD patients (Frank et al. 2007), and E. coli have been 
isolated in greater numbers in the neoterminal ileum and mesenteric lymph nodes of 
patients with CD compared to controls (Ambrose et al. 1984, Laffmeur et al. 1992, Neut 
et al. 2002, Bamich et al. 2007). E. coli DNA is found in 80% of micro-dissected 
granulomas of CD patients. Antibody titres to E. coli have been found to be higher in 
serum of CD patients than in controls (Tabaqchali et al. 1978), and high levels of 
antibodies against E. coli outer membrane protein C (Omp-C) are present in 37-55% of 
patients with CD, but in less than 5% of controls (Amott et al. 2004).
A unique, potentially pathogenic group of E. coli associated with CD mucosa has been 
identified. Adherent invasive E. coli (AIEC) were recovered from 65% of chronically
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inflamed ileal resections, 36% of mucosal biopsies of the neoterminal ileum of patients 
with early post-resection recurrent CD and 22% of endoscopically normal ileal CD 
biopsies, in contrast to 3.7% of colonic biopsies from the same patients and 6% of the 
normal control ileal biopsies (Darfeuille-Michaud et al. 2004). AIEC do not possess any 
o f the known genetic invasive determinants described for E. coli and Shigella strains 
(Boudeau et al. 1999, Bamich et al. 2007), but do express virulence factors that are 
closely related to avian and uropathogenic E. coli strains (Baumgart et al. 2007, Packey 
& Sartor 2008).
AIEC are unique in that invasion depends on functioning host cell microtubules as well 
as actin microfilaments. Type 1 pilus-mediated adherence, a mechanism which is 
distinct from that o f (EPEC), plays a critical role in AIEC’s invasive ability by inducing 
membrane extensions (Boudeau et al. 2001). AIEC pili adhere to CEACAM 6 on the 
apical surface of IECs (Bamich et al. 2007), particularly in the ileum, which AIEC 
selectively colonises in CD (Sartor 2008). CEACAM 6 expression is stimulated by IFN- 
y and TNF (Sartor 2008). AIEC also persist within IECs and macrophages, induce 
secretion of large amounts of TNF and other cytokines, but do not induce cell death of 
infected macrophages (Glasser et al. 2001). Molecular deletion studies have implicated 
a number of genes (f7/C, NIP1, OmpC, yfg  L) that regulate type 1 pilus expression and 
mediate IEC adherence/invasion and another gene (htrA) mediates intracellular 
replication o f AIEC strains within macrophages (Boudeau et al. 2001, Mow et al. 2004, 
Rolhion et al. 2005, Rolhion et al. 2007). In addition, E. coli isolated from IBD patients 
express serine protease autotransporters similar to uropathogenic strains that are 
postulated to facilitate mucosal invasion (Kotlowski et al. 2007). Serine proteases, such 
as gelatinase, promote experimental colitis and in vitro bacterial translocation across 
epithelial monolayers. E. coli strains are likely to acquire virulence genes by horizontal 
transfer from pathogens (Sartor 2008).
There is also a tenuous link with Staphylococcus aureus to CD. S. aureus has been 
found in intestinal lymphoid follicles in CD tissue (Chiba et al. 2001) and data has been 
provided in animal models, and to a lesser extent in cohorts of patients with CD, to 
support a role for bacterial SAgs in initiation and/or exaggeration of IBD (Posnett et al. 
1990, Drake & Kotzin 1992, Aisenberg et al. 1993, Ibbotson & Lowes 1995, Baca- 
Estrada et al. 1995, Kay 1995, Gulwani-Akolkar et al. 1996, Dalwadi et al. 2001,
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McKay 2001). Staphylococcal infection induces an influx of neutrophils (Fournier & 
Philpott 2005) which in CD show increased intracellular survival of S. aureus (Couper 
et al. 1991, Worsaae et al. 1982). In addition, the antimicrobial effect against S. aureus 
was observed to be significantly lower in CD. It is conceivable that persistence of 
Staphylococcus in the GI tract due to defective innate immune responses could lead to a 
chronic inflammatory response and thus induce or enhance CD (Nuding et al. 2006).
1.8.6.4 Functional changes in commensal bacteria
The commensal intestinal microbiota is critical to the healthy host, as described in 
section 1.6.5. Alterations in the composition of the indigenous intestinal microbiota 
could play a role in the aetiology of IBD by altering dominant antigens or metabolic 
function of the gut bacteria (Frank et al. 2007, Shih & Targan 2008).
Colonic specimens from patients without IBD are nearly free of bacteria when they are 
washed of faecal contents, in contrast to high bacterial concentrations from IBD colon 
biopsy specimens (Swidsinski et al. 2002, Swidsinski et al. 2005, Packey & Sartor
2008). Despite the increase in bacteria most studies demonstrate decreased microbial 
diversity in active IBD (Ott et al. 2004). Almost all studies have shown an increase in E. 
coli in faecal and mucosal microbiota in patients with CD, particularly in tissues within 
granulomas and adjacent to fistulae and ulcers (Cartun et al. 1993, Liu Y 1995, 
Swidsinski et al. 2002, Ryan et al. 2004, Baumgart et al.2007, Kotlowski et al. 2007, 
Sasaki et al. 2007). There is a decrease in the numbers of the phyla Firmicutes (Frank et 
al. 2007). Firmicutes are Gram positive class of bacteria that include the genus 
Clostridium and Bacillus (Shih & Targan 2008). No consistent differences have been 
demonstrated in the probiotic genera Lactobacillus and Bifidobacterium (Conte et al. 
2006, Iwaya et al. 2006, Scanlan et al. 2006, Sartor 2008). Reports of increased 
Bacteroides species in IBD are also inconsistent (Swidsinski et al. 2002, Swidsinski et 
al. 2005, Bibiloni et al. 2006).
Broad-range bacterial 16s rDNA PCR allows for amplification and identification of 
most bacterial phylotypes in a microbial community, but does not differentiate amongst 
strains or identify functional changes. Therefore, virulence factors, toxin production and 
the reciprocal regulation of bacterial and host epithelial genes must be investigated 
further (Packey & Sartor 2008). Moreover, despite the differences in the microbiota,
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one must keep in mind that the dysbiosis seen in IBD patients may not be causal, but 
simply reflect the different ecological conditions of the inflamed gut such as changes in 
pH, redox potential, substrate availability, etc. (Shih & Targan 2008).
1.8.6.5 Defective Mucosal Barrier Function and Microbial Killing
Mucosal homeostasis depends on efficient exclusion of commensal bacteria by 
secretion of luminal AMPs and complexing IgA/IgM, a relatively impermeable mucosal 
barrier, extrusion of xenotoxins, rapid repair of epithelial defects, down-regulation of 
innate and adaptive immune responses to bacteria and secondary phagocytosis, and 
killing of bacteria that translocate across the epithelial barrier (Sartor 2006). Defects in 
any of these homeostatic mechanisms could result in enhanced microbial antigenic 
exposure that overwhelms immune tolerance, leading to pathogenic T-cell responses 
and chronic intestinal inflammation (Sartor 2008).
The importance of effective barrier exclusion is demonstrated by increased translocation 
of luminal bacteria, induction of pathogenic T-cell responses, and onset of severe colitis 
in mice with IEC-targeted deletion of IKKy (NEMO). These mice exhibited increased 
epithelial apoptosis and disrupted epithelial integrity as a consequence of blocking 
epithelial NF-kB signalling (Nenci et al. 2007).
Over a decade ago Hollander proposed that reduced barrier function was a primary 
defect in CD (Hollander 1992). Equally provocative has been the repeated 
demonstration of increased gut permeability in first-degree relatives of patients with CD 
and preliminary data showing that spouses of patients with CD can also have increased 
intestinal permeability (Soderholm et al. 1999, Breslin et al. 2001, Thjodleifsson et al.
2003). Whether such individuals go on to develop IBD or other enteropathies is 
unknown. An intriguing case report did show that a youth with increased intestinal 
permeability was diagnosed with CD a number of years later (Irvine & Marshall 2000). 
However, controversy exists as to whether increased gut permeability sets the stage for 
the development of CD or if the barrier defect is a consequence of an existing immune 
or inflammatory response (Sartor 2008). Molecular mechanisms for increased 
permeability in CD have been reported and include up-regulation of the pore-forming 
Claudin 2, down-regulation and redistribution of tight junction components Claudins 5 
and 6, and increased epithelial apoptosis (Zeissig et al. 2007).
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It is possible that the disruption of the function of OCTN and DLG5 and abnormal 
mucus composition alters the gut permeability (Shih & Targan 2008). Spontaneous 
colitis in MUC2-deficient mice and potentiated DSS-induced colitis in intestinal trefoil 
factor knockout mice illustrate the importance of the mucus barrier (van der Sluis et al. 
2006, Mashimo et al. 1996). IBD patients often show a thinner mucus layer and 
depletion of goblet cells in the colonic epithelium (McCormick et al. 1990). The 
increase in bacteria in the mucus layer of IBD patients contributes to further mucus 
degradation by the production of mucinase, sulfatase, and glycosidase. Interestingly, 
altered colonic glycoprotein expression in unaffected identical twins of IBD patients 
was found to be associated with pre-clinical NF-kB activation (Van Limbergen et al.
2007).
In CD, decreased mRNA levels of MUC3, MUC4, and MUC5B were found in healthy 
and inflamed ileal mucosa compared with controls, whereas MUC1 mRNA was reduced 
in inflamed mucosa only (Buisine et al. 1999, Shirazi et al. 2000). Using different 
assays, Buisine et al. reported normal expression of MUC2 and MUC3 in non inflamed 
ileal mucosa from CD patients compared with controls (Buisine et al. 2001). Also, 
enhanced numbers of bacteria closely attached to the mucus were described in patients 
with IBD indicating reduced barrier function of the mucus layer in these patients 
(Schultsz et al. 1999, Kleessen et al. 2002, Swidsinski et al 2002).
CD patients have defective AMP production, most notably a-defensin 5 in ileal disease 
and human (V-defensin 2 copy numbers in colitis (Wehkamp et al. 2005, Fellermann et 
al. 2006). Decreased a-defensin production in ileal CD is a consequence of reduced 
expression of Tcf-4, a Wnt-signalling pathway transcription factor, whose activity is 
independent of NOD2 genotype (Wehkamp et al. 2007). Due to the defensin deficiency 
CD patients exhibit defective microbial killing of Bacteroides vulgatus, E. coli and 
Enterococcus faecal is (Nuding et al. 2007). Defective killing results in increased 
exposure to commensal bacteria and activation of compensatory pathogenic T cells 
(Korzenik 2007). Together, these observations support the concept that defective innate 
immune responses in CD could lead to defective bacterial clearance with activation of 
compensatory pathogenic T cells by microbial antigens (Korzenik 2007, Marks et al.
2006).
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1.9 Probiotic therapy in CD
Conventional drug therapy is associated with a number of disadvantages, including a 
considerable burden of side effects and less than comprehensive efficacy, with a marked 
percentage of patients still requiring surgery (Hedin et al. 2007). Manipulating the 
abnormal enteric microbiota to decrease the more pathogenic species and enhancing the 
concentration and metabolic activity of the beneficial species has tremendous potential 
for therapeutic benefit (Sartor 2008). The evidence for the use of probiotics in IBD is 
strongest in the case of pouchitis, particularly for the use of VSL#3. In addition, E. coli 
Nissle 1917 appears to be at least equivalent to 5-aminosalicylic acid treatment in UC 
and may be useful in the form of enemas for distal disease (Hedin et al. 2007). 
However, studies of probiotics in CD have been contradictory and disappointing, a 
physiologic and nontoxic approach has not yet been achieved and a Cochrane 
systematic review has concluded that their use cannot be recommended based on the 
available evidence (Rolfe et al. 2006). Thus, probiotic therapy has not yet reached its 
acclaimed potential.
In total fifteen non-randomized and thirty one randomized trials of probiotics in IBD 
have been conducted. Of the latter twenty three were double-blind and eight were open- 
label randomized controlled trials. In thirty two of the total trials, different probiotics 
were used, while ten used different prebiotics and four used synbiotics. In fourteen non­
randomized trials, the outcome was successful. In the randomized controlled trials 
twelve of sixteen UC, but only two of CD trials were successful. No superiority of any 
probiotic was clearly evident although probiotic Lactobacillus rhamnosus GG appears 
less useful in IBD, especially CD (Heilpem & Szilagyi 2008).
Interestingly, adverse events have been attributed to the use of the probiotic LGG. 
Rautio et al. report, a case of liver abscess due to consumption of LGG (Rautio et al.
1999). Schultz et al. also report, during a trial to determine the effect of oral LGG, a 
case of intestinal abscess although no LGG could be identified by culture (Schultz et al.
2004). Two patients receiving 18xl09 viable LGG per day and two patients receiving 
LGG plus mesalazine withdrew from a trial after experiencing nausea, epigastric pain 
and constipation. A third group receiving mesalazine alone experienced no adverse 
events (Zocco et al. 2003). In children, two patients receiving LGG withdrew from the
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study due to vomiting and intolerance of the medication (Bousvaros et al. 2005). Given 
the known pro-inflammatory potential of many Lactobacillus species, this might explain 
the overall lack of success of probiotics in CD (Macfarlane et al. 2009).
A number of reports have been published that describe the influence of probiotic 
consumption on colitis in animal trials (Madsen et al. 1999, O’Mahony et al. 2001, 
McCarthy et al. 2003, Sheil et al. 2004, Sheil et al. 2006, Schultz et al. 2002, Dieleman 
et al. 2001, Schultz M et al. 2004, Kamada et al. 2005). From these studies, in addition 
to the clinical trials, it has become apparent that probiotics are more efficient in 
preventing relapse of inflammation and infection than reversing established disease 
(Schultz et al. 2002, Dieleman et al. 2003, Sartor 2004, Sartor 2005). In addition, 
individual probiotic agents have different properties and are not equally beneficial, each 
may have individual mechanisms of action, and host characteristics may determine 
which probiotic species and even strain may be optimal in a given setting. Thus, one 
cannot consider probiotics as a generic form of therapy. Therefore, results must be 
interpreted accordingly and trials designed to consider phenotypic and genetic subsets 
of patients (Dieleman et al. 2003, Sartor 2004, Sartor 2005).
The body of early probiotic clinical research in IBD has been of inconsistent quality 
because of poor design and methodology. Most studies have enrolled small numbers of 
patients, which limits statistical power and is of particular relevance given the high 
placebo response rates seen in clinical trials of IBD (Su et al. 2004, Su et al. 2007). 
Furthermore, interpretation of the current literature on probiotics in IBD is undermined 
by marked heterogeneity between trials frequently precluding meta-analysis (Hedin et 
al. 2007). Variables include the choice of probiotic and their dose, number of probiotic 
strains used in combination, the trial duration and design, and the outcome measures 
reported; in addition different probiotic delivery methods (enema, oral ingestion of 
tablets, liquids, or foodstuffs such as yogurt) (Hedin et al. 2007, Fedorak & Dieleman
2008). The populations studied differ, with some trials enrolling patients with active 
disease, also with a range of symptoms, and others studying maintenance of remission 
induced by antibiotics, conventional drug treatment or surgery (Hedin et al. 2007, 
Fedorak & Dieleman 2008). Further influencing probiotic IBD human trials is the 
limited reporting of medical history, the general absence of knowledge regarding the 
indigenous intestinal microbiota and none have reported the prevalence of susceptibility
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genotypes (NOD2 etc), or details of the patients’ diet, which could exert a marked 
influence on the efficacy of microbial therapies (Hedin et al. 2007, Fedorak & Dieleman
2008).
The precise mechanisms of action of probiotics remain to be elucidated. For example, it 
is not clear whether intestinal colonisation with probiotic species is necessary, as some 
studies demonstrating clinical efficacy have not demonstrated such colonisation 
(Bibiloni et al. 2005, Sartor 2005, Hedin et al. 2007). At present, the impact of viability 
of probiotics remains unclear. Some studies suggest that Lactobacilli cell viability is a 
prerequisite (Salminen et al. 1998, Gill et al. 2000, Maassen et al. 2000, Cross et al. 
2004, Park et al. 2005b); whereas others have shown heat-killed or cell wall fractions of 
Lactobacillus are effective (Perdigon et al. 1986, Davidkova et al. 1992, Sasaki et al. 
1994, de Ambrosini et al. 1996, Kiijavainen et al. 2003, Matsuguchi et al. 2003, Jijon et 
al. 2004, Zhang et al. 2005, Wong & Ustunol 2006, Lin et al. 2007).
With the aetiology of IBD still not fully understood, and the complex nature of mucosal 
bacterial interactions and the host immune system just beginning to be studied in any 
detail, the selection of synbiotic combinations needs to be made on the basis of a more 
rigorous scientific understanding of the predicted immune and bacterial effects (Steed et 
al. 2008).
1.10 Aims
Discoveries of mutations in innate immunity and epithelial barrier integrity have served 
to focus research, into the pathogenesis of CD, resolutely into the innate immunology. 
In addition, there is an overwhelming body of evidence to suggest that the aetiology of 
CD is linked to innate responses to bacterial stimuli. Thus, the aims of the studentship 
were to characterise and compare the innate mucosal signals generated in vitro in 
response to the presence of commensal, probiotic and pathogenic bacteria. As well as, to 
establish what a typical ex vivo mucosal response is to commensal, probiotic and 
pathogenic bacteria. In order to ascertain if innate immune responses to bacterial stimuli 
in CD are abnormal, and thus could prime an aberrant adaptive response leading to the 
pathology seen in CD.
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CHAPTER 2: Materials & Methods
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2.1 Reagents
Please see Appendix 1 for a list of all reagents 
Please see Appendix 2 for a list of all buffers
2.2 Bacterial culture
Unless otherwise mentioned each bacterial strain was first cultured on Brain Heart 
Infusion (BHI) agar plates at 37°C over 24h, providing a “mixed” culture population 
with organisms in various phases of growth. A single colony from this plate was then
cultured overnight in 3ml of BHI broth at 37°C without shaking, producing a culture
broth containing mainly bacteria in the stationary phase of growth.
Bacteroides thetaiotaomicron (B. theta) was cultured on blood agar plates, consisting of 
BHI base supplemented with 5% v/v defibrinated horse blood (Oxoid Basingstoke, UK) 
at 37°C in a micro-aerobic chamber (Oxoid Basingstoke, UK) containing an anaerogen 
micro-aerobic sachet (Oxoid, Basingstoke, UK) producing 85% N2, 10% O2 and 5% 
CO2 . A single colony was then cultured overnight in 3ml of Thioglycollate medium at 
37°C without shaking, producing a culture broth containing mainly bacteria in the 
stationary phase of growth.
Staphylococcus aureus strains were first cultured on Tryptic Soy Broth (TSB) agar 
plates at 37°C over 24h, providing a “mixed” culture population. A single colony from 
this plate was then cultured overnight in 3ml of TSB at 37°C without shaking. 
Overnight cultures were then diluted 1:20 in TSB and incubated for l-2h, lOOrpm at 
37°C. The optical density (OD) was measured spectrophotometrically at 600nm 
(UV/VIS spectrophotometer Lambda 3B, Perkin Elmer, Bucks, UK) until an OD of 0.6 
was achieved. This OD represents a culture broth containing bacteria in the logarithmic 
phase of growth.
2.2.1 Colony counts
Bacteria were cultured overnight at 37°C in BHI broth and serially diluted in Luria 
Bertani (LB) broth. lOpl of bacterial suspension was then applied in triplicate to LB
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plates and grown overnight at 37°C. Resulting colonies were counted and an average of 
three results was considered the colony forming units (CFU).
2.2.2 Storage of bacterial Species
All bacterial species were stored at -70°C in a Microbank (ProLab Diagnostics, UK). 
Routine culture was performed on LB agar plates grown overnight at 37°C to check for 
appropriate colony morphology before use. Single colonies were sub-cultured into BHI 
prior to use. Plasmid-complemented mutant strains were cultured in growth medium 
supplemented with the appropriate antibiotic for selection. Antibiotics ampicillin 50- 
lOOpg/ml, kanamycin 50|ig/ml, chloramphenicol 30pg/ml and tetracycline 30pg/ml 
(Sigma-Aldrich, Poole, UK) were used in this study.
2 J23 Induction of virulence factors (i.e. activation) prior to co-culture studies
Each bacterial strain was cultured overnight in 3ml BHI at 37°C without shaking. To 
induce expression of virulence genes, overnight cultures were diluted 1:30 in 3ml of 
DMEM followed by incubation at 37°C and lOOrpm, until an OD of 0.6 was obtained. 
Growth in DMEM increases the production of LEE encoded virulence factors (Jarvis & 
Kaper 1996).
2.2.4 Heat killing of Bacteria
Heat-killed bacteria were prepared as described above (section 2.2.3) and then heated 
(80°C, 20min) according to Zhang et al. 2005. Effectiveness of the heat-killing method 
was confirmed as follows: 200pl of the heat-killed and untreated samples, were plated 
on LB agar and incubated for 72h at 37°C. No colonies grew from the heat-killed 
sample.
2.2.5 Bacterial overgrowth
To prevent bacterial overgrowth in co-cultures studies (section 2.7) lOOpg/ml of 
gentamycin (Sigma-Aldrich, Poole, UK) was added 3h post-infection (Bambou et al.
2004).
Page 110
2.2.6 Bacterial conditioned media
Over-night, log-phase or activated cultures, were filtered [0.22pm pore filter (Sarstedt, 
Leicestershire, UK) or 30kDa cut off centrifugal filter (Millipore, Watford, UK)] to 
separate whole bacteria from culture supernatants.
2.2.7 Bacterial Species
Species utilised are listed in Table 2.1. No Shiga-toxin positive strains were employed 
as category III facilities are required to work with such pathogenic strains. Category III 
facilities were not available during the course of this study.
Table 2.1 Bacterial Species
Commensal species
Strain/Serotype Source Reference
E. coli K12, 
strain HB101
Prof James B 
Kaper
ATCC 33694 
http://www.uni-
giessen.de/~gx 1052/ECDC/ecdc.htm
VPI-5482
Bacteroides
Thetaiotaomicron
Dr. Fredrick 
Backhed
ATCC 29148
Xu J et al. 2003 (Xu et al. 2003)
http://cmr.tigr.org/tigr- 
scripts/CMR/GenomePage.cgi?org=ntbtO 1
Probiotic species
Strain/Serotype Source Reference
Lactobacilli Rhamnosus GG Dr. David R 
Mack
Mack DR et al. 2003
Lactobacilli Plantarum 299v Dr. David R 
Mack
Mack DR et al. 2003
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Enteroaggregative Escherichia coli [EAEC] species
Strain/Serotype Strain
Characteristics
Test Source Reference
042 Wild Type
Serotype:
044:H18
Plasmid encoded
cytotoxin,
flage 11a, fimbriae
SEM,
-VE
TEM
Prof
James P 
Nataro
Nataro JP et al. 1995
042 AfliC 
(pJP5603 in 
fliO  
Serotype: 
044:H18
Plasmid encoded
cytotoxin,
fimbriae
Flagella negative
-VE
TEM
Prof
James P 
Nataro
Steiner TS et al. 2000
042 aafA 3.4.14 
(TnphoA in 
aafA)
042 AAF/I1
Serotype:
044:H18
Plasmid encoded 
cytotoxin, flagella
No AAF/II 
fimbria
-VE
TEM
Prof
James P 
Nataro
Czeczulin et al. 1997
042 aafB 
(pJP5603 in 
aafB)
Serotype:
044:H18
Plasmid encoded 
cytotoxin, flagella
AafB adhesin -ve
-VE
TEM
Prof
James P 
Nataro
Elias et al. 1999
Enteropathogenic E. coli [EPEC] species
Strain/Serotype Strain
Characteristics
Test Source Reference
E l0 Wild Type
Serotype:
OU9:H6
Fimbriae,
Flagella, TTSS, 
effecter proteins, 
Intimin
-VE TEM Prof James 
B Kaper
Toledo MRF et al. 
1983
AGT04 
E10AfliC  
Serotype: 
OU9:H6
Fimbriae, TTSS, 
effecter proteins, 
Intimin
Flagella negative
-VE TEM Dr. Jorge A 
Giron
Gir6n JA et al. 
2002
E10 AfliC 
(pfliC)
Serotype:
0119:H6
Fimbriae,
Flagella, TTSS, 
effecter proteins, 
Intimin
Complemented
strain
-VE TEM Dr. Jorge A 
Giron
Gir6n JA et al. 
2002
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IEnteropathogenic E. coli [EPEC] species cont
Strain/Serotype Strain Characteristics Source Reference
E2348/69 (E69 
Wild Type) 
Serotype: 0127:H6
Fimbriae, Flagella, TTSS, 
effecter proteins, Intimin
Prof James P 
Nataro
Levine MM et al. 1978
Smooth LPS 
Serotype: 0127:H6
Fimbriae, Flagella, TTSS, 
effecter proteins, Intimin
Dr. Ilan 
Rosenshine
Unpublished
Rough LPS 
Serotype: 0127:H6
Fimbriae, Flagella, TTSS, 
effecter proteins, Intimin
Lacking o-polysacharide 
chains
Dr. Ilan 
Rosenshine
Unpublished
AGT01
E2348/69 AfliC 
Serotype: 0127:H6
Fimbriae, TTSS, effecter 
proteins, Intimin
Flagella negative
Prof James B 
Kaper
Gir6n JA et al. 2002
AGT02
E2348/69 fliC *  
Serotype: 0127:H6
Fimbriae, Flagella, TTSS, 
effecter proteins, Intimin
Flagella enhanced
Prof James B 
Kaper
Gir6n JA et al. 2002
31-6-1 (TnphoA 
in bfpA)
Serotype: 0127:H6
Flagella, TTSS, effecter 
proteins, Intimin
No type IV fimbriae
Prof Michal S 
Donnenberg
Donnenberg MS et al. 
1992
JPN15 (Cured 
of pMAR2) 
Serotype: 0127:H6
Flagella, TTSS, effecter 
proteins, Intimin
No type IV fimbriae 
EAF- Bfp-
Prof James B 
Kaper
Jerse AE et al. 1990
E2348/69 + 
mannose 
Serotype: 0127:H6
Flagella, TTSS, effecter 
proteins, Intimin
No type I fimbriae
Prof James P 
Nataro + 
Sigma- 
Aldridge
Cravioto A et al. 1988
CVD452 
E2348/69 AescN 
Serotype: 0i27:H6
Fimbriae, Flagella, Intimin
No TTSS so No secretion of 
effecters
Prof James B 
Kaper
Jarvis KG et al. 1995
UMD872 
E2348/69 A espA 
Serotype: 0127:H6
Fimbriae, Flagella, effecter 
proteins, Intimin
Diffuse secretion of effecters 
but no translocation
Prof Michal S 
Donnenberg
Kenny B et al. 1996
MAS111 
E2348/69Ae$/?C 
Serotype: 0127:H6
Fimbriae, Flagella, TTSS, 
Intimin
No effecter
Prof Brett B 
Finlay
Stein M et al. 1996
UMD874 
E2348/69 A espF 
Serotype: 0127:H6
Fimbriae, Flagella, TTSS, 
Intimin
Effecter Increased 
permeability
Prof Michal S 
Donnenberg
Crane JK et al. 2001
UMD704 
E2348/69 
Ali/A/efal 
Serotype: 0127:H6
Fimbriae, Flagella, TTSS, 
Intimin
Loss of ability to inhibit IL-2 
expression
Prof Michal S 
Donnenberg
Klapproth JMA et al. 2000
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Pathogenic Staphylococcus aureus species
Strain/Serotype Pathogenic
factors
Pathology Test Source Reference
Staphylococcus 
aureus B
EDIN-B
enterotoxin
Enteropathy Toxin
PCR
RFH
Staphylococcus 
aureus SEB
SEB
enterotoxin
Enteropathy Toxin
PCR
RFH
Staphylococcus 
aureus RN6911
Agr genes 
but non 
enterotoxin 
producing
Epithelial apoptosis Toxin
PCR
Prof
Richard
Novick
Staphylococcus 
aureus RN6930
Agr genes 
but non 
enterotoxin 
producing
Epithelial apoptosis Toxin
PCR
Prof
Richard
Novick
Kahl et al. 
2 0 0 0
Patient strain 1 SEG/I
enterotoxin
Severe enteropathy 
partial villous 
atrophy, diffuse 
infiltration of 
lymphocytes, 
neutrophils, 
eosinophils
SC
Toxin
PCR
Clinical
Isolate
(RFH)
LA Edwards 
et al. 
presented for 
publication, 
2008
Patient strain 2 SEG/I
enterotoxin
Severe enteropathy 
partial villous 
atrophy, diffuse 
infiltration of 
lymphocytes, 
neutrophils, 
eosinophils
SC
Toxin
PCR
Clinical
Isolate
(RFH)
LA Edwards 
et al. 
presented for 
publication, 
2008
Patient strain 3 SEG/I
enterotoxin
Partial villous 
atrophy, diffuse 
infiltration of 
lymphocytes, 
neutrophils, 
eosinophils
SC
Toxin
PCR
Clinical
Isolate
(RFH)
LA Edwards 
et al. 
presented for 
publication, 
2008
Abbreviations: SEM = scanning electron microscopy, -VE TEM = negative staining 
electron microscopy, FAS = Fluorescent actin staining test, SC = growth on selective 
culture medium (Carried out by the Centre for Medical Microbiology - Hampstead 
Campus) Royal Free Hospital, Toxin PCR = Characterisation of toxin expression by 
RT-PCR (Conducted by: The department of Biological Sciences, University of 
Warwick).
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2.3 Assessment of bacterial surface structures by negative staining 
Transmission Electron Microscopy (TEM)
Negative staining was used to visualise bacterial surface structures. Formvar/carbon 
coated copper/rhodium 100 mesh TEM grids were floated, coated surface down, on a 
drop of activated bacterial culture (section 2.2.3) for lmin. A wooden toothpick was 
used to remove the grid from the drop and to hold one edge against filter paper to 
remove excess fluid. The grid was air dried for lmin and then placed on a drop of 1% 
aqueous ammonium molybdate (Agar Scientific, Stanstead, UK) for 10s prior to 
removal and drying with filter paper. Grids were air dried and examined using a Philips 
Transmission Electron Microscope (Philips CM 120, Eindhoven, Netherlands) at an 
accelerating voltage of 80kV. Each bacterial culture was examined in duplicate on three 
separate occasions. The size of the surface structures were estimated by direct 
measurement from printed micrographs using a measuring magnifier (x7) fitted with a 
20mm graticule (Polaron, Watford, Hertfordshire UK).
2.4 Cytokine stimulation
Recombinant cytokine interleukin- lp (IL-lp) was reconstituted according to the 
manufacturer’s instructions (Sigma-Aldrich, Poole, UK). lOng/ml of IL-ip was 
routinely used in the present study as Schuerer-Maly et al. found this concentration 
induced a maximal IL- 8  production in Caco-2 cells (Schuerer-Maly et al. 1994). 
Furthermore, this level is known to have minimal cytotoxic effects on epithelial cells 
(Brew et al. 2000).
2.5 Mannose inhibition of type 1 pili
For adhesion tests, mannose (Sigma-Aldrich, Poole, UK) was added during the period 
of attachment so that any adhesion due to mannose-sensitive type 1 pili was 
competitively inhibited (Cravioto et al. 1979). Cells were incubated with 0.5% D-(+)- 
Mannose according to (Cravioto et al. 1988).
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2.6 Mammalian cell culture
2.6.1 Caco-2 cell culture
The Caco-2 cell line is derived from colonic cells isolated from a case of colorectal 
adenocarcinoma in a 72 year-old Caucasian male (American Type Culture Collection 
ATCC: HTB-37) (Fogh et al. 1977). However, Caco-2 cells can undertake a 
spontaneous and complete intestinal-like program of differentiation (Pinto et al. 1983, 
Vachon & Beaulieu 1992). Caco-2 cells are widely used as a model system for the study 
of enterocytic function (Pinto et al. 1983, Meunier et al. 1995) and as a model of the 
intestinal barrier (Sambuy et al. 2005). Although this is a “colonic” tumor-derived cell 
line, it differentiates post-confluence into a polarised monolayer with properties of fetal 
“ileal” epithelial cells, including altered morphology with production of microvilli, and 
increased expression of small intestinal-specific gene products (Engle et al. 1998). 
These cells grow in a monolayer, show a cylindrical polarised morphology, with 
microvilli on the apical side, tight junctions between adjacent cells and express small 
intestinal hydrolase enzyme activities on the apical membrane (Sambuy et al. 2005). 
This cell line reaches confluence by 7 days and acquires full morphological polarity by 
21 days (Pageot et al. 2000). The limitations of these model cells are their transformed 
nature and their colonic origin (Rousset 1986, Moyer et al. 1990, Menard & Beaulieu 
1994).
2.6.2 HEp-2 cell culture
The HEp-2 human larynx carcinoma cell line was established in irradiated-cortisonized 
weaning rats, after injection with epidermoid carcinoma tissue from the larynx of a 56 
year old male (American type culture collection: CCL-23) (Moore et al. 1955). The 
larynx is covered with non-keratising squamous epithelium similar to that lining the oral 
cavity and the oesophagus (Underwood 2000). This epithelial cell line has been used as 
a model for oesophageal epithelia (Chen & Jiang 2004). HEp-2 cells are widely used as 
a model system to study the adhesion properties of human bacterial enteropathogens 
(Ismaili et al. 1999). This epithelial cell line is non-polarised and shows a different 
morphology in comparison to Caco-2 cells upon confluence, with a limited number of 
microvillus-like processes on the surface.
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Both Caco-2 and HEp-2 cell lines were maintained in 75cm2 flasks containing DMEM 
supplemented with 10% heat inactivated foetal calf serum (FCS), 2mM L-glutamine 
and 1% non-essential amino acids (Sigma, Poole, UK). This culture medium is referred 
to as “Caco-2/HEp-2 complete medium” here after. The cells were routinely incubated 
at 37°C in a 5% CO2 incubator (Sanyo NC0-17A, Sanyo-Biomedical, Loughborough, 
Leicestershire, UK) as and when required.
2.63 HIEC cell culture
Primary human intestinal epithelial cells (HIECs) were isolated from foetal small 
intestine with typical crypt cell proliferative characteristics (Perreault & Beaulieu 1996). 
Cell populations were expanded and then kept frozen at passage 2 or 3 in liquid 
nitrogen. HIEC cells were kindly provided by Dr. Frank Rummelle. The HIEC exhibit 
an apparently non committed and undifferentiated epithelial morphology, this is 
considered typical of crypt epithelium (Pageot et al. 2000).
HIEC cells were maintained in 75cm2 flasks containing culture medium which consists 
of DMEM with glutimax and 25pM HEPES (Gibco, Invitrogen, Paisley, UK), 
supplemented with 10% heat inactivated FCS, 1% penicillin/streptomycin, 25ng/ml 
epidermal growth factor (EGF) (Sigma-Aldrich, Poole, UK) and lx Insulin-transferrin- 
selenium (Gibco, Invitrogen, Paisley, UK). This culture medium is referred to as 
“complete HIEC medium” here after. Cells were grown and maintained at 37°C in a 5% 
CO2 incubator. HIEC cells were seeded in complete HIEC medium minus EGF and 5% 
FCS; inoculation was carried out in complete medium minus FCS, EGF and antibiotics.
2.6.4 Cell Passage
Cells were regularly monitored (Olympus CK2 inverted microscope, Olympus Watford, 
Hertfordshire, UK) to check for morphological features of growth and differentiation. 
When monolayers reached confluence, cells were passaged. Cells were washed twice 
with 5ml of sterile phosphate buffered saline (PBS) pH 7.4. 2ml of pre-warmed 0.1% 
trypsin/0.02% EDTA (Sigma-Aldrich, Poole, UK) was added to cover the cell surface 
prior to incubation at 37°C in a 5% CO2 incubator for 5-10min until the adherent cells 
detached. Trypsin was inactivated by the addition of 8 ml of Caco-2/HEp-2 or HIEC 
complete media. The resultant cell suspension was centrifuged (1000 rpm, lOmin, 4°C) 
(multispeed refrigerated centrifuge, PK121R, ALC International, Jencons-PLS, East
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Grinstead, West Sussex, UK). Cells were re-suspended in their appropriate complete 
medium. 50pl of cell suspension was routinely used for quantifying cell numbers with a 
haemocytometer (Bright-line hemacytometer, Sigma-Aldrich, Dorset, UK). 50pl was 
removed and added to 50pl of 0.4% trypan blue (Sigma-Aldrich, Poole, UK). lOpl of 
this mixture was used and viable cells were counted using an Olympus CK2 inverted 
microscope at x 40 magnification. Non-viable cells were distinguished from viable cells 
by the uptake of dye. The concentration of viable cells was estimated by using the 
following formula:
Number of cells within 16 squares x dilution factor (2)
= Total number of cells x 104 cells/ml
The cells were then used to seed 75cm2 flasks for maintenance cultures (106 cells for 
Caco-2 and HEp-2 cells and 1.5 x 106 cells for HIEC cells).
2.6.5 Freeze storage of cells
For long-term storage, lxlO6 Caco-2 or HEp-2 cells or 3xl06 HIEC cell aliquots were 
stored in liquid N2 . Cells were re-suspended in chilled (4°C) 10% dimethyl sulfoxide 
(DMSO) (Sigma-Aldrich, Poole, UK) 90% FCS in cryovials (Nalgene-nunc, Roskilde, 
Denmark). To maintain greater viability and integrity cells were cooled gradually to - 
70°C using the Mr. Frosty system (Nalgene-nunc, Roskilde, Denmark). The Mr. Frosty 
container provides a constant cooling rate of l°C/min using vial holders surrounded by 
100% isopropyl alcohol. Once aliquots reached -70°C they were then placed in liquid 
N2 for long-term storage.
2.6.6 Thawing cells from -70°C storage
All cell lines were seeded from aliquots stored in liquid N2 . An aliquot was removed 
and immediately placed at 37°C for rapid thawing. Thawed cells were added to 30ml of 
their respective complete culture medium and centrifuged (lOOOrpm, lOmin, room 
temperature [RT°]) to allow removal of DMSO. The resultant cell pellet was re­
suspended in 15ml of complete culture medium and re-centrifuged. The cell pellet was 
re-suspended in 2ml of complete medium and used to inoculate a 75 cm tissue culture 
flask containing 25ml of medium. The cells were maintained and allowed to grow at 
37°C with 5% CO2 .
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2.7 Co-Culture of epithelial cells with bacterial or cytokine stimulus
2.7.1 Analysis of host immune responses by RT-PCR, cytokine and nuclear 
transcription factor ELISA
2.7.1.1 Co-culture in 6 well microtitre plates
5xl06 cells (Caco-2) or 6xl06 cells (HEp-2) cells were seeded into a 6 -well plate; Caco- 
2 cells were grown for 7 days with medium exchanged on alternative days, routinely 
achieving confluency in this time period. In contrast, HEp-2 cells were grown only for 
48h to achieve 70-80% confluency. HIEC cells, like Caco-2 cells required 7-8 days to 
gain confluency when initially seeded at a cell concentration of lx l 0 6 cells.
All cells were washed three times with complete culture medium and then incubated 
overnight in 1ml of complete culture medium without FCS (and without EGF for HIEC 
cells) at 37°C with 5% C0 2 - Cells were then inoculated with either lOng/ml of IL-ip as 
a positive control, or with 160pl of live bacterial cells in logarithmic phase of growth (~ 
3xl07 bacteria), or with 160pl heat-killed cultures, or 160pl conditioned culture 
medium incubated for various time periods (30min to 16h) at 37°C with 5% CO2 . The 
inoculation was carried out in complete culture medium. To prevent bacterial 
overgrowth with live cultures, lOOpg/ml gentamicin (Sigma-Aldrich, Poole, UK) was 
added 3h post-infection.
2.7.1.2 Co-culture in 6 well Transwell® plates
Transwell® inserts (24mm diameter, 4.7cm , 0.4pm pore size) were first coated with 
Rat tail collagen (Sigma-Aldrich, Poole, UK) (1 mg/ml stock diluted to 50pg/ml in 60% 
absolute ethanol). The membranes were coated at 10pg/cm2 and left to dry. Before use 
the collagen was equilibrated in DMEM for 30min. Caco-2 cells were seeded at a 
density of 9.3x105 onto pre-coated Transwell® filter inserts (Hurley et al. 1999). The 
filters were placed in a 6 -well plate with 1.5 and 2.6ml of complete DMEM medium 
added to upper and lower chambers respectively. Fresh medium was replenished every 
2 days for both chambers. The transepithelial electrical resistance (TER) developed 
across the cell monolayer was monitored with an epithelial tissue Voltohmeter (EVOM) 
resistance reader (World Precision Instruments, Stevenage, Herts). Cells were allowed 
to differentiate for 14 days, when TER values of 500-1000flcm2 indicative of intact TJ
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formation were routinely achieved. The wells were then inoculated either apically or 
basolateraly with 10 ng/ml IL-lp or with 160pi log-phase bacteria.
2.7.2 Investigation of host-bacterial interaction by immuno-histochemistry, 
fluorescent-actin staining (FAS) test and Scanning Electron Microscopy (SEM)
2xl06/ml (Caco-2) or 5xl05/ml (HEp-2) cells were seeded onto 13mm glass cover slips 
maintained in a 24-well plate. Caco-2 cells were grown for 7 days reaching confluence, 
with medium change on alternative days. HEp-2 cells were grown only for 24h to 
achieve 70-80% confluency. HIEC cells required 7-8 days to gain confluency when 
initially seeded at 3x10s cells/ml.
All cells were washed three times with complete culture medium and incubated 
overnight in 1ml of complete culture medium without FCS (and without EGF for HIEC 
cells) at 37°C with 5% CO2 . Cells were then inoculated with either lOng/ml of IL-ip as 
a positive control, or with 25pl of live bacterial cells in logarithmic phase of growth (~ 
3xl07 bacteria) 25pl heat-inactivated cultures or 25pl conditioned culture medium. The 
inoculation was carried out in complete culture medium. To prevent bacterial 
overgrowth with live cultures, lOOpg/ml gentamicin was added 3h post-infection.
2.8 Cytoxicity assay
2.8.1 Standard Cytoxicity assay
Caco-2 cells were seeded at 2xl06 cells/ml in complete medium, onto 13mm glass 
coverslips maintained in a 24 well plate. The cells were incubated for 7 days at 37°C 
with 5% CO2 ; with 3 media changes. HEp-2 cells were seeded at a density of 5x10s 
cells/ml of complete medium onto 13mm glass coverslips in a 24-well plate. The cells 
were incubated for 24h at 37°C with 5% CO2 . Prior to each assay the wells were washed 
three times with DMEM and replaced in 1ml of complete DMEM. Cells were co­
cultured at 37°C overnight with either 5-25pl/ml of the live bacterial suspension or 
1:100 conditioned medium. At the end of the experiment cells were washed twice with 
PBS, then fixed in ice cold methanol for 2min on ice, prior to staining with 10% Giemsa 
(Sigma-Aldrich, Poole, UK) for 60min. Cells were then washed twice with PBS, dried
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and mounted in citifluor (Agar Scientific Stanstead, UK). The cells were examined 
using a Zeiss microscope (Zeiss, Welwyn Garden City, Hertfordshire, UK) with 40x 
lens (numerical aperture 1.5) and images were acquired with a Zeiss Axiocam digital 
camera system (8 -bit, 1300 x 1300 pixel-standard resolution) (Software-Image 
Associates, UK). The number of cells displaying cytotoxic characteristics per 100 cells, 
in a randomly selected field of view were counted and expressed as a percentage of the 
total cells observed. For each inoculation per experiment three fields of view were 
selected at random and separate experiments were also conducted in triplicate. The 
result was expressed as an average of the counts taken.
2.8.2 Cytoxicity assay with Transwell® plate
Caco-2 cells were seeded at a density of 2x106 cells/ml in complete medium onto 13mm 
glass coverslips at the bottom of wells of a 24-well Transwell® plate (Costar) (Fig 2.1). 
The cells were incubated for the 7 days reaching confluence, with 3 medium changes 
during 7 days. Similarly, HEp-2 cells were seeded at a density of 5x10s cells/ml in 
complete medium reaching 70% to 80 % confluence with 24h. Prior to each assay cells 
were washed three times with DMEM and the sterile filters were placed into the 24-well 
transwell plates with 600|il of complete DMEM medium in the lower chamber. The 
upper chamber was inoculated with 5-25pl/100pl live bacterial suspension in DMEM. 
After incubation, cells were washed twice with PBS and fixed in ice cold methanol for 
2min on ice prior to staining with 10% Giemsa (Sigma-Aldrich, Poole, UK) for 60min. 
Cells were washed twice with PBS, dried and mounted in citifluor. The cells were 
examined and counted as described above (2 .8 .1 ).
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bacterial culture
  0.4pm pore filter
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Figure 2.1: Cartoon depicting Transwell filter culture model
2.9 The in vitro organ culture assay (IVOC)
2.9.1 Ethical Approval
Ethical approval for obtaining intestinal mucosal biopsies from patients undergoing 
routine endoscopic procedure was granted to the Centre for Paediatric Gastroenterology, 
Royal Free and University College London Medical School by the local Ethical 
Committee of the Royal Free Hampstead NHS Trust Hospital (Ethics Reference 
04/Q0501/122). The biopsies were taken under the direction of the clinician in charge 
after fully informed parental consent was obtained.
2.9.2 Tissue Samples
Intestinal biopsies were obtained during routine investigation of paediatric patients for 
potential intestinal disorders. All procedures were performed using Olympus PCF or 
Fujinon EG/EC-41 paediatric endoscopes, and took place between 8:30 and 13:00. The 
patients were being investigated for abdominal pain, chronic diarrhoea, failure to thrive, 
bloody diarrhoea, polyps or inflammatory bowel disease. Tissue was obtained from 
proximal (fourth part duodenum or duodeno-jejunal flexure), distal (terminal ileum with 
or without Peyer’s Patches) small bowel and colon (cecum, ascending colon, transverse 
colon, descending colon, sigmoid colon and rectum). Tissue referred to as “normal” was 
biopsied from regions that showed no disease macroscopically and was reported as 
histologically normal following routine examination by the Histopathology Department. 
Tissue referred to as “inflamed” during endoscopy was also confirmed to be inflamed
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histologically. Although in the majority of colonoscopies access into the terminal ileum 
was achieved, this was not for every patient as entry through the ileo-cecal valve is a 
difficult endoscopic manoeuvre. Thus, terminal ileum or Peyer’s Patch samples were 
more difficult to obtain. Immediately after removal, biopsy explants were placed in 5 ml 
of pre-warmed (37°C) in vitro organ culture medium for co-culture studies or explants 
were snap-frozen immediately for gene (RT-PCR) and protein (immuno-histochemistry) 
analyses.
2.93 In-Vitro Organ Culture (IVOC)
Intestinal biopsies were cultured as described by (Phillips & Frankel 2000). Tissue 
samples were studied using an Olympus SZ40 dissecting microscope (Olympus 
Watford, Hertfordshire, UK) to screen for preservation, and intact, non-haemorrhagic, 
samples were placed on foam squares (approximately 0.25cm2) orientated with the 
mucosal surface facing upwards and incubated in 1 2 -well plates containing 0 .8 - 1 .0 ml of 
pre warmed (37°C) IVOC medium, ensuring that the tissue was not completely 
submerged in the medium. The plates were placed on a rocking platform (Biometra 
WT15, Thistle scientific, Uddington, Glasgow, UK) and incubated at 37°C in 
9 5 %0 2 /5 % CO2 for 8 h. The IVOC assay was carried out by inoculating 25pl of an 
overnight or log-phase bacterial culture onto the mucosal surface of the explant. For 
strains harbouring plasmids, IVOC medium was supplemented with the appropriate 
antibiotic. To prevent bacterial overgrowth and drop in pH, the IVOC medium was 
changed every 2 h using aseptic technique; supernatants were centrifuged ( 1 2 0 0 0 rpm, 
5min, 4°C Eppendorf 5414C microfuge, (Eppendorf Histon, Cambridge, UK) and stored 
at -20°C. As the bacteria could not be completely removed from the foam support re­
inoculation was found to be unnecessary. After the 8 h incubation period, biopsies were 
removed from their foam supports and processed appropriately.
2.10 lnterleukin-8 (IL-8) and Chemokine Ligand 20 (CCL20) quantitative 
sandwich Enzyme-Linked Immunosorbent Assay (ELISA)
Following infection of cell lines or biopsies, co-culture media was aspirated and 
decanted into a 1.5ml Eppendorf tube. The culture media was centrifuged (12000rpm, 
5min, 4°C) to remove particulates. The resulting supernatant was aliquoted and stored at
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-20°C until required. In studies conducted in Transwells®, culture media was aspirated 
separately from the upper and lower chambers and stored.
For the detection of IL- 8  and CCL20, 96 well ELISA microplates, which were pre­
coated with a mouse monoclonal (Quantikine, R&D, Abingdon, UK) were used, all 
required reagents were also supplied with the plates. The standard IL- 8  or CCL20 
solution was diluted with the corresponding calibrator diluent to produce a 1 : 2  dilution 
series, from 2000 pg/ml to 31.25pg/ml for IL- 8  and from 500pg/ml to 7.8pg/ml for 
CCL20. lOOpl of assay diluent, a buffered protein base, was pipetted into wells of the 
plate followed by the addition of 50pl of standards and samples, 50pl of calibrator 
diluent serving as the zero standard (Opg/ml). All samples were analysed in duplicate. 
After 2h incubation at RT°, each well was aspirated and washed four times with 400pi 
of wash buffer to ensure complete removal of unbound proteins. lOOpl of conjugate 
containing the corresponding polyclonal antibody against IL- 8  or CCL20 conjugated to 
horseradish peroxidise was added to each well and incubated at RT° for lh for IL- 8  or 
2 h for CCL20. Each well was aspirated and washed four times with 400pi of wash 
buffer, to remove any unbound antibody-enzyme complex. 2 0 0 pl of substrate solution 
was added and incubated for 30min at RT° protected from light. The substrate solution 
contained the chromogen, 3,3',5,5'-tetramethylbenzidine, which upon oxidation by 
peroxidase yielded a coloured product which was measured spectrophotometrically. The 
two electron oxidation of tetramethylbenzidine yields a component with an absorbance 
maximum at 450nm. The enzyme reaction was terminated by lowering the pH (less than 
1.0); which was achieved by the addition of 50pl of 2N sulphuric acid. The optical 
density (OD) was determined using a microplate reader (BioRad 3550, BioRad, 
Hertfordshire, UK) reading at wavelength of 450 nm with a correction at 540nm. The 
amount of product directly correlates to the presence of peroxidise enzyme which in 
turn correlates to the presence of bound IL- 8  or CCL20. The duplicate readings for each 
standard, control, and samples were averaged and average control OD subtracted from 
each sample reading. A standard curve allowed estimation of the concentration (pg/ml) 
of IL- 8  or CCL20 protein in the sample. Representative standard curves are shown in 
Fig 2.2 and 2.3 respectively.
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Figure 2.2: Representative standard curve generated by the IL-8 sandwich ELISA
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Figure 23: Representative standard curve generated by the CCL20 sandwich 
ELISA
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2.11 Human p-Defensin-2 (hBD2) quantitative sandwich ELISA
Cell line or biopsy co-culture media was obtained as described above (2.10). For the 
detection of hBD2, 96 well ELISA microplates, which were pre-coated with a 
polyclonal hBD2 antibody (Immundiagnostik AG, Bensheim, Germany) were used; all 
reagents were also supplied in the kit. The hBD2 standard and control solutions were 
diluted with aqua bidest to produce a standard series, from O.lng/ml to 3ng/ml. lOOpl of 
controls, standards or samples were decanted into wells. All samples were analysed in 
duplicate. After lh incubation at RT°, each well was aspirated and washed five times 
with 250pl of wash buffer to ensure removal of unbound proteins. lOOpl of detection 
antibody solution containing a biotinylated goat anti-hBD2 antibody was added to each 
well and incubated at RT° for lh. Each well was aspirated and washed five times with 
250pl of wash buffer. lOOpl of conjugate solution containing streptavidin conjugated to 
horseradish peroxidase was added to each well and incubated at RT° for lh. Each well 
was aspirated and washed five times with 250pl of wash buffer. lOOpl of substrate 
solution was added and incubated for 20min at RT° and protected from the light. The 
reaction was terminated by addition of 50pl of 2N sulphuric acid. The OD was 
determined at wavelength of 450 nm with a correction at 620nm. A standard curve 
allowed estimation of concentration of hBD2 protein (ng/ml) in the sample. A 
representative standard curve is shown in Fig 2.4.
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Figure 2.4: Representative standard curve generated by the hBD2 ELISA
2.12 RNA extraction, Reverse Transcription (RT) and Polymerase Chain 
Reaction (PCR)
2.12.1 Total RNA extraction
Following infection of cell lines or biopsies, a monophasic solution of phenol and 
guanidine thyiocynate (TRizol) was utilised to extract total cellular RNA. 1ml of Trizol 
was added directly to cell monolayers. For cells grown on Transwell® inserts, the filter 
support was excised by a sterile scalpel and placed in a 6  well plate before addition of 
TRizol. Detachment of cells was achieved by gently shaking on ice for 5min, 
subsequently cells were homogenised by vigorous pipetting. For tissue, a mini 
borosilicate glass mortar and pestle tissue homogeniser chamber was used (Fisherbrand, 
Fisher Scientific, Leicester, UK). 200pl of chloroform (Sigma-Aldridge, Poole, UK) 
was added to each 1ml of Trizol in a sterile 1.5ml eppendorf tube and thoroughly mixed 
by vortex for 15s (Clifton cyclone vortex mixer, Jencons-PLS, East Sussex, UK) 
Samples were left to stand at RT° for 3min to permit dissociation between nucleic acid- 
protein complexes and then centrifuged (12000rpm, 15min, 4°C); (Eppendorf 5414C 
microfiige, Eppendorf Histon, Cambridge, UK). This organic extraction procedure 
allowed total RNA, to remain in the aqueous phase leaving cellular debris at the
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interface and in the organic phase. Following centrifugation, the top aqueous layer was 
aspirated (~ 600pl) and transferred into a fresh eppendorf tube. RNA was precipitated 
by the addition of 600pl of isopropanol (Sigma-Aldridge, Poole, UK), samples were left 
at room temperature for lOmin. Total RNA was pelleted by centrifugation (12000rpm, 
lOmin, 4°C) and washed with 75% ethanol (BDH Laboratories, Poole, UK). The RNA 
pellet was air dried to remove traces of ethanol prior to re-suspension in RNA storage 
solution (Ambion, Cambridgeshire, UK) and stored at -70°C.
2.12.2 Total RNA Quantification
Extracted RNA was quantified by spectrophotometry. 5 pi of re-suspended RNA 
solution was diluted in 495pi of RNAse flee water and the concentration determined by 
absorbance (GeneQuant pro Spectrophotometer, GE Healthcare, Bucks, UK) at 260nm 
and 280nm. The amount of RNA (pg/pl) was calculated as follows:
|*260/*280 x 100 (dilution factor) x 40] /1000
Pure RNA gives a ratio of 1.8 at *2607*2800111. Values of 1.7-2.0 were routinely 
observed in all experiments. In order to assess the integrity of total RNA, 2pl re­
suspended RNA solution was run on a 1.5% agarose (Bioline, London UK) Tris Borate 
EDTA (TBE) gel (Horizon 11.14 electrophoresis apparatus and 250EX power supply, 
Life Technologies Gibco/BRI, Jencons-PLS, East Sussex, UK). Bands were visualised 
by ethidium bromide staining (AMERCO, NBS Biologicals, Cambs, UK). Mammalian 
ribosomal 28S and 18S rRNAs are approximately 5kb and 2kb in size, thus the 
theoretical 28S:18S ratio is approximately 2.7:1; but 2:1 is considered the benchmark 
for intact RNA, with sharp 28S and 18S rRNA bands indicative of un-degraded RNA. 
A representative gel is shown in Fig 2.5 showing RNA extracted from Caco-2 cells 
according to section 2 . 1 2 .1 .
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Figure 2.5: A series of RNA preparations visualised on a 1.5 % agarose gel. The two 
bands represent the 28s and 18s rRNA subunits.
2.12.3 Reverse transcription (RT)
5^ig of total cellular RNA was transcribed to complementary DNA (cDNA) using 
Superscript II Reverse Transcriptase (RT) (Invitrogen, Paisley, UK), lpl of Oligo(dT) 
(0.5jig/p.l) and 1 jil of deoxynucleoside Triphospates (dNTPs) were added to 5pg of total 
cellular RNA and heated to 65°c for 5min followed by immediate chilling on ice to 
permit specific annealing between the oligo-dT and the poly-A tail bound at the 3’ end 
of mRNA molecules. The following components of the reaction mix were added to the 
RNA:
lOx First strand buffer 2pl 
25mM MgCl2 4pl
0.1MDTT 2pl
RNAseout lpl
Samples were then heated to 42°c for 2min. Subsequently 2\i\ of Superscript II RT was 
added to samples (apart from RT minus samples run as a negative control). The reaction 
was allowed to proceed at 42°c for 50min. The reaction was then terminated by heat 
inactivation at 70°c for 15min. To increase the sensitivity of the subsequent PCR, the 
RNA template was removed from the newly synthesised cDNA by digestion with 
RNAse H. 1 |il of RNAse H was added to each reaction and samples were then heated to 
37°c for 20min. The cDNA was then stored at -70°c until required.
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2.12.4 Polymerase chain reaction (PCR)
The obtained cDNA formed the template for subsequent PCR reactions. Reaction 
volumes were 50pl, comprising the following components:
1 Ox PCR buffer minus Mg 5.0pl
50 mM MgCl2 1.5pl
10 mM deoxynucleotide triphosphates (dNTP) mix 1 .Opl
10 pM sense primer 1 .Opl
10 pM antisense primer 1 .Opl
Tag DNA polymerase (5U/pi) 0.4pl
RNAse free water 38.1 pi
cDNA (from first strand synthesis) 2.0pl
Master mixes were prepared for multiple reactions to minimize inter-sample variation. 
Sequences of primers used in this study are listed in Table 2.2. The contents of the PCR 
tubes were gently mixed and then centrifuged. PCR amplification was carried out in a 
thermal cycler (Genius thermocycler, Techne, Jencons-PLS, East Sussex, UK) as 
follows:
94°c for 2min to denature the template - 1 cycle
94°c denaturation for 30s 
60°c annealing for 30s 
72°c extension for 30s
>-25 cycles
The PCR products were quantified by agarose gel electrophoresis, lOpl of PCR product 
was loaded and run on a 1.5% agarose gel in Tris-buffered EDTA (TBE). Bands were 
visualized by ethidium bromide staining. Semi-quantitative analyses was conducted by 
densitometric measurements of bands and normalised to the house-keeping gene, 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (BioRad gel doc 2000, BioRad, 
Hertfordshire, UK)
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Target gene Sense primer Anti-sense primer Product size 
In base pairs
hBDl n»TTG TCT g a c  a t g  
GCC TCA GGT GGT 
AAC136
342 AT A CTT CAA AAG 
CAA TTT TCC TTT 
AT337
253
hBD2 "CCA GCC ATC AGC 
CAT GAG GGT CTT34
WCAT GTC GCA CGT 
CTC TGA TGA GGG 
AGC261
276
hBD3 ^G G T  GAA GCC TAG 
CAG CTA TGA GGA 
TC221
3K,GAG c a c  t t g  c c g
ATC TGT TCC TCC362
183
IL- 8 4'ATG ACT TCC AAG 
CTG GCC GTG62
3'*TCT CAG CCC TCT 
TCA AAA ACT TCT
C332
291
LL-37 |/JGCG GTG GTC ACT 
GGT GCT CCT GCT 
GCT199
” 'GAA GAA ATC 
ACC CAG CAG GGC 
AAA TC532
384
GAPDH 6J°CTA CTG GCG CTG 
GCA AGG CTG T65'
VSVGCC ATG AGG TCC 
ACC ACC CTG CTG966
358
Table 2.2: Sequences of synthetic oligonucleotide primers utilised in this study 
2.13 Real time PCR
Total RNA extraction and quantification was conducted as described above. To remove 
genomic DNA contamination, RNA samples were subjected to DNAse treatment using 
a TURBO DNAse-free kit (Ambion, Cambridgeshire, UK), following the manufacturers 
protocol for extended digestion.
2.13.1 cDNA Synthesis
Approximately 1.5pg of total RNA was reversed transcribed using the BioScript cDNA 
synthesis kit (Bioline, London, UK) according to the manufacturer’s instructions. lOOng 
of random hexamers, 275ng of oligo (dT)i8 and 50U of BioScript reverse transcriptase
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were used in each reaction. Duplicate reactions omitting the BioScript reverse 
transcriptase were also carried out. The reactions were incubated at 25°C for lOmin, 
42°C for 60min and 75°C for lOmin. The cDNA was diluted 1:4 in Tris-EDTA (TE) 
buffer (lOmM Tris-HCL, 0.1 mM EDTA, pH8.0), aliquoted and stored at -20°C.
2.13.2 Real-time quantitative PCR (Q-PCR)
Primers for GAPDH, MUC3A and MUC3B (Table 2.3) were designed by Mr. M. Lucas 
of Centre for Paediatric Gastroenterology, RFH. Using Primer3 software (Rozen & 
Skaletsky 2000) (http://frodo.wi.mit.edu). The primer sequence RTPrimerDB ID: IL- 8  
(2627) for the gene IL- 8  was downloaded from the public RTPrimerDB database 
(Pattyn et al. 2003) (http://medgen.UGent.be/rtprimerdb/). Primer sequences for RPLP0 
(ribosomal phosphoprotein PO) a housekeeping gene which is stable during Caco-2 cell 
differentiation were obtained from (Dydensborg et al. 2006). Primers were intron-exon 
spanning, in order to minimise the amplification of genomic DNA and tested to obtain 
optimum PCR efficiency and minimal primer-dimer formation. Primers were 
synthesised by VH-BIO, (Gateshead, Newcastle, UK.) Q-PCR was performed in a 
Mastercycler EP realplex thermal cycler (Eppendorf, Histon, Cambridge, UK), using a 
QuantiTect SYBR Green PCR kit (Qiagen, Crawley, UK).
Amplification reactions were carried out in a volume 20pl comprising:
QuantiTect master mix 10.0 pi
0.5 pM forward & reverse primers 1.5 pi
cDNA 1.0 pi
Water 7.5 pi
The PCR parameters comprised:
95°C for 15min as an initial hot start step - 1 cycle
95°C denaturisation for 30s 
58°C annealing for 30s 
72°C extension for 30s
> - 45 cycles
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PCR product specificity was analysed by melting curve analysis and by running PCR 
products on 2% TBE agarose gels. For the Mastercycler EP Realplex reactions, Q  
values (The point at which the fluorescence crosses the threshold) for each gene were 
acquired using the noise band detection threshold option on the Mastercycler software. 
Every sample was analyzed in triplicate, and the geometric mean of the Ct values was 
calculated. In addition, RT- samples and no template controls were included in each run 
to exclude false signals generated by contaminating genomic DNA or primer-dimer 
formation. To determine PCR amplification efficiencies for each gene, standard curves 
were constructed using 5x four-fold serial dilutions of cDNA. All PCR reactions 
demonstrated amplification efficiencies ranging between 90% and 100%, except for 1L- 
8 , which demonstrated an efficiency of 85%. The difference in expression between 
infected and matched non-infected controls was determined using the ACt method, with 
correction for differing PCR efficiencies (Meijerink et al. 2001).
Target gene Sense primer Anti-sense primer Product 
size in base 
pairs (bp)
IL- 8 GAA CTG AGA GTG 
ATT GAG AGTGGA
CTC TTC AAA AAC TTC 
TCC ACA
8 8
RPLPO GCA ATG TTG CCA 
GTG TCT G
GCC TTG ACC TTT TCA 
GCA A
103
Muc3A TTT CTC TTG CTC TCA 
TTC CTT GT
ATC GGA GGG GAT 
GGGTTT
240
Muc3B TTT CTC TTG CTC TCA 
TTC CTT GT
TCC GGT GGC TGG 
GTG ATG
216
GAPDH AGG TCG GAG TCA 
ACG GATTT
TGG AAG ATG GTG 
ATG GGA TTT
178
Table 23: Sequences of synthetic oligonucleotide primers utilised in this study
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2.14 NF-kB activation
2.14.1 Nuclear extract
Nuclear extracts were obtained using a nuclear extract kit (Active Motif, Rixensart, 
Belgium). Firstly, cells were collected in ice-cold PBS in the presence of phosphate 
inhibitors. The cell suspension was transferred into a pre-chi lied 1 .5ml eppendorf and 
pelleted by centrifugation (500 rpm, 5min, 4°C). The supernatant was then discarded 
and the pellet placed on ice. Subsequently, cells were gently re-suspended in 62.5pi of 
IX hypotonic buffer and incubated on ice for 15min, to swell the cel 1-membrane and 
make it fragile. 4pl of detergent was added to each sample, which was then vortexed 
for 10s on high power to complete cell-membrane lysis. The nuclear fraction was 
pelleted by centrifugation (14000g, 30s, 4°C). The cytoplasmic fraction was decanted 
into an eppendorf and was stored at -80°C. The pellet containing the nuclear fraction 
was re-suspended in 2 0 pl of complete lysis buffer (in the presence of the protease 
inhibitor cocktail) and vortexed for 10s at high power. The resulting suspension was 
then incubated for 30min on ice on a rocking platform (Gyro-Rocker STR9, Bibby 
Stuart, Jencons-PLS, East Grinstead, West Sussex, UK) at 150rpm. After incubation on 
ice the suspension was vortexed for 30s at high power then centrifuged (14000g, lOmin, 
4°C). Aliquots of the supernatant containing the nuclear fraction was decanted into pre­
chilled micro-centrifuge tubes and stored at -80°C.
2.14.2 Analysis of protein concentration
The protein concentration of the cell extract was measured by the Bradford-based assay. 
To determine the protein concentration of the nuclear fraction, the sample was diluted 
1:200 in distilled H2O, in duplicate and decanted into a 96 well ELISA plate. A protein 
standard, 25pg/ml of bovine serum albumin (BSA), was prepared and serially diluted in 
duplicate to form a standard curve and decanted into the plate. To these standards or 
samples 50pl of dye concentrate (BioRad, Hertfordshire, UK) was added and mixed 
thoroughly using a plate mixer and incubated for 5min to lh at RT°. The OD was 
measured at 595nm versus a reagent blank using an ELISA plate reader (BioRad 3550, 
BioRad, Hertfordshire, UK). A standard curve was plotted with OD595 versus 
concentration of standards (Fig 2.6) and the sample values were then determined from 
the curve and the final concentration were determined using the following equation:
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Sample Concentration (pg/pl)
= Sample concentration determined by standard curve (pg/ml) X 200 
1000
y = 0.0167x + 0.0024 
R2 = 0.9943
C oncentration of BSA (ug/ml)
Figure 2.6: Representative standard curve generated by the Bio-Rad protein assay using 
bovine serum albumin (BSA)
2.143 Active motif Trans AM™ ELISA-based assay to detect and quantify 
activated NF-kB
The assay is based on an indirect ELISA principle, except that the protein of interest, 
NF-kB, is captured not by an antibody but by a double-stranded oligonucleotidic probe 
containing the consensus binding sequence for NF-kB. The binding of NF-kB to its 
consensus sequence was detected using a primary anti-NF-xB antibody specific for 
recognition of the nuclear localization sequence (NLS) of NF-kB (Zabel et al. 1993), a 
domain of the protein that is masked by IkB when the transcription is in its inactive 
form, followed by a secondary antibody conjugated to horseradish peroxidase, the 
results were quantified by a chromogenic reaction; thus activation of NF-kB can be 
visualised by immunofluorescence.
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The first stage is the binding of NF-kB to a double stranded probe. 30pl of complete 
binding buffer (Active motif, TransAM™ Belgium) was added to each well used of a 
Streptav id in-coated 96 well microplate, which contain the double-stranded 
oligonucleotide probe containing a consensus binding sequence for NF-kB bound to the 
streptavidin (Active motif, TransAM™ Belgium). In addition, as a control measure to 
investigate competitive binding, 30pl of complete binding buffer containing either 
20pmol of the wild-type or a mutated consensus oligonucleotide (Active motif, 
TransAM™ Belgium) was added to additional wells (Fig 2.8).
Subsequently, 20pl of standard, control or sample diluted in complete lysis buffer were 
decanted into each well (in duplicate) and incubated for lh at RT° with mild agitation 
(lOOrpm). During this time any activated NF-kB p65 molecules present would have 
bound to the immobilised DNA probe.
Recombinant NF-kB p65 protein (Active Motif, Belgium) was used to generate a 
standard curve. A stock solution of 100ng/pl was diluted in complete lysis buffer 
(Active motif, TransAM™ Belgium) to generate a range of 0.625ng to 20ng per well. 
For blank wells, only 20pl complete lysis buffer was added. Sample nuclear extracts 
were used at a concentration of 5pg of total protein, diluted in 20pl complete lysis 
buffer in duplicate. Positive controls were 5pg of the Raji nuclear extract or 5pg of 
Caco-2 nuclear extract (Active motif, TransAM™ Belgium) diluted in 20pl complete 
lysis buffer in duplicate (Fig 2.8).
Each well was aspirated and washed 3 times with 2 0 0 pi of wash buffer (Active motif, 
TransAM™ Belgium), followed by addition of lOOpl of anti-NF-kB antibody diluted 
1:1000 in IX antibody binding buffer (Active motif, TransAM™ Belgium) incubated 
for lh at RT° without agitation. Each well was washed 3 times with 200pl of wash 
buffer. Before adding lOOpl of HRP-conjugated antibody diluted 1:1000 in IX antibody 
binding buffer incubated for lh at RT° without agitation. Each well was washed 3 times 
with 200pl of wash buffer. For colorimetric detection, lOOpl of developing solution 
(Active motif, TransAM™ Belgium) was added to the wells and incubated for lOmin at 
RT°, protected from light. The reaction was stopped by the addition to each well of 
lOOpl of stop solution (Active motif, TransAM™ Belgium) containing 2N sulphuric 
acid. The optical density was determined at 450nm with a correction at 655nm. A
Page 136
wstandard curve was created (Fig 2.7) and from the averaged optical density readings for 
each sample the concentration of activated NF-kB ng/well was determined. Fig 2.8 
shows representative negative and positive controls generated with the NF-kB P65 
ELISA. Addition of the wild type NF-kB consensus oligonucleotide resulted in 
competitive binding and a reduction in plate bound activated NF-kB P65. However, the 
oligonucleotide with a mutated NF-kB consensus sequence did not affect the binding of 
activated NF-kB to the plate. Raji and Caco-2 nuclear extracts were added as positive 
controls.
2-5
y = 0.2252x + 0.082 
R2 -  0.9864
05
Concentration of P65 (ng)
Figure 2.7: Representative standard curve generated by the NF-kB P65 ELISA
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Figure 2.8: Representative controls generated by the NF-kB P65 ELISA
2.15 Scanning electron microscopy (SEM)
Infected cell monolayers and explants were washed three times (PBS or IVOC medium) 
to remove non-adherent bacteria and mucus, and then fixed in 2.5% glutaraldehyde in 
phosphate buffer pH 7.2 and stored at 4°C until further processing.
The glutaraldehyde-fixed cells/explants were washed in cold 0.1M phosphate buffer 
containing 3% sucrose (w/v) (Sigma-Aldridge, Poole, Dorset, UK) for 30 and 90min 
respectively prior to post-fixation in l% aqueous osmium tetroxide (Agar Scientific, 
Stanstead, UK) for 30 and 90min respectively. Cells/explants were then washed three 
times in distilled H2O over lOmin and dehydrated with 2,2-dimethoxypropane (Sigma- 
Aldridge, Poole, Dorset, UK) for 2 or 9min respectively before transfer to 100% ethanol 
for 5 or lOmin respectively.
The cells/explants and were then critically point dried in liquid CO2 using an Emitech 
K850 critical point drier (Emitech, Ashford, Kent, UK). The specimens were mounted 
onto 10mm aluminium stubs (Agar Scientific, Stanstead, UK) using silver paint as a 
conducting mountant and subsequently sputter coated with gold/palladium using a
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¥Polaron E5100 series II sputter coater (Polaron, Watford, Hertfordshire UK). This 
provided a conductive surface over the specimen and base. The samples were then 
examined using a JEOL JSM 5300 SEM (JEOL Ltd. Welwyn Garden City, 
Hertfordshire, UK) at an accelerating voltage of 30kV. SEM photographs were captured 
with a SemaFore digital capture device (JEOL Ltd. Welwyn Garden City, Hertfordshire, 
UK).
2.16 Immunohistochemistry and Fluorescent Microscopy
2.16.1 Fluorescent-actm staining (FAS) test
The FAS test was carried out with 4% formalin/PBS-flxed Caco-2 and HEp-2 
monolayers, for visualising actin recruitment beneath bacterial attachment by 
florescence microscopy (Knutton et al. 1989).
Following co-culture experiments on 13mm glass cover slips cell monolayers were 
washed three times with PBS to remove non-adherent bacteria. The cells were then 
fixed with 4% formalin/PBS pH 7.4 for 20min at RT°. Once fixed, the cells were 
washed three times with PBS, and stored at 4°C in PBS prior to processing.
The cell monolayers were permeabilised with 0.1% Triton- X 100/PBS for 4min. The 
cells were washed three times in PBS and incubated with 5pg/ml FITC-conjugated 
phalloidin (Sigma-Aldridge, Poole, Dorset, UK) for 20min at RT°. Phalloidin binds to 
filamentous actin and is used to recognise actin recruitment at the site of bacterial 
adherence. The nucleation of actin by bacteria to form filamentous or F-actin, which is 
stained by FITC conjugated phalloidin, allows the bacteria to be divided into FAS 
positive or negative bacteria. After staining, the cells were washed in sterile 0.01 M 
PBS pH 7.4 three times for lmin and mounted onto glass slides using citifluor (Agar 
Scientific, Stanstead, UK) or Vectashield mountant (Vector, Peterborough, UK). The 
cells were examined using a Zeiss UV microscope with 4Ox lens (numerical aperture 
1.5), and images were acquired with a Zeiss Axiocam digital camera system (8 -bit, 
1300 x 1300 pixel-standard resolution) (Software-Image Associates, UK).
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2.16.2 NF-kB transcription factor staining
Infected or stimulated cell monolayers were fixed with 4% paraformaldehyde in PBS 
(PFA) for 15min, and then washed three times with 1% BSA in PBS. Bacterial-infected 
Caco-2 or HEp-2 monolayers were then permeabilised in 0.1% TritonX-100 (Fisher 
Scientific, Loughborough, UK) in PBS with 1% BSA at RT° for 30min. The 
monolayers were blocked with 5% goat serum (Sigma-Aldridge, Poole, UK), 1% BSA 
in PBS for 60min. The staining was performed by incubation with a polyclonal rabbit 
anti-NF-KB p65 antibody (1:50 dilution) (Santa Cruz, Heidelberg, Germany sc-372) in 
1% BSA in PBS for 60min at RT°, after which cells were washed three times with 1 % 
BSA in PBS. This was followed by incubation with a FITC-conjugated goat anti-rabbit 
antibody (1:160 dilution) (Sigma-Aldridge, Poole, UK F9887) in 1% BSA in PBS for 
60min at RT°, protected from the light. Finally, the monolayers were mounted with 
Vectashield mounting medium with DAPI (for visualisation of nuclear DNA) (Vector, 
Peterborough, UK H-1200). The images were observed under a Zeiss UV microscope 
with 40 or lOOx lens (numerical aperture 1.5), and images were acquired with a Zeiss 
Axiocam digital camera system (8 -bit, 1300 x 1300 pixel-standard resolution) 
(Software-Image Associates, UK).
2.17 Statistics
Statistical analyses were performed using SPSS 14 for Windows. Differences in gene or
protein expression between control cells and stimulus (which will be denoted as * on
reaching statistical significance) and between wild type strains and their respective
mutant strains (which will be denoted as +  on reaching statistical significance) were
evaluated using a two-tailed Mann-Whitney U-test. A p value of <0.05 was considered 
statistically significant. In the case of tissue data the fold difference in gene or protein 
expression between infected and matched non-infected controls was then calculated. 
Fold differences were evaluated using a two-tailed t-test.
I
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CHAPTER 3: Gram-negative pathogen
and the host: the recognition of 
enteropathogenic Escherichia coli 
virulence factors
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3.1 Background
Host PPRs recognise an array of prokaryote motifs, shared by both pathogenic and 
commensal bacteria, suggesting that all bacteria may have the potential to initiate 
epithelial innate immune responses (Bambou et al. 2004). At present, little is known of 
the mucosal response to commensal bacteria. In comparison, responses of IECs to 
pathogenic bacteria such as EPEC and EAEC have been well characterised.
EPEC induces IL- 8  secretion leading to transmigration of neutrophils (Savkovic et al. 
1996), and this is dependent on both the presence of the TTSS and intimate adhesion 
(Savkovic et al. 1996, Savkovic et al. 1997, Czerucka et al. 2001, de Grado et al. 
2001a). TLR5 recognition of EPEC flagellin has also been implicated in early EPEC- 
IEC interactions (Zhou et al. 2003, Sharma et al. 2006, Ruchaud-Sparagano et al. 2007). 
However, recent studies suggest that EPEC produces and secretes an array of proteins, 
via the TTSS, which modulate NF-kB activation and IL- 8  induction (Hauf & 
Chakraborty 2003, Sharma et al. 2006, Ruchaud-Sparagano et al. 2007). Further, the 
response seen is currently postulated to be a balance between the IEC pro-inflammatory 
response and the bacterial affecter protein-mediated anti-inflammatory response (Hauf 
& Chakraborty 2003, Sharma et al. 2006, Ruchaud-Sparagano et al. 2007).
Pathogenic EAEC strain 042 also induces IL- 8  release from non-polarised Caco-2 
IECs. The presence of the bacterial pAA plasmid is required for inflammatory effect 
(Steiner et al. 1998). Jiang et al. detected significant IL- 8  levels in faecal samples of 
travellers infected with EAEC strains harbouring the pAA plasmid borne aggR or aa/A 
genes, compared with plasmid-negative EAEC (Jiang et al. 2002). However, more 
recent studies suggest that it is not the pAA plasmid but rather the flagellin that is the 
major pro-inflammatory stimulus (Steiner et al. 2000, Donnelly & Steiner 2002, Khan et 
al. 2004). Subsequently others have suggested that IL- 8  release is in response to a 
combination of both plasmid and flagellin (Huang et al. 2004a, Harrington et al. 2005b). 
The main aim of this chapter was to characterise and identify which bacterial motifs 
contribute to the innate epithelial response. For this purpose, a range of EPEC and 
EAEC isogenic mutant strains were employed. In addition to structural motifs, 
bacterial-host contact was predicted to be important. Therefore, the role of bacterial 
adhesion in eliciting IEC responses was also investigated.
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3.1.1 Contribution of Lipopolysaccharide (LPS) to IEC innate immune response
LPS is the dominant component of the outer membrane of Gram-negative bacteria 
(Beutler & Rietschel 2003). When bacteria multiply and die LPS is released. Exposure 
to even picomolar amounts of LPS triggers host cells to synthesise and release a cascade 
of inflammatory mediators. Such a response when dysregulated may progress to toxic 
shock and death (Glauser et al. 1991, Cohen 2002). It is now known that cytokines such 
as TNF-a, IL-6 and IL-1 play a critical role in LPS-induced host responses.
LPS consists of a lipid A moiety, a core polysaccharide and an O-polysaccharide of 
variable length (Raetz 1990), (Fig 3.1). Lipid A is a phospoglyco-lipid, the architecture 
of which is unique in nature (Zahringer et al. 1994). The core region of enterobacterial 
LPS can be subdivided into an outer and inner portion. The O-specific chain is a 
polymer composed of repeating units of oligosaccharide. The structure of the repeating 
units differs from strain to strain and determines the serotype of the bacteria, which is 
an important surface antigen (Rietschel et al. 1994). Colony morphology is indicative of 
O-glycosylation status. Smooth colony forming strains express the complete core with 
varying chain lengths; whereas rough colony forming mutants lack the O- 
polysaccharide chain (Jiang et al. 2005).
Core glycolipid
O-specific poiysaccharide chain
ipidA
O -specific  
otogosacctw ide
( o u te r )  <ii
eon oligotacchande
Figure 3.1s The structure of LPS (From freespace.virgin.net/r.barclay/edtxschl.htm)
Despite extensive studies the structures that induce IEC inflammatory response have not 
been unequivocally identified. It is thought in order for the host to provide a response to 
a broad spectrum of Gram negative bacteria, the LPS receptors are targeted against the 
conserved lipid-A moiety. Moreover, the TLR4/MD-2 receptor complex recognises the 
lipid-A acyl chains (Lien et al. 2001, Akashi et al. 2001, Erridge et al. 2002, Beutler & 
Rietschel 2003, Kohara et al. 2006, Jerala 2007). Because Lipid A had been shown to be
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the bioactive moiety of LPS the O-polysaccharide chains are thought to have a 
subsidiary role in endotoxicity (Jiang et al. 2005, Kohara et al. 2006).
The TLR4/MD-2 receptor complex recognises the lipid A structure of LPS. However, 
with intact bacteria the lipid A remains buried in the outer envelope. To present the lipid 
A structure to the TLR 4/MD-2 complex, initial binding to LPS-binding protein (LBP) 
and CD 14 is required (Kohara et al. 2006). Following TLR4 activation, signalling 
pathways have been described as MyD8 8 -dependent (Feng et al. 2003, Miyake 2004) or 
-independent (Hoebe et al. 2003, Oshiumi et al. 2003). Activation of the MyD8 8 - 
dependent pathway results in recruitment of MyD8 8  and Mal/TIRAP adaptor protein to 
the TLR4-TIR domain resulting in the activation of TRAF6  followed by rapid, early 
phase of NF-kB and MAPK activation leading to the synthesis and release of pro- 
inflammatory cytokines such as TNF-a, IL-ip, IL- 6  and chemokines like IL- 8  and 
CCL20 (Takeda & Akira 2004, Huang et al. 2004b, Zughaier et al. 2005). Activation of 
the MyD8 8 -independent pathway leads to recruitment of a second set of Toll- 
interleukin 1 receptor domain adaptors, TRIF and TRAM, culminating in the 
phosphorylation and dimerization of the transcription factor IRF-3 and interferon-p 
(IFN-P) production. This ‘MyD8 8 -independent’ pathway can also activate NF-kB 
signalling at late times (Godowski 2005).
As detailed in section 1.4.2.4, reports of the expression of TLR4 and its associated 
proteins in primary IECs remains contradictory. In addition, the expression of TLR4 
and its associated complex remains unclear in routinely used IEC lines (Caco-2, HT-29, 
T84 and SW620) (Cario et al. 2000, Funda et al. 2001, Maeda et al. 2001, Abreu et al. 
2002, Haller et al. 2002, McCracken et al. 2002, Uehara et al. 2002).
3.12 Contribution of outer membrane vesicles to host innate immune response
Gram-negative cell walls have a dynamic feature which is not seen in gram-positive 
counterparts. Outer membrane vesicles (OMVs) are spherical vesicles composed of a bi- 
layer membrane with electron-dense luminal contents (Mayrand & Grenier 1989). 
OMVs are constantly being discharged from the bacterial surface during normal growth 
(Wai et al. 2003). At present, mechanism(s) responsible for generation of OMVs are not 
well understood. Lytic transglycosylases excise the cell wall and liberate membrane
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components from the PGN, leading to the accumulation of muramyl peptides in the 
periplasmic space triggering membrane blebbing (Fig 3.2) (Zhou et al. 2003).
}<*
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Figure 3.2 Model of vesicle biogenesis. (LPS) Lipopolysaccharide, (Pp) periplasm, 
(OM) outer membrane, (PG) peptidoglycan, (IM) inner membrane, (Cyt) cytosol 
(Kuehn et al. 2005).
The major constituents of OMV are LPS, OM proteins and phospholipids, OMVs may 
also entrap some of the underlying periplasm (Fig 3.2) (Soderblom et al. 2005). OMVs 
from pathogenic bacteria may contain adhesins, toxins, and immunomodulatory 
compounds. They may also directly mediate bacterial binding and host cell invasion. 
OMVs can cause cytotoxicity as they can act as vehicles for delivery of bacterial 
molecules into foreign cells (Kadurugamuwa & Beveridge 1998, Beveridge 1999, Wai, 
et al. 2003). In addition, OMVs may enable bacteria to escape immune detection during 
colonisation (Beveridge 1999). By participating in such diverse aspects of the host- 
pathogen interactions, OMVs may be considered virulence factors (Kuehn & Kesty 
2005). In addition to specific virulence factors, these vesicles contain compounds that 
are recognised by eukaryotic cells in the innate and acquired immune response 
pathways. For instance LPS, lipoprotein, and OM proteins present in vesicles are all 
biologically active, able to trigger immunity via TLRs and induce leucocyte migration 
(Galdiero et al. 1999, Akira et al. 2001). OMVs can present LPS to TLR4 and induce 
IL-8; a TLR4-independent mechanism of IL-8 induction has also been proposed 
(Soderblom et al. 2005). It is worth noting that OMVs change during a bacterial
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infection (such as the O antigen of LPS), thus the impact of vesicles on the modulation 
of the immune system will also vary during the course of infection (Kuehn & Kesty
2005).
3.13 Contribution of Lipoteichoic acid (LTA) to IEC innate immune response 
LTA units inserted into the cytoplasmic membrane, via a lipid anchor, extend through 
the cell wall PGN onto the surface of gram-positive cells (Navarre & Schneewind 1999, 
Deininger et al. 2003). LTA appears to be crucial for bacterial viability as its 
biosynthesis remains unaltered even during phosphate deficiency. The biological 
functions attributed to LTA include binding to metal cations and regulation of autolytic 
enzymes (Deininger et al. 2003). To the host, LTA represents a structural motif for 
immune recognition, similar to LPS. The amphiphilic LTA molecule resembles LPS in 
that it forms micelles, is lipid anchored, and carries phosphate and repetitive subunits of 
carbohydrates. LTA is recognised by macrophages via membrane-associated CD 14 and 
TLR2 and does not require participation of LPS-binding protein (Deininger et al. 2003).
3.1.4 Contribution of Exopolysaccharide (EPS) to EEC innate immune response
Little is known about the role of EPS which is another major product of gram positive 
bacteria. It is a polymer structure with long polysaccharide chains and additional lipid 
or peptide groups (Targosz et al. 2006). The receptor for EPS remains unknown. 
However, EPS and LPS do compete for the same receptors on macrophage membranes 
(Targosz et al. 2006).
3.13 Contribution of flagella to IEC innate immune response
Many bacteria possess flagella, whip like organelles, which attach to a rotary motor 
embedded in the bacterial cell wall; providing motility and thus the ability to colonise. 
Flagella perform several functions that can influence bacterial colonisation (Rawls et al. 
2007). These include swimming motility facilitating invasion (O'Neil & Marquis 2006), 
chemotaxis toward preferred habitats and nutrient sources (Ottemann & Lowenthal 
2002), and then act as adhesins allowing bacteria to interact with IECs a role 
independent of their motility (Arora et al. 1998, Giron et al. 2002). Flagella can also 
serve as a secretion apparatus for virulence factors (Young et al. 1999, Konkel et al. 
2004).
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TLR5 binds to a 13 amino acid motif present in the flagellin profillament, which is not 
accessible in polymerised flagella (Smith et al. 2003). However, many flagellated 
bacteria readily release flagellin monomers into their milieu, thus suggesting that the 
immune system may encounter flagellin more frequently than other bacterial products, 
such as LPS (Gewirtz et al. 2001a, Sanders et al. 2006).
In model IECs, TLR5 expression is restricted to the basolateral membrane (Gewirtz, et 
al. 2001a, Reed et al. 2002). One may hypothesise that apical TLR5 expression is 
undesirable as the gut surface is chronically exposed to commensal bacteria. Thus, a 
TLR5 -mediated pro-inflammatory response would occur only on breach of the 
epithelium by bacteria or their products. It has been argued that this allows enterocytes 
to discriminate between commensal and pathogenic species as the latter are able to 
reach the basolateral membrane upon invasion (Gewirtz et al. 2001a, Gewirtz et al. 
2001b, Zeng et al. 2003).
3.1.6 Contribution of adherence to IEC innate immune response
Once the bacterium has transversed the mucus layer and reached the epithelial surface, 
adherence and colonisation follows.
3.1.6.1 Localised adherence of EPEC
As previously described in section 1.6.7.1.1, the first stage of EPEC colonisation is a 
characteristic pattern of adherence called “localised adherence”. Several bacterial 
surface-organelles and secreted products have been implicated in this adherence. Of 
these BFP, type 1 fimbriae and EspA were investigated for their involvement in the IEC 
response. Maternal antibodies to BFP protect infants from EPEC infection by 
interfering with adhesion (Loureiro et al. 1998). In addition, strong antibody responses 
to type-1 fimbriae develop when volunteers are experimentally infected with E69 
(Karch et al. 1987) both findings highlight the immunogenic nature of these bacterial 
components (Elliott & Kaper 1997).
3.1.6.2 Aggregative adherence of EAEC
EAEC has a distinctive aggregative adherence, with a stacked brick-like pattern 
distinguishable from that manifested by EPEC (Nataro et al. 1987a). As detailed in 
section 1.6.7.2, EAEC adherence requires expression of aggregative adherence fimbriae
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and fimbrial-associated adhesins, which were both investigated here for their role in 
inducing IEC responses.
3.1.7 Contribution of the EPEC TTSS to IEC innate immune response
The second stage of EPEC infection is characterised by the TTSS injecting effecter 
proteins directly into host cells, which alter host cell signal transduction (Section 
1.6.7.1.2). At this stage what remains unclear is the contribution of the secreted effecter 
proteins versus that of the syringe apparatus itself, in eliciting an immune response. 
Therefore, structural components EscN and EspA were investigated for their 
involvement in the IEC response. EspA filaments contain a central variable region and 
within this, a hyper-variable region that resembles a domain of flagellin (Spears et al.
2006). This region forms an unstructured exposed loop, implicated in EspA 
polymorphism (Spears et al. 2006). The immunogenic properties of EspA are 
characterised by the presence of antibodies to EspA in the colostrum of mothers and the 
serum of both mothers and infants (Parissi-Crivelli et al. 2000).
3.1.8 Contribution of effecter proteins to IEC innate immune response
The contribution of the secreted effecter proteins EspF, EspC and LifA in eliciting an 
immune response was investigated. EspF functions in immune evasion (Martinez- 
Argudo et al. 2007). LifA is a non-TTSS-secreted protein, which inhibits peripheral 
blood and, human and murine GI lymphocyte proliferation and cytokine production 
(Klapproth et al. 1995, Klapproth et al. 2000).
3.1.9 Contribution of the EPEC intimate adherence to IEC immune response
The third stage of EPEC infection is characterised by intimate adherence to the mucosal 
membrane forming an attaching and effacing lesion, described in more detail in section 
1.6.7.1.3. Ultra structural studies show the accumulation of cytoplasmic fibrils 
identified as cytoskeletal actin, beneath intimately attached bacteria, an additional 
feature of the AE lesion. On the basis of an additional observation by Knutton et al. that 
EPEC strains produce an identical AE lesion when they adhere to some tissue culture 
cells (Knutton et al. 1987), Knutton et al. developed a specific fluorescent-actin staining 
(FAS) test, which is diagnostic for the AE adherence property (Knutton et al. 1989). 
Cells infected with EPEC and EHEC strains, known to produce the AE lesion, all 
exhibited intense spots of fluorescence which corresponded in size and position with
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each adherent bacterium. In contrast, cells infected with adherent E. coli strains, known 
not to produce the AE lesion, did not produce this striking pattern of fluorescence and 
were indistinguishable from uninfected control cells. These results indicate that such 
site-specific concentrations of cytoskeletal actin are characteristic of the AE membrane 
lesion and can form the basis of a simple, highly sensitive diagnostic test for EPEC and 
EHEC (Knutton et al. 1989). The intimate adherence status of the EPEC strains to IECs 
was investigated using the FAS test.
3.2 Results
3.2.1 Bacterial morphology by negative staining TEM
Bacteria comprise a spectrum of surface organelles and secreted products, features that 
allow them to conquer many different niches (Pizarro-Cerda & Cossart 2006). To gain a 
greater insight into bacterial-host interactions it was important to determine the presence 
of microbial structural components that are known to interact with the host PPRs. 
Negative staining followed by TEM was the method of choice. A range of bacterial 
species and EPEC and EAEC structural mutants were characterised prior to further 
usage.
Fimbriae and flagella were assessed visually based on previous morphological reports. 
Fimbriae were observed as hollow rod-like structures and were distinct from flagella. 
Type 1 and 2 fimbriae are 7-8nm wide; and type 3 is 4-5nm wide. Type 1, 2 and 3 
fimbriae can be approximately 0.5-2pm long and are peritrichous (Old 1972). Type 4 
fimbriae are 10-20pm long and are polar. Long polar fimbriae (LPF) are 2-10pm long. 
Flagella are not rigid rod structures and are wider and longer than fimbriae as well as 
being peritrichous. Figure 3.3 shows commensal species, HB101 (Fig 3.3a) and B. theta 
(Fig 3.3b). A large number of long fimbriae were found dispersed around the HB101 
strain and the presence of secreted OMVs was also observed. In contrast, B. theta did 
not express any external structures but did release OMVs. The probiotic species L299v 
and LGG are shown in Fig 3.4. L299v was found to express many fimbriae surrounding 
the bacterium and several peritrichous flagella (Fig 3.4a). The gram positive L299v also 
exuded some form of vesicle or secretion product which maybe one of several known 
products to be secreted by Lactobacilli species; such as an exopolysaccharide, i.e.
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mucilage or slime; or LTA vesicles (Chan et al. 1985, Reid et al. 1996, Boris et al. 
1998, Deininger et al. 2003). LGG (Fig 3.4b) was found to express single 
(monotrichous) flagella. Interestingly, these bacteria grouped together in a colony with 
the flagella polarised in the same direction. LGG also produced a substance which like 
L299v could be slime or exopolysaccharide or alternatively could be cellular debris or 
residual stain trapped amongst the flagella.
Figure 3.5 shows the pathogenic wild type EPEC strains E10 and E69. E10 (Fig 3.5a) 
expressed fimbriae/pili and flagella as well as OMVs. E69 (Fig 3.5b) was found to 
express a monotrichous flagellum and OMVs. There was no evidence of O- 
polysaccharide chains blebbing off the surface of either wild type strains. E69 LPS 
mutant strains are shown in Fig 3.6. The smooth strain (Fig 3.6a) expressed O- 
polysaccharide chains of LPS, which appeared to bleb in a different manner to that of 
OMVs. The rough LPS mutant (Fig 3.6b) expressed fimbriae and OMVs and lacked O- 
polysaccharide chains. Fig 3.7 shows the E69 flagella mutants. E69 tsfliC (Fig 3.7a) did 
not express any flagella. In fact, this strain had a strong resemblance to the E69 smooth 
mutant strain, as the E69 A/7iC strain was also found to express O-polysaccharide chains 
of LPS, which like the smooth strain could be seen to bleb off the bacterial surface. The 
fliC* complemented E69 strain (Fig 3.7b) was found to express fimbriae and OMVs. 
The EAEC wild type serotype 042 (Fig 3.8a) expressed OMVs and the presence of 
detached flagella could be seen. The 042 A/7/C mutant strain (Fig 3.8b) did not express 
flagella but did express fimbriae and OMVs and formed colonies in the characteristic 
stacked brick formation. The aggregative adherence fimbria mutant AafB (Fig 3.9a) 
expressed OMVs only. Another aggregative adherence fimbria mutant AAF/II (Fig 
3.9b) expressed a rope like exopolysaccharide and OMVs but did not express fimbriae.
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Figure 3.3: Structure of commensals HB101 (a) and B. theta (b) as observed by
negative staining TEM. Magnification range was between 15000- 88000x.
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Figure 3.4: Structure of probiotic L299v (a) and LGG (b) as observed by negative
staining TEM. Magnification range was between 40000- 300000x.
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Figure 3.5: Structure of pathogenic EPEC E10 (a) and E69 (b) wild type strains as
observed by negative staining TEM. Magnification ranged between 8800- 66000x.
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Figure 3.6: Structure of E69 smooth (a) and rough (b) LPS mutant strains as 
observed by negative staining TEM. Magnification range was between 40000- 
140000x.
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Figure 3.7: Structure of flagella mutants E69 fliC* (a) and fliC& (b) as observed by
negative staining TEM. Magnification range was between 25000- 66000x.
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Figure 3.8: Structure of pathogenic EAEC 042 WT (a) and 0 4 2 /7/CA (b) mutant 
as observed by negative staining TEM. Magnification range was between 5600- 
115000x.
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Figure 3.9: Structure of 042 aggregative adherence fimbriae mutants 042 AAafB 
(a) and 042 AAAF/II (b) as observed by negative staining TEM. Magnification 
range was between 25000- 88000x.
Page 157
3.2.2 Contribution of LPS to IEC immunity
Due to the conflicting reports as to whether Caco-2 cells express biologically active 
TLR4, MD-2 or CD 14 the host innate immune response to E. coli LPS in HEp-2 cells 
was initially established. Although HEp-2 cells are now considered a Hela cell 
contaminant, they have to date provided a well established model to study EPEC 
interactions with human IECs (Rosenshine et al. 1992, de Grado 2001a). In this series of 
experiments, the involvement of LPS in the innate immune response to EPEC WT E69 
was investigated with the use of smooth and rough LPS mutant strains. The strains were 
co-cultured with HEp-2 cells for 4 or 16h (Section 2.7). IL- 8  gene expression was 
determined by RT-PCR at 4h (Section 2.12) and IL- 8  and CCL20 protein expression 
was assessed by ELISA at 4 and 16h (Section 2.10). These experimental conditions are 
the same for all data presented within this chapter unless otherwise stated.
Low IL- 8  gene expression was observed in control, uninfected HEp-2 cells. On 
exposure to wild type E69, or smooth/rough LPS mutants only a minimal increase in IL- 
8  expression 4h post-infection was noted (Fig 3.10). At the protein level, a modest 
increase in IL- 8  was also observed (Fig 3.1 la). However, a marked induction in IL- 8  
and CCL20 protein in response to all strains was observed 16h post-bacterial exposure. 
(Fig 3.11a and b). Smooth LPS increased CCL20 expression however, there was no 
significant difference between wild type and smooth LPS isogenic mutant strain for 
either IL- 8  or CCL20. The rough LPS strain exhibited marked reduction in its ability to 
induce both IL- 8  and CCL20 protein expression.
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Figure 3.10: Modulation of IL-8 gene expression at 4h. HEp-2 cells were either co­
cultured with E69, E69 smooth LPS or E69 rough LPS (MOl = 60), or stimulated with 
IL-lp (lOng/ml) as a positive control. Gene expression 4h post-infection was 
determined and normalised to GAPDH. Variations in mRNA levels are expressed as 
fold induction compared to the uninfected control cells. Data shown is mean (+SD, * 
P<0.05) induction of three independent experiments.
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Figure 3.11: Effect of LPS on IL-8 (a) and CCL20 (b) protein production at 4 and 
16h. HEp-2 cells were either co cultured with E69, E69 smooth LPS or E69 rough LPS 
strains (MOl = 60), or stimulated with IL-lp (lOng/ml) as a positive control. 4 or 16h 
post-infection cell and bacterial co-culture supernatants were harvested and protein 
levels evaluated by ELISA. Data shown is mean (+SD,*/+ P<0.05) induction of three 
independent experiments.
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3 3 3  Contribution of flagella to IEC innate immunity
In the following experiments the contribution of flagella to eliciting innate immune 
responses to wild type EPEC E69 and EAEC 042 strains was investigated. The main 
aim was to determine the response of flagellated bacteria, and compare the data 
obtained to established observations of the flagellin monomer. To elucidate the TLR5- 
independent response, the HEp-2 cell line which expresses little or no TLR5 was used 
(Donnelly & Steiner 2002, Khan et al. 2004, Sharma et al. 2006). To investigate the 
TLR5-dependent response, the Caco-2 cell line was used, which does express TLR5 
(Sierro et al. 2001, Berin et al. 2002). Furthermore, the effect of TLR5 basolateral 
localisation to host response was conducted in polarised Caco-2 cells.
333 .1  Response of HEp-2 cells to apical stimulation with flagellated E69
In this series of experiments the effects of apical stimulation with flagellated (E69 WT 
and E69 fliC *) and non flagellated (E69 AfliC) viable bacterium was investigated. At 4h 
only E69 induced any significant up-regulation of IL- 8  mRNA but none of the strains 
induced any significant IL- 8  and CCL20 protein in HEp-2 cells (Fig 3.12 and 3.13). At 
16h E69 WT and the two flagella mutants all induced a significant increase in IL- 8  
protein (Fig 3.13a). Only the wild type strain E69 induced significant production of 
CCL20 protein at this time point (Fig 3.13b). A statistically significant reduction in IL- 8  
expression between the wild type strain and the E69 A/7/C mutant was observed and a 
further reduction was seen with the E69 fliC* mutant strain (Fig 3.13a). There was no 
significant difference in the induction of CCL20 between the wild type strain and the 
E69 AfliC  flagella deficient strain but there was a statistically significant reduction in 
response with the complemented strain in comparison to the wild type strain (Fig 
3.13b).
3 3 3 3  Response of HEp-2 cells to apical stimulation with flagellated 042
In the next series of experiments the response of HEp-2 cells to apical stimulation with 
the EAEC wild type strain 042 and its flagella mutant 042 A/7iC was investigated. At 
16h the 042 WT and the flagella mutant both induced a significant amount of IL- 8  and 
CCL20 protein (Fig 3.14). In contrast, the flagella negative mutant showed less ability 
to induce IL- 8  and CCL20 protein when compared to the wild type strain (Fig 3.14).
Page 161
25
3
*
0
Non Stimulated E69
Figure 3.12: Effect of flagella on modulation of IL- 8  gene expression at 4h
Cells were either co-cultured with E69, the E69 flagella mutant AfliC strain, the E69 
flagella complemented mutant fliC* strain (MOI = 60), or stimulated with IL-lp 
(lOng/ml) as a positive control. Gene expression 4h post-infection was determined and 
normalised to GAPDH. Variations in mRNA levels are expressed as fold induction 
compared to the uninfected control cells. Data shown is mean (+SD,* P<0.05) induction 
of three independent experiments.
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Figure 3.13: Effect of E69 flagella on production of IL- 8  (a) or CCL20 (b) at 4 and 
16h. HEp-2 cells were co cultured with E69, E69 AfliC and E69 fliC* (MOI = 60), or 
stimulated with IL-lp (lOng/ml) as a positive control. At 4 or I6h post-infection cell 
and bacterial co-culture supernatants were harvested and evaluated by ELISA. Data 
shown is mean (+SD,*/+ P <0.05) induction of three independent experiments.
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Figure 3.14: Effect of 042 flagella on production of IL- 8  (a) or CCL20 (b) at 16h.
HEp-2 cells were co-cultured with 042 and 042 AfliC (MOI = 60), or stimulated with 
IL-lp (lOng/ml) as a positive control. At 16h post-infection cell and bacterial co-culture 
supernatants were harvested and evaluated by ELISA. Data shown is mean (+SD,*/+ P 
<0.05) induction of three independent experiments.
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3 .2 3 3  Response of Caco-2 cells to apical stimulation with flagellated E69
The response of Caco-2 cells, which express TLR5, to apical stimulation with the EPEC 
wild type strain E69 and its respective flagella negative mutant strain E69 A/7/C was 
studied. The strains were co-cultured with Caco-2 cells for 16h (Section: 2.7). At 16h 
the E69 WT and the flagella mutant both induced a significant increase in IL- 8  protein, 
although IL-ip was a ten fold less than that seen with the HEp-2 cell line (Fig 3.15). At 
16h the flagella negative mutant showed a reduced ability to induce of IL- 8  protein 
when compared to the wild type strain (Fig 3.15).
3 3 3 .4  Response of Caco-2 cells to basolateral stimulation with flagellated E69
As TLR5 is reported to be located on the basolateral membrane the response of Caco-2 
cells to basolateral stimulation with the EPEC wild type strain E69 and the flagella 
AfliC  mutant strain was investigated. Caco-2 cells were grown on transwell filters until 
polarised. The cells were stimulated basolaterally and the cell supernatant was collected 
from the apical and basolateral compartment (Section: 2.7.1.2). At 16h, no IL- 8  protein 
was secreted apically by control and £69 WT infected cells. A modest amount of IL- 8  
protein was seen with the flagella negative mutant (Fig 3.16). Minimal IL- 8  was 
detected in the basolateral compartment of control cells. Interestingly, during infection 
with the wild type strain, IL- 8  secretion into the basolateral chamber was found to be 
below the levels measured in uninfected control cells. In comparison, a marked increase 
in IL- 8  protein was observed on stimulation with the flagella mutant. Thus, the 
aflagellated strain induced a statistically significant increase in IL- 8  secretion in 
comparison to the wild type strain both apically and basolaterally (Fig 3.16).
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Figure 3.15: Effect of E69 flagella on production of IL-8 by Caco-2 cells stimulated 
apically at 16h. Caco-2 cells were co-cultured with E69 wild type or E69J/7iC strain 
(MOI = 60), or stimulated with IL-lp (lOng/ml) as a positive control. At 16h post­
infection cell and bacterial co-culture supernatants were harvested and evaluated by 
ELISA. Data shown is mean (+SD,*/+P<0.05) induction of three independent 
experiments.
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Figure 3.16: Effect of E69 flagella on production of IL-8 by Caco-2 cells stimulated 
basolaterally at 16h. Caco-2 cells were co cultured with E69 wild type or E69AfliC 
strain (MOI = 60), or stimulated with IL-lp (lOng/ml) as a positive control. At 16h 
post-infection cell and bacterial co-culture supernatants were harvested apically (a) and 
basolateraly (b) and evaluated by ELISA. Data shown is mean (+SD,*/+P<0.05) 
induction of three independent experiments.
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3.2.4 Contribution of adherence to IEC innate immune response
3.2.4.1 Role of adherence of EPEC to IEC immunity
In the following series of experiments the contribution of adherence to HEp-2 cell 
responses to EPEC wild type strain E69 was investigated. The role of BFP was studied 
with mutant E. coli strains JPN15 (lacks the EAF plasmid) and 31-6-1 (1) (TnphoA in 
bfpA), the effect of type 1 fimbriae was abolished by the addition of mannose to 
infections of wild type E69 and the role of EspA by using a AespA isogenic mutant.
At 4h, E69 WT induced a statistically significant up-regulation of IL- 8  mRNA 
expression; unexpectedly E69 WT incubated in the presence of mannose also induced a 
significant increase in IL- 8  mRNA, which was not seen with stimulation of mannose 
alone (Fig 3.17). Upon infection with the bundle forming pilus mutant strains JPN15 
and 31-6-1 and the TTSS mutant AespA, levels of IL- 8  mRNA at 4h were found to be 
even lower than the ‘constitutive’ expression noted in uninfected control cells and were 
significantly reduced in comparison to the wild type strain (Fig 3.17).
At 4h the E69 WT and the wild type plus mannose caused a modest induction in IL- 8  
protein (Fig 3.18a). Strains JPN15 and 31-6-1 showed no expression of IL- 8  protein. At 
4h none of the strains investigated induced any significant change in expression of 
CCL20 protein (Fig 3.18b). At 16h the E69 WT, the wild type plus mannose and the 
EspA mutant induced a marked increase in IL- 8  and CCL20 protein (Fig 3.18). At 16h 
strains JPN15 and 31-6-1 showed minimal increase in IL- 8  protein, with a decrease in 
CCL20 protein (Fig 3.18). In comparison to the wild type E69 the protein expression 
correlated with mRNA expression, in that 31-6-1 and JPN15 showed a statistically 
significant reduction in expression of IL- 8  and CCL20 protein. E69 plus mannose 
induced the most statistically significant increase in IL- 8  and CCL20 protein amongst 
the strains tested and there was no significant difference in IL- 8  and CCL20 protein 
expression between EspA and E69 (Fig 3.18).
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Figure 3.17: Effect of adherence on modulation of IL- 8  gene expression
Cells were either co-cultured with E69, E69 plus mannose (5pg/ml), E69 30-6-1, E69 
JPN15, E69 AespA (MOI = 60), or stimulated with IL-lp (lOng/ml) as a positive 
control. Gene expression 4h post-infection was determined and normalised to GAPDH. 
Variations in mRNA levels are expressed as fold induction compared to the uninfected 
control cells. Data shown is mean (+SD, */+P<0.05) induction of three independent 
experiments.
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Figure 3.18: Effect of EPEC adherence on production of IL-8 (a) and CCL20 (b) at 
4 and 16h. HEp-2 cells were co-cultured with E69, E69 plus mannose (5pg/ml), E69 
30-6-1, E69 JPN15, E69 AespA (MOI = 60), or stimulated with IL-lp (lOng/ml) as a 
positive control. At 4 or 16h post-infection cell and bacterial co-culture supernatants 
were harvested and evaluated by ELISA. Data shown is mean (+SD, */+P<0.05) 
induction of three independent experiments.
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3.2.4.2 The role of EAEC adherence to IEC immunity
In this series of experiments the role of adherence via the aggregative adherence 
fimbriae on HEp-2 cell immunity to wild type EAEC strain 042 was investigated. A 
fimbriae negative strain (AAAF/II) and adhesin negative strain (AAafB) were utilised. 
At 4h there was no statistically significant induction of IL-8 mRNA with any of the 
strains investigated (Fig 3.19); as was the case for IL-8 and CCL20 protein expression 
(Fig 3.20). However, at 16h all strains induced a statistically significant induction of IL- 
8 and CCL20 (Fig 3.20); both mutant strains reduced the response in comparison to the 
wild type strain.
Non Stimulated 042 042 AAf IA IL-1p
Figure 3.19: Effect of EAEC adherence on modulation of IL-8 gene expression.
HEp-2 cells were either co-cultured with 042, 042 AAAF/II (MOI = 60), or stimulated 
with IL-ip (lOng/ml) as a positive control. Gene expression 4h post-infection was 
determined and normalised to GAPDH. Variations in mRNA levels are expressed as 
fold induction compared to the uninfected control cells. Data shown is mean (+SD, * 
P<0.05) induction of three independent experiments.
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Figure 3.20: Effect of EAEC adherence on production of IL- 8  (a) and CCL20 (b) at 
4 and 16h. HEp-2 cells were either co-cultured with 042, 042 AAAF/II, 042 AAafB 
(MOI = 60), or stimulated with IL-lp (lOng/ml) as a positive control. At 4 or 16h post­
infection cell and bacterial co-culture supernatants were harvested and were evaluated 
by ELISA. Data shown is mean (+SD, */+P<0.05) induction of three independent 
experiments.
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3.2.5 Contribution of the type three secretion system to host innate immune 
response
3.2.5.1 Investigation of intimate adhesion status
In this series of experiments the intimate adherence status of the EPEC strains was 
investigated using the FAS test (Section: 2.16.1). The nucleation of actin by bacteria to 
form filamentous or F-actin, which is stained by FITC conjugated phalloidin, allows the 
bacteria to be divided into fluorescent actin staining (FAS) positive or FAS negative 
bacteria
The control, uninfected HEp-2 cells at 16h (Fig 3.21) showed a typical negative FAS 
test, with actin fluorescence localised at the cell periphery. Upon infection, with E69 
WT the FAS test was positive with, fluorescence localizing at the cell periphery, and in 
addition, intense spots of actin fluorescence, which in comparison with the 
complementary phase-contrast image; correspond in size and position with adherent 
bacteria (Fig 3.21). The EPEC E69 LPS smooth and rough mutant strains (Fig 3.21) 
were both FAS Test positive, as was the EPEC E69 flagella negative mutant (A/7/C) and 
flagella complemented (fliC f+) strain (Fig 3.22). The EPEC E69 bundle forming pilus 
mutant 31-6-1 (Fig 3.22) which has a TnphoA in bjpA no longer conferring localised 
adherence, was FAS test negative; with actin fluorescence localised at the cell 
periphery. The EPEC E69 mutant JPN15 (Fig 3.22) that lacks the EAF plasmid on 
which BFP is encoded, which also does not form localised adherence, was FAS test 
positive showing, albeit weakly, characteristic spots of actin fluorescence corresponding 
in size and position with adherent bacteria.
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Figure 3.21: Phase-contrast and fluorescence micrographs showing control HEp-2 
cells (a) and E69 WT (b) E69 Smooth (c) and Rough (d) LPS mutants at 16h. Each 
co-culture was examined in triplicate, shown is a representative of those seen. 
Complementarity o f cell or bacterial location and actin fluorescence was confirmed by 
simultaneously recording phase-contrast and fluorescence images.
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Phase contrast Fluorescence
Figure 3.21: Phase-contrast and fluorescence micrographs showing control HEp-2 
cells (a) and E69 WT (b) E69 Smooth (c) and Rough (d) LPS mutants at 16h. Each 
co-culture was examined in triplicate, shown is a representative of those seen. 
Complementarity of cell or bacterial location and actin fluorescence was confirmed by 
simultaneously recording phase-contrast and fluorescence images.
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Figure 3.22: Phase-contrast and fluorescence micrographs showing E69 mutants of 
flagella A/7/C (a) and fliC *  (b) and BFP 31.6.1 (c) and JPN15 (d) at 16h. Each co­
culture was examined in triplicate, shown is a representative of those seen. 
Complementarily of cell or bacterial location and actin fluorescence was confirmed by 
simultaneously recording phase-contrast and fluorescence images.
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Figure 3.22: Phase-contrast and fluorescence micrographs showing E69 mutants of 
flagella SfliC  (a) and JliC** (b) and BFP 31.6.1 (c) and JPN15 (d) at 16h. Each co­
culture was examined in triplicate, shown is a representative of those seen. 
Complementarily of cell or bacterial location and actin fluorescence was confirmed by 
simultaneously recording phase-contrast and fluorescence images.
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3.2.5.2 Contribution of TTSS to IEC immunity
To investigate the potential role of the TTSS in IEC immune response(s) to EPEC, the 
mutant strains AescN and AespA were used. At 4h, only E69 induced a significant 
increase in IL- 8  mRNA expression in HEp-2 cells and there appeared to be a reduced 
expression with both TTSS mutant strains (Fig 3.23). At 4h only E69 induced a modest 
but significant expression of IL- 8  protein with no strains modulating CCL20 production 
(Fig 3.24). Again, reduction was noted during infection with both TTSS mutant strains. 
At 16h all strains induced a significant expression of IL- 8  and CCL20 protein. 
Stimulation with EspA gave a greater increase in CCL20 when compared to the wild 
type however, it was not significant. The AEscN strain caused significant effect on 
expression of IL- 8  and CCL20 with a reduction in expression when compared to the 
wild type strain.
3.2.6 Contribution of EPEC effecter proteins to IEC immunity
To investigate the role of EPEC secreted effecter proteins, the AespC, AespF and AlifA 
mutant strains were used. At 4h, the lymphostatin negative strain induced statistically 
significant expression of IL- 8  mRNA, which was not the case with any other strain 
investigated except the wild type (Fig 3.25). At 4 and 16h the AespF and AlifA mutant 
also induced IL- 8  protein (Fig 3.26). At 4h the production of CCL20 was increased by 
AlifA mutant compared to that of the wild type strain. At 16h however, the levels were 
similar to the wild type strain. At 4h there was a statistically significant reduction in IL- 
8  expression with the AespC strain in comparison to the wild type, with a significant 
reduction in both IL- 8  and CCL20 protein at 16h (Fig 3.26).
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Figure 3.23: Effect of the Type Three Secretion System on modulation of IL- 8  gene 
expression. HEp-2 cells were either co-cultured with E69, E69 AescN, E69 AespA 
(MOl = 60), or stimulated with IL-ip (lOng/ml) as a positive control. Gene expression 
4h post-infection was determined and normalised to GAPDH. Variations in mRNA 
levels are expressed as fold induction compared to the uninfected control cells. Data 
shown is mean (+SD,* /+P<0.05) induction of three independent experiments.
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Figure 3.24: Effect of the Type Three Secretion System on production of IL- 8  (a) 
and CCL20 (b) at 4 and 16h. HEp-2 cells were either co-cultured with E69, E69 
AescN, E69 A espA (MOI = 60), or stimulated with IL-ip (lOng/ml) as a positive 
control. At 4 or 16h post-infection cell and bacterial co-culture supernatants were 
harvested and were evaluated by ELISA. Data shown is mean (+SD, */+P<0.02) 
induction of three independent experiments.
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Figure 3.25: Effect of effecter proteins on modulation of IL- 8  gene expression at
4h. HEp-2 cells were either co-cultured with E69, E69 A espC, E69 A espF, E69 bdifA 
(MOI = 60), or stimulated with IL-lp (lOng/ml) as a positive control. Gene expression 
4h post-infection was determined and normalised to GAPDH. Variations in mRNA 
levels are expressed as fold induction compared to the uninfected control cells. Data 
shown is mean (+SD,* P<0.05) induction of three independent experiments.
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Figure 3.26: Effect of effecter proteins on production of IL- 8  (a) and CCL20 (b) at 
4 and 16h. HEp-2 cells were co-cultured with E69, E69 AespC, E69 AespF, E69 tslifA 
(MOI = 60), or stimulated with IL-ip (lOng/ml) as a positive control. At 4 or 16h post­
infection cell and bacterial co-culture supernatants were harvested and were evaluated 
by ELISA. Data shown is mean (+SD, */+P<0.05) induction of three independent 
experiments.
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3.3 Discussion
IECs respond to microbial stimuli by secretion of pro-inflammatory cytokines and 
chemokines such as IL- 8  and CCL20 (Savkovic et al. 1997, Steiner et al. 2000, 
Izadpanah et al. 2001). IL- 8  plays an important role in the attraction of neutrophils to 
sites of inflammation and in the activation of cells in the underlying mucosa (Baggiolini 
et al. 1994). Once IL- 8  is released, this leads to the accumulation of neutrophils in the 
intestinal mucosa, leading to tissue disruption and fluid secretion. Immature DCs 
expressing CCR6  on their surface are selectively attracted to the site of infection by the 
CCL20 chemokine, allowing DCs to take up foreign antigen and become mature. As 
iDCs capture antigen they undergo a functional and phenotypic change that includes a 
decrease in CCR6  expression with a concomitant increase in CCR7, this change enables 
DCs to traffic out of the tissue and migrate to secondary lymphoid organs (Dieu et al. 
1998). The coupling of CCL20 and IL- 8  transcriptional activation could be crucial for 
induction of protective immune responses in the gut (Sierro et al. 2001).
Responses of IECs to pathogenic bacteria such as EPEC and EAEC have been well 
characterised. EPEC attachment to IECs induces secretion of IL- 8  and stimulates the 
trans-epithelial migration of neutrophils (Savkovic et al. 1997). Intestinal cells infected 
with EAEC 042 are also known to elicit increased amounts of IL- 8  in vitro (Steiner et 
al. 1998). Thus, the main aim of this chapter was to characterise and identify which 
bacterial motifs contribute to the innate epithelial response. For this purpose a range of 
isogenic mutant strains were employed. In addition to structural motifs, bacterial-host 
contact was postulated to be important, so the role of bacterial adhesion in eliciting IEC 
responses was also investigated. None of the bacteria studied were invasive by nature. 
Therefore, IEC responses observed were more probably initiated by bacterial soluble 
factors or by direct adherence and interaction with IECs.
TLRs recognise an array of prokaryote motifs that are shared by both pathogenic and 
commensal bacteria. Suggesting that all bacteria may have the potential to initiate IEC 
immune responses (Bambou et al. 2004). This was confirmed as commensal, probiotic 
and pathogenic bacteria not only expressed similar external structures such as flagella 
(Fig 3.3-9) but the critical role of flagella in eliciting IEC immunity was clearly
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identified during EPEC/EAEC infection (Fig 3.12-16) as were other external 
components. External structures (such as flagella) were found on the non-pathogenic 
strains. However, their role in eliciting IEC immunity was not investigated, as mutant 
strains were not available. At present, little is known of the innate mucosal response to 
commensal bacteria which will be investigated in chapter 5.
The involvement of LPS in the innate immune response to E69 was investigated. 
Conflicting information is available as to the LPS structures that induce IEC 
inflammatory responses. It is thought that the LPS receptors are targeted against the 
conserved lipid-A moiety and the O-po 1 ysaccharide chains are thought to have a 
subsidiary role. Primarily to clarify the conflicting information available, rough and 
smooth LPS isogenic mutants were co-cultured with HEp-2 cells and IL- 8  and CCL20 
was quantified. Both isogenic mutants induced IL- 8  and CCL20, with the smooth LPS 
mutant evoking a response similar in magnitude to the wild type strain (Fig 3.11). In 
contrast, the rough LPS mutant showed a marked reduction in its ability to activate IEC 
responses. This study is the first to investigate the potential role of E69 LPS moiety in 
HEp-2 cells. This data would suggest that the lack of the O-antigen in rough LPS 
mutants, abolishes the EC response, indicative of a role for polysaccharide chains in 
LPS-induced immunity.
In support of this finding, O-specific chains, as well as parts of the core, have been 
shown to possess intrinsic biological activity (Frank et al. 1977). Furthermore, Riley et 
al. found that O-antigen was involved in localised adherence of EPEC (Riley et al. 
1987). In addition, variability in O-antigen has been reported to significantly affect the 
response as well as the type of signalling pathway (Jiang et al. 2005, Zughaier et al.
2005).
Jiang et al. found that TLR4-MD2 distinguishes between smooth and rough LPS, where 
TLR4-MD2 can bind rough but not smooth LPS in the absence of CD 14; activating 
MyD8 8 -dependent signalling and IL- 8  and TNF-a release. However, activation of 
MyD8 8 -independent signalling and induction of IFN-p by either LPS chemotype 
requires CD 14 (Jiang et al. 2005). The contribution of LPS mediated MyD8 8  dependent 
and independent pathways requires further investigation. In this series of experiments
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the IEC immune response was not completely ablated with the rough mutant suggesting 
that other factors are likely to be involved in the response to E69.
Once a bacterium has successfully avoided the host chemical barrier, the bacteria has to 
transverse the mucous layer and reach the epithelial surface. Flagella mediate motility 
and can thus facilitate chemotaxis towards the epithelia (Ottemann & Lowenthal 2002, 
O'Neil & Marquis 2006). In the next set of experiments the potential role of EPEC and 
EAEC flagella in IEC responses was explored. Most studies to date have utilised 
‘flagellin monomers’ the natural ligand for TLR5, in contrast in the present study the 
potential of flagella in its “native” form, i.e. as present in flagellated bacteria, was 
studied.
The effects of apical stimulation with flagellated (E69 WT and E69 fliC*) and non 
flagellated (E69 AfliC); viable bacterium on HEp-2 cells was investigated. 4h post­
infection a statistically significant induction of IL- 8  protein by the wild type strain was 
noted (Fig 3.13). Interestingly, at the same time post-infection the increase in CCL20 
was not significant. This suggests that different signalling events may dictate IL- 8  and 
CCL20 expression.
In contrast to the wild type strain, the E69 tsfliC mutant had a modest effect on IL- 8  
protein induction with the complemented strain E69 fliC* showing a further reduction. 
The induction of CCL20 was also reduced in response to the complemented strain in 
comparison to the wild type. This was a surprise finding as bacteria which are 
complemented in flagellin genes should exhibit a similar response to the wild type 
strain. This data suggests that the complementation may not be optimal. However, SEM 
analysis of the E69 fli(T  complemented strain showed the presence of flagella 
suggesting structural integrity was restored (Fig 3.7). Alternatively, it has previously 
been suggested that EPEC has the ability to secrete proteins via its flagella apparatus 
which may modulate IEC host responses (Giron et al. 2002). The secretory role of 
EPEC flagella apparatus has not been studied further in the literature and in this thesis. 
The reduction seen with the flagella mutant indicated that flagella may play a role in 
HEp-2 cell recognition and immune response. As HEp-2 cells are not thought to express 
TLR5 (Donnelly & Steiner 2002, Khan et al. 2004, Sharma et al. 2005), this would 
imply a TLR5 independent mechanism of recognition. Recent studies suggest that
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flagellin is also recognised by a TLR5 independent mechanism involving ICE protease 
activating factor (Ipaf) a member of the Nod-like receptor (NLR) family (Miao et al.
2006).
Caco-2 cells, which express TLR5, were apically stimulated with EPEC WT, E69 and 
E69 A/7iC. A similar pattern to that seen in HEp-2 cells was observed, although IL-lp 
levels were =10 fold less (Fig 3.15). The reduction seen with the flagella mutant 
suggests that flagella do play a role in Caco-2 cell response to EPEC. Activation of 
innate defence by both E69 WT and the E69 AfliC mutant when applied apically 
suggests these effects are due to interactions independent of TLR5 activation, as TLR5 
is reported to be expressed basolateraly (Rhee et al. 2005). Induction of IL- 8  by apical 
stimulation has, been observed in polarised Caco-2, HT-29, T84 and HCA-7 IECs in 
response to flagellin from S. typhimurim, EHEC and HB101 (Sierro et al. 2001, Berin et 
al. 2002, Yu et al. 2003, Bambou et al. 2004). Although Bambou et al. found 2- to 3- 
fold grater IL- 8  production when flagellin was added to the basolateral surface (Bambou 
et al. 2004). Bambou et al. suggest that variation in IEC responses to apical versus 
basolateral stimulation may be dependent on TLR5 distribution which may vary 
between cell lines and cell-culture conditions employed amongst individual laboratories 
(Bambou et al. 2004).
The response of Caco-2 cells to basolateral stimulation with the EPEC WT, E69 and the 
flagella negative mutant strain E69 A/7 iC was investigated. Surprisingly, the WT strain 
did not induce IL- 8  expression (Fig 3.16). In comparison the E69 A/7 iC mutant showed 
significant increase in IL- 8  secretion both apically and basolaterally, with greater levels 
into the basolateral chamber. One possible explanation of these findings is that the WT 
strain may secrete inhibitory effecter proteins via its flagella apparatus, the effect of 
which would be abolished in the absence of the flagella (Giron et al. 1999, Konkel et al.
2004).
As basolateral stimulation with flagellin the subunit of flagella is reported to induce IL- 
8  expression (Vijay-Kumar et al. 2006). This would imply that the response to the 
flagellin monomer is different to that of flagella presented in its native context bound on 
live bacteria. This could also imply that the down-regulation seen on basolateral 
stimulation with EPEC was an active process requiring the presence of viable bacteria.
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Other researchers have also noted a differential host response to “intact” flagella versus 
“monomeric” flagellin protein and aflagellated bacteria versus flagellated bacteria, 
where pathogenic aflagellated bacteria do not induce IL- 8  (Yu et al. 2003, Zeng et al. 
2003, Cunningham et al. 2004, Feuillet et al. 2006, Zeng et al. 2006). As was the case 
for the comensal HB101 (Bambou et al. 2004).
Zeng et al. & Vijay-Kumar et al. have shown that the pro-inflammatory response 
directed towards flagellin prevents apoptosis and limits disease during enteric infection 
(Zeng et al. 2006, Vijay-Kumar et al. 2006). However, they found the aflagellate 
bacteria to be more potent caspase activators, inducing epithelial apoptosis, when 
compared to their wild type counterpart This response correlates with a delayed but 
markedly exacerbated mucosal inflammation at the later stages of infection.
It was postulated that bacterial host contact may also be important, particularly in early 
stages of infection, thus the contribution of localised and intimate EPEC adherence was 
investigated. Firstly, the intimate adhesion status of the adhesion mutant strains was 
studied. Control, uninfected HEp-2 cells at 16h showed a typical FAS test negative, 
with actin fluorescence localised at the cell periphery (Fig 3.21). A typical FAS test 
positive was seen with EPEC E69 WT-infected cells. Thus, the WT strain behaved as 
shown previously (Knutton et al. 1989). The E69 bundle forming pilus mutant 31-6-1 
which has a TnphoA in bfpA and does not form localised adherence, was FAS test 
negative (Fig 3.22). This data suggests that initial localised adherence may influence 
intimate adherence and the formation of AE lesions. Indeed, Knutton et al. found FAS 
test positivity correlated with localised adherence (Knutton et al. 1989). However, the 
E69 mutant JPN15 was weakly FAS Test positive (Fig 3.22) even though it could not 
form localised adherence, as it lacks the EAF plasmid and BFP (Knutton et al. 1987); 
suggesting that this strain adheres by other unknown mechanism(s) to form AE lesions. 
In support of this Knutton et al. also found low levels of FAS test positivity with this 
strain, in addition JPN15 is capable of adhering to human intestinal mucosa and 
producing the AE lesion, albeit not as efficiently as the parental strain (Knutton et al. 
1998, Knutton et al. 1989).
The adhesion status of the LPS and flagella E69 isogenic mutants was studied. Smooth 
and rough LPS, flagella negative (AfliC) and flagella complemented (/7/C++) strains
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were all FAS test positive (Fig 3.21 and 3.22), suggesting that the mutant strains are 
able to form AE lesions in a manner similar to the WT strain, indicating that these 
mutations do not alter the strain phenotype or their adhesion status and therefore, any 
reduction seen with the mutant strains in not due to alteration in intimate adhesion 
status.
The effect of localised EPEC adherence to IEC immunity was studied. The EPEC 
isogenic bundle forming pilus JPN15 and 31-6-1 and the TTSS EPEC isogenic mutant 
strains AespA were investigated. In addition, co-incubation of WT E69 and mannose 
(disrupts interaction of IECs with type 1 common fimbriae) was performed. 4h post­
infection E69 WT induced IL- 8  gene expression and surprisingly E69 WT incubated in 
the presence of mannose also led to a significant increase in IL- 8  mRNA (Fig 3.17). IL- 
8  protein expression at 4 and 16h was also increased (Fig 3.18). CCL20 expression 
paralleled that observed for IL- 8  at 16h (Fig 3.18). As mannose alone had no effect on 
IEC responses it is possible that the bound mannose acts as a MAMP and thus the role 
of mannose in the context of infection requires further investigation.
EPEC isogenic strains JPN15, 31-6-1 and the TTSS mutant AespA produced a 
statistically significant reduction in IL- 8  mRNA when compared to the WT, with JPN15 
and 31-6-1 being the most statistically significant of all the adhesion mutants tested (Fig 
3.17). At 4h JPN15 and 31-6-1 showed reduced expression of IL- 8  protein with 31-6-1 
eliciting no response (Fig 3.18). This was also the case at 16h although at this time point 
the AespA strain also reduced IL- 8  expression, although not to the same extent as the 
BFP mutants. 4h post-infection none of the strains induced any change in CCL20 
protein however, at 16h the BFP mutants showed the same reduction as seen for IL-8 . 
Taken collectively, data suggests that adherence is a strong determinant of IL- 8  and 
CCL20 induction, particularly adhesion via bundle forming pili. Savkovic et al. found 
that JPN15 was unable to cause polymorphonuclear leukocytes to cross the epithelium 
(Savkovic et al. 1996). As suggested above, the BFP mutants showed a reduced level of 
intimate adhesion, further implicating the importance of adherence.
At present it is not clear if a PRR is responsible for detection of fimbriae and 
subsequent cytokine induction. Fimbriae themselves can activate the target cells through 
receptor-mediated pathways (Hedges et al. 1992, Svensson et al. 1994, Hedlund et al.
Page 188
1996). Several molecules have been described with receptor activity for type 1 fimbriae. 
These include mannosylated glycoprotiens synthetic derivatives, peptides neutrophil- 
derived molecules and CD48 on mast cells and CD1 lb/CD 18 on macrophages (Bar- 
Shavit et al. 1977, Beachey et al. 1988, Krogfelt et al. 1990, Sokurenko et al. 1994, 
Karlsson et al. 1996, Karlsson & Dahlgren 1996).
Fimbriae also dock the bacteria to sites at which receptors are expressed and may 
influence the host response by presenting other bacterial components, such as LPS 
(Hedlund et al. 2001b). In addition, co-receptors are needed to enhance the TLR 
response to these conserved ligands (Poltorak et al. 1998, Medzhitov & Janeway, Jr. 
2002, Beutler 2004,). Therefore, fimbriae may alternately supply a co-stimulatory 
signal.
UPEC type 1 fimbriae are known to trigger cytokine responses and neutrophil 
recruitment by two mechanisms, one LPS-TLR4-dependent and one lectin dependent 
pathway (Hedlund et al. 2001b, Fischer et al. 2006). In addition, P-fimbriae couple to 
carbohydrate residues on glycosphingolipid receptors which are co-localised to TLR4 in 
lipid rafts in the cell membrane (Frendeus et al. 2001). The receptor and transmembrane 
signalling pathway(s) involved in the lectin-dependent responses are not known. 
However, TLR4 and the fimbriae receptors constitute a functional TLR signalling 
complex in epithelial cells and depending on the type of fimbriae expressed, the 
fimbriae receptor/TLR4 signalling platform engages either the MyD8 8  (type 1- 
fimbriated bacteria) or the TRIF/TRAM (P-fimbriae) adaptor molecules for signalling 
(Fischer et al. 2006).
An alternative receptor could be TLR2, as thin curled fimbriae of Salmonella enterica 
type Typhimurium are recognised by TLR2 in calf ileum; THP-1 and HEK293 cells and 
induce JL- 8  expression (Tukel et al. 2005). In addition, P. gingivalis fimbriae and their 
recombinant fimbrillin subunit induce cytokine release in monocytes via interactions 
with CD 14, CD11/CD18 and TLR2 and TLR4. This activation required lipid raft 
function and formation of heterotypic receptor complexes of TLR2/CD 14/CD 1 lb/CD 18 
and either TLR1 or TLR6  (Asai et al. 2001, Hajishengallis et al. 2002, Hajishengallis et 
al. 2005, Hajishengallis et al. 2006). Therefore, further work is required to determine if 
a PRR is responsible for detection of EPEC fimbriae and subsequent cytokine induction.
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As discussed previously flagella have a definite role in mobility and colonisation. 
However, flagella have also been implicated in adhesion to host cells (Giron et al.
2002). In the present study deletion of the fliC  gene resulted in reduced IL- 8  expression 
in HEp-2 and Caco-2 cells, when compared to the WT strain (Fig 3.13), at present it 
remains unclear whether this is due to loss of initial adherence or loss of flagellin 
induced signalling.
The contribution of intimate adherence was investigated. The TTSS is essential to the 
induction of an inflammatory response(s). At this stage, the contribution of the secreted 
effecter proteins versus that of the syringe apparatus is unknown. 4h post-infection, IL- 8  
mRNA and protein expression was reduced with both TTSS mutant strains tested in 
comparison to the WT (Fig 3.23-24). Interestingly, no strains induced CCL20 after 4h 
co-culture, again suggesting differential signalling pathways are involved in IL- 8  and 
CCL20 production. At 16h only the EscN deleted strain showed a significant reduction 
in expression in IL- 8  and CCL20 protein. Thus, in the model system employed here, 
structural recognition of the TTSS is involved in immune responses to E69 however, the 
varying responses to the two mutants indicate that the two structural proteins impact in 
a differential manner. Other authors have reported that the TTSS is necessary for the 
activation of MAPK pathways and IL- 8  production (Czerucka et al. 2001, de, 
Rosenberger et al. 2001a). Interestingly, a minimal role for the EPEC TTSS has also 
been reported (Zhou et al.2003). In contrast, Sharma et al. indicated that a functional 
TTSS is required for an anti-inflammatory response (Sharma et al. 2005). Furthermore, 
Ruchard-Sparangano et al. found in Caco-2 cells, apical EPEC infection triggers a rapid 
TTSS-dependent inhibition of signalling responsible for IL- 8  expression (Ruchaud- 
Sparagano et al. 2007). The inconsistent data is probably due to differences in the 
infection protocols and culture conditions used between different labs (Zhou et al.
2003).
The effect of EPEC TTSS secreted and non TTSS secreted effecter proteins to EC 
immunity were also studied. The EPEC isogenic mutant strains AEspF (TTSS); AlifA 
and AEspC (non-TTSS) were utilised. 4h post-infection the AlifA strain induced 
statistically significant IL- 8  mRNA, which was not the case with any other strain 
investigated except the WT (Fig 3.25). At 4 and 16h the AlifA mutant also induced IL- 8  
and CCL20 protein (Fig 3.26). At 4h post-infection the production of IL- 8  and CCL20
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was increased compared to that of the WT strain. As lymphostatin inhibits peripheral 
blood and, mucosal lymphocyte proliferation and synthesis of IL-2,1L-4, IL-5 and INF- 
y (Klapproth et al. 1995, Klapproth et al. 2000); it is possible that lymphostatin may 
exert an inhibitory effect on epithelial responses. A recent study found the lifA gene of 
atypical EPEC to be strongly associated with diarrhoea, supporting its role in virulence 
(Afset et al. 2006). The absence of EspC protein caused a statistically significant 
reduction in the expression of IL- 8  protein at 4 and 16h and CCL20 at 16h post­
infection. However, in contrast EspF did not appear to be involved in modulating IL- 8  
and CCL20 responses.
The innate immune response to the EAEC WT 042 was also investigated utilising 
isogenic mutants. At 16h the pathogen 042 induced strong expression of IL- 8  and gave 
the greatest induction of CCL20 amongst strains tested (Fig 3.14 and 3.20). 042 AfliC 
showed reduced induction of IL- 8  and CCL20 protein at 16h, compared to the WT 
strain (Fig 3.14); suggesting that flagella are involved in HEp-2 cell responses to 042 
and this may occur via a TLR5 independent mechanism. Recently, flagellin has been 
shown to have a TLR5-independent pro-inflammatory activity that depends on two 
related intracellular PRRs, Naip5 and Ipaf, which are members of the NACHT-leucine- 
rich repeat-containing receptor (NRL) family, which also includes NOD and Apaf 
proteins (Ren et al. 2006, Molofsky et al. 2006, Franchi et al. 2006, Miao et al. 2006, 
Steiner 2007). The mechanisms of NaipS or Ipaf-dependent flagellin signalling and/or 
recognition remains unknown (Steiner 2007).
The response was not completely eliminated, thus other factors are likely to be 
involved. On investigation of the role of aggregative adherence fimbriae (AFF), 
fimbriae negative (AAAF/II) and adhesin negative (AAafB) strains also showed reduced 
induction of IL- 8  and CCL20 protein at 16h (Fig 3.20). This suggests that adherence via 
AAF may contribute to IL- 8  and CCL20 expression. However, the response is not 
completely abolished and thus would confer that multiple factors must be involved with 
this wild type strain. Several studies have shown that EAEC has a heterogeneous ability 
to modulate IL- 8  either by chromosomal {fliC) or pAA plasmid-borne virulence genes 
such as those for the aggregative adherence fimbriae (Steiner et al.1998, Steiner et al. 
2000, Donnelly & Steiner 2002, Zhou et al. 2003, Huang et al. 2004a, Harrington et al. 
2005b).
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In summary, in the model systems employed the innate immune response to EPEC WT 
E69 and EAEC WT 042 was found to be due to the recognition of groups of external 
structures such as flagella and fimbriae. Indeed, from the literature it is becoming 
increasingly apparent TLRs do not function in isolation but co-operate with other PRRs 
(Akira et al. 2001, Asai et al. 2001, Triantafilou & Triantafilou 2002, Underhill 2003, 
Brown et al. 2003, Nau et al. 2003. Tukel et al. 2005, Jiang et al. 2005, Hohl et al. 2005, 
Feuillet et al. 2006). Furthermore, those TLRs and other PRRs accumulate in membrane 
micro-domains known as lipid rafts and form multi-receptor complexes for optimal 
induction of TLR signalling (Hajishengallis et al. 2005).
Adherence was also a strong determinant in induction of the IL- 8  and CCL20 response 
to the E69 and 042. It may be that the contact dependence is due to the bacterium being 
docked to the cell allowing lipid rafts to form, and the recognition of several external 
structures being detected, thus providing the necessary numbers of signals to induce a 
response. Or that contact with epithelium is a major danger signal and that an additional 
co-stimulatory signal comes in the form of recognition of external structures.
However, EPEC WT E69 is able to down-regulate the host response possibly via 
flagella; perhaps by secreting some unknown effecter protein, or by secretion of 
lymphostatin, and possibly through the TTSS. An active but transient repression of 
cellular responses by distinct bacterial signalling is known to occur with E. coli (Hauf & 
Chakraborty 2003, Sharma et al. 2006, Ruchaud-Sparagano et al. 2007).
Fischer et al. suggest that commensal bacteria may not have the virulence factors 
present to act as co-stimulatory signals (Fischer et al. 2006). It is demonstrated here that 
both pathogenic bacteria and non-pathogenic bacteria do express combinations of 
external structures associated with virulence (Fig 3.3-9). It may well be the case that 
non-pathogenic bacteria are not inherently “good bacteria” but simply that they do not 
normally make contact with the epithelium and yet when they do so, they do not possess 
the ability to down-regulate the host immune response and thus initiate an immune 
response that brings about their elimination. Pathogenic bacteria persist, due to their 
ability to reduce the immune response, leading to pathology and chronic infection.
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In conclusion it would seem that there are many layers of complexity to the interaction 
between bacteria and IECs. From the host point of view the particular anatomical 
location or PRR compartmentalisation may be important. On the side of the bacterium 
the immune response is dependent on the expression of external structures which are 
essential for colonisation but can be detected by the host and the ability to make contact 
with the epithelium. This response is offset against the bacterium’s intrinsic ability to be 
able to down-regulate the response for example via the TTSS.
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CHAPTER 4: Gram-positive
Staphylococcus aureus and the host: a 
contact dependent cytopathic response
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4.1 Background
S. aureus is an opportunistic pathogen, often colonizing hosts asymptomatically 
(Fournier & Philpott 2005). S. aureus is a common coloniser of human skin and 
mucosal surfaces (Kluytmans et al. 1997). S. aureus is a normal inhabitant of the GI 
tract and can be found in small numbers as part of the normal bowel microbiota in up to 
10% of healthy people (Christie et al. 1988). Breached mucocutaneous membranes or 
impaired host immunity can facilitate tissue invasion and blood dissemination of S. 
aureus. The primary site of infection is usually the skin or soft tissue rather than the 
enteric system (Reuben et al. 1989, Fournier & Philpott 2005). Once barrier breach and 
dissemination occurs, S. aureus causes life-threatening systemic diseases. Diseases such 
as osteomyelitis, endocarditis, pneumonia as well as septic and toxic shock (Marrack & 
Kappler 1990, Fournier & Philpott 2005). This is due to the pathogen’s ability to attach 
to cells or tissues and to escape the host immune system. The pathogen elaborates 
proteases, exotoxins, and enzymes, factors that specifically cause cell and tissue damage 
(Projan & Novick 1997). In the GI tract, in certain situations, the organism may 
overgrow and become associated with disease. However, since the advent of the 
antibiotic era, reports of staphylococcal enterocolitis have been uncommon in adults and 
children (Christie et al. 1988).
4.1.1 Adaptive immune response to Staphylococcus aureus
Due to the systemic complications seen with staphylococcal infections the systemic, 
adaptive immune response to S. aureus has been extensively studied. It is known that S. 
aureus produces staphylococcal enterotoxins (SEs), which can also behave as 
superantigens (SAgs), stimulating T-cell proliferation, enhancing endotoxic shock; they 
suppress immunoglobulin production, and are pyrogenic (Munson et al. 1998).
Unlike conventional antigens, SAgs are not processed by antigen-presenting cells 
(APC) (Fleischer & Schrezenmeier 1988), but rather bind to major histocompatibility 
complex (MHC) class II molecules, outside the peptide-binding groove, and the variable 
portion of the p-chain of the T-cell receptor (TCR), to form a tri-molecular complex 
(Dellabona et al. 1990, Gascoigne & Ames 1991, Fraser et al. 2000) (Fig 4.1).
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Figure 4.1s Comparison of antigen and superantigen binding to TCR
(From: www.bio.davidson.edu/.../restricted/TSS.html)
SAgs stimulate specific T cells based on the T cell receptor vp  gene expressed (White 
et al. 1989, Herman et al. 1991). This property explains their remarkable potency 
because relatively large percentages of T cells usually share expression of the same Vp 
gene. Thus, 10-25% of all T cells may respond to a given SAg; by contrast, the 
frequency of T cells responding to a nominal antigen is on the order of 1 x 10'5 (Banks 
et al. 2003, Lu et al. 2003a). SAgs stimulate the production of cytokines such as IL-1, 
IL-2, IFN-y and TNF-a (Marrack & Kappler 1990). The resulting high levels of 
cytokines stimulated by SAgs are thought to be the main cause of clinical toxic shock, 
(Banks et al. 2003).
In addition, LPS may work in concert with these toxins to greatly amplify the potential 
for lethality. For example, mice are ordinarily unaffected by staphylococal enterotoxin 
B (SEB) and related toxins, but they become susceptible to doses in nanogram amounts 
when co-administered with non-lethal amounts LPS (Stiles et al. 1993).
The question that emerges is why would a pathogen evolve to produce a molecule that 
causes such a strong induction of a pro-inflammatory response? One plausible 
mechanism is that superantigens have been shown to prevent the normal development
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of immunity to infection through their ability to induce T-cell anergy (Llewelyn & 
Cohen 2002). Many elegant studies have shown that the murine immune response to 
SAgs is biphasic: an initial activation phase characterised by T-cell proliferation, 
cytokine production, and enhanced cytotoxic activity is followed by a period of anergy 
and/or depletion of the appropriate Vp-expressing T cells (White et al. 1989, Rellahan et 
al. 1990, Kawabe & Ochi 1990, Benjamin et al. 1998).
Interestingly, T-cell anergy, induced by administration of SEB systemically to 
experimental animals, is associated with failure to mount an antibody response, not just 
to SEB itself but to other antigens administered simultaneously or subsequently 
(Lussow & MacDonald 1994). Taken together these observations suggest that SAgs 
may cause anergy of T cells and failure of T cell help to establish humoral immunity, 
not just to the SAg but to other microbial antigens (Llewelyn & Cohen 2002).
In addition to the induction of a systemic response due to SAgs; a systemic response can 
also be induced by staphylococcal cell wall-associated and secreted structural proteins. 
However, no single virulence factor has been shown to be sufficient to provoke a 
staphylococcal immune response and it is more likely to be promoted by the co­
ordinated action of various virulence factors (Fournier & Philpott 2005). For example, 
although staphylococcal PGN by itself promotes a weak systemic induction of 
cytokines, it shows synergistic effects with LTA or LPS (De Kimpe et al. 1995, 
Kengatharan et al. 1998, Yang et al. 2001, Thiemermann 2002). PGN of S. aureus also 
synergises with low doses of LPS to cause multiple organ failure (Thiemermann 2002).
As well as the systemic shock symptoms SEs cause staphylococcal food poisoning with 
marked secretory diarrhoea in man, (Bergdoll et al. 1982, Bohach et al. 1990) although 
episodes are generally self-limiting (Novick 2003). SE-induced gastroenteritis is 
defined by a characteristic set of histological abnormalities; hyperaemic mucosa with 
neutrophilic infiltrates in the epithelium and underlying lamina propria. A mucopurulent 
exudate is observed in the lumen of the duodenum. In the jejunum, there is crypt 
extension and disruption or loss of the brush border. Extensive infiltrates of neutrophils 
and macrophages appear in the jejunum (Dinges et al. 2000).
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The superantigenicity and GI toxicity functions are separate and distinct from one 
another in that these activities are located in different domains of the molecule (Alber et 
al. 1990). However, if enteric exposure to the enterotoxins is prolonged or host defences 
are impaired, S. aureus has the potential to induce a T-cell mediated inflammatory 
intestinal disease via the superantigen capability of these toxins (Krakauer 1999). 
Indeed, SE-elicited secretion of IFN-y and TNF from lymphocytes has been shown to 
lead to epithelial transport and barrier abnormalities, which would allow SAgs in the gut 
lumen to enter the mucosa and initiate or exaggerate an inflammatory cascade (McKay 
& Singh 1997).
Chronic T-cell mediated enteropathy due to Staphylococci is not well recognised in 
man, although it has been demonstrated in animal models (Tan et al. 1959, Van 1963, 
Warren et al. 1964, Kent 1966, Benjamin et al. 1998, McKay et al. 1998, Spiekermann 
& Nagler-Anderson 1998, McKay et al. 1999, Kamaras & Murrell 2001a, Kamaras & 
Murrell 2001b, Lu et al. 2003a). In a model of in vitro organ culture of human fetal 
intestine, culture with SEB induces V^-restricted T cell-mediated enteropathy (Guarino 
et al. 1995, Murch et al. 1999), in which TNF-a induced expression of matrix 
metalloproteases (MMP’S) leads to extracellular matrix degradation and tissue damage 
which can be inhibited by interleukin-10 (IL-10) (Guarino et al.1995, Krakauer 1999). 
Thus, the potential exists for toxin-producing Staphylococci to induce chronic intestinal 
inflammation in humans if clearance mechanisms or epithelial barrier function are 
impaired.
4.1.2 Staphylococcus aureus - link to Crohn’s Disease
Evidence in support of a role for the commensal microbiota in the pathophysiology of 
CD has increased exponentially over the past decade. However, identification of a 
specific organism responsible for IBD has not been forthcoming, raising the possibility 
that the aberrant immune response mounted by the host may be directed toward a 
bacterial produces) derived from the commensal microbiota rather than a particular 
micro-organism.
S. aureus a gram-positive pathogen has been found in intestinal lymphoid follicles in 
CD tissue (Chiba et al. 2001). Data from animal models, and to a lesser extent from
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patient cohorts supports a role for bacterial SAgs in initiation and/or exaggeration of 
IBD (Posnett et al. 1990, Drake & Kotzin 1992, Aisenberg et al. 1993, Ibbotson & 
Lowes 1995, Baca-Estrada et al. 1995, Kay 1995, Gulwani-Akolkar et al. 1996, 
Dalwadi et al. 2001).
For instance, some patients with CD can have increased numbers of circulating and 
mesenteric lymph node Vp81 T cells (Posnett et al. 1990, Gulwani-Akolkar et al. 1996). 
Also, peripheral blood T cells from patients with CD have altered cytotoxic activity 
(Baca-Estrada et al. 1995).
Lu et al. demonstrated that intraluminal exposure to SAgs results in a low-grade 
inflammatory response, and that mice recovering from DSS-induced colitis, experienced 
a significant worsening of their disease when SEB was delivered into the lumen of their 
colons (Lu et al. 2003a). In addition, Dionne et al. observed that SEB is capable of 
inducing TNF-a release from explants of colonic biopsies from patients with IBD, with 
a more marked response in inflamed tissue (Dionne et al. 2003). Dionne et al. suggest 
that bacterial luminal products amplify the immune response in IBD tissue in part by 
inducing TNF-a and IL-1 release. Furthermore, they suggest that their data substantiates 
the role of bacterial products in IBD relapse or initiation (Dionne et al. 2003).
After reaching the GI tract, SEB is capable of affecting intestinal mucosal physiological 
functions (McKay 2001, Ibbotson & Lowes 1995). SEB can induce colonic epithelial 
barrier deficiency via induction of IFN-y and TNF-a production (McKay et al. 1999, 
McKay & Perdue 2002, McKay & Singh 1997). SEB can also induce a dose-dependent 
cytotoxicity through cytoskeletal rearrangement in cultured endothelial cells (Campbell 
et al. 1997). This leads to colonic epithelial barrier dysfunction (McKay & Singh 1997, 
Lu et al. 1998), which promotes uptake of exogenous antigens, microbial products and 
other noxious substances, such as SAgs, into the intestinal tissue to contact immune 
cells and to initiate immune reactions (McKay & Singh 1997, Lu et al. 2003a, Yang et 
al. 2005).
Benjamin et al. demonstrate that SEB treatment of normal but not T cell deficient mice 
evokes a self limiting enteropathy that is characterised by altered villus-crypt 
architecture, which they suggest has the potential to predispose the host to enhanced
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immune responsiveness to other antigens that gain access to the mucosa and/or sub­
mucosa (Benjamin et al. 1998). McKay et al. suggest that bacterial SAgs have the 
capacity to initiate or evoke relapses in IBD because SAgs are potent pro-inflammatory 
stimuli possessing the potential to elicit enteropathy. In addition to the fact that SEB- 
induced activation of immune cells decrease barrier function; the spectrum of cytokines 
induced by T cell activation are predominantly those of a TH1 response as seen in CD 
(McKay 2001). Indeed, Yang et al. found that swallowing sinusitis-derived SEB played 
a role in the pathogenesis of chronic inflammation in the intestinal mucosa, via 
impairing the epithelial barrier function and inducing inappropriate immune reactions 
that further progresses to UC (Yang et al. 2005).
Interestingly, a novel bacterial sequence was identified in some patients with CD that 
was subsequently identified as a Pseudomonas fluorescens-derived SAg and was 
designated 12 (Sutton et al. 2000, Dalwadi et al. 2001); the same investigators reported 
that 50% of a cohort of 330 patients with CD were sero-reactive for 12 (Landers et al. 
2002).
Furthermore, the innate immune response to S. aureus has possible links to CD. 
Staphylococcal infection induces an influx of neutrophils (Fournier & Philpott 2005). In 
CD these neutrophils show increased intracellular survival of S. aureus (Couper, 
Kapelushnik et al. 1991, Worsaaeetal. 1982).
Genetic mutations in NOD2 have been conclusively associated with CD (Hugot et al. 
2001, Ogura et al. 2001). Colonic CD is characterised by an attenuated induction of 
inducible p-defensins (Fahlgren et al. 2004, Wehkamp et al. 2003), partly caused by a 
reduction in P-defensin gene copy numbers on chromosome 8  (Fellermann et al. 2006). 
Voss et al. found over expression of NOD2 containing the 3020insC frame shift- 
mutation, the most frequent NOD2 variant associated with CD, resulted in defective 
induction of hBD2 via MDP (Voss et al. 2006). In addition, Nuding et al. investigated 
the antimicrobial effect of cationic protein extracts from colonic biopsies taken from 
patients with CD and found a reduced antimicrobial effect (Nuding et al. 2006). 
Specifically, the effect against E. coli was significantly lower in CD and activity against 
S. aureus disclosed a similar pattern, but was less pronounced. It is conceivable that
Page 200
persistence of Staphylococcus in the GI tract due to a defective innate immune response 
could lead to a chronic inflammatory response and thus induce or enhance CD.
4.13 Innate immune response to Staphylococcus aureus
The Gl innate immune response to S. aureus has not been extensively investigated. 
Which is surprising considering the evidence described above, linking staphylococcal 
SAgs to perpetuation of CD and mutations in NOD2 being linked to reduced killing of 
S. aureus in CD tissue.
Furthermore, the pathogenicity of S. aureus is postulated to depend on the expression of 
a wide range of cell wall-associated and secreted bacterial proteins. Although key for 
staphylococcal virulence, their role in innate immunity remains largely unknown. PGN 
and LTA have been well studied (Sriskandan & Cohen 1999, Vora et al. 2004, Fournier 
& Philpott 2005). However, the majority of investigations that have been conducted are 
with monocytes and macrophages or keratinocytes in vitro (Harder et al. 2001, Dinulos 
et al. 2003, Midorikawa et al. 2003, Menzies & Kenoyer 2005, Komatsuzawa 2006, 
Menzies & Kenoyer 2006). Therefore, the GI epithelial innate immune response to S. 
aureus is largely unknown and the aim of this work was to characterise IEC innate 
responses to S. aureus.
In vitro keratinocytes up-regulate hBD3 in response to S. aureus, hBD3 in turn is a 
potent bactericidal against S. aureus (Harder et al. 2001, Midorikawa et al. 2003, 
Sorensen et al. 2005, Menzies & Kenoyer 2006, Nuding et al. 2006); hBD2 is 
bacterostatic towards S. aureus (Harder et al. 1997, Harder et al. 2000), whereas hBDl 
is ineffective against S. aureus (Harder et al. 2001). Expression of these AMPs in IEC 
lines in response to S. aureus is not known. Moreover, how or if S. aureus modulates p- 
defensin in IECs has not been reported.
With regard to cell wall-associated products, the outer cell wall of Staphylococci is 
composed of exposed PGN, LTA and other toxic secreted products (Sriskandan & 
Cohen 1999). TLR2 deficient mice are highly susceptible to S. aureus when inoculated 
intravenously (Takeuchi et al. 1999, Hoebe et al. 2005). Recognition of S. aureus LTA 
by TLR2/1 provokes secretion of IL- 8  from monocytes or macrophages and in turn 
recruitment of neutrophils and formation of pus (Standiford et al. 1994, von Aulock et
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al. 2003b, Fournier & Philpott 2005). In addition, S. aureus LTA induces hBD3 in 
kerationcytes via TLR2 and is regulated by p38 (Midorikawa et al. 2003, Menzies & 
Kenoyer 2005). S. aureus is capable of modulating the D-alanylation of teichoic acids, 
which in turn modulates the properties of the envelope of S. aureus (Fournier & Philpott
2005); protecting S. aureus against cationic AMPs produced by the host (Peschel et al. 
1999, Rydengard et al. 2006). However, alanylation of teichoic acids increases the 
release of TNF-a and MIP-2 in mice (Kristian et al. 2003). S. aureus PGN is sensed 
through NOD2, which induces hBD2 expression (Voss et al. 2006). Functional binding 
sites for NF-kB and to a lesser degree AP-1 in the hBD2 promoter are required for 
NOD-2-mediated induction of hBD2 through MDP. However, NODs may well 
synergise with TLR2 to activate NF-kB.
4.1.4 Species investigated
The bacteria investigated in this study were pathogenic species: a known enterotoxin B 
producing strain of S. aureus (SEB); S. aureus B producing EDIN-B exotoxin (Staph 
B). In addition, clinical isolates taken fiom 3 infant cases of severe persistent bloody 
diarrhoea, due to enterocolitis caused by methicillin sensitive S. aureus (Patient 1-3). 
The 3 strains were analysed for toxin expression, by Elizabeth M Wellington and 
Colette O’Neill, from the department of Biological Sciences at the University of 
Warwick. Toxin analysis identified only SEG and SEI enterotoxins in each case, 
without any other toxins with known potential to induce cytoskeletal rearrangement or 
cytopathy, including haemolysins ETA or B, PVL, TSST or EDIN-A-C. The EPEC E69 
strain was included as a comparative control species. Also, included in the study were 
two pathogenic but non-enterotoxin producing mutant strains RN6911 and RN6390 
(Kahl et al. 2000); to determine the effect of enterotoxins on AMP gene expression and 
the production chemokines IL- 8  and CCL20.
4.1.5 Superantigens expressed in the species investigated
SEB is also a SAg and possesses powerful immune regulatory capabilities that result in 
increased T cell activation and proliferation. The Coding region of the (entB) gene 
(Johns, Jr. & Khan 1988) contains approximately 900 nucleotides. The entB gene is 
chromosomal in clinical isolates of S. aureus from food poisoning cases (Shafer & 
Iandolo 1978). However, in other strains, the gene is carried by a 750 kb Plasmid 
(Shalita et al. 1977).
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The genes for most SAgs are located on mobile genetic elements called pathogenicity 
islands (SaPIs), which can spread horizontally (Novick & Muir 1999, Kuroda et al. 
2001). The genes for SEG and SEI are located within a cluster of SAG genes on 
SaPIn3. They are excised, replicated, and encapsulated as phage like particles and, 
finally, integrated as intact units by an integrase encoded within the SaPl itself (Novick 
& Muir 1999). This explains why the SEG and SEI genes are usually present together 
(Banks et al. 2003). SEG and SEI are produced with other egc cluster enterotoxins, 
including SEL, SEM, SEN and SEU (Jarraud et al. 2001), each capable of 
superantigenic T cell stimulation. The propensity of egc cluster organisms to induce 
severe pathology is demonstrated in rabbits, in which highly virulent strains are 
typically of this type (Vancraeynest et al. 2006). SEG is most similar to SEB; SEI 
however, has the lowest homology to other SEs (Munson et al. 1998).
Epidermal cell differentiation inhibitor (EDIN) is another exotoxin produced by S. 
aureus. There are at least three types of EDIN isoforms (Yamaguchi et al. 2002), EDIN- 
A, was initially discovered as an inhibitor of morphological differentiation of epidermal 
keratinocytes in vitro (Sugai et al. 1990). It was later shown to be a mono-ADP- 
ribosyltransferase that specifically inhibits eukaryotic small GTP~binding proteins 
belonging to the Rho family (Sugai et al. 1992, Inoue et al. 1991, Wilde et al. 2001). 
Rho GTPases are central regulators of the eukaryotic actin cytoskeleton (Matozaki et al. 
2000, Takai et al. 2001, Van & Souza-Schorey 1997), and their inactivation by toxins 
and modulins of virulent bacteria has been shown to block important cellular functions 
(Aktories et al. 2000). It is well accepted that, through inactivation of Rho GTPases, 
toxins of A and B of C. difficile cause pseudomembranous colitis (Aktories et al. 2000). 
Despite its presumed importance in virulence, the exact role of EDIN in the 
pathogenesis of S. aureus remains to be elucidated. It might function in such a way that 
it destroys epithelial barriers, thus helping the bacteria to spread or to invade the tissues 
for the exacerbation of infection (Yamaguchi et al. 2002). EDIN-B (termed C3Stau by 
Wilde C et al.) shows 78% identity to EDIN-A and was reported to be an ADP- 
ribosylate RhoE (Wilde & Aktories 2001).
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4.2 Results
4.2.1 Modulation of hBDs and LL-37 expression during S. aureus infection
As there is a link of S. aureus to CD and the IEC immune response to S. aureus is 
virtually unknown, the IEC response to S. aureus was investigated. To my knowledge 
this is the first study to investigate the effect of S. aureus infection on hBD3 in any IEC 
line, and is the first study to investigate hBDl-3 and LL-37 expression in Caco-2 and 
HEp-2 cells in response to S. aureus. In fact, P-defensins and LL-37 to date have not 
been investigated in HEp-2 cells.
In this series of experiments the effect of S. aureus on hBD2-3 and LL-37 was 
investigated. The strains were co-cultured with Caco-2 or HEp-2 cells for 16h (Section
2.7) and gene expression was determined by RT-PCR (Section 2.12). The expression of 
hBD2 mRNA was found to be inducible in Caco-2 cells by IL-lp and by bacterial 
stimulus (Fig 4.2a). RN6911 and E69 induced a definite increase in hBD2 mRNA (Fig 
4.2a and 4.3a). The remaining bacteria induced only a minor increase in hBD2. In 
contrast to hBD2, hBD3 mRNA expression in Caco-2 cells was constitutive (Fig 4.2a). 
RN6911, RN6930 and E69 appeared to reduce hBD3 expression however, there was no 
statistically significant modulation compared to control cells (Fig 4.2a and 4.3b). LL-37 
mRNA expression was also constitutive in uninfected Caco-2 cells; interestingly LL-37 
was induced by S. aureus infection with patient strains 1 and 3 (Fig 4.2a and 4.4a). In 
comparison to Caco-2 cells, HEp-2 cells did not constitutively express hBD2 and 3 
mRNA and remain refractory to AMP production by IL-lp or bacterial stimulus (Fig 
4.2b). However, HEp-2 cells did constitutively express LL-37 mRNA, which could be 
further induced by strains RN6930 and SEB (Fig 4.2b and 4.4b).
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Figure 4.2: Modulation of hBD2, 3 and LL-37 gene expression by S. aureus at 16h 
with Caco-2 cells (a) or HEp-2 cells (b). Cells were co-cultured with RN6911, 
RN6930, SEB, Staph B, 3 clinical isolates (PI-3) or E69 (All 5pl [OD6oo=0.7]), or IL- 
ip. 16h post-infection RNA was extracted and amplified by RT-PCR. The gels shown 
are a representative of 3 independent experiments.
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Figure 43 : Modulation of HBD2 (a) and hBD3 (b) gene expression at 16h.
Caco-2 cells were co-stimulated with RN6911, RN6930, SEB, Staph B, PI-3 or E69, or 
IL-ip. Gene expression 16h post-infection was normalised to GAPDH. Variations in 
mRNA levels are expressed as fold induction compared to the uninfected control cells. 
Data shown is mean (+SD, * p < 0.05) induction of three independent experiments.
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Figure 4.4: Modulation of LL-37 gene expression by Caco-2 (a) or HEp-2 (b) cells 
at 16h. Cells were co-stimulated with RN6911, RN6930, SEB, Staph B, PI-3 or E69, or 
IL-ip. Gene expression 16h post-infection was normalised to GAPDH. Variations in 
mRNA levels are expressed as fold induction compared to the uninfected control cells. 
Data shown is mean (+SD, * p < 0.05) induction of three independent experiments.
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4.2.2 Modulation of expression of IL - 8  and CCL20 by S. aureus enterotoxins
The effect of S. aureus on IL- 8  gene expression by Caco-2 cells and HEp-2 cells was 
investigated. In addition to the range of S. aureus bacteria described previously, S. 
aureus conditioned culture medium (CCM) was also included (Section 2.2.6); to 
investigate the effect of secreted superantigens. 16h co-culture of Caco-2 cells with S. 
aureus strains or CCM were conducted (Section 2.7, 1:100, 0.22pm pore). After the 16h 
infection RNA was extracted from the epithelial cells which, was amplified by RT-PCR 
(Section 2.12).
At 16h all strains induced IL- 8  mRNA expression by Caco-2 and HEp-2 cells, to 
varying degrees with RN6911 being the most potent in Caco-2 cells and SEB and PI in 
HEp-2 cells (Fig 4.5). Interestingly, none of the bacterial-CCM had an effect on IL- 8  
expression in either cell line indicating a contact-dependent mechanism for IL- 8  
expression may be important (Fig 4.5).
Subsequently, the effect of S. aureus and the CCM on IL- 8  and CCL20 protein 
production by Caco-2 cells was investigated. 16h post-infection supernatants were 
harvested and chemokines measured by ELISA (Section 2.10). Surprisingly, despite the 
contact-dependent induction of IL- 8  mRNA observed in Caco-2 and HEp-2 cells, no 
statistically significant increase in IL- 8  or CCL20 was observed. Furthermore, no 
difference in induction between viable bacteria or CCM was noted (Fig 4.6).
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Figure 4.5: Modulation of IL- 8  gene expression in Caco-2 (a) and HEp-2 (b) cells 
by S. aureus at 16h. Cells were co-cultured with RN6911, RN6930, SEB, Staph B, 3 
clinical isolates (PI-3) (All strains 5pl [OD6oo=0.7]) or the respective bacterial CCM or 
IL-lp. 16h post-infection RNA was amplified by RT-PCR. The gel shown is a 
representative of 3 independent experiments.
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Figure 4.6: Modulation of IL- 8  (a) and CCL20 (b) protein expression in Caco-2 
cells by 5. aureus at 16h. Cells were co-cultured with RN6911, RN6390, SEB, Staph 
B, Patient strains 1-3 or 1:100 sterile filtered (0.22pm pore) logarithmic cultures or IL- 
lp. 16h post-infection supernatants were evaluated by ELISA. Data shown is mean (+ 
SD) induction of three independent experiments.
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4.23 Induction of cytotoxicity during S. aureus infection in vitro; effect of S. aureus 
enterotoxins
As no significant induction of IL- 8  was noted during S. aureus infection, it was 
pertinent to confirm the presence of the enterotoxins; especially as, S. aureus has been 
previously shown to provoke secretion of IL- 8  from monocytes or macrophages 
(Standiford et al. 194, von Aulock et al. 2003a, Fournier & Philpott 2005). In addition, 
SE-induced gastroenteritis is defined by neutrophilic infiltrates (Dinges et al. 2000).
433 .1  Induction of cytoxicity with viable bacteria
Therefore, cytoxicity assays were performed with S. aureus on Caco-2 and HEp-2 cells 
(Section 2.8.1). Cytoxicity was characterised by vacuolisation, nuclear enlargement, and 
features of cytoskeletal rearrangement: with pseudopod extension, cell retraction and 
rounding with membrane ruffling (characteristic of cells undergoing apoptosis) (Fig
4.7). No evidence of cytoxicity was observed in HEp-2 or Caco-2 cells exposed to 
RN6911 or RN6930 (Fig 4.8 c-f and 4.13) or to EPEC E69 (Fig 4.9 k & 1 and 4.13). 
Cells show a typical cobblestone appearance without pathological changes. However, 
disruption to the monolayer integrity and in vitro cytopathic effects could be induced in 
HEp-2 cells upon culture with Staph B and SEB strains (Fig 4.9 g-j), and the patient 
strains (Fig 4.10 n, p and r). Upon culture with whole organisms, cytoxicity was 
induced in 31.5 ± SD 2.4% HEp-2 cells by PI, 30 ± 2.2% by P2, 40 ± 5.5% by P3, 21.3 
± 2.1% with Staph B, 30.5 ±5.1% with SEB (Fig 4.13).
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Figure 4.7: Morphological observations of cytotoxic effect of S. aureus on HEp-2 
cells at 16h. Cells were infected with SEB (5pl [OD6oo=0.7]). After 16h cells were 
fixed, stained and examined using UV microscope (40x). Shown here is a representative 
of the cytoxicity seen.
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Figure 4.8: Effect of S. aureus on confluent Caco-2 or HEp-2 cells at 16h.
Cells were co-cultured with RN6911, RN6390. 16h post-infection cells were fixed, 
stained and examined by microscope (40x). Shown here is a representative of 3 
independent experiments.
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Figure 4.9: Effect of S. aureus on confluent Caco-2 or HEp-2 cells at 16h
Cells were co-cultured with SEB, Staph B or E69. 16h post-infection cells were fixed, 
stained and examined by microscope (40x). Shown here is a representative of 3 
independent experiments.
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Figure 4.10: Effect of S. aureus on confluent Caco-2 or HEp-2 cells at 16h.
Cells were co-cultured with Patient strains 1-3. 16h post-infection cells were fixed, 
stained and examined by microscope (40x).
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4.23.2 Induction of cytoxicity on exposure to bacterial-CCM
Enterotoxin-negative strains showed no cytoxic effect on HEp-2 cells, suggesting 
cytoxicity is most likely due to the expression of enterotoxins. Caco-2 or HEp-2 cell 
monolayers were exposed to sterile bacterial-CCM and incubated as described above for 
the viable bacterium, and the occurrence of cytoxicity was investigated. Surprisingly, 
epithelial cytoxicity could not be induced in Caco-2 or HEp-2 cells with monolayers 
remaining intact, although occasional vacuolisation was observed (Fig 4.11 and 4.13).
To investigate whether the lack of cytoxicity seen with CCM, in comparison to 
cytoxicity seen with the live stimulus, was not due to an increased concentration of 
enterotoxin produced with the live stimulus over the course of infection; co-culture 
experiments were conducted using transwell filters to prevent access of live replicating 
bacterium to the cells, yet allowing enterotoxins access (Section 2.8.2). Once again, 
epithelial cytoxicity could not be induced in HEp-2 cells and monolayers remained 
intact (Fig: 4.12 and 4.13).
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Figure 4.11: Effect of S. aureus endotoxin on Caco-2 or HEp-2 cells at 16h.
Cells were stimulated with sterile bacterial-CCM of RN6911, RN6390, SEB, Staph B or 
P I-3. 16h post-stimulation, cells were fixed, stained and examined by microscope (40x). 
Shown here is a representative of 3 independent experiments and is representative of the 
other strains investigated. Viable bacteria are shown for comparison (a, c, e and g).
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Figure 4.12: Effect of S. aureus on confluent HEp-2 cells when direct bacterial 
access is restricted. RN6911, RN6390, SEB, Staph B, or Patient strains 1-3 were 
inoculated into the upper chamber of a transwell filter where HEp-2 cells had been 
grown to confluence in the lower chamber. After 16h cells were fixed, stained and 
examined by microscope (40x). Shown here is a representative of 3 independent 
experiments and is representative of the other strains investigated. Viable bacteria are 
shown for comparison (a and c).
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Figure 4.13: Effect of S. aureus on confluent HEp-2 cells at 16h. HEp-2 cells were 
co-cultured with RN6911, RN6390, SEB, Staph B, Patient strains 1-3 or E69. 16h post­
infection cells were fixed, stained and examined by microscope (40x). The number of 
cells displaying cytotoxic characteristics per 100 cells, per field of view, selected at 
random, were counted and expressed as a percentage of cytotoxic cells. For each 
inoculation per experiment three fields of view were selected at random and separate 
experiments were also conducted in triplicate, the data shown is mean (+SD,* P<0.05).
Page 219
4.2.4 In vitro induction of cytotoxicity during Staphylococcus aureus infection 
The ability of S. aureus to induce cytoxicity was investigated ex vivo. The In vitro organ 
culture assay (IVOC) was utilised (Section 2.9). Histologically normal intestinal 
biopsies were inoculated with RN6911, RN6390, SEB, Staph B, Patient strains 1-3 or 
E69 (All 25pl [0 0 6 0 0 =0 .7 ]). At 8 h post-inoculation the biopsies were fixed and 
processed for SEM (Section 2.15).
No evidence of cytopathy was seen in control, non-infected tissue (Fig 4.14) RN6911 
and RN6390 strains showed intact mucosa with normal polygonal units (Fig 4.15). In 
addition, tissue inoculated with the comparative control species EPEC E2348/69 also 
showed similar regular polygonal units however, an increase in goblet cells and mucus 
was observed in comparison to the control tissue (Fig 4.16).
Inoculation of tissue with Staph B the EDIN-B enterotoxin producing strain showed 
epithelial cell extrusion and rounding characteristic to that observed in the IEC lines 
(Fig 4.17). Inoculation with the SEB producing strain showed marked epithelial cell 
extrusion, cell rounding and severe structural abnormalities; with irregularities in 
polygonal units and crypt atrophy (Fig 4.17b). Inoculation with the SEG and SEI 
producing patient strains also showed epithelial cell extrusion, cell rounding and 
structural abnormalities to varying degrees (Fig 4.18-19). Patient strain 2 showed the 
most marked epithelial cell extrusion and rounding and acute structural abnormalities; 
with irregularities in polygonal units and crypt atrophy (Fig 4.18b). As no response was 
seen with the non-enterotoxin producing strains, this would confirm the observations in 
epithelial cell lines ex vivo suggesting that staphylococcal cytoxicity is caused by 
enterotoxins.
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Figure 4.14: Uninfected human transverse colon
A representative SEM image of a colonic biopsy incubated by IVOC for 8h.
Page 221
2  5  k  U  X  5  O  Q 5 0 ^ m 0 0 ?f0
Figure 4.15: RN6911 (a) and RN6390 (b) infected human transverse colon
Representative SEM images of a colonic biopsy incubated by IVOC for 8h.
Page 222
Figure 4.16: Enteropathogenic Escherichia coli E2348/69 WT infected human 
transverse colon. A representative SEM image of a transverse colon biopsy incubated 
by 1VOC for 8h.
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Figure 4.17: Staph B (a) and SEB (b) infected transverse colon.
Representative SEM images of a colonic biopsy incubated by IVOC for 8h.
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Figure 4.18: Transverse colon infected with SEG and SEI producing Patient 1 (a) 
and Patient 2 (b) strains. Representative SEM images of a transverse colon biopsy 
incubated by IVOC for 8h.
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Figure 4.19 SEG and SEI producing Patient 3 strain infected transverse colon
A representative SEM image of a colonic biopsy incubated by IVOC for 8h.
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4.3 Discussion
Due to a link of S. aureus to CD, and as the innate immune response to this pathogen is 
largely unknown, the IEC immune response to S. aureus was investigated to gain a 
better understanding of S. aureus-IEC “cross-talk”.
LL-37 was found to be constitutively expressed in both Caco-2 and HEp-2 cells (Fig 
4.2). LL-37 was also further induced during S. aureus infection with patient strains 1 
and 3; suggesting that LL-37 may be involved in IEC barrier defence against S. aureus. 
In respect to hBD production the cell lines studied differed. As hBD3 was constitutively 
expressed in Caco-2 cells and hBD2 and hBD3 was induced on bacterial exposure (Fig 
4.2a). While HEp-2 cells did not constitutively express hBD2 and hBD3 mRNA, and 
expression could not be induced with IL-ip or with the bacteria investigated (Fig 4.2b). 
Others have reported that HEp-2 cells do not express hBD2 even upon bacterial 
challenge (Ball et al. 2004).
RN6911, RN6930 and E69 appeared to reduce hBD3 gene expression however; this was 
not found to be statistically significant (Fig 4.3b). Down-regulation of AMPs by S. 
aureus has been reported, nasal carriage of S. aureus is accompanied by subclinical 
inflammation, enhanced attachment to nasal ECs compared to a non carrier strains, 
delayed expression of TLR2 and suppression of both hBD2 and hBD3 (Quinn & Cole 
2007).
The induction of hBD2, 3 and LL-37 seen in Caco-2 cells on infection with S. aureus 
(Fig 4.3b and 4.4a) could be due to PGN or LTA, which have been shown to induce 
AMPs in other cells (Voss et al. 2006). TLR2 has also been implicated in the host 
response to Staphylococci, and LTAs are sensed through TLR2/1 inducing hBD3 in 
keratinocytes (Takeuchi et al. 2000, Midorikawa et al. 2003, Hoebe et al. 2005, Menzies 
& Kenoyer 2005, Travassos et al. 2005, Menzies & Kenoyer 2006).
Schauber et al. have reported the effect of S. aureus on hBDl, hBD2 and LL-37 
expression in HT29 cells. They found S. aureus, staphylococcal PGN and LTA did not 
induce hBD2 expression and had no effect on the constitutive expression of LL-37 and 
hBDl (Schauber et al. 2006). However, Schauber et al. also investigated expression of
Page 227
these AMPs in keratinocytes and did not find the same profile of expression, thus they 
suggest that expression of AMPs is cell specific (Schauber et al. 2006); as observed in 
this study. Furthermore, the response observed here may require the PGN or LTA to be 
in their “native” form requiring the whole bacterium in comparison to the isolated 
bacterial products used by Schauber and colleagues.
All bacteria induced 1L-8 mRNA expression in Caco-2 and HEp-2 cells, albeit to 
varying degrees (Fig 4.5). As the CCM from all strains had no effect, this suggested a 
contact-dependent mechanism for IL-8 mRNA expression may be critical. Despite the 
contact-dependent induction of IL-8 mRNA, no production of IL-8 or CCL20 protein 
was observed (Fig 4.6). This suggests that IL-8 mRNA maybe post-translationally 
regulated.
In support of this data, Melmed et al. demonstrate that IECs were unresponsive to 
staphylococcal-derived TLR2 ligands; with respect to pro-inflammatory gene 
expression and IL-8 secretion but not to hBDs (Melmed et al. 2003). Although they did 
not find activation of NF-kB or secretion of IL-8, they suggest the role of TLR2 is likely 
to aid in tissue healing or protection from pathogens, through secretion of AMPs 
(Melmed et al. 2003). In addition, Schauber et al. demonstrate that AMPs can be 
triggered independently of the release of pro-inflammatory molecules (Schauber et al.
2006).
It may be that IECs in the GI tract do not invoke a pro-inflammatory response to S. 
aureus derived products, such as PGN and LTA, as a mechanism of tolerance. Indeed, 
low expression of TLR2 has been reported in IECs (Cario & Podolsky 2000, Hausmann, 
et al. 2002, Melmed et al. 2003). Furthermore, Cario et al. demonstrated that TLR2 is 
found in a sub apical location in polarised T84 cells and traffics to a basolateral location 
in response to basolateral PGN (Cario et al. 2002). It is likely that the IL-8 production 
seen in S. aureus infection may not be directly IEC-mediated but due to the pathogen 
breaching the barrier. As staphylococcal PGN and LTA have been shown to stimulate 
the production of IL-8 in monocytes and macrophages, and in turn recruitment of 
neutrophils and formation of pus (Wakabayashi et al. 1991, Mattsson et al. 1993, 
Timmerman et al. 1993, Heumann et al. 1994, Standiford et al. 1994, von Aulock et al. 
2003a, Fournier & Philpott 2005).
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Co-culture of HEp-2 cells and intestinal tissue with Staph B, SEB and the patient strains 
could directly induce epithelial cytotoxicity and barrier disruption (Fig 4.9, 4.10, 4.13 
and 4.17-19). Cytotoxicity was characterised in HEp-2 cells by vacuolisation, nuclear 
enlargement, and features of cytoskeletal rearrangement: with pseudopod extension, cell 
retraction and rounding with membrane ruffling (characteristic of cells undergoing 
apoptosis) with disruption to epithelial monolayers (Fig 4.7). Inoculation of tissue with 
the S. aureus EDIN-B enterotoxin producing strain (Staph B) showed epithelial cell 
extrusion and rounding characteristic to that observed with the IEC lines. Inoculation of 
tissue with the SEB producing strain showed marked epithelial cell extrusion, rounding 
and severe structural abnormalities; with irregularities in polygonal units and crypt 
atrophy. Inoculation with the patient derived strains, which are SEG and SEI producing, 
also showed epithelial cell extrusion, rounding and structural abnormalities to varying 
degrees. Patient strain 2 was the most severe, showing marked epithelial cell extrusion, 
rounding with acute structural abnormalities; with irregularities in polygonal units and 
crypt atrophy. This property was not seen in the two non-enterotoxin producing strains 
with either cell lines or tissue (Fig 4.8 and 4.15). In addition, cells and tissue inoculated 
with EPEC E69 displayed no evidence of the cytopathy characteristic of that seen with 
the Staphylococcus species (Fig 4.9 and 4.17) confirming that staphylococcal 
cytotoxicity is caused by enterotoxins.
Evidence for a contact-mediated cytopathic effect on intestinal epithelium was shown, 
as in the presence of high concentrations of bacterial-CCM, the cytopathic response 
could not be induced and cell monolayers remained intact (Fig 4.11). Moreover, when 
experiments were conducted using transwell filters to prevent access of live bacteria; 
once again no cytotoxicity was evident (Fig 4.12). This is suggestive of contact- 
dependent pathogenesis, although it does not exclude the possibility that exfoliative or 
cytopathic toxins might be secreted at very high concentration in close proximity to the 
epithelium or may point to an ingress-dependent pathogenesis.
Clear differences were noted between HEp-2 cells, which were susceptible to cytopathy 
and Caco-2 cells that were resistant. The epithelial cell lines show different morphology 
upon confluence, although both express microvilli-like structures and are both 
commonly used for the study of adherence and pathogenicity amongst intestinal 
organisms. The cell lines differed in respect of (3-defensin production, as the resistant
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Caco-2 cells produced hBD2 and hBD3 on exposure to these organisms, whereas 
susceptible HEp-2 cells did not do so during infection. Thus, it is plausible that the lack 
of production of defensins in HEp-2 cells allow the staphylococcal strains access to the 
epithelial cells, further supporting the role of a contact dependent cytopathic effect. It 
will be important to determine in future studies whether the enhanced resistance of 
Caco-2 cells to staphylococcal infection relates to enhanced defensin expression or 
TLR-2 signalling.
In support of a contact mediated cytopathy when S. aureus reaches the GI tract, SEB 
has been shown to induce dose-dependent cytotoxicity through cytoskeletal 
rearrangement in cultured endothelial cells leading to colonic epithelial barrier 
dysfunction (Campbell et al. 1997, McKay & Singh 1997, Lu et al. 1998). Furthermore, 
Ulrich et al. found that rhesus monkeys exposed to a lethal dose of aerosolised SEB 
developed gastrointestinal signs within 24h after exposure (Ulrich et al. 1998). The 
monkeys developed erosive enterocolitis, with superficial mucosal loss. Crypt 
enterocytes had a high nuclear to cytoplasmic ratio and numerous mitoses. Some of the 
monkeys* colons contained many small crypt abscesses.
Epithelial damage similar to that described in the patient cases of this study, have been 
identified in a number of cases of sudden infant death syndrome, with toxin-producing 
S. aureus the most common pathogen detected (Kamaras & Murrell 2001a, Kamaras & 
Murrell 2001b). Damage varied from removal of microvilli, damage to villus tips, 
separation of and removal of epithelial cells from the lamina propria, and removal of 
enterocytes leaving goblet and tuft cells, to damage and breakdown of the lamina 
propria. The results support the hypothesis that the cause of death in a significant 
proportion of SIDS babies may result from the absorption of toxins from the intestinal 
tract initiating a toxic shock reaction (Kamaras & Murrell 2001b). Moreover, Lionetti et 
al. showed that the treatment of human fetal intestinal explants with SAgs resulted in 
hyperplasia of epithelial crypt cells and altered the ratio of crypt to surface epithelium 
(Lionetti et al. 1993). These events were associated with the increased production of IL- 
2 and IFN-y. In addition, Christie et al. report that on infection of Henle human 
intestinal cells with an enteric S. aureus isolate cultured from an infant with 
enterocolitis showed extensive cytopathogenic effect, including cell rounding, 
fragmentation and death. Although they suggest an ingress-dependent mechanism in
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which S. aureus resided within vacuoles in the cytoplasm, which has not been ruled out 
in this study (Christie et al. 1988).
Although S. aureus is not traditionally considered an intracellular pathogen, it is 
however, well documented that in vitro S. aureus can enter non-professional phagocytic 
cells such as endothelial cells, epithelial cells, enterocytes, fibroblasts, osteoblasts and 
neutrophils (Buggy et al. 1984, Hamill et al. 1986, Vann & Proctor 1987, Tompkins et 
al. 1990, Tompkins et al. 1992, Hudson et al. 1995, Almeida et al. 1996, Beekhuizen et 
al. 1997, Bayles et al. 1998, Menzies & Kourteva 1998, Gresham et al. 2000, Kahl et al. 
2000, Hess et al. 2003). Intracellular Staphylococci are sometimes present within 
vacuoles. However, the majority appear to be tree and replicating within the cytoplasm, 
having escaped from the endosome (Hudson et al. 1995, Bayles et al. 1998, Menzies & 
Kourteva 1998). On escape from the endosome S. aureus has been found to cause 
apoptosis of the keratinocytes, HEp-2 and Caco-2 cells (Bayles et al. 1998, Kintarak et 
al. 2004). Interestingly, neutrophils of patients with CD show increased intracellular 
survival of S. aureus (Couper et al. 1991, Worsaae et al. 1982).
Bayles et al. explored the possibility that maintenance in an intracellular niche can 
promote long-term colonisation in the host and can also play a role in maintaining 
chronic infections. Uptake requires host cytoskeletal rearrangements and induced 
membrane structures similar to those seen during entry of Listeria and Yersinia species 
(Bayles et al. 1998). S. aureus invades by a mechanism requiring interaction between 
fibronectin binding proteins and integrin a5pi on the host cell (Isberg et al. 1994) 
leading to signal transduction and subsequent rearrangement of the host cell 
cytoskeleton. Endosomal escape is dependent on the expression of the virulence 
regulators Agr and SarA (Wesson et al. 1998); probably by regulating the expression of 
membrane active toxins (Qazi et al. 2001, Shompole et al. 2003).
The barrier defect due to this cytotoxicity has been shown to promote uptake of 
exogenous antigens, microbial products and other noxious substances into the intestinal 
tissue to contact immune cells and to initiate immune reactions (Benjamin et al. 1998, 
McKay & Singh 1997, Lu et al. 2003a, Yang et al. 2005). For example, Hamad et al. 
showed that SEs can gain rapid access to the immune system after ingestion. They 
found in Caco-2 cells that SEB and TSST-1, but not SEA can cross the epithelium in an
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immunologically intact form (Hamad et al. 1997). Furthermore, jejunal sections from 
SEB-treated mice have been observed to have various degrees of oedema, increased 
epithelial vacuolation and neutrophils in the vasculature at the base of the crypts. In 
addition, SEB has been found to induce pro-inflammatory responses in gut-associated 
lymphoid tissue and chronic enteropathy in T cell-reconstituted SCID mice (Benjamin 
et al. 1998, Spiekermann & Nagler-Anderson 1998); the mucosa in these animals 
demonstrated villous atrophy, increased crypt depth and a significant increase in MHC 
II expression with increased mucosal T cell density. Interestingly, Hamad et al. 
introduced SEA or SEB into the stomachs of mice and the appearance of the functional 
toxin in the circulation was followed by substantial deletion of T cells after 10 days 
(Hamad et al. 1997); collectively, suggesting that staphylococcal enterotoxins can 
breach the epithelial barrier and induce a T cell mediated pathology and subsequent T 
cell anergy.
While investigating the innate immune response to S. aureus it has become evident that 
if this pathogen is able to gain direct access to the intestinal epithelial mucosal barrier 
via innate immune deficiency. It has evolved a novel mechanism which enables it to 
breach the intestinal mucosal barrier via cytopathy characterised by cytoskeletal 
rearrangement and apoptosis of epithelial cells allowing antigens, possibly including 
commensal microbiota as well as staphylococcal SAgs, access to the underlying 
immune system. Thus, leading to activation of the immune system and T cell mediated 
pathology, which with the capacity S. aureus to reside intercellularly and induce T cell 
anergy leads to chronic inflammation.
As colonic CD is characterised by an attenuated expression of inducible P-defensins 
(Wehkamp et al. 2003, Fahlgren et al. 2004, Fellermann et al. 2006, Nuding et al. 2006). 
One may hypothesize that S. aureus is able to bind to colonic epithelial cells and induce 
apoptosis, and in turn enabling a breach of the mucosal barrier. Therefore, as has been 
previously suggested, S. aureus has the capacity to prime an individual for the 
development of CD or evoke relapses in enteric inflammatory disease (McKay 2001, 
Dionne et al. 2003, Lu et al. 2003a, Yang et al. 2005).
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CHAPTER 5: Commensal, probiotic
and pathogenic bacteria and the host: 
the innate immune response of the 
epithelium
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5.1 Background
The aetiology of CD still remains unknown; due to the presence of granulomas 
associated with the pathology a search for a specific pathogen has been supported. As 
detailed in section 1.8.6.3, two of the pathogens linked to CD are E. coli and S. aureus, 
which have been investigated in chapters 3 and 4 respectively.
However, considerable clinical and experimental evidence links immune responses, 
which are directed against the normal bacterial microbiota to die pathogenesis of IBD 
(Section 1.8.6.1). Paradoxically, non-pathogenic bacteria are also thought to contribute 
to the immune homeostasis purported to underlie the therapeutic basis for the benefits 
observed with the use of probiotics in IBD (Malin et al. 1996, Kruis et al. 1997, 
Campieri & Gionchetti 1999, Rembacken et al. 1999, Gupta et al. 2000, Marteau et al. 
2001, Schrezenmeir & de Vrese 2001).
Despite the increasing recognition of the importance of therapeutic approaches that 
modulate the composition of the bacterial load, little is known about the mucosal 
immunological response to non pathogenic “commensal” or “probiotic” bacteria. Thus, 
the aim of this study was to characterise the innate mucosal signals generated in 
response to “commensal” and “Probiotic” non-pathogenic bacteria in comparison to 
wild type pathogenic bacteria.
Since the publication by Neish et al. showing that a non-pathogenic salmonella strain 
could down-regulate pro-inflammatory responses via inactivation of NF-kB (Neish et al.
2 0 0 0 ); there has been a number of investigations into the effects of non-pathogenic 
bacteria, on IL- 8  expression induced by IECs. However, the literature is somewhat 
conflicting as to whether non-pathogenic bacteria reduce or increase the expression of 
pro-inflammatory cytokines. A further aim of this series of experiments was to try to 
address this issue.
5.1.1 Species investigated in the present study
The species investigated in this series of experiments were Bacteroides thetaiotamiron a 
commensal species (B. theta), Escherichia coli K12 HB101 a commensal like 
laboratory species (HB101), Lactobacilli plantarum 299v and Lactobacilli rhamnosus
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GG probiotic species (LGG and L299v). The known interactions of these bacterial 
species with the epithelial barrier have been described in section 1 .6 .
Within these series of experiments EPEC strains E69 and E10, and EAEC strain 042 
have been included as a comparative control species; since the signalling pathways 
activated by these bacterium that lead to the production of IL- 8  has been well 
characterised by the following: Savkovic et al. 1997, Steiner et al. 1998, Steiner et al. 
2000, de Grado et al. 2001a, Czerucka et al. 2001, Savkovic et al. 2001, Donnelly & 
Steiner 2002, Jiang et al. 2002, Savkovic et al. 2003, Zhou et al. 2003, Huang et al 
2004a, Khan et al. 2004, Harrington et al. 2005b, Sharma et al. 2006, Ruchaud- 
Sparagano et al. 2007. The known interactions of theses bacterial species with the 
epithelial barrier have also been described further in section 1. 6  and in chapter 3.
Furthermore, Hecht suggests that the signalling cascades activated by EPEC, that 
contribute to activation of the transcription factor NF-kB, may also be involved in the 
inflammatory response that underlies IBD (Hecht 2005).
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5.2 Results
5.2.1 Modulation of constitutively expressed antimicrobial peptides (LL-37, hBDl 
and hBD3) in response to bacteria
In this series of experiments, the effect of B. theta, HB101, L299v, LGG and E69 on the 
gene expression of LL-37, hBDl and 3 was investigated in Caco-2 cells. 8  or 16h co­
culture was conducted (section 2.7). RNA was extracted from IECs and amplified by 
RT-PCR (section 2.12). All experiments were performed at least three times unless 
otherwise stated. These experimental conditions are the same for all data presented 
within this chapter unless otherwise stated.
Caco-2 cells constitutively expressed LL-37 and hBDl as shown in Fig 5.1 and 5.2 
respectively, which were not up-regulated by the pro-inflammatory cytokine IL-ip or 
by bacterial infection. At 8 h post-infection a trend for down-regulation of both LL-37 
and hBDl was observed. However, this modulation did not reach statistical significance 
with any of the bacterial species tested (Fig 5.1a and 5.2a). Fig 5.1c and 5.2c represent 
the data of three independent experiments. Interestingly, at 16h post-infection all 
bacteria down-regulated LL-37 gene expression (Fig 5.1). In addition, except for 
HB101, all species down-regulated hBDl gene expression (Fig 5.2). In both instances 
the most statistically significant down-regulation was with L299v, LGG and E69.
Regulation of hBD3 gene expression was investigated (Fig 5.3). Expression of hBD3 
was also found constitutively in Caco-2 cells. However, the expression was low when 
compared to LL-37 and hBDl (Fig 5.1 and Fig 5.2) and was not induced by IL-lp; 
although, hBD3 could be induced by infection with B. theta at 8 h (Fig 5.3). While 
modulation of hBD3 8 h post-infection was variable amongst the species; at 16h the two 
Lactobacilli species showed the greatest ability to down-regulate hBD3 expression (Fig 
5.3c). Interestingly, the E69 also showed reduction in hBD3 expression.
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Figure 5.1: LL-37 gene expression in response to bacterial species at 8h (a) and 16h 
(b) post-infection. Caco-2 cells were infected with L299v, LGG, B. theta, HB101, or 
E69 (MOI = 60), or stimulated with IL-ip (lOng/ml) as a positive control. Gene 
expression was amplified by RT-PCR and normalised to GAPDH. Variations in mRNA 
levels are expressed as fold induction compared to the uninfected control cells (c). Data 
shown is mean (+SD, * p < 0.05) induction of three independent experiments.
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Figure 5.2: Modulation of hBDl gene expression in response to bacterial species at
8h (a) and 16h (b). Caco-2 cells were infected at an MOl = 60. IL-ip served as a 
positive control. The mRNA levels are expressed as fold induction compared to the 
uninfected control cells (c). Data shown as mean induction (+SD, * p < 0.05).
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Figure 5.3: Modulation of hBD3 gene expression in response to bacterial species at
8h (a) and 16h (b). Caco-2 cells were infected at an MOI = 60. IL-ip served as a 
positive control. The mRNA levels are expressed as fold induction compared to the 
uninfected control cells (c). Data shown as mean induction (+ SD, * p < 0.05).
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5.2.2 Modulation of ‘inducible’ hBD2 gene expression by a range of bacteria
In this series of experiments, the effect of B. theta, HB101, L299v, LGG and E69 on 
hBD2 gene expression was investigated in Caco-2 cells. No hBD2 gene expression was 
observed in control Caco-2 cells (Fig 5.4). The expression was inducible in Caco-2 cells 
by IL-lp and by bacterial stimulus. At 8 h post-infection all species induced hBD2 to 
varying degrees. However, only B. theta and HB101 induced a statistically significant 
increase. At 16h hBD2 induction had reached statistical significance for all strains 
except E69. Once again, B. theta and HB101 induced the greatest increase. Although 
hBD2 gene induction was noted at 8  and 16h in response to bacteria, as hBD2 is an 
early innate response gene it was therefore, pertinent to investigate if differences in 
kinetics of induction occurred in response to different classes of bacteria.
All species induced hBD2 gene expression in a time dependent manner, expression was 
rapid and biphasic (Fig 5.5). Most species showed an initial peak at 2h, which had 
declined by 4h; B. theta was the most potent inducer at this early time point. Similar 
kinetics were seen with IL-lp although with greater magnitude. The hBD2 gene 
induction by E69 and HB101 was more rapid peaking at lh. Interestingly, E69 appeared 
to induce a triphasic response with a second wave at 4h. At 5-6h post-infection hBD2 
gene expression increased for all bacteria. LGG, L299v and E69 infection showed a 
maximal induction at 8 h. Thereafter hBD2 expression remained steady in the presence 
of the probiotics in comparison to E69 infection where hBD2 levels declined slowly. 
HB101 and B. theta were still inducing hBD2 expression at 16h.
5.23 Modulation of epithelial IL-8 in Caco-2 cells in response to infection
In this series of experiments, the effect of B. theta, HB101, L299v, LGG and E69 on IL- 
8  gene and protein expression was investigated in Caco-2 cells. Co-culture supernatants 
were harvested and IL- 8  Protein expression was quantified by ELISA (section 2.10). 
These experimental conditions are the same for all data presented within this chapter 
unless otherwise stated. As shown in Fig 5.6, low basal IL- 8  expression was observed in 
control Caco-2 cells (Lane 1 Fig 5.6a and b). At 8  and 16h all bacterial species 
irrespective of pathogenicity induced IL- 8  gene expression; as did the pro-inflammatory 
cytokine IL-lp (positive control).
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Figure 5.4: Modulation of hBD2 gene expression in response to bacterial species at 
8h (a) and 16h (b). Caco-2 cells were infected at an MOI = 60. IL-lp served as a 
positive control. The mRNA levels are expressed as fold induction compared to the 
uninfected control cells (c). Data shown as mean induction (+SD, * p < 0.05).
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Figure 5.5: Time dependent modulation of hBD2 gene expression in response to 
bacterial species. Caco-2 cells were infected with L299v, LGG, B. theta, HB101 or 
E69 (MOl = 60), or IL-lp (lOng/ml) as a positive control. Gene expression up to 16h 
post-infection was amplified by RT-PCR and normalised to GAPDH. Variations in 
mRNA levels are expressed as fold induction compared to the uninfected control cells. 
Data shown is mean induction of three independent experiments.
Page 242
IL-8
GAPDH
Non L299v LGG B. theta HB101 E69 IL-1p
Non L299v LGG B.theta HB101 E69 IL-ip
3 C Z 3IL-8
GAPDH
I I  1—,1
3.5
2.5
1 15
0.5
JL4_
8 Hours 
116 Hours
J_
i
1 1
Non Stimulated L299v LGG B. Theta HB101 E69 IL-lp
Figure 5.6: Modulation of IL-8 gene expression at 8h (a) and 16h (b) post-infection.
Caco-2 cells were infected with L299v, LGG, B. theta, HB101, or E69 (MOl = 60), or 
IL-lp (lOng/ml). Gene expression 8 and 16h post-infection was amplified by RT-PCR 
and normalised to GAPDH. Variations in mRNA levels are expressed as fold induction 
compared to the uninfected control cells (c). Data shown is mean (+SD, *p<0.05) 
induction of three independent experiments.
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Kinetics of IL- 8  gene and protein induction was further characterised (Fig 5.7a). As 
observed for hBD2 (Fig 5.5) IL- 8  mRNA expression was also found to be rapid and 
biphasic. Initial expression peaked at 2h post-infection followed with a steady decline 
prior to a second peak of induction 6 -8 h post-bacterial exposure. Measurements 
obtained suggested sustained IL- 8  gene expression at 16h; however, further time points 
were not investigated. In general, HB101, L299V and LGG remained the most potent 
inducers of IL- 8  gene expression over the time period of the experiment. Interestingly, 
the probiotic L299v appears to induce an additional peak of IL- 8  gene expression at 6 h.
In contrast to IL- 8  gene expression, protein analyses showed minimal increases in 
protein levels in the first 3h of infection (Fig 5.7b). However, marked induction was 
observed between 6  and 8 h post-infection. Interestingly, IL- 8  protein levels in the 
presence of bacteria declined when measured after co-culture at 16h. The chemokine 
levels in contrast steadily increased during IL-lp stimulation. Maximal induction of IL- 
8  by the probiotic LGG was reached at 6 h. The HB101, L299v and E69 species reached 
a maximum at 8 h with HB101 being the strongest inducer at this point. Over the first 8 h 
of the infection no IL- 8  protein was produced by B. theta; however, over the subsequent 
8 h B. theta steadily induced IL- 8  protein where at 16h it was the strongest inducer of 
IL-8 .
Subsequently, the effect of bacterial dosage on IL- 8  production was investigated (Fig
5.8). Co-culture of Caco-2 cells was conducted as described previously; however, 
infections were conducted with various starting doses (lxlO3, lxlO5, lxlO7 and lxlO9) 
of bacterial suspension. IL- 8  protein induction was found to be dose-dependent. At the 
lowest dose of 103 bacteria, only LGG induced IL- 8  production (150 pg/ml). Upon 
exposure to 105 bacteria HB101 and L299v induced IL- 8  to a maximal level (350pg/ml 
and 580pg/ml respectively). It was interesting to note that the IL- 8  levels induced by 103 
LGG did not substantially increase in the presence of more bacteria. E69 induced a 
modest increase in IL- 8  levels even in the presence of high bacterial numbers (107 and 
109). Surprisingly, B. theta infection yielded a unique IL-8 , dose-dependent profile. At
- *7
low dose (up to 10 ) no IL- 8  production was found. However, at high doses of 10 and 
109 a progressive increase in IL- 8  protein was observed with 109 B. theta inducing 
maximum IL- 8  levels noted amongst all the species tested (700 pg/ml). For all other 
species this dose was cytotoxic to the cells and no IL- 8  protein was detected.
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Figure 5.7 Bacterial driven time dependent modulation of IL-8 gene (a) and 
protein (b) expression. Caco-2 cells were infected with L299v, LGG, B. theta, HB101, 
or E69 (MOI = 60), or IL-lp (lOng/ml) as a positive control. The mRNA levels are 
expressed as fold induction compared to the uninfected control cells and protein as 
pg/ml. Data shown is mean (± SD) induction of three independent experiments.
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Figure 5.8: Effect of bacterial-dose on IL-8 protein production in Caco-2 cells. All
bacterial species were cultured at 103, 105, 107 and 109 cfu with Caco-2 cells for 16h 
prior to IL-8 protein analysis by ELISA. Data shown is mean (± SD) induction of three 
independent experiments.
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5.2.4 Modulation of epithelial chemokines IL-8 and CCL20 in HEp-2 cells in 
response to infection
In a parallel series of experiments, epithelial chemokine responses to infection were also 
studied in HEp-2 cells. This cell line is the cell line of choice for investigating bacterial 
adhesion. In this study, IL- 8  and CCL20 levels were investigated. Where IL- 8  is a 
neutrophil chemoatractant, CCL20 is a chemoattaractant for dendritic cells. The species 
used were those described previously (B. theta, HB101, L299v, LGG and E69) In 
addition, the following pathogenic species were also investigated; EAEC 042 and the 
EPEC strain E10.
IL- 8  gene expression was quantified in HEp-2 cells 4h post stimulation (Fig 5.9). LGG 
caused a striking increase in IL- 8  mRNA levels, an increase which was as potent as IL- 
1 p. Interestingly, the closely related probiotic species L299v caused a minimal change 
in IL- 8  levels. Amongst the remaining species there was variability in induction with 
E69 being the stronger inducer. Despite a marked increase in IL- 8  mRNA expression by 
LGG, protein levels at 4h remained low with only E69 giving a statistically significant 
induction of IL- 8  protein (Fig 5.10a). At 16h all bacterial species, with the exception of 
B. theta, induced a statistically significant increase in IL- 8  protein, with LGG, HB101 
and 042 being the more potent agonists. CCL20 protein was constitutively expressed in 
HEp-2 cells (Fig 5.10b). 4h post-infection no statistically significant change in CCL20 
protein was observed with any of the bacterial species. At 16h, 042, HB101, L299v and 
LGG induced significant amounts of CCL20. The 2 EPEC strains E69 and E10 had little 
or no effect on CCL20 protein induction. As observed for IL- 8  (Fig 5.10a) CCL20 
induction remained minimal during infection with the commensal B. theta.
Page 247
E10 E69 042 HB101 L299v LGG
1299V
Figure 5.9: Modulation of IL-8 gene expression 4h post-infection in HEp-2 cells.
Cells were infected with L299v, LGG, B. theta, HB101, or E69 (MOI = 60), or IL-lp 
(lOng/ml) as a positive control. Gene expression 4h post-infection was amplified by 
RT-PCR and normalised to GAPDH. The gel shown is a representative of 3 
independent experiments (a). Variations in mRNA levels are expressed as fold 
induction compared to the uninfected control cells (b). Data shown is mean (+SD, 
*p<0.05) induction of three independent experiments.
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Figure 5.10: Production of IL-8 (a) and CCL20 (b) by various bacterial species 4
and 16h. HEp-2 cells were infected with E10, E69, 042, B. theta, HB101, L299v or 
LGG (MOI = 60), or IL-lp (lOng/ml) as a positive control. At 4 and 16h post-infection, 
cell and bacterial co-culture supernatants were harvested. Production was evaluated in 
the respective supernatants by ELISA. Data shown is mean (+SD; *p<0.05) induction of 
three independent experiments.
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5.3 Discussion
Current evidence links immune responses directed against the commensal microbiota to 
the pathogenesis of IBD (Sartor et al. 2007). Despite this hypothesis our understanding 
of IEC responses to non-pathogenic “commensal” or “probiotic” bacteria remains ill- 
defined. Indeed, to the best of my knowledge, this is the first study to investigate the 
effects of non-pathogenic bacteria on LL-37 and hBD3. Since the publication by Neish 
et al. showing that a non-pathogenic Salmonella strain could down-regulate pro- 
inflammatory responses via inactivation of NF-kB; there has been a number of 
investigations on the effects of non-pathogenic bacteria on IL- 8  and CCL20 expression 
(Neish et al. 2000, Bambou et al. 2004, Kelly et al. 2004). However, the literature is 
somewhat conflicting as to whether non-pathogenic bacteria reduce or increase the 
expression of pro-inflammatoiy cytokines. Differences may well be due to variations in 
cell lines and different infection procedures that have been adopted. Thus, the aim of 
this study was to characterise the innate mucosal signals generated in response to the 
presence of a range of bacteria; non-pathogenic; “commensal” and “Probiotic” bacteria 
in comparison to wild type pathogenic bacteria.
In this study, it has been shown that the E69 and the probiotic species LGG and L299v 
down-regulated the constitutive expression of hBDl, 3 and LL-37 in Caco-2 cells (Fig
5.1-5.3). Wehkamp and colleagues have suggested previously that some pathogens may 
suppress defensin release, probably as a self defence mechanisim (Wehkamp et al. 
2004a). Indeed, Shigella down-regulates hBDl and LL-37 gene expression (Islam et al.
2001), the protozoan parasite Cryptosporidium parvum also down-regulates mBD-1 
(Zaalouk et al. 2004), in a murine model of infection and Neisseria gonorrhoeae down- 
regulates LL-37 at both transcriptional and peptide level (Bergman et al. 2005). This is 
the first study to investigate EPEC and AMP expression. One may speculate that EPEC 
with its TTSS and eflfecter proteins could be capable of down-regulating defensin. 
Furthermore, down-regulation of defensins allows its colonisation of the mucosa.
The obvious question is, why and how would a probiotic, a non-pathogenic bacteria 
down-regulate defensin? In support of this finding Di Caro et al. also found that LGG 
could down-regulate defensin alpha 1 in duodenal mucosa (Di Caro et al. 2005a). One 
possibility is that these probiotic species have obtained this ability via horizontal gene
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transfer from pathogenic species, to aid in transient colonisation of the host. As O’Neil 
et al. have suggested that hBDl could mediate epithelial interactions with commensal 
microbiota, i.e. killing any commensal bacteria that manage to get access to the mucosa 
(O'Neil et al. 1999). In addition to, Ouwehand et al. who suggest that adhesion aiding 
prolonged transient colonisation is important to the function of probiotics. Furthermore, 
that adhesion to intestinal mucosa is considered important for the immune modulatory 
properties of probiotics (Ouwehand et al. 2000). It would therefore be a logical process 
for these probiotic bacteria when evolving, to develop this ability in order to aid 
colonisation.
Interestingly, as previously mentioned, Zaalouk et al. suggested that C. parvum reduced 
hBD expression, they in turn found, that synthetic hBDl kills C. Parvum sporozoites in 
vitro (Zaalouk et al. 2004). Giacometti et al. also found that LL-37 had killing activity 
against C. parvum sporozoites in vitro (Giacometti et al. 2003). Thus, if an organism is 
susceptible to these AMPs it would be logical inference that those that have evolved to 
down-regulate AMP expression would survive. Nuding et al. found hBD3 had strong 
bactericidal effects against pathogenic E. coli and the commensal E. coli HB101 
(Nuding et al. 2006). In addition, hBD2 is microbicidal against E. coli (Harder et al. 
1997, Harder et al. 2000). Furthermore, LGG is sensitive to hBD2 although not hBDl 
(De Keersmaecker et al. 2006).
In this study it has been demonstrated that in Caco-2 cells, all species investigated, 
irrespective of pathogenicity status induced hBD2 expression (Fig 5.4). A time course 
study demonstrated that the bacteria induced hBD2 in a time dependent manner, where 
expression was rapid and biphasic; with IL-lp showing similar kinetics (Fig 5.5). 
Interestingly, the pathogen E69 and the commensal HB101 induced hBD2 gene 
expression more rapidly than the other species with a peak at lh which would suggest 
that the response is due to a feature that the Gram negative E. coli have in common and 
is unrelated to pathogenicity.
In support of this data, a probiotic E. coli strain Nissle 1917 and Lactobacilli plantarum 
as well as various other Lactobacilli species and UPEC were observed to strongly 
induce hBD2 (Wehkamp et al. 2004a). Wehkamp and colleagues suggest that the 
induction of AMPs may be a common feature of probiotics, which enables these
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bacteria to strengthen barrier function. Induction of hBD2 by UPEC and Nissle, 
suggests that these bacteria contain similar (or the same) unique molecular patterns that 
are responsible for hBD2; features that may not be present in other E. coli strains that do 
not induce hBD2 (Wehkamp et al 2004a).
In contrast to our findings however, Wehkamp et al. found hBDl remained unaffected 
by any bacterial species they tested. Furthermore, HB101 and EPEC did not influence 
any tested defensin expression at any time (Wehkamp et al. 2004a). In addition, O’Neil 
et al. found neither E. coli nor Salmonella affected hBDl expression (O'Neil et al. 
1999). An explanation for these discrepancies could lie in the fact that in our study all 
species were activated in DMEM before inoculation, to simulate conditions within the 
GI tract. This activation of the bacteria could lead to a differential expression of effecter 
proteins produced by the species as well the external structures expressed on the 
bacteria used in our study, which would inevitably lead to variation in recognition by 
PRRs and in turn the triggering different signalling pathways.
In this study IL- 8  was induced in Caco-2 cells by all bacterial species irrespective of 
pathogenicity (Fig 5.6). IL- 8  mRNA expression and subsequent protein induction was 
time dependent, whereas expression of IL- 8  mRNA was rapid and biphasic as was 
found with hBD2 (Fig 5.7). Similar kinetics were seen with the pro-inflammatory 
cytokine IL-ip, which was always more potently induced. IL- 8  protein induction was in 
fact dose-dependent and IL- 8  mRNA was more potently induced than that of hBD2 (Fig
5.8). Biphasic activation of NF-kB has previously been reported (Saccani et al. 2001). 
Saccani et al. found that pro-inflammatory stimuli induce the rapid and transient 
translocation of nuclear factor NF-kB to the nucleus; where it activates transcription 
from several genes, including those encoding inflammatory cytokines and chemokines, 
adhesion molecules, and cytoprotective proteins (Saccani et al. 2001). They showed that 
after an acute stimulation two distinct waves of NF-kB  recruitment to target promoters 
occur: a fast recruitment to constitutively and immediately accessible promoters and a 
late recruitment to promoters requiring stimulus-dependent modifications in chromatin 
structure to make NF-kB sites accessible (promoters with regulated and late 
accessibility [RLA]). Their results suggest that a mechanism of specificity in NF-kB- 
dependent transcriptional responses relies on the ability of individual stimuli to make 
RLA promoters accessible to NF-kB  before its rapid extrusion from the nucleus.
Page 252
Intriguingly, IL- 8  protein levels in the presence of bacteria declined when measured 
after co-culture at 16h, whereas the chemokine levels steadily increased during IL-lp 
stimulation (Fig 5.7b). Possible reasons for bacterial-mediated decrease in IL- 8  protein 
levels could be that the bacteria degrade IL-8 , which has been reported in the literature 
(Mikolajczyk-Pawlinska et al. 1998, Edwards et al. 2005).
Also striking, was the fact that the IL- 8  profile seen with the commensal B. theta 
differed from all other species tested in time and dose-responses. No IL- 8  protein could 
be detected until 16h or with a large dose of 109 cfu (Fig 5.7 and 5.8). One may 
speculate that to the host this strain is not recognised as a potential threat and thus does 
not induce IL- 8  protein, however, in the case of bacterial overgrowth a host response is 
induced.
In parallel experiments, the response of HEp-2 cells was investigated. In addition, the 
pathogenic species: EAEC strain 042 and the EPEC strain E10 were also investigated. 
EAEC has been shown to induce IL- 8  (Steiner et al. 1998) and was included in this 
study as a comparative control as the virulence factors that lead to the production of IL- 
8  has been extensively studied (Steiner et al. 1998, Steiner et al. 2000, Donnelly & 
Steiner 2002, Huang et al. 2004a, Khan et a; 2004, Harrington et al 2005b). This is the 
first study to investigate the effects of EPEC E10 on IL- 8  and CCL20 induction.
In HEp-2 cells, IL- 8  is described as an inducible chemokine and CCL20 is 
constitutively expressed. However, both cytokines can be induced by pro-inflammatory 
cytokines such IL-ip and bacterial and viral products (Schutyser et al. 2000, Khan et al. 
2004, Arikawa et al. 2005, Meraz et al. 2006,), which was also found to be the case in 
this study (Fig 5.9 and 5.10).
Variability in IL- 8  mRNA and, IL- 8  and CCL20 protein induction was seen amongst all 
the bacteria investigated, which was irrespective of pathogenicity. For example at 4h the 
probiotic LGG caused a striking increase in IL- 8  mRNA levels, which was as potent as 
IL-ip (Fig 5.9). Interestingly, the closely related probiotic species L299v caused a 
minimal change in IL- 8  levels. Furthermore, probiotic LGG, commensal HB101 and the 
pathogen 042 were the more potent inducers of IL- 8  and CCL20 protein at 16h (Fig 
5.10). The 2 EPEC strains E69 and E10 had little or no effect on IL- 8  and CCL20
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protein induction. This data in conjunction with the Caco-2 data would suggest that the 
response is not specifically due to pathogenicity but perhaps due to structural features 
common to the two strains. Thus, the induction of IL- 8  and CCL20 is multi factorial and 
bacteria cannot be simply divided into “Good and Bad” depending on the immune 
response they elicit.
It is generally assumed that the induction of an intestinal pro-inflammatory response is a 
property of pathogenic intestinal bacteria, whereas commensal bacteria should not 
induce this response as it might hamper establishment of mutualistic relationships 
between the bacteria and their mammalian host (Bambou et al. 2004). Thus, the capacity 
of non-pathogenic enteric bacteria to induce pro-inflammatory responses is under debate 
in terms of its effects on symbiosis between the mammalian host and its commensal gut 
microbiota (Bambou et al. 2004). However, PRRs recognise an array of prokaryote 
motifs, shared by both pathogenic and commensal bacteria, suggesting that either type 
of bacteria may have the potential to initiate innate immune host responses in IECs 
(Bambou et al. 2004). Furthermore, in chapter 3 it was found that both the pathogenic 
and non-pathogenic bacteria investigated in this study, expressed similar external 
structures (Fig 3.4-10).
There is also much confusion in the literature with some authors supporting the finding 
presented here; of non-pathogenic bacteria inducing a proinflammatory response. For 
example, HB101 has been observed to increase IL- 8  and CCL20 production (Bambou et 
al. 2004). In addition, 1010cfu/L of LGG induces the production of IL- 8  in Caco-2 cells 
(Zhang et al. 2005). The probiotic E. coli Nissle also induces IL- 8  secretion from T84 
and HT29 cells (Otte & Podolsky 2004). Frick et al. found L. fermentum induced a 
slight induction of IL- 8  protein in HeLa cells (Frick et al. 2007); this is a similar cell 
line to HEp-2. However, Riedel et al. investigated effects of different strains of 
bifidobacteria and non-patogenic E. coli strain D224 on NF-kB activation in HT29 cell. 
They found that the non-pathogenic E. coli induced significant reporter gene activity but 
none of the bifidobacterial strains had any effect (Riedel et al. 2006). Thus, suggesting 
that induction of a proinflammatory response is not indicative to all non-pathogenic 
bacteria.
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However, in contrast non-pathogenic bacteria have also been observed to down-regulate 
the pro-inflammatory alert responses. Neish et al. was the first to show that a non- 
pathogenic Salmonella strain not only failed to activate epithelial cells but could also 
prevent the pro-inflammatory response induced by a pathogenic strain of Salmonella 
(Neish et al. 2000). In addition, Kelly et al. investigated IL- 8  induction by B. theta on 
Caco-2 cells; they found that B. theta attenuated IL- 8  production by prompting nuclear 
export of NF-kB subunit RELA, through a PPAR-y-dependent pathway (Kelly et al. 
2004). The difference in response related to this study may well be in the timing. The 
Kelly et al. study investigated responses at an early time point of 2h. Within this study, 
no IL- 8  could be detected either, on investigation at earlier time points. It was not until 
a much later time point of 16h or with a large dose of 109 cfu that IL- 8  induction was 
noticed (Fig 5.7 and 5.8). So, it could be that at later time points, the host has managed 
to overcome the inhibition reported by Kelly et al. and/or as mentioned previously that 
the host has mechanisms to overcome this inhibition in the case of bacterial overgrowth. 
O’Hara et al. found B. infantis and L. salivarius attenuated IL- 8  secretion at base line, 
and TNFa and S. typhimurim-mduced IL- 8  secretion, in HT29 cells. They also found 
that prior exposure to either B. infantis or L. salivarius significantly reduced S. 
typhimurium-mduced NF-kB binding activity (O'Hara et al. 2006). Ma et al. also found 
L. reuteri inhibited constitutive synthesis of IL- 8  and TNFa by T84 and HT29 cells, and 
S. enterica serovar-induced IL- 8  secretion. L. reuteri required pre-incubation and 
adherence for effect and inhibited translocation of NF-kB, and prevented degradation of 
IkB (Ma et al. 2004). Collectively, the literature may suggest that there is a variation in 
ability to induce or suppress NF-kB and in turn induce IL-8 , which is species and strain 
specific. The differences may well also be due to the variations in infection protocol. 
For example, pre-incubation, timing and dose, or even the variations in cell lines and 
cell differentiation status.
Interestingly, in the HEp-2 cell experiments the two EPEC wild type stains (E10 and 
E69) possessing a TTSS were least antagonist for the production of IL- 8  and CCL20, 
implicating the TTSS in a possible down-regulation of response (Fig 5.10). Indeed, it 
has been recently reported in the literature that through the TTSS EPEC can actively but 
transiently repress cellular responses by distinct bacterial signalling (Hauf & 
Chakraborty 2003, Sharma et al. 2006, Ruchaud-Sparagano et al. 2007). Furthermore, 
the adherent 042 strain and the probiotic species LGG and L299v, which have been
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suggested in the literature to adhere to cells, were the more potent agonists for the 
production of IL- 8  and CCL20; suggesting that contact with the epithelia may be a 
determinant of the innate immune response.
In support, the literature also suggests that contact with the epithelial mucosa may be of 
importance. For example, Vizoso Pinto et al. investigated 5 L. plantarum strains and 2 
L. johnsonii strains, 2 of these strains significantly increased IL- 8  production in HT29 
cells and showed the highest adherence to the cell monolayer (Vizoso Pinto et al. 2007). 
In addition, McCracken et al. found L299v significantly increased IL- 8  mRNA 
expression in TNFa-treated HT29 cells in an adhesion-dependent manner (McCracken 
et al. 2002). Whereas, Berlutti et al. found Caco-2 cells infected with non-invasive 
HB101 induced only a slight increase in the expression of IL- 8  mRNA and protein 
(Berlutti et al. 2006). Furthermore, Lammers KM et al. found bacterial conditioned 
supernatant of LGG or L299v did not induce IL- 8  in HT29 cells (Lammers et al. 2002). 
Alternatively, Ma et al. found L. reuteri inhibition of IL- 8  by prevention of IkB 
degradation and inhibited translocation of, NF-kB to the nuclei of HeLa cells, required 
adherence for effect (Ma et al. 2004).
Furthermore, the literature suggests that contact is an important determinant in the 
response to pathogenic bacteria. McCormick et al. suggest that attachment and not 
invasion of host epithelial cells is important for IL- 8  release and thus in turn stimulating 
PMN transmigration (McCormick et al. 1993). In addition, the non-invasive pathogens 
EHEC 0157 and EAEC have been shown to increase IL- 8  secretion (Jung et al. 1995, 
Steiner et al. 1998); as does the pathogen Helicobacter pylori, which rarely invades 
gastric epithelial cells.
In this study it was found that hBD2 mirrors the responses of IL- 8  and CCL20 and is 
being induced in a different manner to that of hBDl, hBD3 and LL-37 (Fig 5.4-7 and
5.1-3 respectively). Furthermore, as defensins are known to exhibit chemokine like 
properties as well as their antimicrobial properties (Yang et al. 2002, Yang et al. 1999). 
I would postulate that there are two distinct innate mucosal responses; the first is to 
external structures on bacteria such as flagella with the production of a pro- 
inflammatory alert type response with production of IL-8 , CCL20 and hBD2; the 
second response being due to “contact”; with the attachment of bacteria to epithelial
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cells, where a defence response is mounted by the induction of hBDl, 3 and LL-37. In 
this study, it has been found that bacteria differentially induce these two responses and 
this is independent of pathogenicity. For example, LGG a probiotic and a non 
pathogenic bacteria down-regulates the barrier defensive response of induction of 
hBDl, hBD3 and LL-37, presumably allowing this strain to colonise the mucosa, yet in 
doing so, it strongly induces the mucosal alert response with the induction of hBD2, IL- 
8  and CCL20 (Fig 5.1-3 and 5.4-7 respectively). This pattern of induction or 
suppression has also been found with the pathogenic bacteria Shigella. Islam et al. 
found that Shigella down-regulated hBDl and LL-37 gene expression, while hBD2 was 
rapidly induced through NF-kB activation. They suggested that this indicates that 
different bacteria interfere with the regulation of genes encoding antibacterial peptides 
in distinct ways (Islam et al. 2001). Interestingly, in our study E69 also down-regulates 
hBDl, hBD3 and LL-37 (Fig 5.1-3). It is known that this bacterium forms an intimate 
attachment to the mucosa, which may be responsible for down regulating this mucosal 
defence response. In addition, E69 only moderately induces hBD2, IL- 8  and CCL20 
(Fig 5.4-7). EPEC strains can produce proteins secreted into host cells via the TTSS, in 
a contact dependent manner, which enables EPEC to modulate NF-kB and thus in turn 
IL- 8  induction. It has been suggested that the response seen to EPEC is thus a balance 
between the cell pro-inflammatory response and the bacterial intracellular anti­
inflammatory response (Hauf & Chakraborty 2003, Sharma et al. 2006, Ruchaud- 
Sparagano et al. 2007). Thus, I would propose that, any strain of bacteria irrespective of 
any classification such as “good or bad” etc, is capable of inducing an innate immune 
response and that the innate immune response observed is individual for each strain. 
The response would depend on that specific strain’s ability to make contact with the 
host epithelium. Also, the particular arsenal of virulence factors the strain has for 
interacting with the host and effecting host responses, which is balanced against the 
external structures it exhibits, and thus the generalised host inflammatory mucosal alert 
response it may induce (See Fig 5.11).
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Figure 5.11: Concept of mucosal innate inflammatory response (Edwards LA)
Given that in theory any strain could induce a response, but the gut is colonised by a 
vast array o f bacteria, which appear to co-exist peacefully, Bambou JC et al. raise the 
question as to what are the strategies developed by the host and commensal bacteria to 
maintain gut homeostasis and avoid inappropriate inflammation (Bambou et al. 2004). 
Many mechanisms o f tolerance to the commensal microbiota have been suggested and 
are detailed in section 1.6.4. It is thought that differences in responses to pathogenic and 
non-pathogenic bacteria may in fact be due to the location of interaction with the 
mucosal barrier and this is investigated further in chapter 7.
Viso Pinto MG et al. make a valid point in that the modulation of a further immune 
reaction, which involves innate and adaptive components, is generally undertaken by 
professional immune cells o f the lamina propria (Vizoso Pinto et al. 2007). 
Accordingly, it is hard to predict the outcome o f the observed IL-8 stimulation on the 
further development o f an immune response when such interactions are tested in cell 
culture in the absence o f immune cells o f the lamina propria. Therefore, the in vitro 
responses to bacteria were investigated in chapter 8.
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CHAPTER 6 : Commensal, probiotic
and pathogenic bacteria and the host: 
investigation of bacterial viability and 
contact
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6.1 Background
6.1.1 Host induction of inflammation to a microbial stimulus
In chapter 5 the strain E69 and the probiotic species LGG and L299v were found to 
modulate epithelial defensin and chemokine production. All three suppressed 
constitutive expression o f hBDl, 3 and LL-37, whilst LGG and L299v and to a lesser 
extent, E69, stimulated hBD2, IL-8 and CCL20 expression. These observations 
indicated that not all bacteria stimulate an innate immune response and some may 
actively inhibit epithelial activation. This is consistent with reports that suggest that the 
resultant epithelial response seen to EPEC, is a balance between the stimulatory and 
suppressive effects o f the bacteria (Hauf & Chakraborty 2003, Sharma et al. 2006, 
Ruchaud-Sparagano et al. 2007).
In chapter 3 experiments were performed that demonstrated that a number of bacterial 
factors appear to be responsible for influencing epithelial chemokine and defensin 
production. Bacterial adherence to the epithelium, as well as structural factors, some of 
which can be secreted, appear to be particularly important. These results were consistent 
with previous studies. For example, it has been suggested that adherence to epithelial 
cells, together with the secretion of virulence associated proteins, induces IL-8 
production by IECs (Eaves-Pyles et al. 1999, Gewirtz et al. 1999). Alternatively, cell 
wall components and some soluble factors have been shown to invoke immune 
responses as they interact with IECs (Miettinen et al. 2000, Matsuguchi et al. 2003, 
Pena & Versalovic 2003, Iliev et al. 2005). However, it is less clear whether the relative 
importance o f bacterial adherence and secretion of soluble bacterial products is 
consistent for all bacteria or differs markedly between different species.
6.1.2 Effect of bacterial viability on modulation of host innate response
Observations in chapters 3 and 5 have indicated that bacteria may inhibit epithelial 
activation. It was important to understand if this inhibition was via an active process 
requiring microbial viability or not. At present, the impact of viable versus non-viable 
microbial stimulus on GI immune modulation remains unclear. For example, evidence 
to date regarding live versus killed Lactobacilli is controversial. Some studies suggest 
that Lactobacilli cell viability is a prerequisite to inducing a host response (Salminen et 
al. 1998, Gill et al. 2000, Maassen et al. 2000, Cross et al. 2004, Park et al. 2005b);
Page 260
whereas others have shown heat-killed or cell wall fractions o f lactobacillus can 
effectively induce an inflammatory response (Perdigon et al. 1986, Davidkova et al. 
1992, Sasaki et al. 1994, de Ambrosini et al. 1996, Kirjavainen et al. 2003, Matsuguchi 
et al. 2003, Jijon et al. 2004, Zhang et al 2005, Wong & Ustunol 2006, Lin et al. 2007). 
Other studies indicate that contact with live L. reuteri is necessary to cause a dose- 
dependent inhibition o f IL-8 in T84 and HT29 cells (Ma et al. 2004).
6.13 Effect of microbial contact on IEC immunity
Understanding the importance of adhesion and/or secretion of bacterial products, related 
to epithelial inflammation, is critical to understanding the limitations of current 
probiotic therapy. Studies on the interaction of orally ingested probiotics with the IECs 
have only recently begun to emerge. However, it is widely recognised that most 
probiotic strains fail to establish permanent colonisation (Fuller 1991, Tannock 1997, 
Gardiner et al. 2004, Klingberg & Budde 2006). It appears that these bacteria only 
persist during periods of dosing or for relative short periods thereafter, which is 
economically attractive. As such, the data described in chapters 3 and 4, which show the 
importance of bacterial adhesion to epithelial cells, may suggest that probiotics could be 
potentially harmful if  they do colonise and induce an increase in inflammatory 
responses such as IL-8. Furthermore, the failure of bacteria to adhere adequately to 
invoke an active epithelial response may be the reason that probiotics have to date been 
of limited value.
In this chapter, the relative importance of bacterial viability, cell contact and secreted 
bacterial products to epithelial defensin and chemokine responses was explored.
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6.2 Results
6.2.1 Effect of heat-killing (HK) bacteria on IEC innate immune response
To investigate the effect of bacterial viability on the modulation of host innate 
responses, Caco-2 cells were co-cultured with live or HK B. theta, HB101, L299v, LGG 
or E69 for 8 or 16h (Section 2.7). At the end o f the infection IL-8, hB D l-3 and LL-37 
gene expression was determined by RT-PCR (Section 2.12). Co-culture supernatants 
were harvested and IL-8 and hBD2 protein expression was quantified by ELISA 
(Section 2.10 and 2.11). These experimental conditions are the same for all data 
presented within this chapter unless otherwise stated.
6.2.1.1 Effect of HK bacteria on modulation of constitutively expressed LL-37, 
hBDl and hBD3
The down-regulation in hBDl, 3 and LL-37 gene expression, which had been observed 
at 16h with live L299v, LGG and E69 bacterial stimuli, and is shown in chapter 4, was 
not evident with the reciprocal HK bacterial strains. This suggests that bacterial viability 
is required for the down-regulation (Fig 6.1-3). Significant induction o f hBDl & hBD3 
with HK L299v at 8h was observed (Fig 6.3a), thus suggesting that heat killing may 
enhance the bacteria’s immuno-stimulatory ability. However, the increases in hBDl and 
3 observed at 8h were not sustained as they were not observed again at 16h (Fig 6.2b 
and 6.3b).
6.2.1.2 Effect of HK bacteria on modulation of ‘inducible’ hBD2 and IL - 8  gene 
expression
On stimulation with the HK bacteria all species induced hBD2 expression except 
HB101 at 8h (Fig 6.4a). There was a statistically significant difference between the live 
and HK stimulus with LGG, L299v and E69 at 8h (Fig 6.4a). Again, suggesting that 
heat killing may enhance each bacteria’s immuno-stimulatory ability. However, by 16h 
except for B. theta no real difference between hBD2 expression with either form of 
stimulus was noted (Fig 6.4b). This could imply that the differences seen between the 
HK and the live stimulus may be due to a difference in kinetics. All HK species induced
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IL-8 mRNA and to a much greater extent than that observed regarding live bacteria (Fig 
6.5).
6.2.1.3 Effect of HK bacteria on IL - 8  and hBD2 protein expression
On stimulation with the HK bacteria all species induced IL-8 mRNA to a much greater 
extent than that observed regarding live bacteria (Fig 6.5). However, a uniform trend of 
increased IL-8 protein expression on heat killing, was not observed (Fig 6.6a). IL-8 
protein levels were reduced during infection with HK E69 and B. theta when compared 
to live infection (Fig 6.6a). In contrast, live LGG and HB101 showed the least IL-8 
production but HK further increased this response. There was no difference between 
live versus HK L299v mediated IL-8 production.
No induction o f hBD2 above the constitutive level was noted (Fig 6.6b). LGG and E69 
appeared to suppress levels below constitutive expression, which was abolished on HK 
(Fig 6.6b). Interestingly, HK E69 appeared to induce hBD2. Furthermore, HK B. theta 
appeared to reduce hBD2. However, only one set of supernatants were analysed and this 
data requires further confirmation.
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(a)
LL-37 8h
L299v
(b)
HB101Non Stimulated B. theta L299v
Figure 6.1: Comparison of Live versus heat killed bacteria on LL-37 gene 
expression at 8h (a) and 16h (b). Caco-2 cells were co-cultured with live or HK B. 
theta, HB101, L299v, LGG or E69 (MOI = 60), or IL-lp as a positive control. Gene 
expression post-infection was determined and normalised to GAPDH. Variations in 
mRNA levels are expressed as fold induction compared to the uninfected control cells. 
Data shown is mean (+SD,*/+ P<0.05) induction of three independent experiments.
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Figure 6.2: Comparison of Live versus heat killed bacteria on hBDl gene 
expression at 8h (a) and 16h (b). Caco-2 cells were co-cultured with live or HK B. 
theta, HB101, L299v, LGG or E69 (MOI = 60), or IL-1 p as a positive control. Gene 
expression post-infection was determined and normalised to GAPDH. Variations in 
mRNA levels are expressed as fold induction compared to the uninfected control cells. 
Data shown is mean (+SD,*/+ P<0.05) induction of three independent experiments.
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Non B. theta HB101 L299v LGG E69 IL-10
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Non Stimulated B. theta HB101 L299v LGG E69 IL-lp
Figure 6.3: Comparison of Live versus heat killed bacteria on HBD3 gene 
expression at 8h (a) and 16h (b). Caco-2 cells were co-cultured with live or HK B. 
theta, HB101, L299v, LGG or E69 (MOI = 60), or IL-lp as a positive control. Gene 
expression post-infection was determined and normalised to GAPDH. Variations in 
mRNA levels are expressed as fold induction compared to the uninfected control cells. 
Data shown is mean (+SD,*/+ P<0.05) induction of three independent experiments.
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Figure 6.4: Comparison of Live versus heat killed bacteria on hBD2 gene 
expression at 8h (a) and 16h (b). Caco-2 cells were co-cultured with live or HK B. 
theta, HB101, L299v, LGG or E69 (MOI = 60), or IL-lp as a positive control. Gene 
expression post-infection was determined and normalised to GAPDH. Variations in 
mRNA levels are expressed as fold induction compared to the uninfected control cells. 
Data shown is mean (+SD,*/+P<0.05) induction of three independent experiments.
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Figure 6.5: Comparison of Live versus heat killed bacteria on IL-8 gene expression
at 8h (a) and 16h (b). Caco-2 cells were co-cultured with live or HK B. theta, HB101, 
L299v, LGG or E69 (MOI = 60), or IL-lp as a positive control. Gene expression post­
infection was determined and normalised to GAPDH. Variations in mRNA levels are 
expressed as fold induction compared to the uninfected control cells. Data shown is 
mean (+SD,*/+ P<0.05) induction of three independent experiments.
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Figure 6.6: Comparison of Live versus heat killed bacteria on production of IL-8
(a) and hBD2 (b) at 16h. Caco-2 cells were co-cultured with live or HK B. theta, 
HB101, L299v, LGG or E69 (MOI = 60), or IL-lp as a positive control. Post infection 
cell and bacterial co-culture supernatants were harvested and were evaluated by ELISA. 
Data shown is mean (+SD,*/+ P<0.05) induction of three independent experiments.
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6.2.1.4 Comparison of live versus heat killed bacterial infection on nuclear 
translocation of NF-kB subunit p65
To investigate whether there is any difference in the kinetics o f the IEC innate response 
between the live or HK stimulus, nuclear translocation o f the NF-kB subunit p65 was 
investigated via immunostaining (Section 2.16.2). Caco-2 cells were seeded onto glass 
cover slips (Section 2.7.2) and co-cultured with live or HK B. theta, HB101, L299v, 
LGG or E69. IL -lp is a known potent NF-kB activator and IL-lp stimulated cells were 
included as a positive control (Section 2.4).
In non-stimulated control cells, the p65 NF-kB subunit was sequestered in the 
cytoplasm o f the cell (Fig 6.7a top panel). However, within 15min of IL-lp stimulation 
p65 was found to be translocated into the nucleus (Fig 6.7a middle panel), with total 
nuclear localisation observed at 30min post-IL-lp exposure (Fig 6.7a bottom panel). In 
LGG HK stimulated cells, p65 was sequestered in the cytoplasm at 15min (Fig 6.7b top 
panel), however, within 30min o f stimulation a small level o f p65 was found to be 
translocated into the nucleus (Fig 6.7b middle panel), as was the case at 45min (Fig 6.7b 
bottom panel). This was also representative of the other species investigated, and at no 
point during this time course did the live stimulus induce translocation of p65 into the 
nucleus (data not shown). At 60min post-infection, with all HK bacteria, p65 
translocation had occurred (Fig 6.7c-g bottom panel). However, in cells exposed to live 
infection p65 remained sequestered in the cytoplasm at this time point (Fig 6.7c-g upper 
panel). Collectively, this suggests that there is a difference in kinetics between the HK 
and the live stimulus.
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(a)
Figure 6.7: Nuclear translocation of p65 NF-kB subunit determined by immuno­
fluorescence showing: a time course for IL -lp  (a), a time course for LGG HK (b), 
and Live LGG (c), L299v (d), B. theta (e), HB101 (f), and E69 (g) versus HK
stimulus at 60min. Caco-2 cells were stimulated with IL-ip for 15-30min or co­
cultured with live LGG, L299v, B. theta, HB101, and E69 (MOI = 60), or respective 
HK bacteria. Cells were then fixed and labelled with anti-NF-KB (p65) antibody and 
FITC-conjugated secondary antibody. Cells were imaged with Zeiss UV microscope 
40x or 1 OOx. Shown here is a representative of three separate experiments.
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6.2.2 Comparison of soluble bacterial products versus bacterial contact
As HK bacteria enhanced IL-8 and hBD2 mRNA expression (Fig 6.4-5), it is possible 
that heat killing may induce the release o f bacterial products, which have enhanced 
immuno-stimulatory ability. Furthermore, the relative importance o f bacterial adherence 
and secretion o f soluble bacterial products for induction of host immunity is not clear. 
Therefore, the importance of bacterial secreted products in these responses was 
investigated. DMEM activated bacterial log cultures (Section 2.2.3) were filtered 
(0.22pm) to remove whole bacteria and termed bacterial conditioned media (CM). 
Otherwise, the cultures were filtered with a centrifugal filter with a 30kDa cut off 
(Section 2.2.6). The low molecular weight fraction (LCM) was collected and studied for 
its immuno-stimulatory properties.
6.2.2.1 Modulation of constitutively expressed LL-37, hBDl and hBD3 by bacterial 
secreted products
The expression profile o f hBDl mRNA (Fig 6.8) differed to those of hBD3 and LL-37 
mRNA (Fig 6.9), who shared the same pattern of expression. However, the down- 
regulation o f hB D l, 3 and LL-37 observed with live LGG, L299v and E69 was not seen 
on incubation with the CM or LCM fraction, thus suggesting that the down-regulation 
could well be contact dependent (Fig 6.8-9).
6.2.2.2 Effect of bacterial contact on modulation of ‘inducible’ hBD-2 and IL - 8  
gene expression
Live LGG and its LCM induced hBD2 and IL-8 mRNA expression, with a significant 
increase in expression with the LCM; which may suggest a low molecular weight 
immune-stimulatory product (Fig 6.10). The CM of LGG did not induce hBD2 but did 
induce IL-8; however, no significant difference was noted compared to the live strain. 
Alternatively, this could suggest a higher molecular weight inhibitor. The live E69 
strain did not induce hBD2 mRNA expression, as was the case for the CM (Fig 6.10b); 
suggesting that contact is not important to these responses. Live E69 induced IL-8 but 
the CM had no effect, thus suggesting a requirement for host-bacterial contact (Fig 
6.10a). However, the LCM of E69 did induce IL-8, which was significantly increased in
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comparison to the WT. The expression profile for L299v was different to that of LGG 
and E69. Live L299v induced hBD2 and IL-8 mRNA expression, with the CM causing 
a significant increase in induction of both hBD2 and IL-8 compared to the live stimulus 
(Fig 6.10). Irrespective of the observed modulation of IL-8 mRNA expression, in 
response to either form of supernatant from LGG, L299v and E69, no IL-8 protein was 
detectable; thus implying that contact is essential for the production of IL-8 protein (Fig 
6.11).
6.23 Identity of the soluble bacterial products
Heat killing bacteria enhanced IL-8 and hBD2 mRNA expression in response to all 
species investigated in this study (Fig 6.4-5). In addition, bacterial CM appeared in 
some instances to show an enhanced or suppressed immune response in comparison to 
the live wild type strain. It was therefore of interest to identify the secreted products 
responsible. Although the bacterial products were not investigated in detail within this 
study, as a preliminary investigation, bacterial conditioned culture medium was 
fractionated below 30kDa and the CM and LCM were compared for differences in 
immuno-modulatory properties (See Table 6.1).
6.23.1 Identity of the immuno-stimulatory soluble products
LGG LCM, but not the CM, induced hBD3, LL-37, hBD2 and IL-8 mRNA. In addition, 
the E69 LCM, but not the CM, induced expression of hBD l-3, LL-37 and IL-8 mRNA. 
Thus, an immuno-stimulatory soluble product(s) < 30kDa is produced by LGG and E69. 
An alternative explanation could be removal of this product or presence o f an inhibitory 
molecule(s) in the higher molecular weight fraction. L299v CM induced expression of 
hBD2-3, LL-37 and IL-8 mRNA, however, the L299v LCM fraction induced only IL-8 
mRNA expression. This would imply the release of at least two stimulatory products by 
L299v one >30kDa and a less stimulatory lower molecular weight product.
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hBD1 16h
Non Stimulated LGG L299v E69 IL-10
Figure 6.8: Effect of bacterial conditioned media on modulation of hBDl gene 
expression. Caco-2 cells were either co-cultured with E69, L299v or LGG (MOI = 60), 
or stimulated with CM or the LCM fraction from these species, or IL-lp as a positive 
control. Gene expression 16h post-infection was determined and normalised to 
GAPDH. Variations in mRNA levels are expressed as fold induction compared to the 
uninfected control cells. Data shown is mean (+SD,*/+ P<0.05) induction of three 
independent experiments.
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Figure 6.9: Effect of bacterial conditioned media on hBD3 (a) or LL-37 (b) gene 
expression. Caco-2 cells were either co-cultured with E69, L299v or LGG (MOI = 60), 
or stimulated with CM or the LCM fraction from these species, or IL-lp as a positive 
control. Gene expression 16h post-infection was determined and normalised to 
GAPDH. Variations in mRNA levels are expressed as fold induction compared to the 
uninfected control cells. Data shown is mean (+SD,*/+ P<0.05) induction of three 
independent experiments.
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Figure 6.10: Effect of bacterial conditioned media on modulation of HBD2 (a) and 
IL-8 (b) gene expression at 16h. Caco-2 cells were either co-cultured with E69, L299v 
or LGG (MOI = 60), or stimulated with CM or the LCM fraction from these species, or 
IL-ip as a positive control. Gene expression 16h post-infection was determined and 
normalised to GAPDH. Variations in mRNA levels are expressed as fold induction 
compared to the uninfected control cells. Data shown is mean (+SD,*/+ P<0.05) 
induction of three independent experiments.
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Figure 6.11: Effect of bacterial conditioned media on production of IL-8 at 16h.
Caco-2 cells were either co-cultured with E69, L299v or LGG (MOI = 60), or with CM 
or the LCM fraction from these species, IL-lp was used as a positive control. 16h post­
infection cellular supernatants were harvested and were evaluated by ELISA. Data 
shown is mean (+SD,*/+ P<0.05) induction of three independent experiments.
6.2.3.2 Identity of the immuno-inhibitory soluble products
In the case of LGG and E69 there was a statistically significant suppression of IL-8 
protein in comparison to the level noted with non-stimulated, control cells. Specifically, 
the CM and the LCM of LGG as well as the LCM of E69 suppressed IL-8 protein 
expression. This would suggest that LGG may have more than one inhibitory soluble 
product; one above 30kDa and one below. It would also appear that the 
immunosuppressive soluble product of E69 is <30kDa and that this product is either 
diluted in the higher molecular weight fraction or that no stimulatory molecule is 
present in this fraction.
IL-8 (pg/ml)16h
■ Live DCM BLCM
IL-lp = 5789.1
*
i
*  *
Non Stimulated LGG L299v
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Constitutive Inducible
hB D l
mRNA
hBD3
mRNA
LL-37
mRNA
hBD2
mRNA
IL-8
mRNA
IL-8
Protein
LGG
Live J 1 11 T *
HK -- -- 1- T 1
CM -- - - .- j 1 1\
LCM -- 11 11 1 1I !1
L299v
Live Ji 1I 11 1 s 1
HK _ - _ - i E
CM -- 11 11 i --
LCM
- - _- - ■ E
E69
Live -1 iI I1 - • 11 1
HK - I “ t i -I
CM -- -I -- _. m 1
LCM 1 I 11 i 1 11
Table 6.1: Summary of the immuno-modulatory effect of HK or soluble bacterial 
products. |  represents induced expression above the constitutive level, |  represents 
reduced expression bellow the constitutive level and (  represents no difference in 
expression compared to the constitutive level.
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6.3 Discussion
It was previously reported (chapter 5) that hBDl, 3 and LL-37 decreased on bacterial 
exposure. The first aim of this chapter was to clarify if the observed bacterial 
modulation of IEC responses required intact viable organisms. For this purpose, 
responses to live bacteria were compared to that of HK bacterial stimuli. Earlier work in 
chapters 3 and 5 also suggested that IL- 8  and hBD2 mRNA was induced in response to 
recognition of external bacterial structures and/or secreted products, and was not 
dependent on bacterial contact, in contrast to IL- 8  peptide that did require contact. The 
second aim was to investigate the potential role of bacterial secretion products on IEC 
immunity. The importance of bacterial secreted products was investigated by 
stimulating with sterile bacterial conditioned culture medium (CM).
The down-regulation observed in hBDl, 3 or LL-37 mRNA seen with live LGG, L229v 
and E69 was not apparent during infection with HK bacteria (Fig 6.1-3). Thus, both 
probiotic and pathogenic bacteria actively modulate the in vitro IEC innate immune 
response. In addition, on stimulation with CM or LCM fraction no suppression of gene 
expression was noted, suggesting that down-regulation required the presence of bacteria 
and further suggesting contact dependence (Fig 6.8-9). In support of this data, it has 
been reported that live L. reuteri, dose-dependently inhibits constitutive synthesis of IL- 
8  and that only live, adherent L. reuteri are able to have these effects (Ma et al. 2004). 
As mentioned previously, various strains have been shown to actively modulate the 
immune response in a contact dependent manner, by modulating NF-kB (Hauf & 
Chakraborty 2003, Kelly et al. 2004, La Ferla et al. 2004, Maresca et al. 2005, Sharma, 
Tesfay et al. 2006, Ruchaud-Sparagano et al. 2007).
In contrast, the commensal B. theta actively induced AMP gene and IL- 8  protein (Fig 
6.3-6). Live B. theta induced a statistically significant increase in hBD3 and hBD2 
mRNA, which was reduced with heat killing. Thus, suggesting that B. theta is actively 
inducing hBD2 and 3. B. theta may have evolved this capacity to induce hBD2 and 
hBD3 in order to kill off other bacteria that are likely to compete for both nutrients and 
space. At present, it is not known if B. theta itself is susceptible to hBD2 and 3. Live B. 
theta and E69 induced the greatest IL- 8  protein response; which was also reduced with 
heat killing. This suggests that these strains are actively inducing IL-8 . Interestingly, La
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Ferla et al. found that commensal E. coli strains from some IBD patients were able to 
activate NF-kB but HK preparations of these strains were not (La, Seegert et al. 2004). 
Although commensal species such as E. coli and B. theta and the pathogen E69 could 
evolve to activate NF-kB, why they should is not yet clear. Another possibility however, 
is that heat killing alters the stimulus in some way that makes it less stimulatory or may 
even induce the release of an immunosuppressive factor such as DNA (Rachmilewitz et 
al. 2002). Thus, commensals, depending on inoculum and length of exposure, are also 
able to actively modulate the innate immune response in vitro and can parallel the IL- 8  
pathogenic responses of E69.
In contrast, LGG and HB101 showed the least IL- 8  production and heat killing 
increased this (Fig 6 .6 ). Thus, suggesting that these species were actively suppressing 
IL-8 . Alternatively, with heat killing, the bacteria are altered in some way, which 
enhances their potential to stimulate release of IL-8 . There was no difference observed 
between either live or dead stimulus in the case of L299v; implying that this strain of 
bacteria is not actively modulating IL- 8  expression, and that whatever the epitope the 
host cell recognises is not altered by heating.
All species investigated, within this study, induced hBD2 and IL- 8  mRNA expression 
(Fig 6.4-5); and the later response was further enhanced by heat killing. This may 
suggest that heat treatment releases previously masked molecules that have the ability to 
modulate innate immune responses. At 8 h there was a significant difference in hBD2 
expression between the live versus HK preparations, with HK giving a great induction. 
However, by 16h, except for B. theta, no significant difference in hBD2 induction with 
either form of stimulus was observed. Thus, suggesting that the early kinetics of 
immune regulation differ, with the HK stimulus being more rapid, this was further 
confirmed by differential activation of NF-kB (Fig 6.7).
For the induction of IL- 8  and hBD-2 mRNA bacterial contact had minimal effect and 
was more dependent on the external bacterial structures. In contrast, release of IL- 8  
protein was found to be dependent on bacterial contact, suggesting post-translational 
regulation of IL- 8  is distinct from its transcriptional control. As irrespective of the IL- 8  
mRNA levels observed, no IL- 8  protein was detectable when supernatants from LGG, 
L299v and E69 were used for co-cultures experiments (Fig 6.11).
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Others have previously suggested that additional translational IL- 8  regulation may 
occur (Yu & Chadee 1998, Muegge 2002, Yu et al. 2003, Ma et al. 2004, Fyfe et al. 
2005, Zhu & Tan 2005, Ito 2007). Regulation of translation may provide a means to 
boost translation rates. Thus, enabling recruitment of neutrophils as soon as possible 
once a pathogen is detected. Conversely, it may be critical to switching off IL- 8  
production more rapidly than would be possible for a gene whose expression was 
controlled solely at the transcriptional level. Such rapid control would appear to prevent 
systemic infection and the uncontrolled inflammation that characterises some chronic 
diseases. An alternative possibility is that IL- 8  protein is produced but secretion is 
inhibited by regulatory signalling mechanisms as previously reported (Netsch et al. 
2006). It may be plausible that recognition of external bacterial products such as flagella 
sends a danger signal to the cell, which primes the cell to respond so it induces mRNA 
expression ready to be able to induce protein expression. However, for the production of 
the protein to occur a second danger signal is required to override the post-translational 
or secretion inhibition regulation. This second confirmation of the danger signal is due 
to bacterial contact. Adherence to epithelial cells, together with the secretion of 
virulence associated proteins, has been reportedly required for IL- 8  production by 
epithelial cells (Eaves-Pyles et al. 1999, Gewirtz et al. 1999).
In support of the data presented, Savkovic et al. found that filter sterilised EPEC 
bacterial culture medium, which could potentially contain released LPS, had no effect 
on PMN transmigration and thus IL- 8  release (Savkovic et al. 1996). Otte & Podolsky 
showed no IL- 8  protein was released during infection with live probiotic mixture and its 
conditioned medium (Otte & Podolsky 2004). Furthermore, cell debris from gram 
positive LGG, L299v, other Lactobacilli and Bifidobacterium species isolated from 
VSL#3 did not induce IL- 8  (Lammers et al. 2002). Zhou et al. found supernatant from 
wild-type E69 grown in LB broth did induced IL- 8  expression, but not when bacteria 
were grown in DMEM (Zhou et al. 2003).
LGG and E69 appear to release a soluble product that is able to down-regulate IL- 8  
protein expression (Fig 5.11). In corroboration, another study suggests that VSL#3 
conditioned medium can inhibit NF-kB activation and thus innate responses (Petrof et 
al. 2004). In addition, probiotic Saccharomyces boulardii produces an anti­
inflammatory factor which inhibits NF-kB and IL- 8  in IECs (Sougioultzis et al. 2006).
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Native bacterial DNA, derived from VSL3 also has suppressive properties although 
variable amoung the species (Jijon et al. 2004). Indeed, studies indicate that DNA 
sequences can directly inhibit signal transduction pathways depending on the sequence 
and backbone structure (Balias et al. 2001, Chen et al. 2001, Kerkmann et al. 2003). 
Thus, it could be plausible that the suppression of immune responses seen with bacterial 
soluble products or the reduction in IL- 8  protein observed with heat killing could in fact 
be due to bacterial DNA. Indeed, early administration of CpG-ODNs or probiotic 
bacterial DNA actually reduces the severity of experimental colitis (Obermeier et al. 
2002, Rachmilewitz et al. 2002, Obermeier et al. 2003, Rachmilewitz et al. 2004, 
Backer et al. 2004).
In contrast, some external or secreted bacterial factors induced innate responses. L299v 
induced a statistically significant increase in expression of hBD3 and LL-37 mRNA and 
this appears to be due to a bacterial product that is >30kDa (Fig 6.9), which may be heat 
stable as HK L299v also induced expression of hBD3 mRNA (Fig 6.3a). In the case of 
IL- 8  and hBD2, L299v induces secretion via bacterial products >30KDa and <30KDa 
(Fig 6.10). LGG secretes products <30kDa, which induce hBD2-3, LL-37 and IL- 8  (Fig 
6.9 and 6.10). LGG also secretes a product(s) >30KD, which induces IL- 8  mRNA (Fig 
6.10b). E69 appears to induce hBD2 and IL- 8  mRNA, via a soluble product <30KD 
(Fig 6.10).
IL- 8  mRNA expression was further enhanced by HK at 8  and 16h (Fig 6.5). At 8 h, HK 
preparations increased induction in hBD2 (Fig 6.4a). In addition, HK increased IL- 8  
production by LGG and HB101 (Fig 6 .6 ). As previously suggested, heat treatment may 
release previously masked molecules that have the ability to modulate innate immune 
responses. Indeed, the kinetics of NF-kB translocation was more rapid with the HK 
stimulus (Fig 6.7). Others have reported that HK Lactobacillus or their cell wall 
fractions and/or soluble factors can effectively stimulate IECs (Perdigon et al. 1986, 
Davidkova et al. 1992, Sasaki et al. 1994, de Ambrosini et al. 1996, Miettinen et al. 
2000, Lammers et al. 2002, Kirjavainen et al. 2003, Matsuguchi et al. 2003, Pena & 
Versalovic 2003, Jijon et al. 2004, Petrof et al. 2004, Iliev et al. 2005, Zhang et al. 2005, 
Wong & Ustunol 2006, Lin et al. 2007).
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Thus, it would be of interest to further characterise the responses observed in this study. 
Some authors have found flagella to be the soluble factor responsible for innate IEC 
responses to commensal and probiotic bacteria (Ogushi et al. 2001, Zhou et al. 2003, 
Schlee et al. 2007, Wehkamp et al. 2007). Yet, Vora et al. demonstrated that LPS and 
PGN stimulated hBD2 expression by IECs (Vora et al. 2004). Alternatively, L. 
pi ant arum -pur i fi ed LTA is found to be pro-inflammatory and this response is TLR2- 
dependent (Grangette et al. 2005). LTAs from pathogenic gram-positive bacteria have 
been shown to induce activation of NF-kB and cytokine production such as IL- 8  
(Bhakdi et al. 1991, Mattsson et al. 1993, Standiford et al. 1994, Schwandner et al. 
1999, Takeuchi et al. 1999, Dziarski & Gupta 2000, Wang et al. 2000).
An alternative bacterial product that could be inducing the increase in IL- 8  production 
on heat killing could be heat shock proteins (HSPs). Most cells and organisms react to 
heat and a variety of stresses, by rapid synthesis of a group of evolutionary conserved 
proteins, ranging in size from 8 kD to 150kD (Wu 1995, Ovelgonne et al. 2000, Malago 
et al. 2002). Surprisingly, HSPs from different bacterial species as well as those of 
mammals are known to stimulate cells of the immune system (Ohashi et al. 2000, Kol et 
al. 2000). The GroEL protein of Lactobacillus johnsonii Lai (NCC 533) is present at the 
bacterial surface and can be detected in bacterial spent culture medium. Lai rGroEL 
stimulates IL- 8  secretion in HT29 cells in a CD 14-dependent mechanism (Bergonzelli et 
al. 2006). Interestingly, the induction of pro-inflammatory cytokines by Hsp60 and 
Hsp70 has been suggested to contribute to the pathogenesis of chronic inflammation 
(Wallin et al. 2002, Pockley 2003, Tsan & Gao 2004).
Bacterial DNA is another well-known pro-inflammatory molecule that acts through 
TLR9 (Hemmi et al. 2000, Krieg 2002, Obermeier et al. 2002, Kobayashi et al. 2003, 
Obermeier et al. 2003, Strober 2004). Caco-2 cells constitutively express TLR9 mRNA 
(Akhtar et al. 2003) and after exposure to E. coli DNA increase in IL- 8  mRNA and IL- 8  
synthesis in a time and dose-dependent manner (Akhtar et al. 2003, Sharma et al. 2006). 
In addition, chromosomal DNA from LGG is a potent inducer of cytokine production in 
mice and human immune cells (Iliev et al. 2005).
In summary, probiotic and pathogenic bacteria actively modulate the in vitro IEC innate 
immune response. In addition, commensals, depending on inoculums and length of
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exposure, are also able to actively modulate the innate immune response in vitro and 
can parallel the IL- 8  pathogenic responses of E69. It would appear that the probiotic 
species L299v and LGG as well as the pathogenic strain E69 are all able to modulate the 
host innate immune response in vitro via two mechanisms. The mechanisms are, down- 
regulation of AMPs via a contact dependent mechanism, and a non-contact-dependent 
modulation of the host immune response via secreted bacterial products, which works in 
synergy with the contact dependent down-regulation. In support, LGG has been 
reported to prevent cytokine-induced apoptosis in epithelial cells via two mechanisms 
working in synergy, one via a contact mediated inhibition and the other response is via a 
soluble factor produced by LGG (Yan & Polk 2002b). Bacterial products could either 
suppress or induce immune responses. However, the specific factors responsible remain 
unknown and it would be of significant interest to further characterise them. As 
previously postulated, for the induction of IL- 8  and hBD2 mRNA bacteria had minimal 
effect and induction was more dependent on external bacterial structures. In contrast, 
release of IL- 8  protein was found to be dependent on bacterial contact. Thus, suggesting 
post-translational regulation of IL- 8  is distinct from its transcriptional control.
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CHAPTER 7: Epithelial cell
development as a host determinant of 
the response to bacteria
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7.1 Background
7.1.1 Evolution of host-microbe relationship in the gut
Immense selective pressure at the host-bacterial interface means that both the host and 
bacteria have evolved numerous ways in which to interact (Aldridge et al. 2005). This 
interaction is termed “microbial-epithelial crosstalk” (Bloom & Boedeker 1996, 
Hromockyj & Falkow 1999). However, innate immunity is the evolutionary product of 
host-microorganism encounters (Finlay & Falkow 1997, Casadevall & Pirofski 2000, 
Medzhitov & Janeway, Jr. 2000, Ozinsky et al. 2000b). Microbes have also co-evolved 
many ways to evade the host immune system. Microbial pathogenesis therefore, is the 
outcome o f these interactions that can range from elimination of the microbe to the 
death o f the host, encompassing states of latency, colonisation, and commensal ism 
(Casadevall & Pirofski 2003). Investigators of microbial pathogenesis must therefore 
consider both the host and the microbe variables in any experimental system 
(Casadevall & Pirofski 2000).
7.1.2 Differentiation as a host variable that alters the outcome of a host-microbe 
interaction
As described previously in section 1.2, in the small intestine, stem cell descendants 
undergo several rounds o f cell division; thus, creating a pool of cells that transit from 
proliferative, undifferentiated crypt stem cells to mature differentiated surface villus 
epithelial cells along the crypt-villus axis (Leblond 1981, Trier & Madara JL 1981, 
Potten & Loeffler 1990). At the villi apex, villus epithelial cells are shed in an apoptotic 
process called ano’ikis (Lotz et al. 2007). Several studies have shown that epithelial cell 
migration from the crypt base to the surface is accompanied by cellular differentiation, 
which involves substantial changes in cellular morphology, growth, proliferation, and 
biochemical marker expression (Louvard et al. 1992, Zweibaum et al. 1991). For 
instance, lactase-phlorizin hydrolase and maltase-glucoamylase complexes, which are 
markers o f functional enterocytes in the developing and adult small intestine, 
respectively, are restricted to the villus; the proliferating antigen Ki67 and the specific 
secretory granule marker MIM-1/39 are expressed only by crypt cells (Fig 7.1) 
(Louvard, Kedinger, & Hauri 1992) & (Menard & Beaulieu 1994).
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Ki67 p21 MIM39 DP DS
Figure 7.1: Expression of enterocyte functional markers. p21 (cyclin-dependent 
kinase inhibitor) DP (Dipeptidases), DS (Disaccharidases) (Pageot et al. 2000)
Comparatively little is known about the alteration of immunological functions of these 
cells during epithelial differentiation. As there are differences in the ability of some of 
these cell types to recognise microbial ligands, depending on their stage of 
development, it is suggested that they are likely to exhibit different immune capacities 
(Suzuki et al. 2003). For example, PRRs exhibit varied expression at different 
anatomical locations of the GI tract. TLR5 is selectively expressed by the surface 
epithelium but not the crypt epithelium (Cario & Podolsky 2000). TLR4 expression has 
been noted at the apical pole of differentiated lECs in culture (Cario et al. 2002). 
Furthermore, TLR4/MD-2 is located in IECs of the intestinal crypts in the small 
intestine with stronger expression in colon segments, where TLR4/MD-2 is strongly 
expressed on the apical surface of the epithelial cells. CD 14 is also expressed in IECs 
located in the bottom of the crypts of the distal small intestine and colon. Ortega- Cava 
et al. speculate that these findings may reflect a strategy of the mucosal innate immune 
system to simplify the task of sensing the gut bacterial content (Ortega-Cava et al. 
2003). By restricting PRRs to the crypt base, this micro-anatomical niche is likely to 
function distinctly from the more microbially exposed villus.
DIFFERENTIATING
Page 290
So far in all the studies described in this thesis, the variable o f interest has been the 
microbe. However, in this chapter the aim was to investigate the ‘host’ as a variable. By 
comparing the immune response of different cell types, as well as cells in different 
differentiation states, to specifically characterize the alteration of immunological 
functions o f cells during epithelial differentiation and thus differences along the crypt- 
villus axis.
7.1.3 Comparison of the innate immune response of different cell models
To investigate the differences in response in different cells the Caco-2 and HEp-2 cell 
lines were used. The HEp-2 cell line was established from the larynx (Moore et al. 
1955); which has a squamous epithelial cell lining, similar to that of the oral cavity and 
the oesophagus (Underwood 2000). This epithelial cell line has been used as a model 
for oesophageal epithelia (Chen & Jiang 2004). In addition, HEp-2 cells are widely used 
as a model system to study the adhesion properties of human bacterial enteropathogens 
(Ismaili et al. 1999). HEp-2 cells do not polarise when confluent and have a limited 
number o f microvillus-like processes on the surface, unlike Caco-2 cells (see below).
Caco-2 cells are a “colonic” tumour-derived cell line that form a confluent monolayer 
and at confluence display characteristics of “colonocytes”. However, over a period of 
20-40 days o f post-confluent culture, the cells differentiate into a polarised monolayer 
with properties o f “foetal ileal enterocytes”, including altered morphology with 
junctional complexes; production o f microvilli with the development of a typical brush 
border; increased expression o f small intestinal-specific gene products such as brush 
border hydrolases, including sucrase-isomaltase (Pinto et al. 1983, Hauri et al. 1985, 
Hidalgo et al. 1989, Matsumoto et al. 1990, Engle et al. 1991, Vachon & Beaulieu 1992, 
Hara et al. 1993, Engle et al. 1998, Goetz, & Alpers 1998).
A study o f the expression o f both enterocyte and colonocyte proteins during Caco-2 cell 
differentiation, on plastic, demonstrated a general decline of colonocyte markers from 
day 3 until day 18 after confluence (Engle et al. 1998). In addition, proteome analysis of 
plastic cultured Caco-2/ATCC cells confirmed that changes in protein expression during 
differentiation represent a shift from a tumoral colonic phenotype towards a more 
“normal” small intestinal phenotype (Stierum et al. 2003).
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The issue o f expression of small intestinal characteristics, such as sucrase-isomaltase 
and lactase in cell lines established from the colon, has been addressed in detail. The 
conclusion is that these cells exhibit similar features to those found in the human foetal 
intestinal epithelium, which before 20-22 weeks, is similar in both small intestine and 
the colon (Menard & Beaulieu 1994, Rousset 1986, Zweibaum & Chantret 1989). Thus, 
confluent Caco-2 cells (Day 7) were used to represent undifferentiated colonic/ileal 
precursor epithelial cells and polarised Caco-2 cells (Day 14+) were used to represent 
differentiated “ileal-like” epithelial cells.
7.1.4. Cell model to recapitulate the crypt-villus axis
To investigate the differential immune responses along the crypt-villus axis a model 
system described by Pageot et al. using different human cells to recapitulate the crypt- 
villus axis was utilised (Pageot et al. 2000). Primary human intestinal epithelial cells 
(HIEC) represent the lower crypt, and Caco-2 cells, in different differentiation states, 
represent from the crypt-villus junction up to the villus tip (Fig 7.2).
HIECs were isolated from foetal small intestine with typical crypt cell proliferative 
characteristics (Perreault & Beaulieu 1996). The HIEC exhibit an apparently non­
committed and undifferentiated epithelial morphology (Pageot et al. 2000). Pageot et al. 
confirmed their epithelial origin by identification of intestinal keratins 8, 18, 19, and 
20/21 as well as components specific for desmosomes and tight junctions (Pageot et al. 
2000). Analysis of the expression of intestinal functional markers provided further 
evidence o f the undifferentiated nature o f the HIEC. Indeed, these cells retain the ability 
to express the 350kDa crypt cell-specific marker MIM-1/39 (Beaulieu et al. 1992, 
Calvert et al. 1993); in addition to the brush border hydrolases aminopeptidase N and 
dipeptidylpeptidase IV, but not sucrase-isomaltase (Perreault & Beaulieu 1996). The 
lack o f sucrase-isomaltase at both the protein and transcript levels (Quaroni & Beaulieu 
1997) in concert with poorly morphological enterocytic differentiation features is 
indicative of the non committed nature of these crypt-like cells. Therefore, HIEC 
behave as stem-like cells representative of the bottom of the crypt (Pageot et al. 2000).
As described above (7.1.3) as Caco-2 cells differentiate they mature to become a 
polarised monolayer with properties of “ileal” epithelial cells. Therefore, Caco-2 cells 
can be used as a model to represent the crypt-villus junction on confluence (Day 7 in
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this study) up to the villus tip on full morphological polarity (Day 21 in this study) 
(Pageot et al. 2000).
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Figure 7.2: Description of host cell model system (Pageot, Perreault, Basora, 
Francoeur, Magny, & Beaulieu 2000). (a) Intestinal cell models that allow the 
recapitulation of the crypt-villus axis of the human small intestine (b) Summary of the 
properties of the various intestinal cell models as compared to the foetal intestinal 
epithelium.
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7.1.5 Differentiation causes down-regulation of IL-lp mediated NF-kB and IL - 8  
expression
There is an increasing evidence to suggest that cellular differentiation along the crypt- 
villus axis alters the pro-inflammatory responsiveness of IECs (Bocker et al. 2000). For 
example, some indirect evidence suggests that only undifferentiated proliferating rat 
colonic crypt epithelial cells are capable of producing IL-lp (Radema et al. 1991). In 
addition, IEC differentiation inhibits Yersinia pseudotuberculosis invasion of Caco-2 
cells due to the redistribution of a bacterial cell receptor, which occurs during the 
process o f cellular differentiation (Coconnier et al. 1994). Immuno-histochemistry 
performed on tissue sections derived from patients with active IBD demonstrates the 
presence o f activated NF-kB in the crypt epithelial cells but not in the surface region 
(Rogler et al. 1998). It has been reported that spontaneous or sodium butyrate-induced 
epithelial cell differentiation inhibits IL-ip induced IL-8 gene expression in Caco-2 
cells (Huang et al. 1997, Huang & Wu 1997). Similarly, cyclosporine A, which 
stimulates cell differentiation, inhibited IL-8 secretion in HT-29 cells (Mengheri et al. 
1996, Saitoh et al. 1997). In addition, Bocker et al. report a strong decrease of IL-lp- 
induced JNK and IKK activity that correlates with reduced NF-kB DNA binding 
activity and subsequently, reduced IL-8 gene expression in methotrexate differentiated 
HT-29 cells (HT-29/MTX) compared with undifferentiated cells of the same lineage. 
Cellular differentiation specifically inhibits the IL-lp signalling pathway as on 
stimulation with TNF-a or phorbol myristate acetate (PMA) IL-8 expression remains 
normal in the differentiated cells. However, TRAF-6 over expression triggers a strong 
induction o f a icB-luciferase reporter gene in HT-29/MTX cells, indicating that 
downstream components o f the IL-ip signalling cascade can be activated in these 
differentiated cells if appropriately stimulated; so inhibition is likely upstream of JNK 
but downstream of IL-1 receptor in HT-29 cells (Bocker et al. 2000).
7.1.6 Differentiation cause attenuation of LPS response
Bocker and colleagues found that HT-29 cells were responsive to LPS but Caco-2 cells 
were not. Differentiation o f HT-29 cells resulted in a reduction in LPS responsiveness 
and as Caco-2 cells differentiated they retained unresponsiveness to LPS (Bocker, 
Schottelius, Watson, Holt, Licato, Brenner, Sartor, & Jobin 2000) & (Bocker et al. 
2003). They found that HT-29 cells and Caco-2 cells constitutively expressed CD 14 but 
that permanently differentiated HT-29 cells did not. However, unresponsiveness of
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Caco-2 and the errantly differentiated HT-29 cells still persisted in the presence of 
soluble CD 14. Furthermore, that Caco-2 and the permanently differentiated HT-29 cells 
did not express TLR4 but undifferentiated HT-29 responsive cells did (Bocker et al. 
2003). However, Bocker and colleagues analysed primary IECs, which had been 
isolated and cultivated, and found that they contained transcript for CD 14 and TLR4 
(Bocker U et al. 2002). Butyrate, a short-chain fatty acid produced by bacterial 
metabolism, induces transient differentiation of IECs (Bocker et al. 1998). Treatment of 
responsive HT-29 cells with butyrate reduced TLR4 transcript levels (Bocker et al. 
2003). In addition, differentiation induced by treatment of HT-29 cells with 
methotrexate (MTX) down-regulates TLR4 expression (Bocker et al. 2003). More 
recently, Lee et al. confirmed that HT-29 cells, but not Caco-2 cells are responsive to 
LPS stimulation and that differentiation down-regulates TLR4 expression and LPS 
response; using different methods to Bocker et al. of sodium butyrate differentiation of 
HT-29 cells or post-confluence culture o f HT-29 cells (Lee et al. 2005, Bocker et al. 
2003). In addition, Lee et al. found that pre-treating HT-29 cells with TNFa or IFNy 
augmented LPS-induced IL-8 secretion and TLR4 expression. This enhancement of the 
LPS response and TLR4 expression were strongly down-regulated by differentiation, 
which suggests that differentiation down-regulates TLR4 expression and LPS response 
in normal steady state and inflammation (Lee et al. 2005).
Moreover, Cario and colleagues found that the expression and localization of TLR4 in 
T84 cells and LPS responsiveness was dependent on the state o f differentiation of these 
cells. TLR4 was present in the apical surface of differentiated T84 cells yet in non­
differentiated T84 cells, where TLR4 was mostly present in the cytoplasm and these 
non differentiated cells were unresponsive to LPS. In polarised cells, on stimulation 
with LPS, TLR4 trafficking was induced with TLR4 redistribution to cytoplasmic 
compartments near the basolateral membrane. This process only happened 24h after 
stimulation, where only minimal redistribution of TLR4 was detected after apical 
stimulation with LPS. In contrast, significant amounts of TLR4 scattered to cytoplasmic 
compartments when LPS was applied only to the basolateral chamber. Staining with 
lysosome tracker red suggested that the LPS was located in lysosomes (Cario et al. 
2002).
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In addition, lipid binding protein (LBP) has been shown to participate in the uptake of 
LPS aggregates by phagocytosis without subsequent cellular activation. This occurs by 
forming a ternary complex with LPS bound to LBP, which binds to membrane CD 14 
(Gegner et al. 1995). It has been demonstrated that the largest amount of LPS taken up 
from enterocytes was found in more differentiated IECs near the villus tip rather than in 
crypts (Ge et al. 2000). Furthermore, evidence exists to suggest that the stage of 
differentiation determines subsequent trans-cellular transport processes for LPS (Beatty 
& Sansonetti 1997).
The finding that cellular differentiation modulates IEC responsiveness to LPS has 
important biologic and clinical implications. It is hypothesised that pro-inflammatory 
responsiveness o f IECs decreases along the crypt-villus axis, representing a mechanism 
whereby IECs protect themselves against dysregulated immune and inflammatory 
response to commensal bacteria and their products (Bocker et al. 2003, Lee et al. 2005).
Furthermore, in vitro the sub cellular expression of IL-8 in IEC changes along the crypt- 
villus axis. It is interesting to note that while the expression is both basolateral and 
apical in crypt cells, it becomes predominantly apical as cell differentiate and migrate 
toward the villus tip (Louvard et al. 1992). Basolateral expression o f proteins has been 
clearly equated with secretion in IECs, whereas apical expression can be associated with 
both passive uptake/adsorption as well as secretion (Rindler & Traber 1988, Appel & 
Koch-Brandt 1994). Maheshwari et al. observed a dual staining pattern in the crypt cells 
consistent with the hypothesis that IL-8 is actively secreted in this region (Maheshwari 
et al. 2004). Direct measurements from polarised Caco-2 monolayers also show a 
similar dual secretory pattern with basolateral predominance. The expression of IL-8 
receptors provides further evidence for this phenomenon, as both CXCR1 and CXCR2 
are also expressed predominantly on the basolateral aspect of these cells, which is the 
same as the site o f secretion of their ligand. These findings are consistent with an 
autocrine role o f IL-8 in these cells (Maheshwari et al. 2004). In mid-villus and villus- 
tip cells, the basolateral immunoreactivity is progressively lost, which is consistent with 
in vitro evidence that differentiation leads to diminution in IL-8 production in IEC 
(Bocker et al. 2000, Maheshwari et al. 2004). It is likely that apical staining in this 
region is secondary to the uptake/adsorption from the luminal contents of the intestine. 
Notably, as these cells migrate toward the villus-tip, the receptor expression also
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becomes progressively more apical, with simultaneous loss of basolateral staining. This 
reversal o f receptor expression would allow the uptake of IL-8 from the intestinal 
contents in the villus-tip region (Maheshwari et al. 2004).
7.2 Results
7.2.1 Investigation of morphological changes of Caco-2 cells over time
The morphological changes that occur as Caco-2 cells differentiate over time were 
investigated. This was to confirm that Caco-2 cells developed brush border like villi 
upon polarization. Caco-2 cells were seeded onto glass coverslips, incubated for 14 days 
(Section 2.7.2) and processed for SEM at regular intervals (Section 2.15). At day 7, the 
cells had formed a confluent monolayer. The cells did not display a polarised 
morphology and were smooth with no microvilli present. By day 11, cells were a fully 
confluent monolayer and the cells displayed a polarised morphology with microvilli 
present (Fig 7.3a). At day 14, a dense brush border of microvilli had developed (Fig 
7.3b). In subsequent experiments, Caco-2 cells were used at day 7 (classed as confluent) 
in order to represent undifferentiated colonic/ileal precursor epithelial cells. Day 14 
cells, (classed as differentiated) were used to represent “ileal-like” epithelial cells.
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Figure 7.3 SEM of Caco-2 cell monolayers at day 11 (a) and 14 (b). Caco-2 cells 
were grown on glass coverslips, processed for SEM and examined using a JEOL JSM 
5300 SEM at an accelerating voltage of 25kV. Each time period was conducted in 
triplicate the picture shown is representative.
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7.2.2 Comparison of innate mucosal responses in different cell models
To investigate the effect o f ‘host’ determined factors, the immune responses of different 
cell types to the same stimuli was investigated. Specifically, responses of confluent 
Caco-2 cells (C-Caco-2), differentiated, “ileal-like” Caco-2 cells (D-Caco-2) and HEp-2 
cells to IL -lp and E69 were compared. Caco-2 cells were seeded and incubated for 7 or 
14 days which resulted in confluent or polarised monolayers respectively (Section 
2.7.1.1). HEp-2 cells were seeded and were incubated for 48h which resulted in 
monolayers at 70-80 % confluence (Section 2.7.1.1). Cells were then co-cultured with 
IL -ip  or E69 (MOI = 60) for 30min to 16h (Section: 2.7). Initially, differences in 
activation o f the NF-kB subunit p65 in the different cell types were investigated by 
TransAM™ NF-kB ELISA (Section 2.14). The data shows fold induction in the levels 
o f translocated activated p65. This is in comparison to the levels in respective control, 
non-stimulated cells (shown by the red dotted line). Polynomial trend lines are shown 
by the black dotted lines.
The different cell types produced 2 waves of activated NF-kB subunit p65 translocation, 
with both the IL -lp  and E69 stimulus (Fig 7.4). In the case of HEp-2 cells, the initial 
peak o f translocation for the IL -lp  stimulus was at 30min and this initial wave had 
declined by 3h (Fig 7.4a). At this time the HEp-2 cells displayed the most potent 
induction o f NF-kB translocation. A second wave of NF-kB translocation occurred 5h 
to 6h post-stimulus, later time points were not investigated. In the case of C-Caco-2, 
similar to HEp-2 cells, an initial peak o f translocation for the IL-lp stimulus was also 
seen at 30min and this initial wave had declined by 3h (Fig 7.4a). A second more 
pronounced wave o f NF-kB translocation was seen at 4 to 5h, which had declined by 
6h. The D-Caco-2 cells showed an initial peak of IL-lp mediated p65 translocation at 
lh , and this wave had declined by 2 to 3h. However, a second wave of significant 
induction of NF-kB was not observed (Fig 7.4a).
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Figure 7.4: Kinetics of NF-kB Subunit p65 DNA-binding activity in EPEC infected 
HEp-2 cells, confluent and differentiated Caco-2 cells. Cells were stimulated with IL- 
lp (a) or infected with E69 (MOI = 60) (b). Nuclear proteins were extracted from a 
series of infections ranging from 30min to 6h and analysed by microwell colorimetric 
NF-kB assay. Data shown is mean (+SD * p<0.05) fold induction of three independent 
experiments.
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Infection with E69, in HEp-2 cells resulted in a dual wave of NF-kB translocation with 
an initial peak between 1 to 2 h, although this wave did not show statistical significance 
(Fig 7.4b). A second, dramatic peak, of NF-kB activation appeared at 5h. No early NF- 
kB translocation was observed with C-Caco-2 cells; a much-later pronounced induction 
of NF-kB translocation was seen at 5h. The D-Caco-2 cells showed an initial peak at 1 
to 2h, which had declined by 3h; a second statistically significant wave was seen at 6 h, 
although not to the same dramatic levels as seen with the HEp-2 and C-Caco-2 cells.
In parallel, 16h post-co-culture RNA was extracted from the epithelial cells and 
amplified by RT-PCR (section 2.12) and IL- 8  mRNA expression was studied (Fig 7.5). 
HEp-2 cells showed initial statistically significant induction of IL- 8  mRNA for the IL- 
lp stimulus at 30min, which continued for the 6 h period investigated, with the most 
significant increase at 3h (Fig 7.5a). C-Caco-2 cells showed a slower response for IL- 8  
mRNA increase, which was observed at lh and this induction also continued for the 6 h 
period investigated. Of the three cell types tested these cells were the greatest producers 
of IL- 8  mRNA. In the case of D-Caco-2 cells the lowest inducers of IL- 8  mRNA, there 
was no statistically significant induction in IL- 8  mRNA with IL-lp until 3h, which 
continued to 6 h. The HEp-2 cells induced a statistically significant increase in IL- 8  
mRNA at 3h with the bacterial stimulus at a much later time to that of the IL-lp 
stimulus (Fi 7.5b). Induction of IL- 8  mRNA in C-Caco-2 cell became significant at 2h, 
which continued to peak at 5h. These cells were the strongest inducers of IL- 8  mRNA 
for this stimulus. No statistically significant induction of IL- 8  mRNA was seen with the 
D-Caco-2 cells. Thus, HEp-2 and C-Caco-2 cells showed parallel induction of IL- 8  
mRNA, for both stimuli of IL-ip and E69 (Fig 7.5). There appears to be some 
correlation between induction in levels of activated NF-kB subunit p65 and IL- 8  mRNA 
expression (Fig 7.4).
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Figure 7.5: Time dependent modulation of IL- 8  gene expression by HEp-2 cells, 
confluent and differentiated Caco-2 cells. Cells were stimulated with IL-lp (a) or 
infected with E69 (MOI = 60) (b). Gene expression from a series of infections ranging 
from 30min to 6h were determined and normalised to GAPDH. Variations in mRNA 
levels are expressed as fold induction compared to the uninfected control cells. Data 
shown is mean (+SD * p<0.05) induction of three independent experiments.
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Also in parallel, co-culture supernatants were harvested at 16h and IL- 8  and CCL20 
protein expression was quantified by ELISA (section 2.10). Differences in the 
expression of IL- 8  (Fig 7.6) and CCL20 protein (Fig 7.7), upon stimulus, between the 
three cell models were compared. As was the case with the IL- 8  mRNA, the HEp-2 and 
C-Caco-2 cells produced a very similar pattern of IL- 8  protein expression for both 
stimuli, with IL-lp being the most potent inducer with a more rapid and greater 
response (Fig 7.6). In both HEp-2 and C-Caco-2 cells, IL-lp induced a statistically 
significant production of IL- 8  protein at lh, which increased and peaked at 5h. At 6 h 
IL- 8  protein expression had begun to decrease, although the expression by HEp-2 cells 
(right axis) was 10 fold greater than that of C-Caco-2 cells (left axis) (Fig 7.6a). The 
E69 stimulus induced a statistically significant increase in IL- 8  protein expression at 2h 
in HEp-2 cells and 3h in C-Caco-2 cells, which continued to increase 6 h post-stimulus 
(Fig 7.6b). The D-Caco-2 cells displayed a different expression profile to the other cell 
types, as was observed for gene expression. Stimulation with IL-ip induced a 
statistically significant increase in IL- 8  post-3h but levels were greatly reduced in 
comparison to HEp-2 or C-Caco-2 cells and no induction of IL- 8  protein was observed 
on stimulation with E69.
In the case of CCL20 protein expression, no major difference was observed between the 
three cell types upon IL-lp stimulation, with significant production of CCL20 protein 
3-6h post-infection (Fig 7.7a). The CCL20 response appeared to be less rapid in 
comparison to that of IL- 8  (Fig 7.6a). E69 induced much lower CCL20 protein when 
compared to IL-lp (Fig 7.7b). Significant differences were however, seen when the 
three cell types were exposed to E69 (Fig 7.7b). In HEp-2 cells, E69 did not cause any 
significant increase in CCL20 protein; in contrast, a statistically significant increase in 
CCL20 protein was seen 4-6h post-infection in the C-Caco-2 cells. In D-Caco-2 cells, 
significant induction was seen only at 6 h. The levels were like IL- 8  protein and reduced 
in comparison to the response obtained in C-Caco-2 cells.
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Figure 7.6: Time dependent production of IL- 8  by HEp-2 cells (1st Y axis), 
confluent and differentiated Caco-2 cells (2nd Y axis). Cells were stimulated with IL- 
ip  (a) or infected with E69 (MOI = 60) (b). Co-culture supernatants were harvested 
from 30min to 6h. Production was evaluated in the respective supernatants by ELISA. 
Data shown is mean (± SD *p<0.05) induction of three independent experiments.
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Figure 7.7: Time dependent production of CCL20 by Hep-2 cells, confluent and 
differentiated Caco-2 cells. Cells were stimulated with IL-1 p (a) or infected with E69 
(MOI = 60) (b). Co-culture supernatants were harvested from 30min to 6h. Production 
was evaluated in the respective supernatants by ELISA. Data shown is mean (± SD 
*p<0.05) induction of three independent experiments.
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7.2.3 Effect of Caco-2 cell differentiation on responsiveness to IL-lp 
As mentioned above (7.1.5), it has been reported in the literature that differentiation 
reduces IL-ip induced expression of IL-8 . To confirm this effect of differentiation, 
Caco-2 cells were seeded and incubated for 7, 14 or 21 days (Section 2.7). Cells were 
then stimulated with IL-lp for 16h. Gene expression of IL-8 , LL-37 and hBDl-3 was 
normalised to GAPDH (Section 2.12). IL- 8  and hBD2 protein expression in the 
harvested supernatants was quantified by ELISA (Sections 2.10 and 2.11). All 
experiments were performed at least three times unless otherwise stated. These 
experimental conditions are the same for all data presented within this chapter unless 
otherwise stated.
There was no significant effect of differentiation on baseline levels of expression (in 
control, non-stimulated cells) of AMP genes and IL-8 , although a trend towards an 
increase in expression of hBDl and LL-37 upon differentiation was noted (Fig 7.8 and 
7.9). Differentiation however, resulted in changes in responses to IL-ip stimulation. A 
statistically significant decrease in IL- 8  mRNA expression in response to IL-1 p was 
seen as the cells differentiated from day 7 to 21 (Fig 7.8a). A similar trend was also seen 
for hBD2 gene expression, although this was not significant (Fig 7.8a). A similar 
pattern of increasing hypo-responsiveness to IL-lp was also observed for IL- 8  protein 
(Fig 7.8b). The IL-lp stimulus did induce hBD2 protein, albeit of much lower levels 
when compared to IL-8 . No difference in hBD2 expression was found on 
differentiation, however, as only one set of supernatants was analysed this data requires 
further confirmation (Fig 7.8b). No significant difference in hBDl and hBD3 mRNA 
expression in response to IL-lp was found on differentiation (Fig 7.9). Conversely, 
similar to IL-8 , LL-37 expression was reduced in response to IL-lp during 
differentiation (Fig 7.9b).
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Figure 7.8: Differentiation dependent modulation of IL- 8  and hBD2 mRNA (a) or 
protein (b) expression by Caco-2 cells. Caco-2 cells at various stages of differentiation 
were stimulated with IL-lp. 16h post-stimulation gene expression was determined and 
normalised to GAPDH. Protein was evaluated in the respective supernatants by ELISA 
assay. Data shown is mean (+SD */+p<0.05) induction of three independent 
experiments.
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Figure 7.9: Differentiation dependent modulation of hBDl, hBD3 and LL-37 gene 
expression by Caco-2 cells. Caco-2 cells at various stages of differentiation were 
stimulated with IL-lp (lOng/ml). I6h post-stimulation gene expression was determined 
and normalised to GAPDH. Data shown is mean (+SD */+p<0.05) induction of three 
independent experiments.
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7.2.4 Effect of Caco-2 differentiation on responsiveness to bacterial stimulus
The effect o f Caco-2 differentiation on modulating innate responses to bacterial 
stimulus has thus far not been reported in the literature and thus was investigated. Cells 
were stimulated with B. theta, HB101, L299v, LGG and E69 for 16h (Section 2.7). 
Reduction in IL-8 mRNA in response to B. theta, HB101 and E69 occurred in cells 
cultured from days 7 to 21 (Fig 7.10a). In contrast, the response to the probiotic species 
LGG and L299v increased as the cells differentiated. No change in hBD2 mRNA was 
noted during E69 infection. However, a trend of increased responsiveness to probiotics 
with decreased response to commensal species was observed, although only the 
reduction o f hBD2 in response to HB101 was statistically significant (Fig 7.10b). 
Increase in IL-8 protein in response to LGG was noted on differentiation, with a 
decrease in expression with B. theta and E69 (Fig 7.1 la). No induction of hBD2 above 
the constitutive level was seen and species LGG and E69 appeared to suppress levels 
bellow constitutive expression, which was abolished on full differentiation by day 21 
(Fig 7.1 lb). However, only one set o f supernatants were analysed and this data requires 
further confirmation. The hBDl and 3 mRNA expression was found to be down- 
regulated by the bacteria at day 7 and was abolished on differentiation (Fig 7.12 and 
7.13). In contrast, LL-37 showed a trend towards increased expression although this was 
not significant (Fig 7.13).
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Figure 7.10: Differentiation dependent modulation of IL- 8  (a) hBD2 (b) gene 
expression by Caco-2 cells at 16h. Caco-2 cells at various stages of differentiation 
were co-cultured with L299v, LGG, B. theta, HB101 or E69 (MOI = 60), or IL-lp 
(lOng/ml), as a positive control. 16h post-stimulation gene expression was determined 
and normalised to GAPDH. Variations in mRNA levels are expressed as fold induction 
compared to the uninfected control cells. Data shown is mean (+SD */+p<0.05) 
induction of three independent experiments.
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Figure 7.11: Differentiation dependent modulation of IL- 8  (a) hBD2 (b) production 
by Caco-2 cells at 16h. Caco-2 cells at various stages of differentiation were co­
cultured with LGG, B. theta or E69 (MOI = 60), or respective heat killed cultures or IL- 
lp  as a positive control. 16h post-infection bacterial and cell co-culture supernatants 
were harvested. Production was evaluated in the respective supernatants by ELISA. IL- 
8 data shown is a mean (+SD */+p<0.05) induction of three independent experiments.
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Figure 7.12: Differentiation dependent modulation of hBDl (a) hBD3 (b) gene 
expression by Caco-2 cells at 16h. Caco-2 cells at various stages of differentiation 
were co-cultured with L299v, LGG, B. theta, HB101 or E69 (MOI = 60), or IL-1 (3 
(lOng/ml) as a positive control. 16h post-stimulation gene expression was determined 
and normalised to GAPDH. Variations in mRNA levels are expressed as fold induction 
compared to the uninfected control cells. Data shown is mean (+SD */+p<0.05) 
induction of three independent experiments.
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Figure 7.13: Differentiation dependent modulation of LL-37 gene expression by 
Caco-2 cells at 16h. Caco-2 cells at various stages of differentiation were co cultured 
with L299v, LGG, B. theta, HB101 or E69 (MOI = 60), or IL-1 p (lOng/ml) as a positive 
control. 16h post-stimulation gene expression was determined and normalised to 
GAPDH. Variations in mRNA levels are expressed as fold induction compared to the 
uninfected control cells. Data shown is mean (+SD */+p<0.05) induction of three 
independent experiments.
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7.2.5 Innate defence of the primary isolated human crypt cells (HIEC) in response 
to IL-lp and infection
As cell differentiation modulates IEC innate immunity it was hypothesised that the 
innate responses may differ along the crypt-villus axis. To further characterise crypt cell 
responses, primary isolated crypt cells (HIECs) were isolated from foetal small intestine 
(Section 2.6.3). The effect of bacterial infection with B. theta, HB101, L299v, LGG and 
E69 on IEC immune responses was investigated. Control, un-stimulated HIEC cells did 
not express LL-37, hBD2 and hBD3 mRNA and no induction had been noted in 
response to IL-lp or the bacteria tested (Fig 7.14). Very low constitutive levels of IL- 8  
and hBDl were observed and could be modulated by bacterial stimulus. 8 h post­
infection with LGG, L299v and HB101 the cells began to round up. By 16h all the 
bacterial infected cells had rounded up, died and detached. These preliminary studies 
suggested that an MOI of 60 was toxic for crypt cells. Therefore, further experiments 
were performed with an MOI of 0.6. At 8  and 16h all bacteria investigated apart from B. 
theta induced statistically significant expression of IL- 8  mRNA and protein at the same 
order of magnitude as that seen for Caco-2 cells, although they were inoculated with a 
100 fold less bacteria (Fig 7.15-17). On stimulation of HIEC cells with B. theta, IL- 8  
mRNA and protein levels were significantly reduced in comparison to the non 
stimulated control cells. Therefore, B. theta seemed to down-regulate constitutive IL- 8  
expression in HIEC cells and yet, the same bacteria were the most potent inducer of IL- 
8  in Caco-2 cells.
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Figure 7.14: Modulation of the IL-8 , hBDl-3 and LL-37 gene expression of HIEC 
cells by bacteria at 8 h. HIEC cells were infected with LGG, L299v, B. theta, HB101, 
E69 (MOI = 60), or stimulated with IL-1 (3. 8h post-infection RNA was extracted from 
the epithelial cells, which was amplified by RT-PCR. The gels shown are a 
representative of 3 independent experiments.
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Figure 7.15: M odulation of the IL-8 gene expression by various bacterial species at
8h. HIEC cells were infected with LGG, L299v, B. theta, HB101, E69 (MOI = 0.6), or 
stimulated with IL-ip as a positive control. 8h post-infection RNA was extracted from 
the epithelial cells which were amplified by RT-PCR and normalised to GAPDH. The 
gels shown are a representative of 3 independent experiments (a). Variations in mRNA 
levels are expressed as fold induction compared to the uninfected control cells. Data 
shown is mean (+SD *p<0.05) induction of three independent experiments (b).
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Figure 7.16: M odulation of the IL-8 gene expression by various bacterial species at 
16h. HIEC cells were infected with LGG, L299v, B. theta, HB101, E69 (MOI = 0.6), or 
stimulated with IL-1 P as a positive control. 16h post-infection RNA was extracted from 
the epithelial cells which were amplified by RT-PCR and normalised to GAPDH. The 
gels shown are a representative of 3 independent experiments (a). Variations in mRNA 
levels are expressed as fold induction compared to the uninfected control cells. Data 
shown is mean (+SD *p<0.05) induction of three independent experiments (b).
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Figure 7.17: Effect on production of IL-8 by a range of bacterial species at 8h (a) 
and 16h (b). HIEC cells were infected with LGG, L299v, B. theta, HB101 or E69 (MOI 
= 0.6), or stimulated with IL-lp as a positive control. 16h post-infection cell and 
bacterial co-culture supernatants were harvested. Production was evaluated in the 
respective supernatants by ELISA. Data shown is mean (+SD *p<0.05) induction of 
three independent experiments.
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7.2.6 Effect of differentiation on Muc3A and Muc3B gene expression
Although many factors are likely to contribute to the difference in IEC innate immune 
responses observed upon cell differentiation, variations in glycocalyx composition 
along the crypt-villus axis is likely to play a role in early microbe-host cross-talk. 
Muc3A and Muc3B are transmembrane mucin-type glycoprotiens forming part o f the 
epithelial cell glycocaylx (Pratt et al. 2000). Muc3A and Muc3B expression was 
investigated by Q-PCR in the HIEC crypt cell line, confluent Caco-2 cells (Day 7) and 
differentiated Caco-2 cells (Day 14) (Section 2.13). The difference in expression 
between the cell types was determined using the ACt method, normalised to GAPDH 
and with correction for differing PCR efficiencies (Meijerink et al. 2001). Muc3A and 
Muc3B expression differed between the three cell types (Fig 7.18). HIEC cells 
expressed the least Muc3A and Muc3B, confluent Caco-2 cells expressed modest but 
significant levels. Polarised Caco-2 cells expressed 70 fold more Muc3A and 10 fold 
more Muc3B than that o f the HIEC and confluent Caco-2 cells.
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Figure 7.18: Differentiation dependent modulation of Muc3A (a) Muc3B (b) gene 
expression by HIEC and Caco-2 cells. Total RNA was isolated from HIEC cells, 
confluent Caco-2 cells or differentiated Caco-2 cells. Q-PCR was performed in 
triplicate. Ct values normalised to GAPDH and variations in mRNA levels are 
expressed as average normalised fold induction. Data shown is mean (+SD */+ p<0.05) 
induction of three independent experiments.
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7.2.7 Effect of location of host-bacterial interaction on the innate mucosal response 
The epithelial barrier itself is critical in modulating host-microbial cross talk at the 
mucosal surface. To analyse the potential role o f barrier function Caco-2 cells were 
grown on transwell inserts and allowed to differentiate for 14 days (Section 2.7.1.2). 
Cells were inoculated basolaterally with E69, 042, B. theta, HB101, L299v, LGG and 
IL-1 p. At 16h post-infection the co-culture medium was aspirated from the different 
compartments and production of IL-8 protein was evaluated by ELISA (Section 2.10). 
Data described previously for differentiated Caco-2 cells is shown for comparative 
purposes. On apical inoculation, all species tested induced IL-8 expression (Fig 7.19a). 
On inoculation o f the basolateral compartment E69 reduced IL-8 expression below the 
level seen with the control cells in the basolateral compartment and no IL-8 was 
detected in the apical compartment (Fig 7.19b). Except for E69 and HB101 all species 
induced significant IL-8 expression both apically and basolaterally. The combined 
apical and basolateral expression o f IL-8 on basolateral stimulation with B. theta and 
IL -lp was greatly enhanced in comparison to the levels seen on apical stimulation (Fig 
7.19a). Conversely, the combined levels of IL-8 on basolateral stimulation with LGG 
induced a reduced level to that seen on apical stimulation of Caco-2 cells.
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Figure 7.19: Apical (a) versus basolateral (b) stimulation on IL-8 production at 
16h. Polarised Caco-2 cells grown in Transwells were stimulated basolateraly with E69, 
042, HB101, B. theta, LGG or L299v (MOI = 60), or IL-ip. At 16h co-culture 
supernatants were harvested (from upper or lower chamber of transwell). Production 
was evaluated by ELISA and data shown is a mean (+SD *p<0.05) induction of three 
independent experiments (b). Day 14 Caco-2 data shown for comparison (a).
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7.3 Discussion
Investigators of microbial pathogenesis must consider both the host and the microbe as 
variables in any experimental system (Casadevall & Pirofski 2000). So far, all studies 
described in this thesis have employed various bacterial species and isogenic mutants to 
elucidate the effect of microbial components on pathogenesis. The aim of this chapter 
was to investigate the effects of ‘host’ components on pathogenesis. As Specific host 
tissues react in different ways to microorganisms and as it is suggested that cell types 
with different immune capacities might exist in the intestine (Suzuki et al. 2003); 
various cell types displaying different features of the gut epithelia were employed. In 
addition, cells in varied differentiation states were employed to recapitulate the crypt- 
villus axis in the small intestine in order to determine the differential innate immune 
responses that may occur along this axis.
Differences in immune responsiveness were observed in comparison of confluent Caco- 
2 cells (undifferentiated colonic/ileal precursor) and differentiated “ileal-like” Caco-2 
cells (Day 14+) and HEp-2 cells. Upon IL-lp and E69 stimulation all cell types 
appeared to produce 2 waves of NF-kB activation (Fig 7.4). Biphasic activation of NF- 
kB has previously been reported with pro-inflammatory stimuli (Saccani, Pantano, & 
Natoli 2001). For the IL-lp stimulus HEp-2 and C-Caco-2 cells produced a rapid peak 
of NF-kB activation with higher magnitude noted for the former (Fig 7.4a). A second 
more pronounced wave was observed with C-Caco-2 cells. However, the “Ileal-like” 
cells showed an initial significant peak of translocation with only a modest second wave 
(Fig 7.4a). In general, the response to the IL-ip was more rapid than that of the bacterial 
stimulus E69 (Fig 7.4b).
In parallel, IL- 8  gene expression was investigated (Fig 7.5). HEp-2 and C-Caco-2 cells 
showed similar induction of IL- 8  mRNA, for IL-ip and E69 (Fig 7.5). Thus, NF-kB 
activation and IL- 8  levels clearly correlated. “Ileal-like” cells exhibited reduced levels 
of IL- 8  mRNA by both IL-lp and more dramatically E69, in comparison to the other 
cell types. HEp-2 and C-Caco-2 cells produced a very similar pattern of expression of 
IL- 8  protein for both stimuli (Fig 7.6). With IL-lp being the most potent inducer with a 
more rapid response; although HEp-2 cell expression was 10 fold greater than that of C- 
Caco-2 cells (Fig 7.6). Once again, a different response pattern was seen in “Ileal-like”
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cells. Stimulation with IL-lp only induced significant IL- 8  after 3h and at levels greatly 
reduced in comparison to the other cell types. Furthermore, no induction of IL- 8  was 
observed with E69. Collectively, cell differential responses support the idea that 
different anatomical sites in the GI tract may respond differently.
CCL20 was constitutively expressed by Caco-2 cells and not HEp-2 cells, suggesting 
differential DC recruitment. In contrast, to IL-8 , no major difference in CCL20 protein 
expression was seen between the three cell types in response to IL-lp (Fig 7.7); which if 
confirmed ex -vivo would imply that dendritic cells are uniformly recruited along the GI 
tract with an inflammatory trigger. The CCL20 response appeared to be less rapid in 
comparison to that of IL-8 , which may suggest that dendritic cells are recruited to the 
site of infection at a later time point that that of neutrophils. The E69 stimulus induced 
much lower levels of CCL20 protein in comparison to IL-ip (Fig 7.7). Interestingly, 
significant differences were seen among the three cell types with the bacterial stimulus. 
Stimulation of HEp-2 cells with E69 did not induce any significant production of 
CCL20 protein. However, a statistically significant increase in CCL20 protein 
expression was seen with the C-Caco-2 cells. With “Ileal-like” cells significant 
induction above the constitutive levels as seen only at 6 h. The levels were once again 
similar to that for IL- 8  protein, reduced in comparison to that produced by the C-Caco-2 
cells. This data suggests that if these cells were truly representative, that the ileum may 
have additional regulatory mechanisms in comparison to the colon, which limit its 
responsiveness. Interestingly, Vinderola et al. found tolerance of IECs to MDP 
stimulation specifically in the small intestine (Vinderola et al. 2005). Alternatively, both 
HEp-2 and C-Caco-2 cells are undifferentiated and yet the day 14 Caco-2 cells are 
differentiated. This indicates a reduction in responsiveness on cell differentiation. 
Indeed, on further investigation of the role of cell differentiation in Caco-2 cells a 
statistically significant decrease in IL- 8  mRNA and protein expression in response to 
IL-ip was observed as the cells differentiated from day 7 to 21 (Fig 7.8). This is 
consistent with that reported in the literature previously (Huang et al. 1997, Huang & 
Wu 1997). In contrast, no difference in defensin gene or protein expression was 
observed (Fig 7.9). Conversely, LL-37 followed the same trend as IL- 8  on stimulus with 
IL-lp. This data suggests a reduction in responsiveness to pro-inflammatory cytokines 
along the crypt-villus axis, leading to reduced expression of the IL-8 . There was no 
difference in defensin expression observed, implying that barrier protection is
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maintained from the crypt-villus junction to the villus tip, and potentially recruitment of 
dendritic cells and thus IgA production. Responsiveness to IL-lp is reduced as cells 
migrate up to the villus tip. This could very well be a mechanism that IECs utilise to 
protect against dysregulated inflammatory responses. It would appear that this occurs 
due to IL- 8  specific regulatory mechanisms that are not present or reduced in non­
differentiated cells. Post transcription and translation regulatory mechanisms of IL- 8  
have been suggested previously (chapter 6 ) and by other authors (Yu & Chadee 1998, 
Muegge 2002, Yu et al. 2003, Ma et al. 2004, Fyfe et al. 2005, Zhu & Tan 2005, Netsch 
et al. 2006, Ito 2007).
The effect of differentiation on the innate immune responses of Caco-2 cells to bacterial 
stimulus has not been previously reported in the literature and thus was investigated. 
Differentiation caused a reduction in innate immune genes and protein in response to 
commensal species B. theta and HB101, as well as the pathogen E69 (Fig 7.10-13). It 
has been postulated that responsiveness of intestinal epithelial cells decrease along the 
crypt-villus axis, representing a mechanism whereby IECs protect themselves against 
dysregulated immune and inflammatory response to commensal bacteria and their 
products (Bocker et al. 2001, Bocker et al. 2003, Lee, et al. 2005). To my knowledge, 
this is the first study to investigate the effect of differentiation on responses to whole 
bacteria. However, it is known that differentiation results in a reduction in 
responsiveness to LPS (Bocker et al. 2000, Bocker et al. 2001, Cario et al. 2002). This 
is attributed to down-regulation of TLR4 expression (Bocker et al. 2001, Cario et al. 
2002, Bocker et al. 2003, Lee et al. 2005). In addition, uptake of LPS aggregates by 
phagocytosis without subsequent cellular activation, is found in more differentiated 
IECs near the villus tip, rather than in crypts (Ge et al. 2000). Furthermore, evidence 
exists to corroborate that the stage of differentiation determines subsequent transcellular 
transport processes for LPS (Beatty & Sansonetti 1997).
Conversely, responses to the probiotic species LGG and L299v increased as the cells 
differentiated (Fig 7.10-13). In support of this finding, Nemeth et al. report a dose- 
dependent difference between crypt and villus cells to Lactobacilli. At lower doses of 
bacteria the responses of the crypt cells are greatly increased in comparison to the villus 
cells, which hardly respond. However, at larger doses in the region, to that used in this 
study, the villus cells response to the Lactobacilli was higher than that of the crypt cells
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(Nemeth et al. 2006). An interesting explanation could be that Lactobacilli have been 
found to adhere to the apical brush border of Caco-2 cells and adhesion is increased in 
parallel with the morphological and functional differentiation of Caco-2 cells 
(Chauviere et al. 1992).
Down-regulation of hBDl and 3 mRNA by L299v, LGG and E69 (also reported 
previously in chapters 5 and 6 ) was abolished on differentiation, suggesting that bacteria 
can only actively down-regulate responses of cells around the upper crypt/crypt villus 
junction (Fig 7.12 and 7.13). Down-regulation may be abolished because of differences 
in bacteria-cell contact between the villus and crypt, due to variations in the dense brush 
border. This was observed to increase with differentiation in Caco-2 cells (Fig 7.3); and 
possibly increased brush border glycocalyx (Fig 7.18) and mucus. For example, TLR 
signalling can be modulated by factors that decrease direct contact, such as integrity of 
the mechanical mucosal barrier and pre-epithelial factors such as mucin and intestinal 
trefoil factor (TFF3) (Shibolet & Podolsky 2007). Thus, it can be postulated that if these 
bacteria get access to the less mature cells they would be able to down-regulate the host 
barrier defence. Possibly enabling colonisation, but in so doing they would induce an 
excessive inflammatory response, which in conjunction could result in damage and 
disruption of the host barrier.
Therefore, the responses of primary isolated crypt cells were investigated. Initial co­
culture experiments with HIEC cells highlighted their “sensitive” nature as the routinely 
used MOI of 60 killed the cells within 16h. This would imply that should the bacteria 
being investigated gain access to crypts they could induce cell death and thus disruption 
of the host barrier. Subsequent experiments with a 100 fold less bacteria (MOI 0.6) 
allowed assessment of crypt immune responses. All bacterial species apart from B. theta 
induced statistically significant expression of IL- 8  mRNA and protein (Fig 7.14-7.17). 
As with Caco-2 cells this induction was irrespective of pathogenicity. IL- 8  protein 
expression was at the same order of magnitude as that seen for Caco-2 cells at this time 
point, although HIEC cells were inoculated with a 100 fold less bacteria (Fig 7.7). 
Different levels of IL- 8  gene and protein induction noted between HIEC and Caco-2 
cells upon infection could be due to structural differences such as an immature 
glycocaylx, mucus and absence of microvilli brush border allowing increased bacteria- 
cell contact. B. theta suppressed IL- 8  mRNA and protein. However, in Caco-2 cells at
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16h B. theta was the most potent inducer of IL- 8  (Chapter 6 ), this difference may also 
be due to enhanced contact. Although the Caco-2 response with B. theta was found to 
be dose-responsive, this could be due to the lower dose used. Collectively, the data 
supports the hypothesis that when the bacteria investigated get access to less mature 
cells they induce an excessive inflammatory response, which in conjunction could result 
in damage and disruption of the host barrier.
In support of these findings, in vitro, there are distinct differences between the immature 
and mature intestine, with respect to interactions with microorganisms (Mobassaleh et 
al. 1988, Eglow et al. 1992, Ciarlet et al. 2002, Lu et al. 2003b). Claud et al. 
demonstrate that a human immature enterocyte cell line and primary IEC from 
immature rodents have higher expression of inflammatory cytokines in response to 
bacterial infection than their more mature counterparts (Claud et al. 2004). In addition, 
IL- 8  production in response to IL-lp and TNF-a has been shown to be significantly 
increased in the human foetal IEC line H4 and foetal intestinal organ cultures from 18- 
to 21-weeks compared with the adult IEC line Caco-2 and biopsies from older children 
(Nanthakumar et al. 2000). Maheshwari et al. also show IL- 8  immuno-reactivity in the 
epithelium was most extensive at 11-18 weeks gestation along the entire crypt-villus 
axis, was relatively restricted to the crypt areas at 22-24 weeks, and only minimally 
detectable in the adult duodenal biopsy sections (Maheshwari et al. 2004).
Immaturity of epithelial barrier function, relative deficiencies in the expression of 
antimicrobial factors, and developmental variations in the pattern of epithelial surface 
glycosylation have all been suggested to contribute to the susceptibility of early 
postnatal intestine to bacterial infection (Dai et al. 2000, Chu & Walker 1986, Udall, Jr. 
1990). These factors could also be responsible for differences in immune 
responsiveness reported in this study. Interestingly, HIEC cells showed no constitutive 
expression of LL-37, hBD2 and hBD3 mRNA and no induction was seen on stimulus 
with IL-ip or bacteria (Fig 7.14). Begue et al. also report similar findings in HIEC cells 
(Begue et al. 2006). Furthermore, a trend towards increased hBDl and LL-37 was noted 
with differentiation (Fig 7.9). In support of this LL-37 expression in skin and the colon 
is known to correlate with cellular differentiation. LL-37 manifests a distinct crypt-to- 
surface cell gradient in the human colon, with predominant expression on surface 
epithelia (Dorschner et al. 2001, Hase et al. 2002, Schauber et al. 2003). Furthermore,
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differences in immune responsiveness may be due to variations in the presence of the 
microvilli brush border preventing access (Fig 7.2). As mentioned above, TLR 
signalling can be modulated by factors that decrease direct contact between the TLRs 
and their ligands, such as integrity of the mechanical mucosal barrier and pre-epithelial 
factors such as mucin and intestinal trefoil factor (TFF3) (Shibolet & Podolsky 2007). 
Indeed, expression of Muc3A and Muc3B was found to differ between the three cell 
types (Fig 7.18) In support of this, MUC2 and MUC3 are associated with a more 
differentiated cell phenotype (Velcich et al. 1995).
Furthermore, immature cells have lower expression of specific IkB genes, key 
regulators of NF-KB-dependent inflammatory pathways (Claud et al. 2004). This 
suggests that developmental ly regulated differences in IkB expression could contribute 
to the differential responsiveness of immature and mature enterocytes to inflammatory 
stimuli. It has also been found that TLR2 and TLR4 are expressed principally on the 
basolateral surface of human foetal small crypt enterocytes (Fusunyan et al. 2001). 
CD 14 is also expressed in epithelial cells located in the bottom of stomach pits and in 
the crypts of distal small intestine and colon (Ortega-Cava et al. 2003). Ortega-Cava et 
al. speculate that these findings may reflect a strategy of the mucosal innate immune 
system to simplify the task of sensing the gut bacterial content (Ortega-Cava et al. 
2003). By restricting PRRs to the crypt bottom, in normal conditions, crypts may 
function as a micro anatomical niche, where the exposure of cells, with high expression 
of PRRs, to commensal bacterial ligands from the lumen could be tightly controlled. 
PPR expression has not been investigated in this study but it would be of interest to 
investigate and characterise further.
It was reported previously (chapters 3-6) that contact with the epithelial barrier was 
important to determining the host response. In addition, bacterial modulation of IEC 
responses varies among the cell types investigated suggesting possible differences in 
immune response in different anatomical locations within the GI tract. Moreover, there 
are changes in responsiveness along the crypt-villus axis; so it would seem that where a 
host-microbe interaction occurs may determine the outcome. Manger et al. argues that 
the selection of time and place during the course of the interaction affects the picture 
obtained and might reflect in part differences between innate and adaptive immune 
responses (Manger & Reiman 2000). Thus, it was of interest to investigate the effect of
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basolateral location on IEC responses. On apical inoculation all species tested induced 
IL- 8  (Fig 7.19a). On basolateral exposure, except for E69 and HB101 all species 
induced significant expression of IL- 8  into the basolateral and apical chambers. The 
combined apical and basolateral expressions of IL- 8  on basolateral stimulation with B. 
theta and IL-lp were greatly enhanced in comparison to the levels seen on apical 
stimulation. Suggesting that the PRRs that recognise these stimuli are expressed 
basolaterally and that if these bacteria managed to breach the “host”-barrier they would 
be a risk factor for recruiting and initiating an adaptive immune response. The combined 
levels of IL- 8  on basolateral stimulation with LGG were at a reduced level to that seen 
on apical stimulation suggesting that detection of this strain can occur apically and 
basolaterally but preferentially apically. On basolateral inoculation E69 suppressed IL- 8  
expression (Fig 7.19b). Perhaps E69 is able to gain better access to the epithelial cell as 
there are no microvilli and reduced mucus.
In conclusion, experiments performed in this thesis collectively highlight the 
importance of microbial contact with IECs for microbial-host “cross-talk” and optimal 
induction or suppression of immune responses. Moreover, the location of the host- 
microbe interaction is important to determining the outcome of this interaction. The 
molecular nature of this contact is likely to differ on a macroscopic level within the 
anatomical location of the GI tract as well as on a cellular level and for example along 
the crypt-villus axis.
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CHAPTER 8 : Ex vivo human intestinal
response to commensal, probiotic, and 
pathogenic bacteria
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f8.1 Background
The overall aim of this studentship was to characterise and compare the innate mucosal 
signals generated in-vitro in response to the presence of non-pathogenic, “commensal”, 
“probiotic” and wild type “pathogenic” bacteria, and to establish what a typical ex-vivo 
mucosal response should be. It was also to ascertain if the immunological response to 
bacterial stimuli in CD is abnormal.
In-vitro experiments performed in this study collectively highlight the importance of 
microbial contact with IECs for microbial-host “cross-talk”. Evidence was also found to 
suggest that the molecular nature of this contact is likely to vary within different 
anatomical locations of the GI tract. It is important to note that the model systems 
employed do not represent the true complexity of the host. The aim of this chapter was 
to investigate host immunity to infection in a model system, which reflects a more 
realistic in vivo condition, by utilising gut biopsies in an ex vivo model system.
IL- 8  is the main chemokine involved in neutrophil recruitment and activation 
(Baggiolini, Dewald, & Moser 1994). A significant role for IL- 8  in mucosal ulcerations 
in IBD has been suspected, as described in section 1.8.4 (MacDermott et al. 1998). 
However, conflicting reports exist regarding expression of IL- 8  mRNA and production 
of IL- 8  protein in patients with IBD (Mahida et al. 1992, Nielsen et al. 1999, Daig et al. 
2000, Imada et al. 2001, Katsuta et al. 2000, Reddy et al. 2007). To date, very few 
studies have evaluated the levels of IL- 8  in IBD patients that have been an exclusively 
paediatric population. By studying children, the factors, which initiate early mucosal 
lesions, can be elucidated. In addition, understanding cytokine production in paediatric 
IBD patients may provide insight into disease pathogenesis (Reddy et al. 2007). 
Therefore, In vitro organ culture (IVOC) was used to assess the IL- 8  mucosal response 
to bacterial stimulus ex-vivo.
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8.2 Results
8.2.1 Comparison of innate immune responses of control versus CD tissue to IL-lp
Mucosal endoscopic biopsies from the terminal ileum (TI) and transverse colon (TC) 
were taken with informed consent and ethical approval from children undergoing 
routine endoscopy for GI complaints. Adjacent specimens were formalin-fixed for 
histology and were examined by an experienced pathologist. Biopsies were obtained 
from two distinct groups of patients, a CD group and a control non CD group, where the 
final diagnosis was not CD and histology was normal or showed only minor 
abnormalities. All diagnoses of CD were made on the basis of clinical and histological 
findings according to the Porto Criteria (IBD Working Group of ESPGHAN 2005). The 
collective age range of all the patients was 2-17 years with a median of 1 2 , and a ratio 
of 23 males to 22 females.
To confirm that the IVOC model system could respond to an immunological stimulus, 
the effect of IL-ip on IL- 8  and CCL20 expression was initially tested. The tissue 
specimens were exposed to IL-lp (n = 20) or IVOC culture medium alone (n = 20) for 
8 h (Hicks et al. 1996) (Section 2.9). IL- 8  and CCL20 protein was measured by ELISA 
and IL- 8  mRNA was quantified by Q-PCR (Sections 2.10 and 2.13). These 
experimental conditions are the same for all data presented within this chapter unless 
otherwise stated.
A variable IL- 8  mRNA response was observed following IL-lp exposure in tissue from 
the TI and TC in control patients. Tissue from both regions of CD patients however, 
showed a trend of hypo-responsiveness to IL-lp (Fig 8.1). Expression of IL- 8  protein 
increased in tissue from the TI and TC of control patients, but was variable in CD TI 
(Fig 8.2a). Biopsies from the TC of CD patients had high IL- 8  production without 
stimulation and showed little increase on stimulation with IL-lp (Fig 8.2b). Expression 
of CCL20 increased in tissue from the TC of control and CD patients with a trend 
towards reduced induction in the TC of CD (Fig 8.3). TI from control and CD patients 
showed minimal increase in induction (Fig 8.3). The background levels of expression of 
IL- 8  and CCL20 protein increased over the course of the 8 h infection in control tissue 
without stimulus (Fig 8.4).
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Figure 8.1: Expression of IL - 8  mRNA in response to IL-lp for 8 h. Human paediatric 
intestinal biopsies from control or CD patients were stimulated with IL -lp  or IVOC 
media alone and IL-8 mRNA was evaluated by Q-PCR. Data shown is the ratio o f IL-8 
levels between the stimulated and medium alone paired biopsies. Values above the red 
dotted line represent induction o f IL-8 mRNA on stimulus and values bellow represent a 
reduction.
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Figure 8.2: IL - 8  protein expression in response to IL-ip for 8 h. Human paediatric 
intestinal biopsies from control or CD patients were stimulated with IL-lp or IVOC 
media alone and production o f IL-8 protein was evaluated by ELISA. Data is shown as 
either the ratio o f IL-8 levels between the stimulated and medium alone paired biopsies
(a) or the raw data for CD transverse colon (b). Values above the red dotted line 
represent induction of IL-8 secretion on stimulus and values bellow represent a 
reduction.
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Figure 8.3: CCL20 protein expression in response to IL-ip for 8 h. Human paediatric 
intestinal biopsies from control or CD patients were stimulated with IL -lp  or IVOC 
media alone and production o f CCL20 protein was evaluated by ELISA. Data shown as 
a ratio o f  IL-8 levels between the stimulated and medium alone paired biopsies. Values 
above the red dotted line represent induction o f CCL20 on stimulus and values bellow 
represent a reduction.
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Figure 8.4: IL-8 (a) and CCL20 (b) protein expression in control tissue over 8h.
Human paediatric intestinal biopsies from control patients were stimulated with IVOC 
media alone and production of IL- 8  and CCL20 protein was evaluated by ELISA.
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8.2.2 Response of CD tissue to bacterial stimulus
Differences in innate immune responses to cytokine stimulus were observed in the 
IVOC model system. The next step was to determine if similar findings could be noted 
in response to a bacterial stimulus. EAEC strains are known to adhere to human 
intestinal tissue in the IVOC model (Hicks S et al. 1996) and EAEC 042 has been 
previously shown to induce IL- 8  in IECs (Steiner et al. 2000) & (Chapters 3 and 4 in the 
present thesis). As described above, TI and TC tissue from the control and CD was 
exposed to overnight cultures of EAEC strain 042 WT (n = 31) or medium alone (n = 
31)
Expression of IL- 8  mRNA increased on exposure to the WT EAEC strain 042 in 
control TI and the TC of CD. However, the TI in CD and the control TC did not 
respond to infection (Fig 8.5). No significant difference in IL- 8  mRNA was observed 
between the control and CD tissue in either anatomical location (Fig 8.5). However, a 
trend towards increased gene induction on exposure to 042 was observed in the CD TC 
but not in the control (Fig 8.5b). Exposure to 042 increased IL- 8  protein in tissue from 
both regions in the control and CD tissue (Fig 8 .6 ). No significant difference was 
observed in IL- 8  protein between the control and CD in either location; although a trend 
to reduced expression was observed in the TI of CD.
Biopsies were also exposed to overnight cultures of the probiotic LGG (n = 30) and 
commensal B. theta (n = 27). Enhanced expression of IL- 8  mRNA on exposure to LGG 
was observed in the TI and TC of some controls (Fig 8.7). However, reduced IL- 8  
mRNA was observed in the TI and TC of the majority of CD patients (Fig 8.7). LGG 
stimulated an increase in IL- 8  protein expression in the control TI of but not in the 
control of TC. A statistically significant decreased IL- 8  in response to LGG was 
observed in CD TI (p=0.014), conversely a statistically significant increase in IL- 8  
protein in response to LGG was observed in the TC of CD (p=0.006) (Fig 8 .8 ). No 
significant induction of IL- 8  mRNA or protein was observed in either the TI or the TC 
of control patients on exposure to the commensal B. theta (Fig 8.9 and 8.10). However, 
a trend towards a reduction in IL- 8  expression was observed in the TC (Fig 8.9b and 
8.10b). In CD induction in IL- 8  mRNA was noted, however, the response was variable 
in both the TI and the TC (Fig 8.9). A significantly enhanced expression of IL- 8  protein 
was observed in comparison to the control patients (Fig 8.10).
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Figure 8.9: Production of IL - 8  mRNA by paediatric Terminal ileum (a) Transverse 
colon (b) tissue in response to B. theta infection for 8 h. Intestinal biopsies from 
Control or CD were cultured with 20pl of B. theta overnight culture or media alone. 
Data shown as fold induction in IL-8 mRNA in the infected biopsy compared to the 
paired control, non-stimulated biopsy.
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Figure 8.10: Production of IL - 8  by paediatric Terminal ileum (a) Transverse colon
(b) tissue in response to LGG infection for 8 h. Human paediatric intestinal biopsies 
from Control or CD were cultured with 20pl of LGG overnight culture or media alone. 
IL-8 protein was evaluated by ELISA and data shown is the percentage increase in 
induction o f IL-8 in the infected biopsy compared to the paired control, non-stimulated 
biopsy.
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8.3 Discussion
As detailed in section 1.8.6.1, considerable clinical and experimental evidence suggests 
that CD involves an abnormal, immunological response to the “commensal microbiota”. 
Despite increasing recognition of the importance of therapeutic approaches that 
modulate the composition of the bacterial load, little is known about the mucosal 
immunological response to “commensal” or “probiotic” bacteria. The overall aim of this 
studentship was to characterise and compare the innate mucosal signals generated in 
vitro in response to the presence of “commensal”, “probiotic” and wild type 
“pathogenic” bacteria. This was in order to establish what a normal ex vivo mucosal 
response is, and to ascertain if the immunological response to bacterial stimuli in CD is 
abnormal.
The majority o f the data presented in this thesis has been obtained while using 
continuous cell lines. These model cells have limitations; they are cancerous in nature 
and may not accurately represent what is occurring in the human host. In this chapter, 
host immunity to infection was investigated by utilising gut biopsies in an ex-vivo 
model system, which at present is the closest we can get to a real life scenario. 
However, the ex vivo data itself has its limitations, for example, the tissue is not 
polarised and if immersed in IVOC media it allows bacteria access to the lamina 
propria. In addition, the edges of the tissue are damaged due to the pinch forceps. There 
is a tissue response to this trauma, as demonstrated by a steady increase in the 
background levels of IL- 8  and CCL20 protein over the time (Fig 8.4). There is also a 
limitation related to the time that the tissue can be maintained alive. In this study, 
paediatric samples have been obtained which are useful when investigating the 
aetiology of Crohn’s disease. This is because the patients will have had limited 
medication and intervention and are therefore closer to the initial time of trigger. 
However, this comes at a price, which is a limited number and reduced size of the 
samples.
Despite the limitations of the IVOC model, there does appear to be a correlation 
between the cell data and ex-vivo data. Cell culture experiments discussed in previous 
chapters o f this thesis have shown variable responses to the range of bacterial species 
adopted. In the ex vivo model system employed, it was found that IL- 8  responses varied
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with the bacterial species studied (Fig 8.5-10). In support of this, Borruel et al. found 
that non-pathogenic bacteria can influence the release of cytokines by mucosal explants. 
Lactobacilli and E. coli species were found to induce different patterns of cytokine 
production; the Lactobacilli species down-regulated IL- 8  expression to varying degrees 
in healthy tissue. Borruel et al. suggested that each strain may induce a different pattern 
of response on mucosal cytokine production (Borruel et al. 2003).
Cell culture experiments have highlighted the importance of microbial contact with 
IECs for microbial-host cross-talk and optimal induction or suppression of immune 
responses. Moreover, the location of the host-microbe interaction is important on 
determining the outcome of this interaction (Chapter 7). It was hypothesised that the 
molecular nature of this contact is likely to differ on a macroscopic level within the 
anatomical location of the GI tract. Indeed, it was found that, in tissue from healthy 
controls, differences in innate immune responses were observed between the terminal 
ileum and the transverse colon. There is increased TI IL- 8  protein expression during 
infection with EAEC strain 042 WT and on exposure to the probiotic LGG (Fig 8 .6 a 
and 8 .8 a). Both species were also found in vitro to induce high levels of IL- 8  (chapter 
5). The IL- 8  response of TC tissue to infection was rather variable and IL- 8  was down- 
regulated by the probiotic LGG (Fig 8 .6 b and 8 .8 b).
Furthermore, on investigation of the ex-vivo innate immune responses of CD tissue, 
both the TI and the TC reacted differently to pro-inflammatory and bacterial stimuli. 
The TI showed a limited response to the 042 WT infection and exposure to the 
probiotic LGG actually reduced the IL- 8  response (Fig 8 .6 a and 8 .8 a). This may well 
suggest that LGG could be a beneficial therapy to patients with ileal CD. Bai et al. also 
found that in colonic biopsies from UC patients co-cultured with the probiotic Bifido­
bacterium the concentrations of IL- 8  in the supernatants were lower than those biopsies 
cultured alone (Bai et al. 2006). A limited response to IL-lp and 042 infection was also 
observed in the transverse colon tissue of CD (Fig 8.2 and 8 .6 b). However, exposure to 
the probiotic LGG increased the IL- 8  response (Fig 8 .8 b), suggesting that this strain 
would not be a safe therapy for those with colonic CD.
Interestingly, both the TI and the TC of CD patients reacted with a statistically 
significant increase in IL- 8  expression on exposure to the commensal B. theta (Fig 8.9
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and 8.10). This initial data supports the hypothesis of an inappropriate innate immune 
response to bacterial microbiota in CD. From the collective cell line data it has been 
hypothesised, in Chapter 7, when bacteria get access to less mature cells they induce an 
excessive inflammatory response, which could result in damage and disruption of the 
host barrier. It is possible that lack of expression and release of defensins in CD would 
allow bacteria access into the sterile crypts and to less mature cells (Wehkamp et al. 
2002, Wehkamp et al. 2004a, Wehkamp et al. 2005, Wehkamp et al. 2007, Fellermann 
et al. 2006). It would be interesting to investigate further and to ascertain if the 
abnormal response of the CD tissue is in fact due to this hypothesis.
In addition, it was found that in colonic CD tissue the background levels of IL- 8  were 
extremely high and the tissue was is in a “hypo-responsive state” to the pro- 
inflammatory cytokine IL-ip (Fig 8.1-2). IL-1 has a pivotal role in the pathogenesis of 
IBD and experimental intestinal inflammation. It is a pro-inflammatory cytokine that is 
produced by activated monocytes, macrophages, fibroblasts, smooth muscle cells, and 
endothelial cells (Dinarello 1991, Dinarello & Wolff 1993).
In physiological conditions treatment with inflammatory cytokine IL-1 leads to 
inflammation through pathways that share several components with TLR signalling. In 
addition to the inflammatory response, activation of TLRs and cytokine receptors also 
leads to transcriptional and translational induction of inhibitors of inflammation (Fig 
8.11) (Kariko et al. 2004). The inhibitors, induced by the first (preconditioning) 
stimulation, include intracellular signalling inhibitors, decoy receptors, decoy ligands, 
and anti-inflammatory cytokines. Signalling inhibitors of TLR and cytokine receptors 
block intracellular signalling at multiple stages, thus reducing the inflammatory 
response. Decoy receptors, such as membrane-anchored and soluble type II receptor of 
IL-1 (IL-1RII and sIL-lRII), bind functional inflammatory cytokines. However, decoy 
receptors do not transduce a signal; thus, they dampen the cytokine effect and limit 
inflammation. Preconditioning also induces IL-IRa (IL-1 receptor antagonist), the 
decoy ligand of functional IL-1RI. IL-IRa functions as a competitive inhibitor of IL-1 
thereby limiting inflammation. Preconditioning-induced feedback inhibitors of 
inflammation suppress inflammatory responses intracellularly and extracellularly to a 
second stimulation (Kariko et al. 2004).
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Imbalance o f interleukin 1 signalling has been reported in colonic tissue o f CD (Andus 
et al. 1997). Joseph et al. found that mucosal T cells isolated from CD biopsies were 
“hypo-responsive” to activation by IECs when compared with control cells (Joseph et 
al. 1997). Furthermore, Bocker et al. found alterations o f IL-IRa expression in 
experimental models o f intestinal inflammation as well as in mucosal biopsy specimens 
from patients with IBD (Bocker et al. 1998). IL-IRa tissue levels increase with activity 
o f  inflammation but to a lesser degree than IL-1, so that the ratio o f IL-lR a/IL-ip 
decreases (Casini-Raggi et al. 1995). Blockade o f endogenous IL-IRa exacerbated 
disease (Ferretti et al. 1994), whereas treatment with exogenous IL-IRa attenuated 
experimental inflammation (McCall et al. 1994).
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Figure 8.11: Feedback inhibitors of inflammation (Kariko et al. 2004)
The high background levels o f IL-8 seen with CD tissue (Fig 8.2b) could support a 
theory, suggested previously that IBD occurs when a genetic predisposition produces an 
inability to efficiently down-regulate the inflammatory response and that following a 
trigger there is persistence o f inflammation leading to tissue injuries (Fiocchi 1998). In 
conclusion commensal microbiota may well have the capacity to prime an individual for 
the development o f  Crohn’s disease or evoke relapses in enteric inflammatory disease.
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CHAPTER 9: Discussion
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9.1 Introduction
Evidence in the literature suggests that CD involves an abnormal, immunological 
response to the “commensal microbiota”. It is hypothesised that when symbiosis 
between the residential intestinal microbiota and the epithelial cells of the GI tract is 
broken, uncontrolled activation of NF-kB occurs and secretion of potent inflammatory 
mediators initiate a chronic pro-inflammatory response. The aims of the studentship 
were to characterise and compare the innate mucosal signals generated in vitro in 
response to the presence of commensal, probiotic and wild type pathogenic bacteria. In 
addition, to establish what a typical ex vivo mucosal response is, in order to ascertain 
whether the immunological response to bacterial stimuli in CD is abnormal.
9.2 Bacterial “properties” that influence host responses are not 
necessarily linked to pathogenicity
In the intestine, it is generally assumed that the induction of a pro-inflammatory 
response is a property of pathogenic bacteria, whereas non-pathogenic bacteria would 
not induce this response as it might hamper establishment of mutualistic relationships 
between the bacteria and their mammalian host (Bambou et al. 2004). Prior to starting 
this piece of work there was a common perception of “good” and “bad” bacteria, with 
nationwide marketing campaigns for probiotics from the food industry based on this 
perception of “friendly bacteria” However, TLRs recognise an array of prokaryote 
motifs, shared by both pathogenic and commensal bacteria, suggesting that either type 
o f bacteria may have the potential to initiate innate immune host responses in IECs 
(Bambou et al. 2004).
It has been demonstrated within this thesis that in Caco-2 and HEp-2 cells, all species 
investigated induced IL- 8  and hBD2 expression irrespective of ‘pathogenicity’ (Fig 5.5- 
9). Furthermore, in agreement with Bambou et al. it has been demonstrated here that 
both the pathogenic and non-pathogenic bacteria studied expressed similar external 
structures such as flagella and fimbriae (Fig 3.3-9) which are likely to induce an 
epithelial response (Bambou et al. 2004).
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Interestingly, both the probiotic species L299v and LGG and the pathogen E69 all 
actively suppressed hBDl, 3 and LL-37 (Fig 5.1-3). This pattern also parallels Shigella 
another pathogenic bacteria. Islam et al. found that with in vitro infection, Shigella 
down-regulated hBDl and LL-37 gene expression, while hBD2 was rapidly induced 
through NF-kB activation (Islam et al. 2001). The commensal strain B. theta, depending 
on inoculum and length of exposure, actively stimulated hBD2 mRNA and paralleled 
the IL-8 responses seen with the pathogen E69 (Fig 5.4-8 and 6.6a). Thus, probiotic and 
commensal bacteria can actively modulate in vitro IEC innate immune responses in a 
similar manner to that expected of pathogenic bacteria. If this were to occur in vivo, 
then a constant low grade inflammation may result. However, host factors may prevent 
this from occurring as detailed in sections 9.7.1-2.
9.3 Epithelial responses to the whole organism are different to that of 
isolated bacterial components
In most previous studies, work of this nature has been conducted with isolated bacterial 
components, e.g. the flagellin monomer. However, as Hedlund et al. suggest the host 
‘sees’ microbial products not as purified molecules but as complexes (Hedlund et al. 
2001b). In this thesis the host response to the whole flagellated bacteria differed to that 
reported in the literature for the flagellin monomer (see section 3.3). On investigation of 
epithelial responses to external structures, using isogenic mutants depleted in various 
structures, responses were reduced to varying degrees in comparison to the wild type. 
However, very rarely were the responses fully ablated, suggesting a response to more 
than one component (Fig 3.10-20 and 23-26). Furthermore, the majority of the strains 
investigated expressed more than one external structural component at a time (Fig 3.3- 
9)
Indeed, it is becoming increasingly apparent that for the innate immune system to 
recognise the wide spectrum of bacterial stimuli, PRRs must cooperate amongst 
themselves (Ozinsky et al. 2000a, Akira, Takeda, & Kaisho 2001, Brown et al. 2003, 
Underhill 2003, Chen & Jiang 2004, Lee et al. 2004, Netea et al. 2004, Watanabe et al. 
2004a, Hohl et al. 2005, Feuillet et al. 2006, Takada & Uehara 2006, Takada et al. 
2007).
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It is now evident that the basic mechanism of signalling by TLRs involves ligand- 
induced dimerization or oligomerization; which in turn modifies the arrangement of TIR 
domains altering the binding specificity required for recruitment of appropriate adaptors 
(Gay et al. 2006). Therefore, specificities do exist in TLR signal transduction pathways 
due to the combinational diversity of different TLR pairs and thus differential 
recruitment of signalling adapters (Ozinsky et al. 2000a, O’Neill 2002, Yeh & Chen
2003).
LPS, flagellin, PGN or DNA may bind directly to TLRs but in addition, co-receptors are 
needed to enhance the TLR response to these conserved ligands (Poltorak et al. 1998, 
Medzhitov & Janeway, Jr. 2002, Triantafilou & Triantafilou 2002, Beutler 2004, Jiang 
et al. 2005). The biological importance of co-stimulation is to signal the presence of 
infection or “danger” to the immune system (Hajishengallis et al. 2005). Co-stimulatory 
receptors can allow cell activation or amplify it, regulate cell survival and determine 
effecter functions (Olive 2006).
TLRs and other PRRs, as well as co-receptors, accumulate in membrane micro-domains 
known as lipid rafts and form multi-receptor complexes for optimal induction of TLR 
signalling (Hajishengallis et al. 2005). One of the functions of lipid rafts is the 
recruitment and concentration of molecules involved in cellular signalling (Pralle et al. 
2000). Providing a micro-environment where receptor molecules are brought into 
proximity with one another, thus facilitating the interactions among them. It would 
appear that molecules from different bacteria promote the formation of different 
receptor clusters (Triantafilou et al. 2004).
9.4 Bacteria interact with the host through both contact dependent and 
independent mechanisms
Experiments performed in this thesis collectively highlight the complicated interplay 
between the microbe and host. In many of the experiments described, bacteria were 
observed to increase the expression of host proteins. However, bacteria were also shown 
to decrease host expression of mRNA and protein. These responses were also found in 
some instances to be contact dependent and/or to external or soluble bacterial products.
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9.4.1 The role of bacterial-host contact in inducing an epithelial response
The work presented in this thesis did not find an association between bacterial-host 
contact and the induction of IL-8 and hBD2 mRNA (Fig 6.10). However, in the case of 
IL-8 protein synthesis/translation contact seems to play a significant role, as no IL-8 
protein is induced with bacterial conditioned media (Fig 6.11). In addition, on 
investigation of localised EPEC adherence on IEC immunity it was found that 
adherence was a strong determinant of IL-8 and CCL20 induction, particularly adhesion 
via bundle forming pili (Fig 3.17-18). Indeed, Savkovic et al. found that EPEC BFP 
mutant strain JPN15 was unable to cause polymorphonuclear leukocytes to cross the 
epithelium (Savkovic et al. 1996).
It could be argued that the contact dependence is due to bacteria being docked to the cell 
allowing concentration of PRRs within lipid rafts to provide the necessary numbers of 
signals to induce a response. Or that contact with the epithelium is a major danger 
signal and that an additional co-stimulatory signal comes in the form of recognition of 
an external structure. Thus, it may be plausible that recognition of external bacterial 
products such as flagella sends a danger signal to the cell, which induces translation. 
However, for transcription to occur a second danger signal is required to override post- 
translational regulation; this second confirmation of danger signal may be due to 
bacterial contact.
This would make sense as in the GI tract there is an excess of bacteria, and thus 
bacterial external structures, yet many of the bacteria expressing these structures have 
co-evolved to reside within the gut, without causing excessive inflammation or damage 
to the host. It is likely that innate barrier defence mechanisms, such as IgA and AMPs 
as well as the mucus layer, prevent commensals making contact with the epithelium, 
and thus they pose no threat and therefore would not induce an epithelial inflammatory 
response. The bacteria only become a threat if, via damage or reduction in barrier 
defence, they gain access to the epithelia and in this situation an immune response 
would be warranted.
9.4.2 Contact dependent active reduction of the host response by bacteria
As well as contact between the host epithelial and the bacteria being imperative for 
inducing a pro-inflammatory response, making contact with the epithelium also appears
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to be important for the bacteria’s ability to be able to down-regulate host responses. For 
example, L299v, LGG and E69 actively suppressed hBDl, 3 and LL-37 in a contact 
dependent manner in vitro (Fig 5.1-3). Various bacterial species have been shown to 
modulate the immune response in a contact dependent manner by modulating NF-kB 
(Hauf & Chakraborty 2003, Kelly et al. 2004, Maresca et al. 2005, Sharma et al. 2005, 
Ruchaud-Sparagano et al. 2007). Some evidence was found that the species investigated 
here can modulate the host’s immune response by sequestration of NF-kB in an as yet 
unknown way (Fig 6.7). In addition, the flagella of E69 appeared to also be involved in 
the down-regulation of the host response in an unknown manner (Fig 3.16); possibly the 
secretory system that produces flagella may also secrete an effecter protein(s) in a 
similar manner to the TTSS.
9.43 Contact dependent induction of cytopathy by bacteria
While investigating the innate epithelial response to Staphylococcus aureus, I have 
found evidence to suggest that if this pathogen is able to gain direct access to the 
intestinal mucosal barrier, (via a defensin deficiency, such as that described in CD by 
(Wehkamp et al. 2007) for example), then it has evolved a novel mechanism which 
could enable it to breach the intestinal mucosal barrier. S. aureus induces cytopathy 
characterised by cytoskeletal rearrangement and apoptosis of epithelial cells (Chapter 
4). This damage to the epithelial barrier would allow its dissemination. In addition, 
antigens, possibly including normal microbiota as well as super antigens, could access 
the underlying immune system. In turn, this could lead to activation of the systemic 
immune system, and in conjunction with T cell mediated pathology, the capacity of S. 
aureus to reside inter-cellularly and induce T cell anergy, could induce chronic 
inflammation.
9.4.4 The role of bacterial secreted products in reduction of the host response
A second mechanism of reduction of epithelial responses via secreted bacterial products 
seems to exist. For example, E69 secretes a protein lymphostatin which inhibits 
peripheral blood, human and murine, gastrointestinal lymphocyte proliferation and the 
mitogen-stimulated synthesis of IL-2, IL-4, IL-5 and INF-y production (Klapproth et al. 
1995, Klapproth et al. 2000). In chapter 3 evidence was found to suggest that 
lymphostatin may at early time points in infection down-regulate IL-8 induction (Fig 
3.25-26). Furthermore, LGG and E69 appeared to release bacterial products which
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significantly suppressed IL-8 protein expression (Fig 6.11). In support of this, Yan and 
Polk found that LGG prevented cytokine-induced apoptosis in epithelial cells via two 
mechanisms working in synergy, one requiring live bacteria suggesting a contact 
mediated response and the other response was via a soluble factor produced by LGG 
(Yan & Polk 2002a).
In summary, regarding this study, hBD2 mRNA expression mirrors the responses of IL- 
8 and CCL20 and is induced in a different manner to that of hBDl, hBD3 and LL-37.1 
would speculate that there are two distinctive innate mucosal responses; the first is due 
to external structures on bacteria (such as flagella) resulting in the production of IL-8, 
CCL20 and hBD2 forming a pro-inflammatory alert type response. The second response 
is due to “contact”, where attachment of bacteria to the epithelial cells results in a 
defence response, with induction of hBDl to 3 and LL-37.
I would therefore propose that any strain of bacteria, irrespective of any classification 
such as “good or bad” is capable of inducing an innate immune response. The innate 
immune response seen is individual for each strain. It would depend on that specific 
strain’s ability to make contact with the host epithelium and the particular virulence 
factors it has for modulating host responses. This has to be balanced against the external 
structures the bacteria exhibits and thus the generalised host inflammatory mucosal alert 
response it would induce.
9.5 The host also determines the outcome of host-bacterial interactions
In this thesis yet another layer of complexity within the intricate interplay between the 
microbe and host was found. It is evident that host factors also affect the outcome of 
these interactions.
As suggested in the literature, the interplay between the pathogen and host is affected by 
the host’s physiological state and genetic background, as well as those of the pathogen 
(Sasakawa & Hacker 2006). If the contributions of the bacterial genes involved in 
virulence are complex, the genetic factors of the host are even more numerous, more 
complex and also strongly determine the outcome of infectious diseases that are caused 
by various pathogens (Falkow 2004). A striking feature of all known infectious diseases
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is that no matter how devastating they may be there is always variation among humans 
regarding their susceptibility. Thus, human susceptibility or resistance to microbial 
attack can be seen as the final result of the genetic makeup of the individual host and the 
pathogen with environmental influences adding additional complexity (Clementi & Di 
2006, Fellay & Goldstein 2007).
Experiments performed in this thesis collectively highlight the importance of the 
location of the host-microbe contact in determining the outcome of this complex 
interaction. For example, on investigation of the ex -vivo innate immune responses of 
CD tissue, the terminal ileum and the transverse colon reacted differently to both pro- 
inflammatory and bacterial stimuli (Chapter 8).
Furthermore, it has been postulated that responsiveness of IECs varies along the crypt- 
villus axis, representing a mechanism whereby IECs protect themselves against 
dysregulated immune and inflammatory response to commensal bacteria and their 
products (Bocker et al. 2001, Bocker et al. 2003, Lee et al. 2005).
Using a model system of primary HIEC cells to represent the lower crypt and Caco-2 
cells in different differentiation states to represent from the crypt-villus junction up to 
the villus tip (Pageot et al. 2000), it was found that differentiation caused a reduction in 
epithelial responses to commensal species B. theta and HB101, and the pathogen E69 
(Fig 7.8-9). In addition, co-culture experiments with HIEC cells highlighted their 
“sensitive” nature and a capacity for enhanced induction of IL-8, like Caco-2 cells this 
induction was irrespective of pathogenicity (Fig 7.14-17). Furthermore, the down- 
regulation of hBDl and 3 mRNA by L299v, LGG and E69 (reported in chapters 5 and 
6) was abolished on Caco-2 cell differentiation, suggesting that bacteria can only 
actively down-regulate responses of cells if they get access into the crypt (Fig 7.12 and 
7.13).
9.6 Limitations to the study
The majority of the data presented in this thesis has been obtained while using 
continuous cell lines in vitro. While having their advantages, such as availability, ease 
of use, reproducibility and ability for modulation, these model cells have limitations
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such as their cancerous nature, and may not directly represent what is truly occurring in 
the human host. Therefore, results should be interpreted only as an indicator as to what 
is happening. Vizoso Pinto et al. make the valid point that it is hard to predict the 
outcome of the observed IL-8 stimulation on the further development of an immune 
response, when such interactions are tested in cell culture, in the absence of the immune 
cells of the lamina propria (Vizoso Pinto et al. 2007). It should be noted that there is 
some ex vivo data presented within this thesis that does correlate with some of the 
continuous cell line data giving an increased confidence that the data presented is more 
true to life. The ex vivo data itself has its limitations (as discussed in section 8.3) 
however, at present in the absence of an animal model that accurately reproduces all the 
features related to CD (Strober et al. 2002), it is the closest we can get to real life.
Another limitation, of this study that must be considered, is that only bacterial 
monocultures have been employed within the in vitro model system. This model is 
simplistic, relative to the in vivo situation as in the GI tract there are over 500 species 
residing at one time, although in the ex vivo model commensal bacteria would have 
been present. Furthermore, due to limitations of funding, timing and the tools made 
available; at the time of investigation, the antimicrobial gene expression has not been 
substantially confirmed on the protein level. However, initial investigations did appear 
to show a correlation.
9.7 Clues to the aetiology of Crohn’s disease
Despite the limitations of this study the data leads to a hypothesis that more mature cells 
are less responsive to bacteria, however, if the bacteria get access to the less mature 
cells they would be able to down-regulate the host barrier defence, if this is not already 
compromised as in CD, possibly enabling colonisation. In so doing they would induce 
an excessive inflammatory response, which could result in damage and disruption of the 
host barrier. This series of events could be responsible for the induction or perpetuation 
of CD and is supported by the findings of others in the literature (Sansonetti 2004, 
Chowdhury et al. 2007).
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9.7.1 Prevention of access of bacteria to the epithelia
In the ‘normal healthy’ host, bacteria are usually prevented from gaining access to the 
intestinal mucosa thus PRR signalling is at a low level. This occurs by rapid induction 
of IgA (Macpherson et al. 2000), as well as a mechanical barrier and pre-epithelial 
factors such as mucin (Swidsinski et al. 2005, Lotz et al. 2007, Shibolet & Podolsky 
2007). Mucins interact with bacterial cell-surface polysaccharides and protein 
appendages (such as flagella), thereby trapping bacteria in the mucus flow so that they 
are washed away by intestinal peristalsis (Wadolkowski et al. 1988). Indeed, Matsuo 
and co-workers used Camoy’s solution to guarantee the preservation of surface mucus 
o f human colon samples, and found bacteria were within the outer layer of the mucus 
(Matsuo et al. 1997). Antimicrobial activity might also prevent bacteria reaching closer 
to the mucosal surface and diminish their potential pro-inflammatory effects (Lotz et al. 
2007).
9.7.2 Unresponsiveness at villus epithelial surfaces
If bacteria do gain access to the mucosa in the ‘normal healthy’ host, cells of the surface 
epithelium in the colon or the villus of the small intestine (the likely point of contact) 
are unresponsive.
Unresponsiveness can be due to the regulation of receptor and co-receptor expression 
(Liew et al. 2005). The intestinal epithelium is highly polarised with two distinctive 
membrane compartments (Xavier & Podolsky 2000) and PRRs are localised to specific 
poles. Although TLR1, TLR2 and TLR6 are expressed on the apical epithelial surface 
(Abreu et al. 2005, Triantafilou et al. 2006); in small intestinal cells TLR4 has been 
reported to be localised at the Golgi apparatus requiring internalization of LPS via lipid 
rafts to activate signalling (Homef et al. 2002, Homef et al. 2003, Albiger et al. 2007). 
TLR3 and TLR7-9 localise within endosomal cell compartments and NODI and NOD2 
are intracellularly localised in the cell cytoplasm; thus requiring ligand internalization 
(Ishii et al. 2008). TLR5 seems to be preferentially expressed at the basolateral pole in 
vitro (Gewirtz et al. 2001a, Reed et al. 2002) and in vivo (Cario & Podolsky 2000). It 
has been further argued that this allows enterocytes to discriminate between commensal 
species remaining in the gut lumen and pathogenic species able to reach the basolateral 
membrane upon invasion (Gewirtz et al. 2001a, Gewirtz et al. 2001b, Zeng et al. 2003). 
However, in crypt epithelia no strict polar localisation of PRRs occurs.
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Another host variable is the levels of expression of PRRs. For example, it has been 
suggested that in the GI tract, healthy intestinal mucosa express low concentrations of 
TLR2 and TLR4 protein and are missing CD 14 and MD-2 and these cells are 
unresponsive to purified protein free LPS (Cario & Podolsky 2000, Abreu et al. 2001, 
Naik et al. 2001, Abreu et al. 2002, Melmed et al. 2003, Abreu et al. 2005, Furrie et al. 
2005). Furthermore, TLR3 is only produced in mature epithelial cells (Furrie et al. 
2005).
Unresponsiveness could be due to the selective usage of the adaptor molecules recruited 
to the TIR domains of the TLRs after ligand recognition and binding (Albiger et al. 
2007). Moreover, the intracellular signalling cascade is also negatively regulated at 
various levels either by post-transcriptional down-regulation (Liew et al. 2005), 
inhibitory adaptor molecules, protein phosphorylation, degradation, or sequestration 
(Doyle & O'Neill 2006, Miggin & O'Neill 2006).
Additionally, TLR signalling can be down-regulated by anti-inflammatory cytokines. 
For instance, TGF-p induces MyD88 degradation by the proteasome and suppresses the 
expression of TLR4 (Naiki et al. 2005). Furthermore, a recent report suggests that TLR9 
signalling is important for maintaining intestinal homeostasis. Lee et al. have shown 
that apical but not basolateral stimulation of TLR9 in IEC induces inhibition of NF-kB 
activation (Lee et al. 2006). TLR5 has also been shown to mediate intestinal 
inflammation. Sun et al. showed that inhibition of TLR5 is rapid and does not require 
protein synthesis, suggesting that an inhibitory molecule and/or mechanism is already in 
place when cells come in contact with flagellin (Sun et al. 2007).
Strikingly, these results indicate that the intestinal epithelium might indeed be able to 
sense the presence of microbial immuno-stimulatory molecules but rely on life-long 
negative regulatory mechanisms to prevent inappropriate immune activation and tissue 
inflammation (Lotz et al. 2007).
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9.7.3 Responsiveness in the crypts
In this thesis evidence was found to suggest that when bacteria get access to the less 
mature cells, such as may be found in crypts, they induce an excessive inflammatory 
response. In addition, these cells are more susceptible to bacterial infection. This would 
imply that should bacteria get access to the crypt they could induce cell death and thus 
disruption of the host barrier.
In the physiologic state, undifferentiated epithelial cells in crypts are usually isolated 
from the luminal environment because a large amount of mucus and fluids are released 
from crypts (Halm & Halm 2000), and the hydrostatic pressure generated in 
combination with the viscosities is sufficient to prevent bacteria and their products 
entering crypts (Lee et al. 2005). Due to the high local AMP concentrations, the crypt 
lumen may be sterile and largely free of immuno-stimulatory mediators; this enables a 
protective environment for the permanent regeneration of the epithelium by resident 
stem cells (Fig 9.1; (Lotz et al. 2007).
Crypt cells are responsive to the presence of overgrowing bacteria through sensing of 
released MAMPs. TLR4/MD-2 is mainly found in epithelial cells from the bottom of 
intestinal crypts (Furrie et al. 2005). CD 14 is also expressed in epithelial cells located in 
the bottom of the crypts of distal small intestine and colon (Ortega-Cava et al. 2003). 
Ortega-Cava et al. speculate that these findings may reflect a strategy of the mucosal 
innate immune system to simplify the task of sensing the gut bacterial content by 
restricting PRRs to the crypt bottom. In normal conditions, crypts may function as a 
micro anatomical niche where the exposure of cells with high expression of PRRs to 
commensal bacterial ligands from the lumen could be tightly controlled (Ortega-Cava et 
al. 2003).
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Figure 9.1: Structure of small intestinal crypt (Lotz et al. 2007)
If bacteria do manage to enter the crypt they induce pro-inflammatory pathways, and in 
turn an array of defence mechanisms account for ‘cleaning up’ the lumen of the crypts, 
including expression and release of AMPs and attraction of neutrophils (Sansonetti
2004). It has been suggested that because of immaturity of epithelial barrier function, 
relative deficiencies in the expression of antimicrobial factors, and developmental 
variations in the pattern of epithelial surface glycosylation all contribute to the 
susceptibility of immature gut to bacterial infection (Chu & Walker 1986, Udall, Jr. 
1990, Dai et al.2000). Furthermore, Claud et al. demonstrate that a human immature 
enterocyte cell line and primary IECs from immature rodents have higher expression of 
inflammatory cytokines in response to bacterial infection than their more mature 
counterparts (Claud et al. 2004).
A mechanistic explanation for these observations was suggested by the finding that the 
immature cells had appreciably lower expression of specific I k B  genes, key regulators 
of NF-icB-dependent inflammatory pathways. This suggests that developmentally 
regulated differences in Ik B  expression could contribute to the differential
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responsiveness of immature and mature enterocytes to inflammatory stimuli. LL-37 
manifests a distinct crypt-to-surface cell gradient in the human colon, with LL-37 
protein being predominantly expressed in surface epithelial cells and adjacent epithelial 
cells in the upper crypts of the normal human colon; with little or no expression within 
the deeper colon crypts or within epithelial cells of the small intestine (Dorschner et al. 
2001, Hase et al. 2002, Schauber et al. 2003). Furthermore, direct access to the cell may 
be a factor, for example due to the variation in expression of a microvilli brush border 
preventing access as was seen from day 7-14 (Fig 7.2). Moreover, a decrease in Muc3A 
and Muc3B expression was seen in HIEC cells (Fig 7.18).
9.7.4 Barrier deficiency allows access to crypt epithelia
In a certain category of patients, the fact that crypt cells are more responsive has raised 
an interesting paradigm that could account for the initiation or propagation of the 
inflammatory process that is observed in CD.
CD of the colon is associated with a low-gene copy number polymorphism of the 
human P-defensin locus resulting in an attenuated epithelial induction of p-defensin in 
the colonic mucosa (Wehkamp et al. 2002, Fellermann et al. 2006). CD of the SI is 
characterised by the presence of mucosal-adherent bacteria (Schultsz et al. 1999) and a 
specific reduction of Paneth cell a-defensins, which results in decreased antimicrobial 
mucosal barrier function and shift in the composition of the luminal microbiota 
(Wehkamp et al. 2004b, Wehkamp et al. 2005, Wehkamp et al. 2007). Additionally, in 
ileal CD there is a reduced expression of the Wnt-signalling pathway transcription 
factor Tcf-4, a known regulator of Paneth cell differentiation and a-defensin expression 
(Wehkamp et al. 2007).
Furthermore, IBD patients often show a thinner mucus layer and depletion of goblet 
cells in the colonic epithelium (McCormick et al. 1990). The increase in bacteria in the 
mucus layer of IBD patients contributes to further mucus degradation by the production 
of mucinase, sulfatase, and glycosidase. Interestingly, altered colonic glycoprotein 
expression in unaffected identical twins of IBD patients was found to be associated with 
pre-clinical NF-kB activation (Van Limbergen et al. 2007). Indeed, immuno- 
histochemistry performed on tissue sections derived from patients with active IBD
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demonstrates the presence of activated NF-kB in the crypt epithelial cells but not in the 
surface region (Rogler et al. 1998).
It is possible that lack of expression and release of defensins will allow bacteria access 
into the sterile crypts leading to uncontrolled bacterial growth and an excessive 
inflammation, and in turn death of crypt cells. This allows bacteria to breach the barrier 
and pass into the lamina propria and in so doing they initiate a systemic adaptive 
immune response, which in turn reduces barrier function.
In support of this theory Nenci et al. found that IEC specific inhibition of NF-kB 
spontaneously causes severe chronic intestinal inflammation in mice. NF-kB deficiency 
leads to an impaired expression of AMPs, TNFa-induced apoptosis of crypt IECs, and 
translocation of bacteria into the mucosa. Concurrently, this epithelial defect triggers a 
chronic inflammatory response, initially dominated by recruitment of neutrophils and 
dendritic cells but later also involving T lymphocytes. TLR activation by the intestinal 
bacteria is essential for disease pathogenesis and the presence of bacteria also drives the 
immune response at later stages (Nenci et al. 2007).
9.7.5 Alteration in differentiation allows access to immature epithelia
In CD epithelial differentiation alters, with increase in epithelial proliferation leading to 
expansion of undifferentiated epithelial cells and crypt hypertrophy. Concomitant 
reduction in differentiated epithelial cells in the mid-crypt region causes villus atrophy 
(Risio 1992, Huang et al. 1997). It has been suggested that the relative abundance of 
undifferentiated IECs in the inflamed mucosa may perpetuate the inflammatory process 
by enhancing cellular responses to IL-lp (Bocker et al. 2000, Bocker et al. 2003) and 
LPS (Bocker et al. 2003, Lee et al. 2005) and the data presented here would also suggest 
that bacteria are an additional stimulus.
Thus, if a microbe can make the voyage to the bottom of the crypt or can gain access to 
the immature epithelia, overcoming the host response, or in an immuno-suppressed 
individual, then it has the potential to be an initiator or perpetuator of CD. This could be 
why no specific microbe has been determined as the cause, and may be why episodes of 
relapse follow food poisoning.
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9.7.6 Evidence for bacterial colonisation of the crypts in Crohn’s disease
Interestingly, there is evidence in the literature for increased bacterial crypt invasion in 
CD. Lewis et al. found a large number of morphologically similar bacteria present in the 
crypt lumen of the colons of paediatric CD patients (Fig 9.2) (Lewis et al. 1987). In 
addition, Phillips and colleagues also found in immune-suppressed children with 
cryptosporidiosis that Cryptosporidium colonised the crypt epithelia. However, no 
colonisation was seen in immune-competent children with cryptosporidiosis, suggesting 
that immune deficiency can lead to bacteria gaining access to crypt epithelia (Fig 9.3, 
(Phillips et al. 1992). This phenomenon of cryptosporidial crypt colonisation has also 
been observed in other cases of immunodeficiency (Booth CC et al. 1980, Guarda et al. 
1983, Current et al. 1983, Kocoshis et al. 1984).
Moreover, LPS non-responder C3H/HeJ mice experience more rapid and extensive 
Citrobacter rodentium colonisation than do other mouse strains. Furthermore, the high 
bacterial load in these mice was associated with accelerated crypt hyperplasia, mucosal 
ulceration, and bleeding, together with very high mortality rates. Bacterial colonisation 
not only occurred more rapidly and involved a larger bacterial load but also spread more 
deeply into colonic crypts. Analysis of the intestinal pathology in the susceptible mouse 
strains revealed significant crypt epithelial cell apoptosis as well as bacterial 
translocation to the mesenteric lymph nodes. These studies identify the adaptive 
immune system, crypt cell apoptosis and bacterial translocation contribute to tissue 
pathology (Vallance et al. 2003).
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9.8 CD tissue responds abnormally to commensal bacteria and is 
hyporesponsive
Fascinatingly, both the terminal ileum and the transverse colon of CD patients reacted 
with a statistically significant increase in IL-8 on exposure to the commensal B. theta. 
This initial data supports the hypothesis of an inappropriate innate immune response to 
bacterial microbiota in CD (Fig 8.9-10).
In addition, it was found that in colonic CD tissue background levels of IL-8 were 
extremely high and the tissue was is in a “hypo-responsive state” to the pro- 
inflammatory cytokine IL-lp (Fig 8.1-2). High background levels of IL-8 could support 
a theory, suggested previously that IBD occurs when a genetic predisposition produces 
an inability to efficiently down-regulate the inflammatory response, following a trigger 
there is persistence of inflammation leading to tissue injuries (Fiocchi 1998). In 
conclusion commensal microbiota could have the capacity to prime an individual for the 
development of CD or evoke relapses in enteric inflammatory disease.
9.9 Future work
I have found evidence to suggest LGG, L299v and E69 actively suppress AMPs in a 
contact dependent manner. I have also found some evidence that these species can 
modulate the host’s immune response by interaction with and thus sequestration of NF- 
kB in an as yet unknown way. Therefore, it would be important to confirm AMP levels 
and determine which factors are able to suppress the response. In addition, E69 appears 
to down-regulate the host response via lyphostatin and by its flagella. It would be a 
significant and ground breaking contribution to determine the mechanism for this 
action. In addition, some external or secreted bacterial factors induced a mRNA 
response. It would be significant to characterise these further. Also, B. theta appears to 
induce expression of defensins, and may have evolved this capacity to kill off other 
bacteria with which it is likely to compete to for nutrients and space. It would be of 
interest to further investigate if LGG, L299v and E69 are susceptible to defensins and 
that could be why they have evolved to suppress them and if B. theta is conversely not 
susceptible. Future work could entail investigation with combinations of bacterial 
stimuli. Furthermore, co-culture has been conducted in the ideal environment for host 
cell survival whereas the gut is relatively anaerobic. It would be of interest to conduct
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experiments with cell lines and tissue in anaerobic conditions to more closely mimic the 
gut situation, such as in an Ussing chamber.
It would be of significant interest to investigate further the hypothesis of increased 
access to immature cells being an initiator of CD. I have provided evidence of both 
potentially beneficial and harmful host responses to probiotics of CD tissue ex vivo; 
which may explain why probiotics are not efficacious in CD. I would suggest that 
clinicians should be cautious before administering probiotics to individuals that have a 
defective barrier, especially as it is demonstrated that if bacteria gain access to the 
mucosa they have the potential to suppress expression of AMPs. More studies need to 
be completed with individual and strain combinations to determine safety and efficacy. I 
have modified the in vitro organ culture model described by Phillips & Frankel 2000 to 
develop an ex vivo model system to investigate innate host responses to bacteria, which 
could be used to investigate probiotic efficacy further.
Future treatments could target barrier function such as the colonic mucus layer (Tai et 
al. 2007). For example, L. plantarum increases mucin production in epithelial cells 
(Mack et al. 2003).
As AMP expression is cell specific, the modulation of AMP expression may be 
approached in a targeted and tissue-specific manner without enhancing local 
inflammation (Schauber et al. 2006). In addition to their different mechanisms of action, 
as compared with those of traditional antibacterial and antiviral drugs make P-defensins 
attractive therapeutic targets (Chang & Klotman 2004, Leikina et al. 2005, Adermann et 
al. 2004, Steinstraesser et al. 2004, Wehkamp et al. 2005, Wang et al. 2007). AMPs 
could also be used for other barrier disorders such as cystic fibrosis.
Cathelicidin, as an antibacterial compound, is a promising prophylactic therapy for IBD 
as Tai et al. showed that intra-rectal administration of a synthetic peptide of cathelicidin 
could mitigate against DSS-induced colitis in a murine model (Tai et al. 2007). 
Interestingly, oral butyrate treatment of Shigella-infected dysenteric rabbits led to 
improvement of the clinical symptoms which was accompanied by upregulation of 
colonic LL-37 expression (Raqib et al. 2006). Schauber et al. has further proved the 
importance of LL-37 in UC in humans (Schauber et al. 2006). Native LL-37, however,
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is toxic to human cells when administered at doses slightly higher than physiological 
concentrations (Johansson et al. 1998). However, a recent study identified a 21-amino- 
acid fragment as the active domain of LL-37 (Sigurdardottir et al. 2006). The fragment 
proved to be less toxic than full-length LL-37 but retained its antimicrobial activity and 
LPS-neutralizing capabilities in vitro (Sigurdardottir et al. 2006). In addition, a diet 
could be prescribed that promotes good barrier function and a balance of certain 
microbes.
9.10 Conclusion
It is evident that there are many layers of complexity to the interaction between bacteria 
and the mucosal epithelial cell layer. From the host point of view where this interaction 
occurs is integral. Variations in response may occur in different anatomical locations. 
This could be due to differences in PRR expression, i.e. TLR4 which is up-regulated in 
the lung but down-regulated in the gut. The cellular location of this interaction may be 
salient, i.e. a cytoplasmic PRR would be required to detect invasive bacteria but would 
not be effective to detect extracellular bacteria. Pertinent to this study the location of 
interaction along the crypt-villus axis, will alter the maturity of the host cells and thus 
their responsiveness.
It also apparent that there is a level of complexity due to combinational diversity of 
TLRs and other PRRs and recruitment of signalling adaptors; so the host recognises the 
bacterium by combinations of microbial products and may also require co-stimulatory 
signals to confirm “danger” before responding.
On the side of the bacterium the response is dependent on the expression of external 
structures which can be detected by the host and the ability to make contact with the 
epithelium. This is off set against the bacterium’s intrinsic ability (if any) to be able to 
down-regulate the host response. Fischer et al. suggest that commensal bacteria may not 
have the virulence factors present to act as co-stimulatory signals (Fischer et al. 2006). 
We have demonstrated here that both pathogenic bacteria and non-pathogenic bacteria 
do express external structures associated with virulence.
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It may well be the case that non-pathogenic bacteria are not inherently “good bacteria” 
but simply that they do not normally make contact with the epithelium and yet when 
they do so they do not possess the ability to down-regulate the host immune response 
and thus initiate an immune response that brings about their elimination. Pathogenic 
bacteria however, due to their ability to reduce the immune response, persist, leading to 
pathology and chronic infection. I would hypothesise that in the case of CD because of 
reduction and/or damage to the epithelial barrier; bacteria gain access to the crypt 
epithelium and induce an inflammatory response. This can become chronic if the 
bacteria are able to modulate the host response or breach the barrier, in combination 
with a genetic susceptibility so that the host is not able to bring the infection to a 
resolution.
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Plastics:
Appleton woods (Birmingham, UK)
0.2ml flat cap PCR tubes, TA511
1.5ml Sterile Micro-centrifuge tube - Ultra Clear, RNAse free, KC134;
1.5ml Micro-centrifuge Tubes -  General Purpose, KC024;
2.0m Micro-centrifuge Tubes -  General Purpose, KC025;
Polypropylene 96 Well PCR Plates, Coming, TA821;
Coming 96 well flat bottomed ELISA plates, CC652;
Costar Transwell filter inserts (24 mm diameter, 4.7 cm2, 0.4 pm pore size), CC411 
Costar Transwell filter inserts (6.5mm diameter, 0.33 cm , 0.4 pm pore size), CC418
Pathology Sundries (NHS supplies)
Universal Container, 30ml, PSS021;
Specimen Pot, 60ml, PSS020;
Triple Red (Buckinghamshire, UK)
75cm tissue culture flasks with filter screw, 2020200;
Tissue culture petri dish 100mm, 2050300;
6 well tissue culture plates, 2030500;
12 well Tissue culture plates, 2030400;
24 well Tissue culture plates, 2030300;
96 well flat bottom Tissue culture plates, 2030100;
5ml serological pipettes, PN5E1;
10ml serological pipettes, PN10E1;
15ml sterile falcon tubes, 2040300;
Sarstedt (Leicestershire, UK)
Sterile 0.2pM filters, D51588;
Sterile cuvettes, 67742;
Miscellaneous
13 mm glass cover slips 406/0189/12 (Merck, VWR, Leicestershire, UK),
Cryovials, 374081, (Nalgene-nunc, Roskilde, Denmark);
Microbank® PL. 160/M (ProLab Diagnostics, Cheshire, UK);
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Microcon 30kD centrifugal filter, YM-30, (Millipore, Watford, UK);
Parafilm M stretch sealing film, 295-109 (Jencons, Bedfordshire, UK);
Sterile syringes, 5ml, 10ml & 20ml, (Kendal monoject, Gosport, Hampshire, UK);
Consumables:
Active Motif Trans AM™ (Rixensart, Belgium)
Caco-2 nuclear extract, 36035;
Nuclear extract kit, 40010;
Recombinant NF-kB p50 Protein, 31102;
Recombinant NF-kB p65 Protein, 31101;
TransAM™ NF-kB Family ELISA, 43296;
Agar Scientific (Stanstead, UK)
Aluminium stubs 15mm x 10mm, G307;
Ammonium molybdate, R1156;
Citifluor 25ml AF1, R1320;
Formvar/carbon coated copper/rhodium 100 mesh TEM grids, G2100PD; 
Glutaraldehyde 25%, R1312;
Osmium tetroxide 4% solution, R1024;
Quick drying Silver paint, G302;
Silver paint diluent, R1272;
Ambion (Cambridgeshire, UK)
RNA storage solution, 7001;
TURBO DNAse-free kit, 1907;
TURBO DNAse-free, 2238;
BDH (VWR, Leicestershire, UK)
Ethanol, 2.5 litres, 28304
Industrial methylated spirits, 2.5 litres, 30244 4E
Methanol, 2.5 litres 1015868;
NaOH pellets, 301674m;
Page 484
Bioline (London, UK)
Agarose, BIO-41025;
BioMix Red, 1.5mM, BIO-25006;
BioScript cDNA synthesis kit, BIO-65031; 
dNTP mix, lOpmol, BIO-39044;
Oligo (dt)i8,27ug, BIO-3 8029;
Immundiagnostik AG (Bensheim, Germany)
p-Defensin 2 ELISA Kit, K 6500
Invitrogen (Paisley, UK)
Dulbecco’s modified Eagle’s medium with Glutimax™ I & 25 pM hepes, 61965-026; 
Insuline-Transferin-Selenium A lOOx, 51300-044;
Superscript II Reverse Transcriptase Kit, 11904-018;
TRIzol® Reagent, 200ml, 15596-018;
Oxoid (Basingstoke, UK)
Anaerogen micro-aerobic sachets, AN0625A;
Defibrinated horse blood, 25ml, SR0050B;
Qiagen (Crawley, UK)
QuantiTect® SYBR® Green PCR kit, 204145;
R&D Systems (Abingdon, UK)
Quantikine® Human CXCL8/IL-8 ELISA, D8000C;
Quantikine® Human CCL20/MIP-3a ELISA, DM3A00;
Sigma-Aldrich (Poole, UK)
0.25% Trypsin/EDTA, 500ml, T4049;
2,2-dimethoxypropane, 25g, 33053;
Acetic acid lOmM, 32009-9;
Agar, 05039, (Fluka);
Ampicillin lOOmg/ml, A5354;
Bovine serum albumin (BSA), A4919;
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Brain Heart infusion broth, 53286, (Fluka); 
Bromphenolblue-Xylene cyanol dye solution, B3269; 
Chloramphenicol 200mg/ml, C6455;
Chloroform PCR grade, C7559;
D-(+)-Mannose powder, M6020;
Dimethylsulfoxide, D8418;
DL-Histidine monohydrochloride monohydrate, H7875; 
Dulbecco’s modified Eagle’s medium (DMEM) D5671; 
FITC-conjugated goat anti-rabbit antibody, F9887;
Foetal calf serum, heat inactivated 500ml F9665;
Gentamycin solution 10 mg/ml, G1272;
Goat serum, G9023;
Glycerol, 500ml, G8773;
Haematin Porcine, H3281;
Human Recombinant Epidermal growth factor (EGF) E9644; 
Human Recombinant IL-1 p, 19401;
Isopropanol for molecular biology >99%, 19516; 
kanamycin 50mg, K0879;
Ladder 1Kb, D0428 
L-glutamine 2Mm, G3126;
Menadione crystalline (Vitamin K3) M5625;
NCTC-135 medium, N3262;
Newborn calf serum, N4637;
Non-essential Amino Acid Solution (100x) M7145; 
Penicillin-Streptomycin lOOx, P4333;
Phalloidin, Fluorescein Isothiocyanate (FITC) Labelled, P5282; 
Phosphate Buffered Saline tablets, P4417;
Rat tail collagen, C7661;
RNAze Zap, 83930;
SDS, 25g, L3771;
Sodium bicarbonate, S5761;
Sucrose, S2395;
Tetracycline lOmg/ml, T7660;
Thioglycollate medium, T9032;
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Tris Borate EDTA (TBE) lOx T4415-4L;
Triton X-100,100ml, T9284;
Trypan blue solution, T8154;
Tryptic soy broth, T8907;
Miscellaneous
Protein Assay Dye Reagent Concentrate, 500-0006 (BioRad, Hertfordshire, UK); 
Rabbit <x-NF-kB p65 polyclonal antibody, sc-372 (Santa Cruz, Heidelberg, Germany); 
Vectashield mounting medium with DAPI, H-1200 (Vector, Peterborough, UK); 
Ethidium bromide 1239-45-B (AMERCO, NBS Biologicals, Cambridgeshire, UK); 
Caco-2 cell line, HTB-37 (American Type Culture Collection);
HEp-2 cell line, CCL-23 (American type culture collection);
4% formalin/PBS, BAF-200-70A (CelPath, Enfield, UK).
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Brain heart infusion broth (BHD
Composition g/L:
Brain heart infusion 250 
Sodium chloride 5
Calf brain infusion 200 
Disodium phosphate 2.5 
Proteose peptone 10 
Bactodextrose 2
Lennox L-broth (LB)
Composition g/L:
Tiyptone (pancreatic digest of casein) 10 
Yeast extract 5
NaCl 5
Glucose 1
Tryptic sov broth (TSB)
Composition g/L:
Casein (pancreatic digest) 17
Soya peptone (papaic digest) 3
Sodium chloride 5
Dipotassium phosphate 2.5
Dextrose 2.5
For making plates or slopes, 1.5% agar was used
Thioglvcollate medium
Thioglycollate medium, 29.8g/L
Vitamin K solution (1 mg/ml) 1 ml/L
Hitidine-haematin 1 m/L
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Vitamin K solution
Dissolve 40 mg Menadione crystalline in 40 ml absolute ethanol
Hitidine-haematin
Mix 4.2 g DL-Histidine monohydrochloride monohydrate with 80ml ddthO 
Adjust pH from 4 to 8 with ION NaOH (Histadine will go into solution as the pH rises) 
Bring final volume to 100 ml with ddH20 
Mix 12g Haematin Porcine with 10 ml of 0.2 M histidine Ph8 
Dissolve by end-over-end rotation for several hours 
Filter-sterilize with 0.2 pm filter
HIEC cell complete culture medium
Dulbecco’s modified Eagle’s medium (DMEM)
Heat inactivated foetal calf serum 
Penicillin/streptomycin 
lOOx Insuline-Transferin-Selenium A 
200 pg/ml Epidermal growth factor (EGF) (25ng/ml)
Dulbecco’s modified Eagle’s medium (DMEM)
4500 pg/L D-Glucose, Glutimax™ I, 25 pM hepes, without pyruvate
lOOx Penicillin-Streptomvcin
Solubilised in a proprietary citrate buffer. Formulated to contain 10,000 units/ml 
penicillin and 10 mg/ml streptomycin.
lOOx Insuline-transferin-selenium A.
Formulation (Prepared in Earle's Balanced Salt Solution w/o Phenol Red):
Component g/L:
Sodium Selenite (anhydrous) 0.00067 
Sodium Pyruvate 11
Insulin 1
Transferrin 0.55
500 ml 
50 ml 
5 ml 
5 ml 
62.5 pi
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25ng/ml Epidermal growth factor (EGFI 
Human Recombinant Epidermal growth factor 2 mg,
Reconstituted with 10 ml 0.2pm-filtered lOmM acetic acid containing 0.1% Bovine 
serum albumin to give a stock 200 pg/ml
IVOC medium
DMEM 200ml
Double processed tissue culture H2O 200ml 
Sodium bicarbonate 0.44g
NCTC -  135 medium 1.34g
10% newborn calf serum
The solution was filtered and as required 0.5% D-mannose was added. It was stored at 
4°C until use and pre-warmed to 37°C before use.
Dulbecco’s modified Eagle’s medium (DMEM)
4500 pg/L D-Glucose, 25 pM hepes, without pyruvate and L-glutamine
NCTC-135 medium
With L-glutamine, without sodium bicarbonate 
D-mannose Stock
25g of Mannose is dissolved in 125ml ddH20 
Stored at 2-8°C
Mannose working stock
500pl of 0.2g/ml stock is diluted in 19.5ml to give a 0.5g/100ml solution 
Collagen Stock
1 mg/ml of Rat tail collagen is dissolved in 0.1 M HAc stir for 2 hours Stored at 2-8°C 
Collagen working solution
1 mg/ml Rat tail collagen stock solution was diluted to 50 pg/ml in 60% ETOH
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1% Aqueous ammonium molvbdate
25g Reconstituted with 2.5L ddH20  
Filter-sterilize with 0.2 pm filter 
stored at 2-8°C
Loading buffer
Composition 10ml:
10% SDS 2ml
Glycerol 2.5ml
Bromphenolblue-Xylene cyanole dye solution 1ml 
ddH20  4.5ml
10% SDS Stock
25g of SDS is dissolved in 250ml ddH20
Bromphenolblue-Xvlene-Cvanole dve concentrate 
Composition:
0.5% Bromphenolblue 
0.5% Xylene cyanole 
Reconstitute to 5ml using ddH20
1Kb Ladder
500pg/ml stock, 30pl is dissolved in 270pl of TBE
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Abstract--007~DD--UK
IL8 response to bacterial exposure in vitro
L Edwards1, S Murch2, AD Phillips1
Background: The acute inflammatory response to bacterial infection is an important 
part of host defences. This is mediated by NF-kB activation inducing an IL-8 response 
that stimulates neutrophil infiltration. This pathway is also implicated in inflammatory 
bowel disease and may represent an inappropriate reaction to the normal flora.
Objective: To set up an in vitro model of bacterial stimulation of IL-8 production and to 
determine virulence factors that influence this host response.
Methodology: HEp-2 cells and non-polarised (NPCC) and polarised (PCC) Caco-2 cell 
lines were exposed to IL-lbeta and a prototypic enteropathogenic E coli strain E2348/69 
over a 6 hour period. Cell IL-8 transcriptional activity was measured by RT-PCR; 
ELISA was used to measure IL-8 protein in culture supernatants. HEp-2 cells were then 
exposed to a range of bacteria (K12 E coli, Lactobacilli, and mutant strains of E69 
[signalling negative, non-motile, non-adherent]) to assess which virulence factors were 
associated with an 11-8 response.
Results: IL-lp produced increased IL-8 mRNA and IL-8 protein in all cell lines. Levels 
decreased from HEp-2 to NPCC to PCC. E69 induced a rise in IL-8 RNA and protein 
by 4-6 hours in HEp-2 and NPCC but not in PCC. Deletions in E9 of flagella, bundle 
forming pili, and type three secretion system structural genes escN & espA reduced the 
HEp-2 cell IL-8 response. In comparison lifA and espF deletions enhanced IL-8 levels.
Conclusion: A model of IL-8 response to bacterial exposure has been established. 
EPEC flagella and adhesins induce IL-8, but EPEC appear to have the ability to reduce 
the IL-8 response.
Acknowledgements: the work was supported by the Crohn’s in Childhood Research 
Appeal
Keywords: IL-8; EPEC; Inflammation
1 Centre for Paediatric Gastroenterology, Royal Free Hospital, London UK
2 Univeristy of Warwick, Coventry, UK.
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Enterocolitis caused by SEG/SEI producing Staphylococci -a  duel pathology of 
epithelial cytopathy and superantigen-mediated T cell stimulation.
EDWARDS Lindsey A m . FURMAN Mark (1), HICKS Susan (1), O'NEILL Colette 
(2), WELLINGTON Elizabeth (2), TORRENTE Franco (1), PHILLIPS Alan D (1), 
MURCH Simon H (2 & 3).
(1) Royal Free Hospital, London. (2) University of Warwick, Coventry. (3) Warwick 
Medical School, Coventry
Aim: Staphylococcal enterocolitis is a severe inflammatory disorder, causing significant 
morbidity and mortality in both infants and in the elderly. While methicillin resistant 
staphylococcus aureus (MRSA) is usually found in post-operative adult cases, 
spontaneous disease in infants is often caused by methicilllin sensitive Staphylococci 
(MSSA). We have previously reported 3 cases of severe persistent infant diarrhoea due 
to MSSA, and now attempt to determine mechanisms of pathogenesis.
Methods: The organisms were extensively characterised for enterotoxins and 
exfoliative toxins using molecular phenotyping. They were incubated in in vitro organ 
culture (IVOC) with normal duodenum, ileum and colon, and compared to E. coli 69 
(EPEC). The organisms or supernatants were co-cultured with Caco-2 and Hep-2 cells, 
as were non-pathogenic and SEB-producing Staphylococci. Cellular response was 
assessed by microscopy, and by study of IL-8 mRNA and protein responses. Expression 
of defensin molecules (HBD-1, HBD-2 and LL-37) by the cell lines was determined.
Results: All 3 MSSA organisms expressed SEG and I toxins, but were negative for all 
other toxins, including PVL. All induced striking pathology in IVOC, with gross 
epithelial extrusion, maximal in duodenum and ileum, and T cell proliferation in lamina 
propria. The epithelial pathology was not inhibited by tacrolimus. The organisms (but 
not supernatants) induced cytotoxicity in 30-40% Hep-2 but 0% Caco-2 cells, while IL- 
8 production was not increased above controls. The cell lines could be differentiated 
only by HBD-2 production, found in Caco-2 but not Hep-2 cells.
Summary: We have found evidence for a novel epithelial cytopathic effect of SEG/I 
producing MSSA. Impaired HBD-2 responses confer epithelial susceptibility to 
staphylococcal cytopathy, which is T cell independent.
Conclusion: Epithelial cytopathy contributes to staphyloccal enteropathy. Low P- 
defensin responses may explain infant and elderly susceptibility.
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